data_1dvv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dvv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.1 Cg_exo . . . . . 0 C--O 1.214 -0.718 0 N-CA-C 110.313 -0.687 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' HA ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 tt0 -52.0 -46.91 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 51.1 t -48.11 -40.39 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.384 -0.822 . . . . 0.0 108.962 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 65.4 mt -64.95 -40.01 94.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 109.734 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' CB ' ' CH2' ' A' ' 77' ' ' TRP . . . -58.23 -27.86 64.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.601 -0.687 . . . . 0.0 110.398 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -90.14 -36.57 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 110.777 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -70.57 -25.95 63.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.204 -0.935 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 22.7 mmtm -97.9 -26.35 14.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 110.202 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.43 18.47 14.52 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 14.1 m -65.0 -32.26 73.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.459 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 69.3 mmm -79.15 2.81 19.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.03 11.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 90.2 m -96.93 -15.6 21.08 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 110.961 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.4 m-70 -104.42 172.39 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.96 -1.087 . . . . 0.0 112.047 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.536 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -152.77 124.4 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.4 mp -37.79 -27.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 111.266 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.0 p-10 -155.24 -32.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.996 -1.065 . . . . 0.0 111.404 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 17.9 p -69.65 151.7 45.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.965 -1.085 . . . . 0.0 109.847 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -93.38 117.76 30.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.671 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.3 mtm -123.02 -117.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.478 -0.764 . . . . 0.0 109.514 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 51.0 t -76.45 -34.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.833 -1.167 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.64 171.72 15.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.632 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.2 137.57 48.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.525 1.276 . . . . 0.0 110.072 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.28 156.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.787 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 5.7 m-85 -69.06 -60.55 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.06 -42.27 65.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.038 -1.039 . . . . 0.0 109.011 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 59.2 m-20 -58.47 -40.86 83.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.865 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.557 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 16.4 t -56.27 -38.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 109.318 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 35' ' ' ALA . . . -74.0 -24.21 59.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.496 -0.753 . . . . 0.0 109.915 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.83 62.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -88.77 -35.44 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 33' ' ' LYS . 3.9 m-30 -94.06 -1.75 53.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 109.84 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -54.05 130.23 37.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.177 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.15 -19.04 15.49 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -66.58 145.78 55.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -1.089 . . . . 0.0 110.027 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.33 2.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.266 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 56.49 0.21 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' O ' HD13 ' A' ' 44' ' ' LEU . . . -75.3 -13.16 60.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -1.161 . . . . 0.0 110.287 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.447 ' CA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -75.18 -30.05 60.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.61 -52.95 17.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.55 -34.64 78.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.911 . . . . 0.0 108.806 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.548 ' CB ' ' HB3' ' A' ' 75' ' ' ALA . 11.5 mt -59.18 -36.6 75.62 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.94 -37.75 86.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 109.667 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -29.54 65.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.974 . . . . 0.0 110.08 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 29.2 mmt180 -88.42 -12.42 43.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.264 -0.898 . . . . 0.0 109.384 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.559 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 38.7 mt -90.28 -25.16 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.452 -0.78 . . . . 0.0 109.446 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -85.53 -14.33 46.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.7 t30 -126.98 -11.71 5.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.55 174.64 0.02 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 163.87 167.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.169 -1.195 . . . . 0.0 111.414 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 3.0 pm0 -101.9 -161.14 0.83 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.435 -0.791 . . . . 0.0 109.925 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 56.4 19.39 25.61 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 56' ' ' TRP . 60.5 t -104.54 -62.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.701 -0.882 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.632 ' CD2' ' CG ' ' A' ' 25' ' ' PRO . 88.2 m95 -120.0 -35.53 3.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.09 -175.93 31.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.517 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.94 6.83 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.379 1.386 . . . . 0.0 111.764 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.1 mt -106.05 85.37 1.59 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.84 -1.162 . . . . 0.0 109.829 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.547 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.7 Cg_endo -54.07 133.86 57.23 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.7 1.369 . . . . 0.0 110.834 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.559 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.2 tmm? -70.52 131.92 87.83 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.145 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.1 Cg_exo -64.38 130.24 26.26 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.73 1.384 . . . . 0.0 109.504 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.7 Cg_endo -59.38 138.24 83.12 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.478 1.251 . . . . 0.0 110.346 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-80 -110.39 160.63 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.26 35.72 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' SER . 19.8 m -79.86 119.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.393 -0.817 . . . . 0.0 110.028 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -46.39 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.569 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.93 -39.2 79.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.939 -1.1 . . . . 0.0 109.94 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.55 -34.77 74.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.871 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.4 mm-40 -71.71 -38.52 70.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 110.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -72.51 -22.82 60.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.221 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -71.73 -41.68 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.466 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.53 -25.84 61.53 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.496 ' CD1' ' HA ' ' A' ' 71' ' ' ALA . 41.6 mt -72.02 -30.99 65.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HB3' ' CB ' ' A' ' 44' ' ' LEU . . . -73.29 -53.62 10.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.517 -0.739 . . . . 0.0 109.545 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 16.8 ptmt -64.87 -20.79 66.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.227 -0.921 . . . . 0.0 109.076 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.61 ' CH2' ' CB ' ' A' ' 7' ' ' ALA . 43.7 t90 -70.7 -43.55 68.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.304 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.584 HG12 ' CD1' ' A' ' 27' ' ' TYR . 13.1 mt -62.81 -48.78 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.918 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -69.19 -9.75 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.475 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 110.693 -179.719 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.582 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 110.519 -0.608 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -38.15 68.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 4.1 t -62.99 -52.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.884 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 1.4 pp -61.77 -33.85 74.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.208 -0.932 . . . . 0.0 109.661 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' N ' HD11 ' A' ' 6' ' ' LEU . . . -68.44 -21.92 64.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -49.91 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 12.6 m-80 -65.31 -23.57 67.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.134 -0.978 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 22.3 mmtm -84.52 -12.41 54.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 109.798 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.3 69.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 59.4 m -65.15 -31.7 73.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.252 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.444 ' HE2' HD11 ' A' ' 18' ' ' ILE . 9.2 mtp -88.41 7.62 31.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 110.301 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 -44.82 18.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 70.8 m -102.67 -17.61 15.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 110.887 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.612 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 11.1 m-70 -93.73 168.26 11.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.947 -1.096 . . . . 0.0 112.353 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -148.05 118.72 7.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.6 mp -38.66 -27.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.399 -0.813 . . . . 0.0 110.913 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.5 p-10 -148.65 -35.9 0.19 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.041 -1.037 . . . . 0.0 110.542 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.506 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.05 -179.29 1.47 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -129.83 89.07 2.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 110.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.82 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.006 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 70.7 t -97.75 -25.65 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.977 -1.077 . . . . 0.0 109.396 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.94 173.76 15.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.619 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -68.61 133.35 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.574 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' HB3' ' C ' ' A' ' 19' ' ' ASP . . . -46.11 151.24 0.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.638 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -61.6 -64.39 0.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.115 -0.991 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -48.1 -46.02 33.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -51.9 -47.1 64.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.486 -0.759 . . . . 0.0 110.147 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.541 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 89.7 t -57.99 -34.25 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 35' ' ' ALA . . . -75.78 -26.35 57.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.18 60.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -85.44 -37.35 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' GLY . 11.5 m-85 -97.8 -3.41 38.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -0.944 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -51.27 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 130.93 69.14 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.4 mt-30 -144.7 149.79 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.26 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.02 39.46 0.96 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.47 50.08 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . . . -84.83 -42.46 15.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -1.175 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 10.0 mp0 -59.73 -38.09 80.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 109.926 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.89 84.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.59 ' CZ ' ' HD2' ' A' ' 47' ' ' ARG . 28.6 t80 -70.68 -20.01 62.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.225 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.5 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.7 mt -72.86 -34.86 67.03 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.8 -31.97 59.66 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -28.13 51.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.863 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.59 ' HD2' ' CZ ' ' A' ' 43' ' ' TYR . 6.9 mmp_? -86.65 -16.81 35.47 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.377 -0.827 . . . . 0.0 109.547 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.558 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 58.8 mt -88.22 -28.97 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.459 -0.775 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -80.26 -20.77 43.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.2 m120 -120.86 -17.91 7.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.109 -0.994 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.74 169.48 0.02 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.6 OUTLIER 164.02 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.086 -1.243 . . . . 0.0 111.375 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.578 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -96.94 -160.97 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.313 -0.867 . . . . 0.0 110.44 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.46 19.04 59.59 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.484 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 9.4 t -98.28 -69.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.675 -0.897 . . . . 0.0 109.48 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.619 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 92.3 m95 -118.53 -38.25 3.17 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 108.953 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.51 -167.73 15.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.58 14.72 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.558 1.505 . . . . 0.0 112.07 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 mt -110.13 96.56 26.26 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.545 -1.347 . . . . 0.0 111.005 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.539 ' CB ' ' HB3' ' A' ' 53' ' ' GLN . 2.5 Cg_endo -65.01 128.64 21.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.615 1.324 . . . . 0.0 110.589 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.558 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tmm? -69.2 128.93 92.34 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.876 -1.14 . . . . 0.0 108.796 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.22 129.97 25.76 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.643 1.338 . . . . 0.0 109.5 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_exo -57.27 148.95 67.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.243 1.128 . . . . 0.0 109.972 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -120.73 163.45 18.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 111.047 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.5 36.37 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 66' ' ' VAL . 16.7 m -84.4 108.62 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' VAL . 17.5 p -42.22 152.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.559 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -45.92 -48.76 16.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.797 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.84 -34.79 75.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.976 . . . . 0.0 110.46 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.452 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.97 -40.93 75.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.16 -21.47 61.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.02 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -70.27 -44.05 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.521 ' CG2' ' HB3' ' A' ' 3' ' ' PRO . 18.9 m -70.84 -23.99 62.44 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 78' ' ' ILE . 31.7 mt -71.7 -37.45 70.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 44' ' ' LEU . . . -65.83 -51.47 58.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.452 -0.78 . . . . 0.0 109.159 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 80' ' ' SER . 13.2 mtmt -66.7 -22.2 66.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.239 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.582 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 62.0 t90 -78.01 -24.04 48.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 109.92 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.557 HG12 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -84.29 -61.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.482 HD11 HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -49.74 -42.17 45.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 9.2 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.553 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.8 Cg_endo . . . . . 0 N--CA 1.484 0.924 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt-20 -65.09 -27.56 68.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 0.0 109.134 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 32.8 t -71.82 -59.25 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.535 -0.728 . . . . 0.0 109.404 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -62.67 -19.2 63.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.85 -53.85 23.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -29.78 69.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 110.463 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -67.17 -37.21 83.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.664 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 10.3 mmtp -82.31 -13.37 57.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.18 12.45 49.0 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 22.5 m -65.26 -38.62 90.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -1.23 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.85 7.26 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.469 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.88 -34.22 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.3 m -110.55 -14.86 14.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 110.745 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.631 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.7 m-70 -102.98 154.38 19.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.895 -1.128 . . . . 0.0 111.846 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 26' ' ' ALA . . . -132.47 121.32 23.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 28' ' ' LYS . 11.2 mt -40.34 -26.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.957 . . . . 0.0 110.724 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 4.6 t70 -152.21 -35.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.81 163.68 25.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 110.518 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -103.44 89.31 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 110.559 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 mtm -85.49 -95.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.683 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.13 -39.35 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.68 -179.41 18.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.614 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.49 129.86 22.3 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.627 1.33 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 17' ' ' ALA . . . -42.91 143.39 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.811 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.631 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 5.8 m-85 -53.92 -48.97 69.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HD2' ' CG2' ' A' ' 18' ' ' ILE . 2.1 mtpp -57.43 -50.67 72.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.8 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.26 -27.13 63.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 110.242 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.58 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 92.0 t -67.06 -43.09 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.047 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 79' ' ' LEU . . . -74.47 -23.86 58.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 110.395 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.62 59.04 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.215 -0.928 . . . . 0.0 110.378 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -90.88 -41.7 11.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE2' ' CZ2' ' A' ' 56' ' ' TRP . 7.7 m-85 -78.35 -7.81 57.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.077 -1.015 . . . . 0.0 110.041 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 31' ' ' ALA . . . -54.86 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 155.44 -45.14 0.54 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 5.4 mm-40 -42.24 157.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 57.58 3.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.663 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.05 57.96 0.39 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -70.7 -44.42 66.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -1.1 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 21.0 pt-20 -50.44 -37.79 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -60.8 -57.79 11.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 85.2 t80 -67.18 -13.86 62.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.557 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 18.8 mt -78.42 -29.39 47.11 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.46 64.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 2.3 mmt180 -81.42 -16.67 51.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.21 -0.932 . . . . 0.0 109.521 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.557 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 9.7 mt -81.08 -34.43 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.34 -12.41 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 110.685 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.32 -8.84 8.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 110.654 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 62.01 160.55 0.16 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 11.5 t -179.2 154.82 0.68 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.639 -1.507 . . . . 0.0 112.54 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.11 -176.31 3.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.679 -0.638 . . . . 0.0 109.703 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 66.05 10.77 52.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.41 -62.25 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.482 -1.011 . . . . 0.0 109.35 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.614 ' CD2' ' CG ' ' A' ' 25' ' ' PRO . 73.9 m95 -115.65 -33.72 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.497 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.36 -167.31 25.76 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.49 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.7 Cg_endo -69.44 6.87 1.04 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.376 1.384 . . . . 0.0 111.695 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.6 mt -110.59 90.17 10.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 120.805 -1.185 . . . . 0.0 110.5 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -61.88 141.34 89.45 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.786 1.414 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.534 ' HE2' ' O ' ' A' ' 47' ' ' ARG . 32.4 ttp -71.92 128.48 89.31 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.902 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -63.0 130.94 30.7 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.589 1.31 . . . . 0.0 109.379 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.1 131.2 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.322 1.169 . . . . 0.0 109.928 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.1 m-80 -105.55 163.89 12.31 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 110.537 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 30.32 1.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.842 . . . . 0.0 109.733 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' CG ' ' A' ' 49' ' ' LYS . 15.8 m -74.16 116.06 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -48.85 179.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.695 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -65.5 -68.89 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -45.83 -32.19 2.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.364 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -68.3 -51.35 45.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.351 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -63.67 -21.07 66.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -71.44 -47.32 56.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.389 -0.819 . . . . 0.0 108.815 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -68.16 -24.43 64.98 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' A' ' 71' ' ' ALA . 70.4 mt -68.99 -41.33 77.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.581 -0.699 . . . . 0.0 109.381 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.7 -48.75 65.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.379 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -63.68 -19.2 64.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.394 -0.817 . . . . 0.0 109.458 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -78.51 -46.18 20.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 110.098 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 27' ' ' TYR . 3.1 mt -63.06 -48.36 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.532 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.461 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -71.75 -13.71 61.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.812 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.552 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.767 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -33.0 57.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.246 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.8 t -66.4 -48.74 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.572 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 3.4 pp -69.36 -30.57 68.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.268 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' N ' HD11 ' A' ' 6' ' ' LEU . . . -58.14 -55.42 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -43.77 82.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.83 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -55.13 -29.45 57.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 16.7 mmtm -90.69 -22.32 21.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.903 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.62 14.44 27.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 19.8 m -66.36 -36.05 81.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -1.198 . . . . 0.0 110.407 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 mtp -82.16 6.82 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 110.882 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.87 -43.87 13.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 89.9 m -101.71 -18.13 15.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.3 m-70 -101.0 167.45 10.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 111.969 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 20' ' ' THR . . . -147.26 122.8 10.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.1 mp -37.45 -27.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.424 -0.798 . . . . 0.0 111.075 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -155.68 -34.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 110.863 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 17' ' ' ALA . 62.4 p -69.62 154.53 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.199 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.66 122.72 39.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mtm -124.73 -98.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 68.1 t -94.2 -36.32 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 109.317 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.25 178.17 16.4 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.579 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -69.23 133.2 25.94 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.656 1.346 . . . . 0.0 110.485 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -42.43 150.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.057 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 8.2 m-85 -60.73 -56.95 15.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.247 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 -49.81 52.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.753 -1.217 . . . . 0.0 109.448 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.33 -41.75 66.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.545 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 49.5 t -53.98 -42.44 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 35' ' ' ALA . . . -73.65 -23.42 59.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.965 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.64 -34.07 77.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HD2' ' CZ3' ' A' ' 56' ' ' TRP . 3.2 ttmt -86.92 -49.97 7.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -76.46 1.22 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -59.01 126.72 28.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.439 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.36 28.67 4.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.48 138.83 50.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 110.24 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.42 41.12 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.95 55.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 44' ' ' LEU . . . -87.15 -17.27 33.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.149 -1.207 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 2.3 mt-10 -75.63 -33.71 60.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.887 . . . . 0.0 109.611 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.68 63.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.554 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.73 -31.65 68.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.087 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.545 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 15.4 mt -67.46 -26.99 66.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.61 -33.41 60.52 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.574 -0.704 . . . . 0.0 109.834 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -75.36 -36.36 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' O ' ' HE3' ' A' ' 61' ' ' MET . 33.5 mmt-85 -82.18 -15.76 52.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 24.9 mt -85.99 -29.6 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.24 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -84.84 -17.75 37.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.4 t30 -126.8 -0.04 6.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.111 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.27 -173.76 0.13 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.2 p 167.42 158.72 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.038 -1.272 . . . . 0.0 111.871 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.552 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -106.15 -164.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 0.0 109.959 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.552 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 53.39 18.98 7.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.72 -69.25 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -1.103 . . . . 0.0 109.17 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.579 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 98.4 m95 -110.41 -39.03 5.06 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.736 0.779 . . . . 0.0 108.941 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.88 -174.0 24.32 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -70.02 8.15 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.349 1.366 . . . . 0.0 111.506 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.3 mt -107.34 82.37 1.21 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.044 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -55.42 145.67 66.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.667 1.351 . . . . 0.0 111.563 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.534 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.6 ttm -74.95 132.42 77.3 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.808 . . . . 0.0 109.406 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -67.59 129.14 19.37 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.624 1.328 . . . . 0.0 109.036 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -56.68 133.92 61.11 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.179 1.094 . . . . 0.0 110.146 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.0 m-80 -105.9 -177.99 3.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.19 35.41 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 27.1 m -87.09 103.14 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.8 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 40.3 t -43.61 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 109.345 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 67' ' ' SER . 1.5 m-20 -42.78 -47.51 5.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.507 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -59.17 -41.42 88.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 17.8 mt-10 -65.87 -38.94 90.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.817 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' A' ' 66' ' ' VAL . . . -70.45 -19.92 62.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.091 -1.006 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -49.05 30.41 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -27.94 66.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 51.1 mt -69.53 -36.12 76.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 44' ' ' LEU . . . -67.46 -53.4 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -0.756 . . . . 0.0 109.505 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 10.4 mttt -61.98 -24.07 66.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.591 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 40.9 t90 -72.03 -35.44 69.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.511 -0.743 . . . . 0.0 109.57 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.582 HG12 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -74.8 -38.96 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mt -74.21 -11.96 60.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.367 -0.833 . . . . 0.0 110.313 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.422 -179.746 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.798 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.526 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 8.9 pt-20 -70.19 -39.09 75.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.259 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.526 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 57.8 t -64.32 -54.93 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.564 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 3.8 pp -67.95 -22.66 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.876 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 3' ' ' PRO . . . -67.92 -33.36 74.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -37.86 33.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.8 m120 -65.11 -30.99 71.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.883 . . . . 0.0 110.877 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 6.3 mmtm -83.82 -18.09 38.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.887 -1.133 . . . . 0.0 109.772 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.8 12.34 43.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 15.0 m -68.03 -35.83 78.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.268 . . . . 0.0 110.417 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 1.69 41.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -38.64 15.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.005 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HA ' HG23 ' A' ' 23' ' ' VAL . 22.1 m -101.24 -26.41 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 110.444 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 32.9 m-70 -106.36 166.79 10.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.46 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -135.21 -176.16 4.17 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 18' ' ' ILE . 45.3 mm -91.32 -26.01 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 110.402 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 19' ' ' ASP . 2.8 p30 -162.22 19.35 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.976 -1.077 . . . . 0.0 111.06 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -114.93 -166.4 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.954 -1.091 . . . . 0.0 110.194 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 87.81 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 110.765 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.3 mtm -97.89 -98.43 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 109.598 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 15' ' ' CYS . 94.9 t -88.87 -45.58 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 0.0 109.231 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.7 172.74 14.4 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 26' ' ' ALA . 3.1 Cg_exo -64.23 143.04 82.4 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.469 1.247 . . . . 0.0 110.275 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 20' ' ' THR . . . -41.42 163.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 1.4 m-85 -81.44 -53.14 6.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.13 -42.11 63.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.05 -38.48 76.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.541 -0.724 . . . . 0.0 109.681 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.575 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 91.1 t -58.55 -46.45 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.825 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 79' ' ' LEU . . . -72.88 -19.93 61.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.552 -0.717 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -32.43 62.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -43.07 13.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.932 . . . . 0.0 109.822 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -78.81 -5.76 54.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.854 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -62.21 89.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.13 -20.94 0.57 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 2.4 mt-30 -71.48 149.91 45.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.101 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.15 40.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 110.428 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.7 56.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . . . -90.28 -20.16 23.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.242 . . . . 0.0 110.45 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.93 -34.84 66.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 109.503 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.35 -50.93 63.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.721 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.526 ' CE1' ' CG ' ' A' ' 47' ' ' ARG . 1.2 t80 -68.11 -30.3 69.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 109.106 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 9.2 mt -65.13 -29.7 70.57 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.92 66.31 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.597 -0.689 . . . . 0.0 110.008 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -76.38 -27.4 56.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 110.363 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' CG ' ' CE1' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -87.72 -15.26 37.55 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.539 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 35.2 mt -86.61 -32.31 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.382 -0.824 . . . . 0.0 109.618 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -85.06 -10.48 56.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 3.1 m-20 -124.16 -12.8 7.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.14 175.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 166.28 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.047 -1.267 . . . . 0.0 111.462 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -102.37 179.67 4.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.766 . . . . 0.0 109.955 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.81 19.26 73.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.58 -67.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.596 -0.944 . . . . 0.0 109.459 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.575 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 88.6 m95 -119.41 -35.48 3.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.509 -0.744 . . . . 0.0 109.041 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.05 -174.29 23.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.485 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.39 11.44 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.426 1.417 . . . . 0.0 112.019 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 59' ' ' ILE . 15.4 mt -109.11 87.06 4.42 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.659 -1.276 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.15 138.41 85.77 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.593 1.312 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.539 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.6 tmm? -79.02 126.68 81.6 Favored Pre-proline 0 C--N 1.299 -1.595 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.372 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.68 127.4 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.3 Cg_exo -55.18 132.99 55.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.241 1.127 . . . . 0.0 110.054 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.23 167.14 10.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.468 -0.77 . . . . 0.0 110.862 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.87 30.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.401 -0.812 . . . . 0.0 109.877 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 67' ' ' SER . 17.9 m -76.13 113.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 109.667 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -50.99 -176.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.778 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.09 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.019 -1.051 . . . . 0.0 110.087 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -52.86 -32.51 45.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mt-10 -68.97 -49.01 61.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -67.62 -17.45 64.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 109.239 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.41 -41.29 61.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.528 ' HA ' ' CG ' ' A' ' 76' ' ' LYS . 60.8 m -76.21 -23.39 54.62 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 53.8 mt -75.9 -34.84 59.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.573 -0.704 . . . . 0.0 109.181 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.459 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -73.49 -48.3 34.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.081 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -66.02 -27.01 67.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.066 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.519 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 36.4 t90 -67.15 -41.46 86.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.413 -0.804 . . . . 0.0 109.355 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.583 HG12 ' CE1' ' A' ' 27' ' ' TYR . 16.2 mt -61.72 -50.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.381 -0.824 . . . . 0.0 109.521 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.466 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 1.6 mt -62.08 -25.35 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.2 Cg_exo . . . . . 0 C--O 1.211 -0.846 0 N-CA-C 110.608 -0.574 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.71 -39.41 66.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.194 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 96.0 t -65.41 -54.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.857 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 2.2 pp -68.57 -24.16 64.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.349 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 3' ' ' PRO . . . -70.13 -33.54 71.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -84.59 -37.64 20.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.16 -35.59 77.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.501 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -85.27 -10.49 56.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.045 -1.034 . . . . 0.0 110.589 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.44 58.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 20.4 m -62.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -1.234 . . . . 0.0 110.412 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mtp -85.51 10.68 12.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.893 . . . . 0.0 110.465 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.21 13.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 92.7 m -105.82 -21.57 13.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 110.711 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 14.8 m-70 -94.95 167.34 11.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 0.0 112.71 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -145.15 120.11 10.0 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 7.8 mt -39.98 -25.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.221 -0.925 . . . . 0.0 111.15 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.9 p30 -147.52 -39.59 0.19 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.792 -1.192 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -70.51 153.93 42.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.013 . . . . 0.0 110.428 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -98.37 97.64 8.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.359 -0.838 . . . . 0.0 109.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.6 mtm -97.13 -121.58 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 64.3 t -70.4 -32.59 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.768 -1.208 . . . . 0.0 109.819 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.99 173.24 15.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.599 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.48 131.61 26.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.627 1.33 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 30' ' ' VAL . . . -47.01 153.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.873 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 16' ' ' HIS . 10.3 m-85 -66.81 -51.15 59.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -53.93 -49.88 67.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.534 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.68 -43.36 68.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.99 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.474 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 75.5 t -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 35' ' ' ALA . . . -72.92 -28.52 62.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.61 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -0.973 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.14 -42.9 10.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -88.28 0.85 55.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -55.24 122.37 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.176 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.57 13.6 20.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.34 141.16 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -1.199 . . . . 0.0 110.214 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.37 52.89 2.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.76 48.03 0.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.83 -22.52 59.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -1.21 . . . . 0.0 110.092 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 3.3 pt-20 -71.3 -29.16 64.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.504 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -65.31 -53.06 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.674 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -70.09 -28.47 65.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 19.7 mt -68.67 -26.24 65.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -73.14 -39.18 65.9 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.408 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -77.26 -23.13 51.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.542 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 19.5 mmt180 -90.13 -17.64 27.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.344 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.537 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 26.8 mt -85.32 -31.02 6.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -86.98 -11.97 48.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 110.1 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' GLY . 86.3 m-20 -121.04 -13.32 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 109.951 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 54.74 169.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 168.88 166.27 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.804 -1.41 . . . . 0.0 111.857 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.6 -173.9 2.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.777 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.0 9.92 54.93 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.82 -50.96 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.398 -1.06 . . . . 0.0 109.459 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.599 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 92.5 m95 -129.22 -36.11 1.75 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.41 -166.53 24.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.2 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.411 1.408 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -109.67 83.14 2.55 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.844 -1.16 . . . . 0.0 110.567 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.64 160.5 17.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.716 1.377 . . . . 0.0 111.1 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.549 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 54.0 ttp -96.91 131.21 28.28 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.501 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.431 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -67.59 132.33 26.78 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.653 1.344 . . . . 0.0 109.033 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.9 139.9 92.85 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.267 1.14 . . . . 0.0 110.344 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.481 ' HB2' HG12 ' A' ' 66' ' ' VAL . 10.9 m-80 -114.8 165.68 12.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 0.0 110.793 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.46 38.31 0.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.034 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 64' ' ' ASN . 27.3 m -71.31 116.41 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.312 -0.867 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 70' ' ' GLU . 29.1 m -51.62 178.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -59.15 5.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 109.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.6 -13.5 9.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mm-40 -82.29 -46.0 14.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.219 -0.926 . . . . 0.0 110.201 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.28 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.026 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -44.32 39.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.492 -0.755 . . . . 0.0 109.059 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 77' ' ' TRP . 35.5 m -74.44 -22.1 59.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 30.2 mt -75.5 -39.46 58.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.662 -0.649 . . . . 0.0 109.393 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . . . -72.06 -43.54 64.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.017 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 80' ' ' SER . 46.5 mttt -65.82 -30.83 71.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.216 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.568 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 33.4 t90 -66.55 -44.38 82.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.634 -0.666 . . . . 0.0 109.918 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.585 HG12 ' CD1' ' A' ' 27' ' ' TYR . 73.4 mt -61.43 -47.02 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.643 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.1 -12.73 60.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -0.824 . . . . 0.0 109.76 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.091 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.533 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.296 -0.694 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.84 -43.33 65.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 99.0 t -54.53 -37.82 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.298 -0.876 . . . . 0.0 109.432 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 3' ' ' PRO . 71.3 mt -65.0 -36.82 85.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.796 . . . . 0.0 109.759 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB1' ' CG ' ' A' ' 13' ' ' MET . . . -69.01 -23.25 64.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.2 -34.5 17.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.342 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.156 -0.965 . . . . 0.0 110.576 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.511 ' NZ ' ' CG ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -89.87 -13.33 36.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.599 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.86 17.93 52.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 35.4 m -63.38 -22.37 66.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -1.083 . . . . 0.0 110.715 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.527 ' CG ' ' HB1' ' A' ' 7' ' ' ALA . 5.6 mtp -90.82 8.79 33.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.822 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.37 -51.41 6.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.566 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 72.5 m -93.7 -16.29 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 110.94 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.582 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 15.1 m-70 -104.68 160.41 14.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.126 . . . . 0.0 112.289 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' CB ' ' SD ' ' A' ' 22' ' ' MET . . . -142.47 126.8 17.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 2.3 mp -38.72 -26.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.421 -0.799 . . . . 0.0 111.243 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 60.8 m-20 -152.19 -37.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.987 -1.071 . . . . 0.0 110.75 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -69.22 165.74 19.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -113.9 95.6 5.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.07 -1.019 . . . . 0.0 110.863 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.515 ' SD ' ' CB ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -85.05 -88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.688 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 71.8 t -104.46 -27.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 109.566 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.27 177.23 16.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.549 ' CG ' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -67.69 137.04 40.95 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.677 1.357 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.534 ' O ' ' CG2' ' A' ' 30' ' ' VAL . . . -44.9 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.584 ' CE1' HG12 ' A' ' 78' ' ' ILE . 3.0 m-85 -78.39 -46.69 19.32 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -56.86 -54.32 47.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -50.67 -36.61 36.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.257 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.571 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 94.7 t -61.5 -44.34 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.131 -0.981 . . . . 0.0 110.446 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -72.71 -23.81 60.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.403 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.79 -23.38 52.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -90.06 -42.27 11.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.48 3.82 38.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.039 -1.038 . . . . 0.0 110.09 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 31' ' ' ALA . . . -57.34 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.49 -39.01 0.86 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -49.21 138.74 12.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.106 -1.232 . . . . 0.0 110.354 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 50.49 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.392 -0.818 . . . . 0.0 110.121 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.69 42.46 0.05 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.494 ' O ' ' CG ' ' A' ' 44' ' ' LEU . . . -75.99 -18.78 59.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.269 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.519 ' HG2' ' CB ' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -75.06 -37.0 61.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.489 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.45 -52.03 50.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -65.91 -32.26 73.66 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 108.78 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.539 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 12.6 mt -64.57 -30.69 71.71 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.65 -34.47 74.05 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.655 -0.653 . . . . 0.0 109.581 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.8 -44.32 64.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.342 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.499 ' O ' ' HE2' ' A' ' 61' ' ' MET . 24.9 mmt180 -73.76 -20.33 60.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.132 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 47.5 mt -80.61 -31.53 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -88.41 -20.28 25.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' GLY . 20.2 t30 -113.73 -5.8 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 57.64 162.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.2 t 177.51 161.4 0.5 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.614 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.26 -175.07 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.836 -0.54 . . . . 0.0 109.951 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 69.09 16.58 70.95 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 56' ' ' TRP . 89.4 t -97.96 -60.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.569 -0.96 . . . . 0.0 109.731 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.571 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 98.3 m95 -118.43 -39.8 2.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.48 -0.763 . . . . 0.0 109.46 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.73 -166.32 21.32 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.483 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.91 12.54 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.31 1.34 . . . . 0.0 111.902 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.61 78.54 1.19 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.612 -1.305 . . . . 0.0 110.431 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.1 140.33 94.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.518 1.272 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.533 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 7.6 ttp -72.89 135.45 80.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.489 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.36 135.11 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.798 1.42 . . . . 0.0 108.725 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.05 148.36 85.77 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.289 1.152 . . . . 0.0 110.392 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 1.7 m-80 -127.76 173.79 9.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.487 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.11 35.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 25.9 m -73.5 103.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.801 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -43.16 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.63 -68.08 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 0.0 110.13 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -21.0 1.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.305 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' CG ' ' NZ ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -73.86 -47.2 39.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 48' ' ' ILE . . . -71.14 -16.51 62.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.167 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -41.92 50.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -76.11 -27.6 57.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 24.1 mt -71.87 -34.17 69.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' HG2' ' A' ' 41' ' ' GLU . . . -70.37 -49.81 45.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.795 . . . . 0.0 109.397 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.2 OUTLIER -67.19 -24.71 65.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.896 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.533 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 54.3 t90 -71.27 -33.33 69.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 109.328 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.584 HG12 ' CE1' ' A' ' 27' ' ' TYR . 15.4 mt -69.88 -48.42 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.612 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 2.6 mp -72.39 -17.05 61.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.87 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 3.1 m . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.213 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.498 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 2.9 Cg_endo . . . . . 0 C--O 1.212 -0.781 0 N-CA-C 110.141 -0.753 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' OE1' ' C ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -69.33 -31.37 69.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.316 -0.865 . . . . 0.0 108.743 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.8 t -70.76 -59.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.177 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -62.08 -21.49 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 109.536 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 3' ' ' PRO . . . -76.0 -29.33 58.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.364 -0.835 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 -27.82 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.807 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.2 m120 -72.34 -38.7 68.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.817 . . . . 0.0 110.33 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HG2' HG13 ' A' ' 66' ' ' VAL . 0.8 OUTLIER -83.09 -4.69 58.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.029 . . . . 0.0 110.193 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.52 18.01 65.02 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 m -63.82 -38.21 90.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.304 . . . . 0.0 110.44 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.76 7.09 13.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.576 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.43 -36.62 17.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.922 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.9 m -106.01 -17.68 14.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.2 m-70 -99.61 171.08 8.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.033 -1.042 . . . . 0.0 111.769 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -146.6 119.03 8.42 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.1 mp -37.78 -33.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.492 -0.755 . . . . 0.0 111.149 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.2 p30 -156.58 8.36 0.2 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.889 -1.132 . . . . 0.0 111.744 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -103.75 -176.1 2.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.708 -1.245 . . . . 0.0 109.921 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 9.8 mmtp -121.22 104.71 9.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.14 -0.975 . . . . 0.0 110.65 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.7 mtp -118.26 -106.55 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -89.07 -39.61 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.85 -1.157 . . . . 0.0 109.666 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.83 168.82 12.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.583 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -66.27 135.29 39.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.605 1.318 . . . . 0.0 110.502 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 17' ' ' ALA . . . -42.8 150.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -63.29 -59.91 4.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -0.938 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -47.59 -47.64 28.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.412 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' OD2' ' HE2' ' A' ' 21' ' ' LYS . 18.2 m-20 -57.33 -39.27 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 0.0 110.009 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 27' ' ' TYR . 73.3 t -57.08 -36.25 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 35' ' ' ALA . . . -79.68 -29.62 40.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.461 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.37 -24.18 62.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.438 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -90.2 -42.89 10.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -90.43 9.18 30.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 31' ' ' ALA . . . -55.83 140.89 40.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -12.0 67.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -54.06 147.25 13.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 110.353 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 49.15 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -0.841 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.82 53.24 0.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -73.47 -20.15 60.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -1.167 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 1.1 pt-20 -66.95 -23.25 65.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 0.0 109.966 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -72.92 -59.54 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.594 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.5 t80 -65.27 -25.7 67.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.927 . . . . 0.0 109.046 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 16.5 mt -66.75 -34.86 78.78 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.86 67.47 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -74.26 -37.12 63.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.11 -0.994 . . . . 0.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.1 mmt180 -84.55 -14.91 47.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.973 -1.08 . . . . 0.0 109.644 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.533 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 30.2 mt -85.98 -25.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.029 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.36 -19.36 33.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.42 -0.8 . . . . 0.0 110.447 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 4.8 m120 -127.99 -4.02 5.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.454 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.14 173.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.7 167.85 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.825 -1.397 . . . . 0.0 111.594 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.578 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -100.21 177.86 4.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 109.921 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.44 21.96 79.06 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.17 -71.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.518 -0.989 . . . . 0.0 109.91 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.583 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 88.1 m95 -117.75 -34.88 4.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.053 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.45 -172.25 20.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.22 13.55 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.56 1.506 . . . . 0.0 112.231 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.63 93.35 16.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.615 -1.303 . . . . 0.0 110.473 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -61.8 131.01 33.34 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.644 1.339 . . . . 0.0 110.811 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.533 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 5.4 tmm? -73.73 132.2 81.01 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -64.37 139.0 63.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.706 1.371 . . . . 0.0 108.702 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.5 Cg_endo -60.27 142.97 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.274 1.144 . . . . 0.0 110.274 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 2.8 m-80 -113.22 161.06 17.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.957 . . . . 0.0 110.529 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.49 34.1 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 28.6 m -80.87 114.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.768 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.0 m -50.52 -177.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.033 . . . . 0.0 109.597 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.1 -59.07 3.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.993 -1.067 . . . . 0.0 109.967 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -33.4 50.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.2 mm-40 -67.47 -50.14 60.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -64.23 -21.68 66.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -45.31 61.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.395 -0.816 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.6 m -72.59 -22.13 61.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' A' ' 71' ' ' ALA . 62.0 mt -73.0 -36.86 67.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.543 -0.723 . . . . 0.0 109.253 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.478 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -70.64 -50.72 33.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.7 OUTLIER -61.51 -24.16 66.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.838 . . . . 0.0 109.021 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.498 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 38.6 t90 -74.55 -41.19 61.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.496 -0.753 . . . . 0.0 109.863 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CD1' ' A' ' 27' ' ' TYR . 37.3 mt -60.51 -42.36 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.591 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -75.05 -13.53 60.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.511 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 110.473 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.467 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 2.8 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 110.302 -0.692 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -38.33 79.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.206 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.438 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 50.8 t -62.65 -50.19 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.711 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 1.3 pp -72.08 -20.92 61.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.457 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.05 -37.51 87.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.782 . . . . 0.0 109.605 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -83.71 -38.06 21.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.823 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.482 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -60.21 -35.34 75.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.442 -0.786 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 46.3 mmtm -87.01 -14.05 42.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.59 10.29 56.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 19.5 m -62.62 -39.03 92.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.261 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 3.32 22.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 111.019 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.88 -43.51 14.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.032 . . . . 0.0 110.423 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 39.9 m -98.04 -23.09 15.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.534 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 30.1 m-70 -103.84 -175.18 2.73 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.362 1.077 . . . . 0.0 112.419 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.607 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -162.11 -171.6 2.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -86.41 -69.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.669 -1.27 . . . . 0.0 110.118 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 4.5 t0 -110.08 -19.56 13.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 1.1 p -72.11 -169.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 5.3 pttt -150.51 87.46 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 mtm -79.88 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.92 . . . . 0.0 109.885 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 11.4 t -83.52 -29.61 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.0 171.48 14.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -65.33 144.05 78.99 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.488 1.257 . . . . 0.0 110.077 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 20' ' ' THR . . . -43.58 162.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.6 m-85 -77.29 -60.62 2.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.97 -37.77 46.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.7 m-20 -61.91 -46.29 90.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.802 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.462 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 68.7 t -52.17 -37.28 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.81 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' CB ' ' HA ' ' A' ' 79' ' ' LEU . . . -85.08 -21.07 29.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 110.299 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.8 -26.25 60.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 15.3 tppt? -87.21 -48.02 8.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.913 . . . . 0.0 110.092 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ALA . 13.9 m-85 -77.1 -13.11 60.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.02 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -43.15 109.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.74 34.3 0.7 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.466 ' CB ' ' HB1' ' A' ' 40' ' ' ALA . 2.5 mt-30 -125.93 144.37 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -1.22 . . . . 0.0 110.304 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.39 47.6 1.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.859 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.78 40.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.013 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' HB1' ' CB ' ' A' ' 37' ' ' GLN . . . -80.72 -31.39 36.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -1.133 . . . . 0.0 109.874 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -67.98 -22.93 64.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.457 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.47 -53.15 20.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.536 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.9 t80 -68.7 -24.87 64.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.546 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 8.9 mt -69.69 -32.52 71.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.56 68.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.94 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.24 -37.31 63.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.036 -1.04 . . . . 0.0 110.287 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.3 mmt-85 -78.18 -18.41 55.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.912 . . . . 0.0 109.569 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 30.7 mt -80.34 -36.04 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.702 . . . . 0.0 109.857 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -78.13 -31.08 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 110.431 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -109.28 -4.46 16.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 57.76 166.38 0.1 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 174.52 164.33 0.23 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.599 -1.53 . . . . 0.0 112.386 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.578 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -108.37 -171.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.626 -0.671 . . . . 0.0 109.848 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 20.58 76.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.636 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 78.7 t -102.81 -70.75 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.583 -0.951 . . . . 0.0 109.58 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.636 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 99.0 m95 -110.67 -41.07 4.39 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.5 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.23 -167.37 19.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.492 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.63 11.41 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.437 1.425 . . . . 0.0 111.895 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.404 HG22 HD12 ' A' ' 59' ' ' ILE . 10.4 mt -107.71 77.45 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.601 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.8 Cg_exo -56.38 139.05 86.03 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.535 1.281 . . . . 0.0 110.841 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.518 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 12.3 ttp -71.29 133.03 85.6 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.511 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -67.64 134.62 33.33 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.681 1.358 . . . . 0.0 108.992 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.32 136.04 69.47 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.269 1.141 . . . . 0.0 110.53 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-80 -113.75 170.47 8.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.474 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.83 34.95 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' SER . 16.0 m -78.15 114.42 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.12 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.7 t -50.84 -176.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -71.1 -42.11 69.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 110.324 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.05 -35.36 80.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.938 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.434 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mt-10 -72.97 -40.79 65.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 66' ' ' VAL . . . -73.74 -21.63 60.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -77.81 -43.35 30.81 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.261 -0.899 . . . . 0.0 108.577 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.8 m -72.87 -24.5 60.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.494 ' O ' HD11 ' A' ' 78' ' ' ILE . 23.6 mt -72.58 -46.17 55.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.459 ' HA ' HD13 ' A' ' 78' ' ' ILE . . . -64.19 -42.93 96.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.371 -0.83 . . . . 0.0 109.183 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.0 OUTLIER -69.56 -26.48 64.51 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 109.044 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 30.6 t90 -68.99 -43.08 75.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.298 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.585 HG12 ' CD1' ' A' ' 27' ' ' TYR . 6.0 mt -62.07 -43.57 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.021 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.533 ' HA ' ' CB ' ' A' ' 31' ' ' ALA . 2.0 mt -75.48 -14.12 60.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.351 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 47.9 t . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.467 -0.771 . . . . 0.0 110.11 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.458 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.96 -32.95 65.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.372 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.69 -51.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.491 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 2.5 pp -66.37 -31.28 71.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.398 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -56.45 -46.72 80.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -68.32 -37.53 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 0.0 109.736 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.88 -22.94 65.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.797 . . . . 0.0 110.229 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 45.5 mmtm -95.5 -25.17 16.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.812 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.57 13.12 28.9 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 24.6 m -64.69 -39.74 94.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.244 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 2.55 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.09 -48.27 16.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 97.0 m -100.31 -27.02 13.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.453 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.586 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.7 m-70 -97.62 168.32 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.211 1.005 . . . . 0.0 112.35 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -151.61 -166.79 2.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.6 mm -90.44 -75.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.781 -1.199 . . . . 0.0 110.145 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.14 -1.44 13.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.501 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 p -81.28 -168.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.958 . . . . 0.0 110.03 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.44 108.84 7.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.6 mtm -117.65 -119.52 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.046 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 42.7 t -77.75 -35.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.845 -1.159 . . . . 0.0 109.807 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.8 168.89 12.76 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.76 139.65 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.726 1.382 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -43.21 154.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.396 -0.815 . . . . 0.0 109.752 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.602 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.4 m-85 -70.51 -58.01 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -47.25 33.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -52.0 -45.56 64.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.413 -0.804 . . . . 0.0 109.929 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.585 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 81.3 t -55.45 -37.96 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' CB ' HD21 ' A' ' 79' ' ' LEU . . . -76.33 -25.48 54.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.38 -29.86 65.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -85.41 -42.12 14.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -90.63 7.09 41.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -61.03 118.28 6.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.384 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.38 -8.17 26.58 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.471 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -66.17 147.03 53.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -1.174 . . . . 0.0 110.098 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.22 56.17 3.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.02 46.63 0.3 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . . . -72.38 -16.03 61.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.408 ' HA ' HD11 ' A' ' 44' ' ' LEU . 2.7 mt-10 -70.17 -37.76 75.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.808 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -51.46 69.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 t80 -67.42 -31.82 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 108.953 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 24.0 mt -64.75 -25.17 67.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.4 -35.06 41.27 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.706 -0.621 . . . . 0.0 109.929 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -77.57 -24.52 49.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 11.8 mmp_? -89.46 -21.8 22.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 48.1 mt -84.6 -26.67 6.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.62 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -90.1 -8.06 52.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.397 -0.814 . . . . 0.0 110.484 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -133.14 -7.49 3.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.062 -1.023 . . . . 0.0 111.202 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 69.06 162.17 2.75 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -174.36 150.11 1.43 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.585 -1.538 . . . . 0.0 112.855 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.6 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.68 -173.71 2.3 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.694 -0.629 . . . . 0.0 109.558 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.25 16.29 53.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.638 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 98.0 t -93.13 -71.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.637 -0.919 . . . . 0.0 109.225 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.638 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 96.8 m95 -109.86 -39.57 5.04 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.718 0.771 . . . . 0.0 109.012 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.58 -178.03 28.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.518 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.91 8.09 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.498 1.466 . . . . 0.0 112.091 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.458 HD12 HG21 ' A' ' 59' ' ' ILE . 4.5 mt -107.12 80.04 0.78 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.674 -1.266 . . . . 0.0 109.651 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HG3' ' CB ' ' A' ' 53' ' ' GLN . 3.0 Cg_endo -55.37 148.9 49.13 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.854 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.549 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 7.9 ttp -76.79 131.97 72.57 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.057 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -65.9 134.57 37.83 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.617 1.325 . . . . 0.0 109.122 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.3 132.42 48.8 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.289 1.152 . . . . 0.0 110.075 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-80 -107.88 160.35 15.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 110.522 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.13 32.8 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.791 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 67' ' ' SER . 22.9 m -72.35 114.62 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 110.212 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' VAL . 33.6 m -47.74 174.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.53 -64.62 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.808 -1.183 . . . . 0.0 110.186 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -22.22 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 11.4 mm-40 -72.42 -52.54 15.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.21 -18.76 65.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.948 . . . . 0.0 108.785 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.93 -47.63 43.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -68.0 -24.49 65.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.534 ' O ' ' CD1' ' A' ' 78' ' ' ILE . 75.6 mt -73.19 -33.6 65.49 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.76 -51.46 40.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.61 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -60.98 -32.07 71.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 109.108 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -64.71 -48.08 75.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.716 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.595 HG12 ' CE1' ' A' ' 27' ' ' TYR . 1.6 mt -60.34 -56.35 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.448 -0.782 . . . . 0.0 110.028 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.514 HD21 ' CB ' ' A' ' 31' ' ' ALA . 1.5 mt -66.82 -11.74 56.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 39.9 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 110.413 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.795 0 N-CA-C 110.462 -0.63 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -48.65 -45.97 39.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 109.542 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 37.9 t -51.06 -47.12 31.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.9 . . . . 0.0 109.078 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 71.0 mt -56.06 -50.52 70.75 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.586 0.707 . . . . 0.0 109.801 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -51.94 -26.27 10.06 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.582 -0.698 . . . . 0.0 110.251 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -56.69 3.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 110.994 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 15.1 m-80 -64.44 -11.3 32.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.911 -1.118 . . . . 0.0 110.467 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 71.2 mmtt -101.42 -15.01 17.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 110.03 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.05 12.11 71.7 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 29.4 m -63.23 -40.46 97.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.245 . . . . 0.0 110.347 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -74.44 2.47 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.14 -50.55 12.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -99.64 -14.26 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 110.785 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 19.6 m-70 -105.34 174.13 6.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.076 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -149.87 -179.47 7.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.445 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.3 mp -90.66 -24.83 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.869 -1.144 . . . . 0.0 110.414 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 12.5 p-10 -157.77 -27.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 0.0 111.463 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 81.0 p -68.86 -173.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.772 -1.205 . . . . 0.0 110.115 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 104.64 8.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 111.011 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.88 -132.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.83 . . . . 0.0 109.112 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.4 -48.17 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.864 -1.147 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.03 167.79 21.89 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -67.0 143.32 65.4 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.572 1.301 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 25' ' ' PRO . . . -44.97 170.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.731 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.5 m-85 -86.93 -54.6 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.953 -1.092 . . . . 0.0 110.04 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 1.1 tmmm? -50.54 -49.74 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.928 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -54.64 -42.81 71.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.073 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.537 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 53.5 t -56.07 -38.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 79' ' ' LEU . . . -76.5 -26.58 55.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.39 -29.11 65.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.2 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -84.64 -47.77 10.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 109.984 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -77.28 -3.71 41.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 31' ' ' ALA . . . -52.27 121.91 7.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.934 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.24 -37.45 2.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -63.17 126.28 26.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -1.082 . . . . 0.0 110.06 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.2 46.05 1.29 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.57 40.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -79.92 -12.74 59.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 109.908 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -75.11 -22.45 58.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.529 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -71.62 -51.52 22.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.664 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.556 ' CE1' ' NE ' ' A' ' 47' ' ' ARG . 45.5 t80 -69.64 -33.4 72.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 22.6 mt -61.38 -30.12 70.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.22 -38.85 60.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -19.44 60.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.051 -1.031 . . . . 0.0 109.845 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' NE ' ' CE1' ' A' ' 43' ' ' TYR . 6.5 mmt180 -90.17 -24.15 21.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.535 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 62.6 mt -86.71 -19.75 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.331 -0.856 . . . . 0.0 109.318 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -22.99 24.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 110.516 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 57.6 m-80 -126.21 -6.71 6.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 110.407 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.16 173.98 0.03 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 2.8 t 162.11 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.413 -1.051 . . . . 0.0 111.172 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.2 pm0 -100.16 -165.26 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 64.14 18.72 62.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 53' ' ' GLN . 2.4 t -95.5 -67.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.739 -0.859 . . . . 0.0 109.099 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.551 ' CB ' ' HG3' ' A' ' 25' ' ' PRO . 95.5 m95 -124.1 -36.38 2.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.65 -177.44 20.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.487 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -69.46 8.25 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.457 1.438 . . . . 0.0 112.038 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.86 100.78 29.58 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.715 -1.241 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' CB ' ' HB3' ' A' ' 53' ' ' GLN . 2.4 Cg_endo -64.63 133.41 36.68 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.457 1.24 . . . . 0.0 110.602 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.535 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -71.87 135.6 83.0 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.487 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.0 Cg_endo -64.21 130.46 27.17 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.735 1.387 . . . . 0.0 109.456 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.23 135.79 64.29 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.401 1.211 . . . . 0.0 110.61 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.424 ' HB2' HG23 ' A' ' 66' ' ' VAL . 5.5 m-80 -109.05 163.83 12.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.67 36.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.969 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 66' ' ' VAL . 15.5 m -84.38 105.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.056 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 75.1 p -42.58 147.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.224 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' GLN . 8.0 p-10 -42.57 -31.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.45 -47.96 68.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.109 -0.994 . . . . 0.0 109.564 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 52.7 mt-10 -63.62 -48.05 78.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 110.161 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -67.27 -16.64 64.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 109.142 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.33 -45.62 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -27.74 63.39 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 49.6 mt -69.77 -34.96 74.48 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.46 -54.65 18.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 80' ' ' SER . 6.2 mttp -58.43 -25.12 61.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 108.871 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.468 ' HB3' ' O ' ' A' ' 74' ' ' LEU . 35.9 t90 -70.51 -43.11 70.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.61 -0.681 . . . . 0.0 109.515 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.596 HG12 ' CE1' ' A' ' 27' ' ' TYR . 4.9 mt -59.38 -50.91 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.739 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -73.72 -9.97 59.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 36.7 t . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 110.326 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.763 0 N-CA-C 110.268 -0.705 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.28 -33.92 73.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 108.626 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 98.0 t -64.45 -58.02 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.643 -0.661 . . . . 0.0 109.718 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 3.7 pp -64.16 -24.42 67.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -67.72 -29.49 68.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -52.16 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.322 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 15.1 m-80 -63.27 -16.48 60.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.091 -1.006 . . . . 0.0 110.383 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 34.2 mmtt -87.97 -18.8 28.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.63 13.53 53.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 57.4 m -69.72 -38.68 76.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -1.235 . . . . 0.0 110.52 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mtp -82.36 6.0 18.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.782 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.52 -35.71 19.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 110.353 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 36.4 m -106.0 -22.95 12.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -0.819 . . . . 0.0 110.391 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 28.7 m-70 -103.35 153.84 20.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 111.415 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -129.89 123.93 31.96 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.476 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 35.7 mm -36.78 -29.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 111.014 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -153.45 -32.33 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.177 -0.952 . . . . 0.0 111.088 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.43 179.33 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.023 -1.048 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -117.69 120.42 37.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -0.872 . . . . 0.0 110.741 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 19.5 mtp -125.22 -108.08 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 25.3 t -86.32 -31.78 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 171.71 17.26 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -66.0 140.42 60.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.682 1.359 . . . . 0.0 110.383 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' O ' ' CG2' ' A' ' 30' ' ' VAL . . . -42.44 149.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 110.233 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 3.0 m-85 -63.43 -60.19 3.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.207 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -49.19 48.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.635 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -55.48 -40.07 71.21 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 110.027 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.603 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 95.5 t -57.84 -38.39 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.003 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 79' ' ' LEU . . . -75.92 -25.83 56.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 110.001 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -27.49 63.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 19.1 tttt -86.56 -43.75 12.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -82.82 -2.25 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 109.978 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.7 101.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.73 33.81 0.42 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.78 145.86 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.229 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.07 41.57 1.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.36 48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 44' ' ' LEU . . . -76.92 -33.66 57.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -1.168 . . . . 0.0 110.1 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HG2' ' CB ' ' A' ' 75' ' ' ALA . 3.0 tm-20 -64.29 -24.79 67.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.34 -51.6 23.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 1.3 t80 -71.32 -21.79 62.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.14 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 40' ' ' ALA . 3.5 mt -74.5 -26.67 60.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.24 46.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.636 -0.665 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.52 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -77.15 -34.66 56.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 75.5 mmt-85 -81.37 -22.11 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 44' ' ' LEU . 19.3 mt -80.98 -30.05 11.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.39 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.35 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -118.63 0.25 11.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.364 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 58.01 158.76 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.492 ' CB ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -177.32 158.63 1.47 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.546 -1.561 . . . . 0.0 112.595 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.34 -172.57 2.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.62 -0.675 . . . . 0.0 109.688 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.4 19.07 75.81 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG12 ' CD1' ' A' ' 56' ' ' TRP . 27.7 t -99.16 -74.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.632 -0.922 . . . . 0.0 109.814 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.603 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 97.5 m95 -106.91 -38.8 5.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.42 -165.74 18.82 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.484 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.05 13.44 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.383 1.389 . . . . 0.0 111.963 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.76 80.16 2.06 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.569 -1.332 . . . . 0.0 110.301 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -60.18 144.71 99.48 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.674 1.355 . . . . 0.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.563 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 5.9 ttp -73.93 134.55 77.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.661 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.469 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -69.77 139.26 39.75 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.668 1.352 . . . . 0.0 109.065 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 132.34 41.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.254 1.134 . . . . 0.0 110.133 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.4 m-80 -108.03 173.38 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.744 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.08 33.4 2.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.969 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 67' ' ' SER . 16.7 m -78.41 120.84 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 109.885 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 66' ' ' VAL . 6.2 m -49.68 -178.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.889 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.04 -58.2 4.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.694 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.86 -17.45 36.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.6 mm-40 -77.6 -50.23 12.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.42 -22.68 66.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.262 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -72.52 -44.61 61.97 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 3' ' ' PRO . 1.6 m -71.24 -24.05 62.11 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 27.1 mt -68.39 -38.21 81.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.494 ' CB ' ' HG2' ' A' ' 41' ' ' GLU . . . -69.79 -51.2 35.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.135 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 80' ' ' SER . 1.2 mttp -62.42 -23.34 66.8 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.309 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.493 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 33.9 t90 -73.64 -42.15 61.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.485 -0.759 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.572 HG12 ' CD1' ' A' ' 27' ' ' TYR . 96.7 mt -63.29 -56.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 75' ' ' ALA . 1.3 mp -65.78 -18.43 65.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.852 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 3.6 t . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 110.148 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 2.8 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 110.577 -0.586 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 4' ' ' GLU . 5.7 tm-20 -68.35 -44.64 74.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.9 t -58.77 -50.13 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 110.087 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.546 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -70.85 -22.6 62.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.351 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.46 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -62.45 -38.95 91.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.571 -0.705 . . . . 0.0 109.392 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -41.14 34.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.504 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.9 m120 -62.95 -23.46 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 17.7 mmtt -91.14 -14.53 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.93 11.59 58.73 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 17.6 m -69.49 -38.58 77.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -1.202 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.35 6.78 9.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.25 -46.56 10.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.319 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 94.8 m -99.0 -16.56 18.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -0.811 . . . . 0.0 110.578 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.7 m-70 -110.07 178.63 4.34 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.387 1.089 . . . . 0.0 112.435 -177.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -155.29 -169.17 3.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.427 HG23 HD12 ' A' ' 18' ' ' ILE . 29.9 mm -90.8 -73.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.683 -1.261 . . . . 0.0 110.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -112.55 -10.14 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 110.004 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -77.4 -161.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 0.0 109.879 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 119.74 9.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.508 ' CE ' ' O ' ' A' ' 16' ' ' HIS . 15.4 mtm -121.58 -113.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.749 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 54.1 t -78.19 -32.78 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.801 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.78 175.33 16.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.513 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.63 142.12 69.41 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.617 1.325 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -42.6 157.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.936 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -73.41 -61.33 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.936 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' TYR . 5.8 tttt -46.29 -45.77 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 0.0 109.462 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -51.58 -45.56 63.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 109.811 179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 88.6 t -55.03 -45.21 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.94 -21.25 63.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.768 . . . . 0.0 110.155 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.68 42.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 110.531 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -35.14 15.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.119 -0.988 . . . . 0.0 110.084 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' ALA . 16.6 m-85 -85.9 -9.24 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -42.73 111.2 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.94 40.28 2.16 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.81 152.22 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.02 42.12 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.98 46.45 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' ' CG ' ' A' ' 44' ' ' LEU . . . -66.19 -29.68 70.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -1.107 . . . . 0.0 110.532 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -68.66 -32.22 71.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.19 -52.86 16.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.561 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 13.3 t80 -70.38 -19.39 63.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.276 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.563 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 10.8 mt -73.97 -33.82 64.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.75 69.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.735 -0.603 . . . . 0.0 109.5 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -43.75 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.561 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.51 -17.21 58.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.437 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 13.3 mt -83.19 -24.75 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -85.34 -29.15 24.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.293 -0.879 . . . . 0.0 110.396 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 36.6 p30 -114.46 -5.15 12.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.634 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 59.05 172.1 0.42 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.62 163.5 0.12 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.705 -1.468 . . . . 0.0 112.422 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.584 ' CB ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -110.33 -178.91 3.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.433 -0.792 . . . . 0.0 109.876 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 74.51 20.22 79.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.584 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 71.3 t -103.91 -67.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.584 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 99.5 m95 -111.07 -40.13 4.56 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.338 -0.851 . . . . 0.0 110.114 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.54 -165.84 18.16 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.496 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.479 1.453 . . . . 0.0 111.619 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.29 85.62 2.87 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.79 -1.194 . . . . 0.0 111.174 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.584 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.16 155.49 39.64 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.627 1.33 . . . . 0.0 110.275 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.545 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 49.9 ttp -87.92 134.85 34.44 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -67.29 132.95 28.96 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.768 1.404 . . . . 0.0 109.172 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -59.04 136.09 70.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.269 1.142 . . . . 0.0 110.461 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.0 m-80 -112.03 163.25 14.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.401 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.8 36.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 67' ' ' SER . 16.0 m -77.71 108.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.374 -0.828 . . . . 0.0 110.421 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -43.72 146.22 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 67' ' ' SER . 7.7 p-10 -41.15 -40.91 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.104 -0.997 . . . . 0.0 110.872 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.35 -45.22 94.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 72.9 mm-40 -64.09 -42.38 96.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.97 -22.17 65.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.008 . . . . 0.0 109.699 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -72.15 -41.21 67.36 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' TRP . 1.2 m -73.96 -24.49 59.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 78' ' ' ILE . 41.8 mt -72.42 -37.86 68.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.557 -0.714 . . . . 0.0 109.18 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -71.83 -49.51 37.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.127 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 80' ' ' SER . 2.8 mttt -63.78 -25.15 68.05 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.353 -0.842 . . . . 0.0 108.816 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 24.7 t90 -70.39 -51.9 26.31 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.541 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 74' ' ' LEU . 4.3 mt -54.68 -49.66 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.15 -17.36 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.973 . . . . 0.0 109.847 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 11.9 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.862 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.442 ' HB3' HG23 ' A' ' 73' ' ' THR . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.541 -0.6 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 20.4 tt0 -56.89 -48.36 78.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.4 t -49.77 -34.26 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.406 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 39.8 mt -71.45 -38.38 71.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.629 ' CB ' ' CH2' ' A' ' 77' ' ' TRP . . . -58.47 -27.14 64.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.676 . . . . 0.0 110.141 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -90.0 -46.9 8.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.932 . . . . 0.0 110.528 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.0 m120 -63.99 -16.75 62.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.243 -0.911 . . . . 0.0 111.052 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 54.4 mmtt -104.46 -25.38 12.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.056 . . . . 0.0 110.487 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' O ' ' HB1' ' A' ' 14' ' ' ALA . . . 104.21 15.0 22.89 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 17.0 m -66.79 -35.05 79.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 0.0 110.2 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.446 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 56.8 mmm -79.71 5.96 12.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.914 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 11' ' ' GLY . . . -88.48 -37.21 15.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.109 -0.994 . . . . 0.0 110.482 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -105.33 -16.59 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.0 m-70 -105.16 166.78 10.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.903 -1.123 . . . . 0.0 112.082 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 20' ' ' THR . . . -146.91 120.13 8.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 17.9 mt -37.36 -29.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.3 p30 -151.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.077 -1.015 . . . . 0.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 17' ' ' ALA . 19.8 p -70.0 163.11 26.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -104.25 129.08 52.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 0.0 110.635 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.42 ' HE2' ' O ' ' A' ' 16' ' ' HIS . 10.3 mtm -127.27 -88.75 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.44 -33.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.47 174.5 16.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.506 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -64.71 129.65 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.56 1.294 . . . . 0.0 110.305 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -38.91 149.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.448 -0.782 . . . . 0.0 110.073 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 3.4 m-85 -65.4 -58.98 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 110.52 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -48.27 -47.12 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.954 -1.091 . . . . 0.0 109.623 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.13 -40.47 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.52 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 59.0 t -58.45 -39.9 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.34 -19.9 55.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.994 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.41 -28.71 46.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 0.0 110.057 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -89.6 -40.34 12.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.85 -11.46 59.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.0 103.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 109.985 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.7 33.82 0.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.75 128.49 42.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -1.198 . . . . 0.0 110.157 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.22 56.17 3.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.52 44.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' HD13 ' A' ' 44' ' ' LEU . . . -74.41 -50.61 17.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.433 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 10.3 pt-20 -48.47 -35.62 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 110.527 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.85 -54.58 44.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 109.881 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.47 -38.11 88.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.932 . . . . 0.0 109.204 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.548 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -59.79 -27.45 66.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.51 -36.48 65.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.644 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -37.34 69.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 23.2 mmt180 -80.65 -16.49 53.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 49.9 mt -87.72 -23.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.709 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -19.95 30.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 51' ' ' GLY . 76.8 m-20 -136.28 2.25 2.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.544 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 50.64 175.33 0.02 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER 169.14 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.761 -1.435 . . . . 0.0 111.802 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.25 -177.72 3.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.8 21.44 79.29 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.536 HG11 ' CD1' ' A' ' 56' ' ' TRP . 8.0 t -99.38 -68.34 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.68 -0.894 . . . . 0.0 109.646 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.536 ' CD1' HG11 ' A' ' 55' ' ' VAL . 86.3 m95 -118.55 -36.71 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.749 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.36 -171.82 23.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.511 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.32 9.73 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 112.115 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -109.53 84.17 2.98 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.714 -1.241 . . . . 0.0 110.453 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.04 144.24 99.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.663 1.349 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.538 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -77.18 134.88 66.86 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.6 Cg_endo -69.18 137.43 37.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 N-CA-C 108.395 -1.425 . . . . 0.0 108.395 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -56.89 156.51 23.36 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.224 1.118 . . . . 0.0 110.081 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 8.0 m-80 -128.62 164.38 22.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 111.059 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.66 34.9 0.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.512 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 66' ' ' VAL . 10.6 m -86.89 109.62 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.513 -0.742 . . . . 0.0 110.441 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 2.1 m -47.06 173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -57.3 13.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.98 -19.29 41.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 10.6 mt-10 -78.58 -45.74 21.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 110.427 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' CB ' HG23 ' A' ' 48' ' ' ILE . . . -70.7 -22.17 62.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.11 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -44.28 58.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.47 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 4.0 m -71.78 -25.2 61.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 71' ' ' ALA . 46.0 mt -77.33 -27.0 52.66 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.468 ' HA ' HD13 ' A' ' 78' ' ' ILE . . . -75.26 -52.58 10.53 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.549 -0.719 . . . . 0.0 109.215 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -59.75 -29.22 68.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 108.623 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.629 ' CH2' ' CB ' ' A' ' 7' ' ' ALA . 31.7 t90 -61.48 -53.34 57.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.61 -0.682 . . . . 0.0 109.507 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.567 HG12 ' CE1' ' A' ' 27' ' ' TYR . 7.2 mt -60.29 -40.98 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.159 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -76.88 -9.81 58.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.598 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 41.7 m . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 0.0 110.644 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 110.28 -0.7 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.09 -32.14 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.861 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 48.8 t -71.51 -45.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 1.4 pp -69.02 -31.4 70.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -59.68 -55.89 28.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -55.45 -42.59 74.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.1 m120 -59.9 -27.89 67.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 110.521 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 75.2 mmtt -93.32 -16.29 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 0.0 110.12 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.95 18.45 34.33 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 9.1 m -68.86 -42.34 77.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.54 5.11 16.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.45 -44.26 11.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 110.651 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 57.4 m -96.73 -19.84 18.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.593 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 26.5 m-70 -98.72 165.88 11.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.015 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.48 ' HB2' ' OG1' ' A' ' 20' ' ' THR . . . -136.82 114.27 10.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 2.5 mp -37.16 -35.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.49 -0.756 . . . . 0.0 110.89 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.78 9.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 111.191 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -112.69 -160.54 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.074 . . . . 0.0 109.889 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.71 131.38 35.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.015 -1.053 . . . . 0.0 110.591 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 mtp -140.83 -99.57 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 5.9 t -93.86 -31.28 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.025 -1.047 . . . . 0.0 109.22 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.76 171.77 18.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_endo -65.92 136.57 45.57 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.6 1.316 . . . . 0.0 110.381 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -42.6 152.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.047 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' A' ' 78' ' ' ILE . 3.6 m-85 -67.37 -57.45 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 0.0 110.213 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.64 -50.13 60.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.855 -1.153 . . . . 0.0 109.638 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.33 -44.14 71.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.357 -0.84 . . . . 0.0 109.992 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.476 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 23.1 t -54.16 -33.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 110.019 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . . . -80.46 -26.35 38.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.373 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.25 -29.37 63.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.1 -38.02 19.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.88 . . . . 0.0 109.749 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -88.15 -4.08 58.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.69 109.04 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.31 -23.76 2.84 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -1.146 . . . . 0.0 110.018 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.85 39.45 0.93 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 110.401 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.49 43.28 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' LEU . . . -69.54 -15.0 63.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -1.176 . . . . 0.0 110.093 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.4 pt-20 -80.49 -34.24 35.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.081 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -65.04 -48.98 71.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -64.64 -46.0 84.38 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.547 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 20.2 mt -55.97 -21.3 20.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -74.91 -43.11 56.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.945 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 43' ' ' TYR . 1.9 pt20 -75.6 -20.53 58.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' CE ' ' A' ' 61' ' ' MET . 8.7 mmt85 -90.54 -16.92 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.311 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.547 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 25.6 mt -85.91 -32.14 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.17 37.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.5 m120 -116.68 -11.45 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 60.84 161.19 0.11 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 1.3 t -179.24 163.33 1.27 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.636 -1.508 . . . . 0.0 112.621 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.583 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -104.68 -178.0 3.53 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.49 20.41 78.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.53 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 44.2 t -96.88 -70.23 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.63 -0.923 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.587 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 98.9 m95 -114.68 -37.53 4.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.525 -0.734 . . . . 0.0 109.679 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.72 -169.45 20.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.21 11.41 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.566 1.511 . . . . 0.0 112.063 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 mt -109.59 86.04 4.23 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.651 -1.281 . . . . 0.0 110.586 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.579 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.3 Cg_exo -59.9 135.32 62.42 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.541 1.285 . . . . 0.0 111.013 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.543 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 52.5 ttp -71.75 130.8 86.58 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.458 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.08 138.52 47.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.648 1.341 . . . . 0.0 109.346 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.02 136.75 71.4 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.342 1.18 . . . . 0.0 110.054 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 3.2 m-80 -107.8 -174.65 2.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.02 . . . . 0.0 110.865 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.88 36.98 3.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.751 . . . . 0.0 110.018 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' SER . 25.8 m -81.37 114.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.044 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.474 ' HB2' ' OE1' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -46.8 174.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.77 -41.11 97.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.994 -1.066 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.17 -23.25 62.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -81.1 -36.75 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 66' ' ' VAL . . . -76.31 -27.9 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.037 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.1 mt-30 -74.1 -41.97 60.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.528 ' HA ' ' CG ' ' A' ' 76' ' ' LYS . 85.8 m -73.8 -24.02 59.76 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 18.5 mt -74.51 -33.72 62.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.7 . . . . 0.0 109.124 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -72.53 -50.04 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -67.46 -23.26 65.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 178.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.465 ' HA ' ' OG ' ' A' ' 80' ' ' SER . 49.3 t90 -75.84 -36.74 59.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.606 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.591 HG12 ' CE1' ' A' ' 27' ' ' TYR . 17.3 mt -65.77 -46.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.805 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -74.12 -13.37 60.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 77' ' ' TRP . 89.2 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.456 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.537 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.7 Cg_endo . . . . . 0 N--CA 1.482 0.821 0 N-CA-C 110.629 -0.566 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 18.9 pt-20 -73.0 -33.64 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.527 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 43.5 t -72.72 -46.69 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.0 pp -73.58 -22.74 59.96 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.209 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 3' ' ' PRO . . . -67.8 -40.96 83.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.706 . . . . 0.0 109.28 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.76 71.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.818 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.9 m120 -63.08 -26.08 68.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.286 -0.884 . . . . 0.0 110.664 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -92.96 -13.2 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 110.345 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.78 66.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 34.1 m -65.95 -15.09 62.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mtp -99.26 10.88 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.119 -0.988 . . . . 0.0 110.332 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.55 -49.73 6.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.494 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.4 m -97.35 -17.84 19.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.402 -0.811 . . . . 0.0 110.702 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 13.2 m-70 -102.87 174.08 6.03 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.138 -0.976 . . . . 0.0 112.169 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -156.29 -170.24 3.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mm -90.36 -62.49 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.72 -1.238 . . . . 0.0 110.272 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -124.76 -3.18 7.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.925 -1.109 . . . . 0.0 110.613 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 69.4 p -83.6 162.44 20.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.91 91.76 3.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.1 -1.0 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.22 -132.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 109.696 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.64 -33.03 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.922 -1.111 . . . . 0.0 109.26 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.92 163.84 12.15 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.511 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -63.8 142.74 83.96 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.706 1.372 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' CB ' ' OD2' ' A' ' 29' ' ' ASP . . . -46.02 153.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.7 m-85 -71.33 -60.74 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.705 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.0 -45.08 31.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.602 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.467 ' OD2' ' CB ' ' A' ' 26' ' ' ALA . 13.8 m-20 -55.44 -45.05 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.731 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.596 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 87.6 t -55.43 -33.81 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.144 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 35' ' ' ALA . . . -75.93 -37.66 58.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 110.511 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.67 66.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.3 -0.875 . . . . 0.0 110.424 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -84.24 -41.06 17.31 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -0.882 . . . . 0.0 109.968 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 15.5 m-85 -88.59 -0.96 57.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.809 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 31' ' ' ALA . . . -53.23 136.27 36.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.991 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.4 -35.24 5.19 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.2 mt-30 -54.02 129.04 32.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 50.63 2.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.72 55.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' HB3' ' OE1' ' A' ' 37' ' ' GLN . . . -90.03 -23.29 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.254 -1.145 . . . . 0.0 110.141 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.0 pt-20 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -68.98 -51.39 39.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.933 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 4.9 t80 -72.29 -27.9 62.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 108.962 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.543 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 21.4 mt -68.18 -26.94 66.0 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.08 -36.36 55.83 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.21 -26.66 59.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.2 mmt-85 -89.26 -17.55 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 37.1 mt -85.33 -26.61 6.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -85.84 -16.22 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.6 t30 -130.93 -1.62 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.095 -1.003 . . . . 0.0 110.584 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 53.83 168.75 0.03 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.6 170.42 0.12 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.605 -1.526 . . . . 0.0 112.084 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.584 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -110.25 -175.63 2.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.584 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.01 23.92 77.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.413 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 34.1 t -105.89 -65.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.732 -0.864 . . . . 0.0 109.901 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.7 m95 -120.83 -37.59 2.97 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.29 -174.56 25.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.74 6.72 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.504 1.469 . . . . 0.0 111.793 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 mt -107.85 81.92 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.214 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.6 Cg_exo -55.28 145.46 66.31 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.586 1.309 . . . . 0.0 111.295 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.525 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 40.9 ttp -79.17 133.9 60.11 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.603 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.427 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.6 Cg_endo -67.56 138.23 45.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.517 1.272 . . . . 0.0 108.99 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.26 140.11 93.08 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.372 1.196 . . . . 0.0 110.16 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.3 m-80 -113.01 170.93 7.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.797 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.53 48.86 0.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.416 -0.803 . . . . 0.0 109.84 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 66' ' ' VAL . 11.2 m -101.56 107.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 66' ' ' VAL . 1.8 m -42.07 148.41 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.847 . . . . 0.0 109.526 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' SER . 14.0 t0 -42.85 -37.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.993 -1.067 . . . . 0.0 110.734 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -64.93 -44.08 90.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.987 -1.071 . . . . 0.0 109.918 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.468 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 62.3 mt-10 -66.03 -46.64 77.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.355 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 48' ' ' ILE . . . -69.61 -19.56 63.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 109.19 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.62 -44.32 57.34 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.8 m -70.53 -27.84 64.47 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.53 ' O ' ' CD1' ' A' ' 78' ' ' ILE . 47.3 mt -65.92 -43.28 88.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.584 -0.697 . . . . 0.0 109.249 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.94 90.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 80' ' ' SER . 5.7 mttm -65.53 -23.88 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.458 ' HB3' ' O ' ' A' ' 74' ' ' LEU . 30.9 t90 -72.32 -46.11 57.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.753 . . . . 0.0 109.831 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.578 HG12 ' CE1' ' A' ' 27' ' ' TYR . 1.8 mp -59.59 -48.25 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.05 -22.68 61.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 109.846 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 12.4 m . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.425 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.2 Cg_exo . . . . . 0 N--CA 1.483 0.864 0 N-CA-C 110.829 -0.489 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -53.5 -45.9 69.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 66.0 t -55.52 -34.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -0.904 . . . . 0.0 109.374 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.19 -30.27 64.8 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.605 0.717 . . . . 0.0 109.548 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -66.87 -30.77 71.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.408 -0.807 . . . . 0.0 110.261 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -87.01 -43.73 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 110.385 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.4 m120 -66.4 -29.06 69.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 73.2 mmtt -96.15 -12.33 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.132 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.27 15.78 63.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 18.6 m -64.15 -21.75 66.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.467 ' HE3' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -93.69 15.24 16.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.482 -179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.55 -31.68 10.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.937 . . . . 0.0 110.373 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -112.0 -16.94 12.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 110.798 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 34.8 m-70 -110.81 160.98 16.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.787 -1.195 . . . . 0.0 112.432 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -135.51 121.6 20.11 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 1.6 mp -38.65 -28.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 110.766 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -149.95 -32.1 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.205 -0.935 . . . . 0.0 111.11 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.533 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -68.9 -161.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.974 -1.079 . . . . 0.0 109.751 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 127.21 18.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -131.9 -100.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.93 -30.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.985 -1.072 . . . . 0.0 109.454 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.1 163.59 17.75 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' ALA . 3.0 Cg_exo -61.7 142.68 94.97 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.587 1.309 . . . . 0.0 110.584 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 20' ' ' THR . . . -43.24 147.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 2.7 m-85 -65.07 -61.48 2.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -47.3 -48.07 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.048 . . . . 0.0 109.336 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.81 -40.89 69.99 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.892 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.479 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 98.7 t -55.97 -44.82 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 110.156 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -30.1 69.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 110.395 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.16 -25.02 62.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.393 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.83 -37.33 14.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -93.63 -0.27 56.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.145 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.09 106.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.428 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.54 76.86 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 40' ' ' ALA . 1.9 mt-30 -145.85 167.96 21.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.59 42.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.55 46.0 0.59 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB3' ' OE1' ' A' ' 37' ' ' GLN . . . -63.12 -29.04 70.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -1.171 . . . . 0.0 110.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.82 -34.86 69.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.184 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.51 -51.16 61.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.302 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -67.6 -26.11 66.1 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.117 -0.99 . . . . 0.0 108.867 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 13.5 mt -68.3 -25.26 65.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.69 -40.28 49.33 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.648 -0.657 . . . . 0.0 109.559 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -76.34 -21.43 56.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.859 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.474 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 5.4 mmm180 -89.05 -19.78 25.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.533 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 43.9 mt -84.98 -30.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.282 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 3.1 ttpm? -81.59 -25.94 35.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 m120 -119.41 -3.54 10.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 49.16 179.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.1 166.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.852 -1.381 . . . . 0.0 111.766 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -106.07 -175.82 2.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.394 -0.816 . . . . 0.0 109.792 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 19.88 76.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.458 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 17.2 t -96.87 -68.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.639 -0.918 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.479 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.3 m95 -117.57 -37.72 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.501 -0.75 . . . . 0.0 109.705 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.99 -172.24 21.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.73 8.04 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.438 1.426 . . . . 0.0 111.973 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -109.06 89.59 6.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.651 -1.281 . . . . 0.0 110.411 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.95 145.4 98.42 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.551 1.29 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.533 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 2.7 tmm? -79.04 131.89 65.26 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.413 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -65.83 134.4 37.41 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.683 1.359 . . . . 0.0 108.973 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.43 135.16 65.99 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.208 1.11 . . . . 0.0 110.211 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.447 ' HB2' HG22 ' A' ' 66' ' ' VAL . 3.8 m-80 -106.65 161.9 14.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.9 43.66 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.087 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 67' ' ' SER . 16.7 m -96.64 114.76 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' VAL . 24.5 p -53.36 -171.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -76.84 -42.75 38.92 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.009 -1.057 . . . . 0.0 109.773 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -64.35 -36.76 85.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 0.0 109.304 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 51.6 mt-10 -69.08 -51.51 38.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -63.5 -18.13 63.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -47.98 49.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 ' HB3' ' A' ' 3' ' ' PRO . 5.1 m -68.41 -24.13 64.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 71' ' ' ALA . 88.7 mt -74.1 -34.51 63.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.613 -0.679 . . . . 0.0 109.349 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.27 -41.64 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.2 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 80' ' ' SER . 4.7 mttt -70.72 -26.8 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.459 -0.776 . . . . 0.0 109.058 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.577 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 35.8 t90 -71.84 -42.27 67.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.912 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 27' ' ' TYR . 11.5 mt -65.35 -48.57 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.31 -16.05 61.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.579 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.977 . . . . 0.0 110.574 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.538 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_exo . . . . . 0 N--CA 1.481 0.756 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.53 -40.61 73.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.6 t -60.28 -54.69 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.429 -0.794 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 1.4 pp -63.29 -32.48 73.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.667 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -65.39 -22.42 66.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -82.35 -50.74 8.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.421 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 18.9 m-80 -63.86 -19.88 65.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 15.1 mmtt -85.04 -16.48 40.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.017 -1.052 . . . . 0.0 109.9 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.97 15.26 45.96 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 9.1 m -71.13 -48.67 50.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -1.213 . . . . 0.0 110.632 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.413 ' HB3' ' HE1' ' A' ' 13' ' ' MET . 81.0 mmm -72.49 3.31 5.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 0.0 110.98 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.14 22.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 0.0 110.425 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.7 m -111.74 -18.43 12.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.629 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 19.2 m-70 -99.14 165.64 11.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 112.043 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -141.6 117.48 10.49 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 22.5 mm -36.2 -29.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.542 -0.724 . . . . 0.0 111.035 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' ALA . 12.9 t70 -161.04 18.04 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.158 -0.964 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -112.01 -177.73 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 110.067 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -119.92 86.16 2.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 110.67 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.2 mtm -95.16 -112.93 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 109.686 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.39 -29.41 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.793 -1.192 . . . . 0.0 109.585 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.09 170.35 15.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.575 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -65.65 134.86 39.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.513 1.27 . . . . 0.0 110.326 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 17' ' ' ALA . . . -43.47 146.77 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.594 ' CE2' ' CH2' ' A' ' 77' ' ' TRP . 5.5 m-85 -57.52 -52.99 63.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.977 -1.077 . . . . 0.0 110.209 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.14 -50.63 58.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.421 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -56.39 -34.32 66.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.192 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.574 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 60.1 t -62.64 -36.87 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.107 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 35' ' ' ALA . . . -78.02 -24.42 47.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.93 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.3 -33.19 69.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.466 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -84.01 -35.51 23.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -90.72 -3.99 57.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 31' ' ' ALA . . . -53.83 128.6 30.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.75 71.86 1.27 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.456 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -145.64 144.1 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.82 46.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 110.627 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.8 42.45 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.456 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . . . -70.22 -21.0 63.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -1.126 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.5 mp0 -74.04 -36.74 64.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.552 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -46.85 82.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.343 -0.848 . . . . 0.0 109.682 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.499 ' OH ' ' NH2' ' A' ' 47' ' ' ARG . 51.5 t80 -73.76 -27.54 61.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.265 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.515 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . 11.3 mt -71.52 -24.92 62.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.83 -32.37 40.63 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -80.05 -24.32 40.79 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.44 -0.787 . . . . 0.0 109.182 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.499 ' NH2' ' OH ' ' A' ' 43' ' ' TYR . 34.5 mmt-85 -90.03 -17.02 28.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 109.088 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.538 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 25.2 mt -88.53 -29.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.722 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -120.09 -13.39 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.238 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.3 175.06 0.02 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.21 171.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.789 -1.418 . . . . 0.0 111.369 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.586 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -107.63 -171.93 1.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.486 -0.759 . . . . 0.0 109.995 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.586 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.22 12.63 61.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 24.9 t -93.97 -59.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.544 -0.974 . . . . 0.0 109.507 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.575 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 97.0 m95 -120.79 -38.92 2.78 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.578 0.704 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.94 -164.54 20.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.7 7.47 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.47 1.447 . . . . 0.0 111.718 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.4 mt -108.11 78.04 0.75 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.768 -1.207 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -56.63 140.11 89.52 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.538 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -74.97 131.01 79.71 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.844 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -67.03 128.66 19.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.642 1.338 . . . . 0.0 109.607 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.65 135.89 70.32 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.379 1.2 . . . . 0.0 110.243 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.28 170.26 8.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.878 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.41 35.18 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.386 -0.821 . . . . 0.0 109.645 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.47 HG13 ' HE3' ' A' ' 10' ' ' LYS . 34.9 m -86.31 105.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 110.151 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -42.41 153.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.251 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 67' ' ' SER . 3.3 m-20 -44.49 -37.57 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.705 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -41.28 90.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.021 -1.049 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 4.8 mm-40 -69.19 -36.99 77.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 66' ' ' VAL . . . -73.6 -20.28 60.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -76.34 -48.79 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -66.48 -25.78 66.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.478 ' O ' HD13 ' A' ' 78' ' ' ILE . 18.6 mt -71.14 -37.4 72.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' CB ' ' HB3' ' A' ' 44' ' ' LEU . . . -67.16 -53.07 33.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.519 -0.738 . . . . 0.0 109.434 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.415 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -63.67 -26.29 68.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.594 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 28.0 t90 -64.89 -36.47 84.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.583 HG12 ' CD1' ' A' ' 27' ' ' TYR . 12.1 mt -71.97 -46.49 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 109.625 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.7 mp -68.65 -11.35 60.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.27 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.569 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.793 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.54 -35.53 70.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.122 -0.986 . . . . 0.0 108.965 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 t -64.91 -53.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.394 -0.816 . . . . 0.0 109.643 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.569 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -68.61 -24.08 64.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' N ' HD11 ' A' ' 6' ' ' LEU . . . -68.13 -29.02 67.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -39.5 19.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.773 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -62.39 -27.75 69.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 110.677 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HG2' HG11 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -88.51 -17.86 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.105 . . . . 0.0 110.413 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.22 13.29 39.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.26 -41.06 90.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -1.205 . . . . 0.0 110.317 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.5 5.93 16.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -0.88 . . . . 0.0 110.598 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.0 -26.51 16.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 110.569 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 m -112.45 -14.65 13.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 29.3 m-70 -111.88 158.33 19.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 111.824 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -129.58 121.36 26.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 16.5 mt -39.73 -26.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.434 -0.791 . . . . 0.0 110.774 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.62 -35.34 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.956 -1.09 . . . . 0.0 111.01 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.06 -164.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.977 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -135.62 92.85 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.649 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -91.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.681 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -100.64 -45.91 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.924 . . . . 0.0 109.674 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.84 178.55 21.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ALA . 2.8 Cg_endo -65.87 137.68 50.1 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.69 1.363 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 30' ' ' VAL . . . -43.07 151.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CD1' HG12 ' A' ' 78' ' ' ILE . 3.3 m-85 -65.32 -59.4 4.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -53.52 -45.13 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.004 -1.06 . . . . 0.0 109.756 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.71 -39.41 77.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 110.021 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 72.2 t -57.98 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 110.116 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB1' ' HG ' ' A' ' 79' ' ' LEU . . . -72.06 -31.26 65.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 110.512 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.21 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 110.169 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -86.53 -48.86 8.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.492 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 8.5 m-85 -73.34 -5.44 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.55 109.94 0.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.16 -27.36 2.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.8 mt-30 -67.52 149.08 50.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -1.124 . . . . 0.0 110.178 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 52.61 2.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.47 50.17 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . . . -71.08 -25.48 62.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 110.042 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 75' ' ' ALA . 1.3 tt0 -67.02 -37.91 84.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 109.65 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.35 56.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.514 ' OH ' ' NE ' ' A' ' 47' ' ' ARG . 6.4 t80 -66.24 -24.15 66.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 109.086 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 13.9 mt -69.44 -30.31 68.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.12 67.42 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -77.07 -26.56 53.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.758 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' CE ' ' A' ' 61' ' ' MET . 4.0 mmt180 -89.77 -16.41 30.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.841 . . . . 0.0 109.242 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 31.2 mt -86.79 -28.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.73 -10.54 53.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -125.48 -15.18 6.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 56.69 161.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.6 OUTLIER 171.72 167.91 0.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.534 -1.568 . . . . 0.0 112.039 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.583 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -103.75 -172.38 2.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.572 -0.705 . . . . 0.0 109.983 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.16 19.9 72.54 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -98.53 -68.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.794 -0.827 . . . . 0.0 109.631 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.6 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 83.0 m95 -116.45 -36.54 3.96 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.39 -0.819 . . . . 0.0 109.497 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.07 -166.48 19.01 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -71.29 15.26 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.405 1.403 . . . . 0.0 112.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 mt -111.48 84.65 5.15 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 110.41 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.576 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.5 Cg_exo -60.81 134.69 55.22 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.648 1.341 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.551 ' CE ' ' O ' ' A' ' 47' ' ' ARG . 52.5 ttp -75.37 133.72 74.24 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.335 -0.853 . . . . 0.0 110.166 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -69.69 134.2 27.57 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.521 1.274 . . . . 0.0 109.146 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.2 Cg_exo -58.17 142.65 97.31 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.202 1.107 . . . . 0.0 110.234 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -112.83 -174.8 2.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.902 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.31 34.17 5.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 7.8 m -74.28 118.74 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.768 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.453 ' C ' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -43.45 159.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 108.996 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -53.24 -50.22 65.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.878 -1.139 . . . . 0.0 110.442 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -21.87 66.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mm-40 -76.36 -40.13 52.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.917 . . . . 0.0 110.321 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.502 ' CB ' HG22 ' A' ' 66' ' ' VAL . . . -71.75 -26.1 62.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -68.85 -44.17 73.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -71.67 -24.42 61.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 38.5 mt -73.46 -33.13 64.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.281 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HB3' ' CG ' ' A' ' 41' ' ' GLU . . . -73.73 -50.73 19.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.139 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -26.94 68.63 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.36 -0.837 . . . . 0.0 109.044 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 40.6 t90 -68.72 -44.15 74.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.581 HG12 ' CD1' ' A' ' 27' ' ' TYR . 20.8 mt -56.99 -51.86 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.862 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.462 ' HG ' ' HB1' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -67.43 -21.74 65.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.664 -0.552 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 12.7 pt-20 -68.23 -37.11 80.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.13 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 4' ' ' GLU . 59.9 t -64.97 -55.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.506 -0.746 . . . . 0.0 109.96 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.0 pp -66.8 -21.89 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.599 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLU . . . -62.54 -47.89 81.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.504 -0.747 . . . . 0.0 109.526 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -40.87 80.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.835 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.7 m120 -65.52 -19.85 66.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.812 . . . . 0.0 110.645 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.467 ' CE ' ' OE1' ' A' ' 70' ' ' GLU . 50.9 mmtt -96.93 -19.69 18.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.058 -1.026 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . 95.63 11.74 54.83 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 37.6 m -67.2 -29.71 69.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.014 -1.286 . . . . 0.0 110.141 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mtp -84.8 7.77 19.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -82.24 -49.49 10.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 110.391 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.6 m -102.9 -19.45 14.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 110.979 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.587 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.5 m-70 -101.61 173.71 6.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.837 -1.164 . . . . 0.0 112.069 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -153.84 -168.19 2.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.473 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 19.2 mm -90.27 -73.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.677 -1.264 . . . . 0.0 110.373 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 28' ' ' LYS . 17.2 p30 -116.03 -1.2 12.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 110.572 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.8 p -87.1 161.41 18.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -105.96 85.85 2.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 110.651 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mtm -88.54 -125.34 0.05 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 0.0 109.84 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 t -69.87 -39.46 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.757 -1.215 . . . . 0.0 109.649 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 173.35 14.91 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.06 136.88 50.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.719 1.379 . . . . 0.0 110.554 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.465 ' HB1' ' OD2' ' A' ' 29' ' ' ASP . . . -42.81 154.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.661 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.4 m-85 -70.11 -62.85 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.975 . . . . 0.0 109.836 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -47.48 -33.01 5.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.077 . . . . 0.0 109.392 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD2' ' HB1' ' A' ' 26' ' ' ALA . 7.2 m-20 -62.68 -46.65 87.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 109.59 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.577 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 49.9 t -57.43 -32.33 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.79 -24.37 38.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.467 -0.771 . . . . 0.0 110.082 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.36 62.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -40.22 12.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 110.098 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 23.3 m-85 -82.7 -7.04 59.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.15 134.74 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.21 5.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.495 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -122.58 138.38 54.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 110.083 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 51.31 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.686 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.07 41.78 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . . . -79.69 -23.29 42.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.226 . . . . 0.0 110.018 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.436 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.36 -36.47 68.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.09 66.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.667 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.75 -28.07 66.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 11.5 mt -68.67 -25.08 64.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.38 40.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.49 -0.756 . . . . 0.0 109.559 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -77.71 -28.03 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.866 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.479 ' O ' ' HE1' ' A' ' 61' ' ' MET . 0.2 OUTLIER -86.48 -20.24 28.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.366 -0.834 . . . . 0.0 109.25 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.547 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 33.9 mt -84.79 -29.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.544 -0.722 . . . . 0.0 110.133 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -86.71 -17.16 34.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.062 -1.024 . . . . 0.0 110.133 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 51' ' ' GLY . 11.1 t-20 -119.0 -13.59 9.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 50.33 174.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 166.47 165.03 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.869 -1.371 . . . . 0.0 111.976 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -99.56 179.59 4.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.611 -0.681 . . . . 0.0 109.544 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.82 16.15 74.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.95 -64.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.566 -0.961 . . . . 0.0 109.373 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.577 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.6 m95 -118.89 -36.66 3.38 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.609 0.719 . . . . 0.0 109.414 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.66 -165.11 15.22 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.484 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.14 11.79 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.506 1.471 . . . . 0.0 112.138 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mt -110.98 88.97 8.87 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.547 -1.346 . . . . 0.0 111.038 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -62.38 132.29 37.8 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.645 1.34 . . . . 0.0 110.821 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.1 tmm? -75.19 129.43 82.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.022 -1.049 . . . . 0.0 109.843 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.419 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -68.47 133.47 28.14 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.528 1.278 . . . . 0.0 108.884 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -57.59 140.85 94.7 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.206 1.108 . . . . 0.0 110.177 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-80 -109.25 164.84 12.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.91 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.45 32.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.832 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' SER . 15.5 m -73.94 120.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.514 -0.741 . . . . 0.0 109.915 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 66' ' ' VAL . 7.4 t -47.4 175.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.46 -69.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -21.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.467 ' OE1' ' CE ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -75.9 -48.39 21.54 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -68.2 -18.95 64.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 108.72 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -48.59 46.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -27.05 68.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.545 ' O ' ' CD1' ' A' ' 78' ' ' ILE . 41.3 mt -66.13 -44.41 84.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -61.23 -52.79 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 1.1 mtpt -60.93 -19.52 60.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.576 ' CZ3' ' CE2' ' A' ' 27' ' ' TYR . 38.6 t90 -80.67 -41.31 23.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.77 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.583 HG12 ' CE1' ' A' ' 27' ' ' TYR . 1.6 mp -61.24 -52.16 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 109.833 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.21 -23.95 67.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.395 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.242 0.544 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 1.6 m-20 -48.68 159.97 0.5 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.17 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.1 Cg_exo -60.98 -49.92 7.26 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.609 1.32 . . . . 0.0 110.313 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' HA ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 tt0 -52.0 -46.91 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 51.1 t -48.11 -40.39 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.384 -0.822 . . . . 0.0 108.962 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 65.4 mt -64.95 -40.01 94.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 109.734 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' CB ' ' CH2' ' A' ' 77' ' ' TRP . . . -58.23 -27.86 64.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.601 -0.687 . . . . 0.0 110.398 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -90.14 -36.57 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 110.777 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -70.57 -25.95 63.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.204 -0.935 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 22.7 mmtm -97.9 -26.35 14.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 110.202 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.43 18.47 14.52 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 14.1 m -65.0 -32.26 73.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.459 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 69.3 mmm -79.15 2.81 19.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.03 11.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 90.2 m -96.93 -15.6 21.08 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 110.961 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.4 m-70 -104.42 172.39 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.96 -1.087 . . . . 0.0 112.047 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.536 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -152.77 124.4 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.4 mp -37.79 -27.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 111.266 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.0 p-10 -155.24 -32.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.996 -1.065 . . . . 0.0 111.404 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 17.9 p -69.65 151.7 45.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.965 -1.085 . . . . 0.0 109.847 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -93.38 117.76 30.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.671 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.3 mtm -123.02 -117.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.478 -0.764 . . . . 0.0 109.514 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 51.0 t -76.45 -34.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.833 -1.167 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.64 171.72 15.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.632 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.2 137.57 48.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.525 1.276 . . . . 0.0 110.072 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.28 156.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.787 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 5.7 m-85 -69.06 -60.55 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -53.06 -42.27 65.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.038 -1.039 . . . . 0.0 109.011 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 59.2 m-20 -58.47 -40.86 83.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.865 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.557 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 16.4 t -56.27 -38.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 109.318 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' CB ' ' A' ' 35' ' ' ALA . . . -74.0 -24.21 59.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.496 -0.753 . . . . 0.0 109.915 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.83 62.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -88.77 -35.44 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 33' ' ' LYS . 3.9 m-30 -94.06 -1.75 53.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 109.84 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -54.05 130.23 37.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.177 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.15 -19.04 15.49 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -66.58 145.78 55.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -1.089 . . . . 0.0 110.027 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.33 2.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.266 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 56.49 0.21 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' O ' HD13 ' A' ' 44' ' ' LEU . . . -75.3 -13.16 60.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -1.161 . . . . 0.0 110.287 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.447 ' CA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -75.18 -30.05 60.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.61 -52.95 17.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.55 -34.64 78.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.911 . . . . 0.0 108.806 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.548 ' CB ' ' HB3' ' A' ' 75' ' ' ALA . 11.5 mt -59.18 -36.6 75.62 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.94 -37.75 86.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 109.667 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -29.54 65.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.974 . . . . 0.0 110.08 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 29.2 mmt180 -88.42 -12.42 43.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.264 -0.898 . . . . 0.0 109.384 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.559 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 38.7 mt -90.28 -25.16 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.452 -0.78 . . . . 0.0 109.446 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' HG21 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -85.53 -14.33 46.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.7 t30 -126.98 -11.71 5.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.55 174.64 0.02 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 163.87 167.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.169 -1.195 . . . . 0.0 111.414 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 3.0 pm0 -101.9 -161.14 0.83 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.435 -0.791 . . . . 0.0 109.925 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 56.4 19.39 25.61 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 56' ' ' TRP . 60.5 t -104.54 -62.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.701 -0.882 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.632 ' CD2' ' CG ' ' A' ' 25' ' ' PRO . 88.2 m95 -120.0 -35.53 3.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.09 -175.93 31.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.517 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.94 6.83 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.379 1.386 . . . . 0.0 111.764 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.546 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 9.1 mt -106.05 85.37 1.59 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.84 -1.162 . . . . 0.0 109.829 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.547 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.7 Cg_endo -54.07 133.86 57.23 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.7 1.369 . . . . 0.0 110.834 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.559 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.2 tmm? -70.52 131.92 87.83 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.145 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.1 Cg_exo -64.38 130.24 26.26 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.73 1.384 . . . . 0.0 109.504 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.486 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.7 Cg_endo -59.38 138.24 83.12 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.478 1.251 . . . . 0.0 110.346 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-80 -110.39 160.63 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.26 35.72 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 67' ' ' SER . 19.8 m -79.86 119.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.393 -0.817 . . . . 0.0 110.028 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -46.39 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.569 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.93 -39.2 79.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.939 -1.1 . . . . 0.0 109.94 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.55 -34.77 74.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.871 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.4 mm-40 -71.71 -38.52 70.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 110.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -72.51 -22.82 60.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.221 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -71.73 -41.68 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.466 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.53 -25.84 61.53 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.496 ' CD1' ' HA ' ' A' ' 71' ' ' ALA . 41.6 mt -72.02 -30.99 65.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HB3' ' CB ' ' A' ' 44' ' ' LEU . . . -73.29 -53.62 10.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.517 -0.739 . . . . 0.0 109.545 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 16.8 ptmt -64.87 -20.79 66.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.227 -0.921 . . . . 0.0 109.076 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.61 ' CH2' ' CB ' ' A' ' 7' ' ' ALA . 43.7 t90 -70.7 -43.55 68.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.304 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.584 HG12 ' CD1' ' A' ' 27' ' ' TYR . 13.1 mt -62.81 -48.78 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.918 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD13 ' CD1' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -69.19 -9.75 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.475 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 81' ' ' GLN . 13.4 t -108.21 -5.13 17.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.528 ' HA ' ' NE2' ' A' ' 81' ' ' GLN . 13.3 mm-40 -50.51 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.026 . . . . 0.0 110.046 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' OXT' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.259 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.546 ' CGD' ' O ' ' A' ' 59' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.215 0.531 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.94 153.76 80.32 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.582 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_endo -60.38 -15.22 34.16 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.726 1.382 . . . . 0.0 110.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -38.15 68.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 4.1 t -62.99 -52.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.884 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 1.4 pp -61.77 -33.85 74.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.208 -0.932 . . . . 0.0 109.661 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' N ' HD11 ' A' ' 6' ' ' LEU . . . -68.44 -21.92 64.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -49.91 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 12.6 m-80 -65.31 -23.57 67.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.134 -0.978 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 22.3 mmtm -84.52 -12.41 54.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 109.798 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' HMC1 ' A' ' 83' ' ' HEM . . . 85.26 14.3 69.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 59.4 m -65.15 -31.7 73.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.252 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.444 ' HE2' HD11 ' A' ' 18' ' ' ILE . 9.2 mtp -88.41 7.62 31.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 110.301 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 -44.82 18.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 70.8 m -102.67 -17.61 15.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 110.887 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.645 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 11.1 m-70 -93.73 168.26 11.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.947 -1.096 . . . . 0.0 112.353 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -148.05 118.72 7.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.6 mp -38.66 -27.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.399 -0.813 . . . . 0.0 110.913 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.5 p-10 -148.65 -35.9 0.19 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.041 -1.037 . . . . 0.0 110.542 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.506 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.05 -179.29 1.47 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -129.83 89.07 2.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 110.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.82 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.006 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 70.7 t -97.75 -25.65 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.977 -1.077 . . . . 0.0 109.396 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.94 173.76 15.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.619 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -68.61 133.35 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.574 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' HB3' ' C ' ' A' ' 19' ' ' ASP . . . -46.11 151.24 0.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.638 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -61.6 -64.39 0.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.115 -0.991 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -48.1 -46.02 33.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -51.9 -47.1 64.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.486 -0.759 . . . . 0.0 110.147 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.541 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 89.7 t -57.99 -34.25 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 35' ' ' ALA . . . -75.78 -26.35 57.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.18 60.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -85.44 -37.35 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' GLY . 11.5 m-85 -97.8 -3.41 38.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -0.944 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -51.27 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 130.93 69.14 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.4 mt-30 -144.7 149.79 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.26 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.02 39.46 0.96 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.47 50.08 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . . . -84.83 -42.46 15.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -1.175 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 10.0 mp0 -59.73 -38.09 80.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 109.926 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.89 84.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.59 ' CZ ' ' HD2' ' A' ' 47' ' ' ARG . 28.6 t80 -70.68 -20.01 62.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.225 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.5 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.7 mt -72.86 -34.86 67.03 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.8 -31.97 59.66 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -28.13 51.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.863 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.59 ' HD2' ' CZ ' ' A' ' 43' ' ' TYR . 6.9 mmp_? -86.65 -16.81 35.47 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.377 -0.827 . . . . 0.0 109.547 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.558 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 58.8 mt -88.22 -28.97 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.459 -0.775 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -80.26 -20.77 43.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.2 m120 -120.86 -17.91 7.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.109 -0.994 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.74 169.48 0.02 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.6 OUTLIER 164.02 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.086 -1.243 . . . . 0.0 111.375 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.578 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -96.94 -160.97 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.313 -0.867 . . . . 0.0 110.44 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.46 19.04 59.59 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.517 HG13 ' CGA' ' A' ' 83' ' ' HEM . 9.4 t -98.28 -69.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.675 -0.897 . . . . 0.0 109.48 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.619 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 92.3 m95 -118.53 -38.25 3.17 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 108.953 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.51 -167.73 15.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.58 14.72 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.558 1.505 . . . . 0.0 112.07 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 8.9 mt -110.13 96.56 26.26 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.545 -1.347 . . . . 0.0 111.005 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' CB ' ' HB3' ' A' ' 53' ' ' GLN . 2.5 Cg_endo -65.01 128.64 21.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.615 1.324 . . . . 0.0 110.589 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.558 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tmm? -69.2 128.93 92.34 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.876 -1.14 . . . . 0.0 108.796 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.22 129.97 25.76 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.643 1.338 . . . . 0.0 109.5 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_exo -57.27 148.95 67.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.243 1.128 . . . . 0.0 109.972 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.467 ' OD1' HBB2 ' A' ' 83' ' ' HEM . 19.0 m-80 -120.73 163.45 18.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 111.047 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.5 36.37 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 66' ' ' VAL . 16.7 m -84.4 108.62 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' VAL . 17.5 p -42.22 152.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.559 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -45.92 -48.76 16.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.797 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.84 -34.79 75.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.976 . . . . 0.0 110.46 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.452 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.97 -40.93 75.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.16 -21.47 61.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.02 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -70.27 -44.05 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.521 ' CG2' ' HB3' ' A' ' 3' ' ' PRO . 18.9 m -70.84 -23.99 62.44 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.529 ' CD1' HMB1 ' A' ' 83' ' ' HEM . 31.7 mt -71.7 -37.45 70.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 44' ' ' LEU . . . -65.83 -51.47 58.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.452 -0.78 . . . . 0.0 109.159 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 80' ' ' SER . 13.2 mtmt -66.7 -22.2 66.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.239 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.582 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 62.0 t90 -78.01 -24.04 48.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 109.92 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.557 HG12 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -84.29 -61.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.482 HD11 HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -49.74 -42.17 45.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 9.2 m -86.58 -42.25 13.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.531 ' CG ' ' HB3' ' A' ' 27' ' ' TYR . 0.7 OUTLIER 37.83 -155.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.1 tpmt? . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.159 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.645 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 8.2 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 3.3 m-20 -54.0 145.99 30.96 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.957 . . . . 0.0 110.123 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.553 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.8 Cg_endo -61.93 -33.32 84.16 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.544 1.286 . . . . 0.0 110.716 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt-20 -65.09 -27.56 68.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 0.0 109.134 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 32.8 t -71.82 -59.25 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.535 -0.728 . . . . 0.0 109.404 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.553 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -62.67 -19.2 63.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.85 -53.85 23.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.932 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -29.78 69.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 110.463 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -67.17 -37.21 83.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.664 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 10.3 mmtp -82.31 -13.37 57.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.18 12.45 49.0 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 22.5 m -65.26 -38.62 90.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -1.23 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.85 7.26 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.469 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.88 -34.22 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.3 m -110.55 -14.86 14.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 110.745 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.631 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.7 m-70 -102.98 154.38 19.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.895 -1.128 . . . . 0.0 111.846 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 26' ' ' ALA . . . -132.47 121.32 23.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 28' ' ' LYS . 11.2 mt -40.34 -26.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.957 . . . . 0.0 110.724 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 4.6 t70 -152.21 -35.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.81 163.68 25.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 110.518 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -103.44 89.31 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 110.559 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 mtm -85.49 -95.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.683 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.13 -39.35 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.68 -179.41 18.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.614 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.49 129.86 22.3 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.627 1.33 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 17' ' ' ALA . . . -42.91 143.39 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.811 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.631 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 5.8 m-85 -53.92 -48.97 69.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HD2' ' CG2' ' A' ' 18' ' ' ILE . 2.1 mtpp -57.43 -50.67 72.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.8 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.26 -27.13 63.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 110.242 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.58 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 92.0 t -67.06 -43.09 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.047 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 79' ' ' LEU . . . -74.47 -23.86 58.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 110.395 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.62 59.04 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.215 -0.928 . . . . 0.0 110.378 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -90.88 -41.7 11.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE2' ' CZ2' ' A' ' 56' ' ' TRP . 7.7 m-85 -78.35 -7.81 57.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.077 -1.015 . . . . 0.0 110.041 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 31' ' ' ALA . . . -54.86 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 155.44 -45.14 0.54 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 5.4 mm-40 -42.24 157.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 57.58 3.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.663 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.05 57.96 0.39 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -70.7 -44.42 66.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -1.1 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 21.0 pt-20 -50.44 -37.79 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -60.8 -57.79 11.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 85.2 t80 -67.18 -13.86 62.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.557 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 18.8 mt -78.42 -29.39 47.11 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.46 64.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 2.3 mmt180 -81.42 -16.67 51.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.21 -0.932 . . . . 0.0 109.521 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.557 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 9.7 mt -81.08 -34.43 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.34 -12.41 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 110.685 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.32 -8.84 8.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 110.654 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 62.01 160.55 0.16 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 11.5 t -179.2 154.82 0.68 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.639 -1.507 . . . . 0.0 112.54 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.11 -176.31 3.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.679 -0.638 . . . . 0.0 109.703 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 66.05 10.77 52.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.529 ' CG1' HBA2 ' A' ' 83' ' ' HEM . 2.1 t -89.41 -62.25 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.482 -1.011 . . . . 0.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.614 ' CD2' ' CG ' ' A' ' 25' ' ' PRO . 73.9 m95 -115.65 -33.72 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.497 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.36 -167.31 25.76 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.7 Cg_endo -69.44 6.87 1.04 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.376 1.384 . . . . 0.0 111.695 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.482 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 15.6 mt -110.59 90.17 10.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 120.805 -1.185 . . . . 0.0 110.5 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -61.88 141.34 89.45 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.786 1.414 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.576 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 32.4 ttp -71.92 128.48 89.31 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.902 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -63.0 130.94 30.7 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.589 1.31 . . . . 0.0 109.379 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.1 131.2 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.322 1.169 . . . . 0.0 109.928 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.1 m-80 -105.55 163.89 12.31 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 110.537 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 30.32 1.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.842 . . . . 0.0 109.733 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' CG ' ' A' ' 49' ' ' LYS . 15.8 m -74.16 116.06 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -48.85 179.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.695 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -65.5 -68.89 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -45.83 -32.19 2.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.364 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -68.3 -51.35 45.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.351 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -63.67 -21.07 66.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -71.44 -47.32 56.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.389 -0.819 . . . . 0.0 108.815 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -68.16 -24.43 64.98 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' A' ' 71' ' ' ALA . 70.4 mt -68.99 -41.33 77.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.581 -0.699 . . . . 0.0 109.381 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.7 -48.75 65.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.379 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -63.68 -19.2 64.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.394 -0.817 . . . . 0.0 109.458 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -78.51 -46.18 20.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 110.098 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 27' ' ' TYR . 3.1 mt -63.06 -48.36 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.532 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.461 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -71.75 -13.71 61.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.812 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -82.35 -31.79 29.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.652 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 65.1 mm-40 -43.09 -54.74 4.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.332 -0.855 . . . . 0.0 110.083 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.621 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.181 0.515 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.3 156.88 83.43 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.552 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 2.9 Cg_endo -60.99 -15.12 36.92 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.678 1.357 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -33.0 57.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.246 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.8 t -66.4 -48.74 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.572 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 3.4 pp -69.36 -30.57 68.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.268 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' N ' HD11 ' A' ' 6' ' ' LEU . . . -58.14 -55.42 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -43.77 82.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.83 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -55.13 -29.45 57.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 16.7 mmtm -90.69 -22.32 21.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.903 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.62 14.44 27.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 19.8 m -66.36 -36.05 81.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -1.198 . . . . 0.0 110.407 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 mtp -82.16 6.82 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 110.882 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.87 -43.87 13.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 89.9 m -101.71 -18.13 15.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.3 m-70 -101.0 167.45 10.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 111.969 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 20' ' ' THR . . . -147.26 122.8 10.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.1 mp -37.45 -27.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.424 -0.798 . . . . 0.0 111.075 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -155.68 -34.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 110.863 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 17' ' ' ALA . 62.4 p -69.62 154.53 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.199 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.66 122.72 39.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mtm -124.73 -98.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 68.1 t -94.2 -36.32 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 109.317 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.25 178.17 16.4 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.579 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -69.23 133.2 25.94 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.656 1.346 . . . . 0.0 110.485 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -42.43 150.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.057 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 8.2 m-85 -60.73 -56.95 15.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.247 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' HE2' ' HD3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -50.32 -49.81 52.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.753 -1.217 . . . . 0.0 109.448 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -53.33 -41.75 66.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 49.5 t -53.98 -42.44 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 35' ' ' ALA . . . -73.65 -23.42 59.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.965 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.64 -34.07 77.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HD2' ' CZ3' ' A' ' 56' ' ' TRP . 3.2 ttmt -86.92 -49.97 7.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -76.46 1.22 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -59.01 126.72 28.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.439 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.36 28.67 4.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.48 138.83 50.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 110.24 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.42 41.12 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.95 55.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 44' ' ' LEU . . . -87.15 -17.27 33.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.149 -1.207 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 2.3 mt-10 -75.63 -33.71 60.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.887 . . . . 0.0 109.611 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.68 63.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.554 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.73 -31.65 68.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.087 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.545 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 15.4 mt -67.46 -26.99 66.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.61 -33.41 60.52 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.574 -0.704 . . . . 0.0 109.834 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -75.36 -36.36 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' O ' ' HE3' ' A' ' 61' ' ' MET . 33.5 mmt-85 -82.18 -15.76 52.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.545 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 24.9 mt -85.99 -29.6 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.24 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -84.84 -17.75 37.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.4 t30 -126.8 -0.04 6.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.111 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.27 -173.76 0.13 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.2 p 167.42 158.72 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.038 -1.272 . . . . 0.0 111.871 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.552 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -106.15 -164.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 0.0 109.959 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.552 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 53.39 18.98 7.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG12 HBA2 ' A' ' 83' ' ' HEM . 6.7 t -94.72 -69.25 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -1.103 . . . . 0.0 109.17 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.579 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 98.4 m95 -110.41 -39.03 5.06 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.736 0.779 . . . . 0.0 108.941 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.88 -174.0 24.32 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -70.02 8.15 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.349 1.366 . . . . 0.0 111.506 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.3 mt -107.34 82.37 1.21 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.044 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -55.42 145.67 66.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.667 1.351 . . . . 0.0 111.563 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.534 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.6 ttm -74.95 132.42 77.3 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.808 . . . . 0.0 109.406 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -67.59 129.14 19.37 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.624 1.328 . . . . 0.0 109.036 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -56.68 133.92 61.11 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.179 1.094 . . . . 0.0 110.146 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.0 m-80 -105.9 -177.99 3.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.19 35.41 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 27.1 m -87.09 103.14 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.8 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 40.3 t -43.61 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 109.345 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 67' ' ' SER . 1.5 m-20 -42.78 -47.51 5.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.507 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -59.17 -41.42 88.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 17.8 mt-10 -65.87 -38.94 90.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.817 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' A' ' 66' ' ' VAL . . . -70.45 -19.92 62.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.091 -1.006 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -49.05 30.41 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -27.94 66.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 51.1 mt -69.53 -36.12 76.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 44' ' ' LEU . . . -67.46 -53.4 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -0.756 . . . . 0.0 109.505 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 10.4 mttt -61.98 -24.07 66.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.591 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 40.9 t90 -72.03 -35.44 69.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.511 -0.743 . . . . 0.0 109.57 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.582 HG12 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -74.8 -38.96 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mt -74.21 -11.96 60.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.367 -0.833 . . . . 0.0 110.313 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.5 p -91.65 -24.24 19.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.422 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 81.9 mm-40 -55.82 125.9 23.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HD3' ' HE2' ' A' ' 28' ' ' LYS . 2.4 tppp? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.141 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.572 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.162 0.506 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -80.41 162.44 61.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 109.901 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.0 Cg_endo -60.43 -19.32 58.29 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.645 1.34 . . . . 0.0 110.673 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.526 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 8.9 pt-20 -70.19 -39.09 75.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.259 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.526 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 57.8 t -64.32 -54.93 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.564 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 3.8 pp -67.95 -22.66 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.876 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 3' ' ' PRO . . . -67.92 -33.36 74.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -37.86 33.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.8 m120 -65.11 -30.99 71.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.883 . . . . 0.0 110.877 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.496 ' HB3' HBB2 ' A' ' 83' ' ' HEM . 6.3 mmtm -83.82 -18.09 38.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.887 -1.133 . . . . 0.0 109.772 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.8 12.34 43.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 15.0 m -68.03 -35.83 78.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.268 . . . . 0.0 110.417 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 1.69 41.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -38.64 15.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.005 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HA ' HG23 ' A' ' 23' ' ' VAL . 22.1 m -101.24 -26.41 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 110.444 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.635 ' NE2' ' ND ' ' A' ' 83' ' ' HEM . 32.9 m-70 -106.36 166.79 10.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.46 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -135.21 -176.16 4.17 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 18' ' ' ILE . 45.3 mm -91.32 -26.01 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 110.402 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 19' ' ' ASP . 2.8 p30 -162.22 19.35 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.976 -1.077 . . . . 0.0 111.06 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -114.93 -166.4 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.954 -1.091 . . . . 0.0 110.194 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 87.81 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 110.765 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.3 mtm -97.89 -98.43 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 109.598 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG13 ' HAC' ' A' ' 83' ' ' HEM . 94.9 t -88.87 -45.58 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 0.0 109.231 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.7 172.74 14.4 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' CD ' HAD2 ' A' ' 83' ' ' HEM . 3.1 Cg_exo -64.23 143.04 82.4 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.469 1.247 . . . . 0.0 110.275 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 20' ' ' THR . . . -41.42 163.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 1.4 m-85 -81.44 -53.14 6.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HG3' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -52.13 -42.11 63.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.05 -38.48 76.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.541 -0.724 . . . . 0.0 109.681 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.575 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 91.1 t -58.55 -46.45 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.825 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 79' ' ' LEU . . . -72.88 -19.93 61.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.552 -0.717 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -32.43 62.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -43.07 13.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.932 . . . . 0.0 109.822 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -78.81 -5.76 54.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.854 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -62.21 89.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.13 -20.94 0.57 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 2.4 mt-30 -71.48 149.91 45.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.101 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.15 40.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 110.428 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.7 56.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . . . -90.28 -20.16 23.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.242 . . . . 0.0 110.45 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.93 -34.84 66.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 109.503 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.35 -50.93 63.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.721 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.526 ' CE1' ' CG ' ' A' ' 47' ' ' ARG . 1.2 t80 -68.11 -30.3 69.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 109.106 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 9.2 mt -65.13 -29.7 70.57 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.92 66.31 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.597 -0.689 . . . . 0.0 110.008 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -76.38 -27.4 56.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 110.363 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' CG ' ' CE1' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -87.72 -15.26 37.55 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CG1' ' CMA' ' A' ' 83' ' ' HEM . 35.2 mt -86.61 -32.31 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.382 -0.824 . . . . 0.0 109.618 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -85.06 -10.48 56.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 3.1 m-20 -124.16 -12.8 7.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.14 175.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 166.28 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.047 -1.267 . . . . 0.0 111.462 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -102.37 179.67 4.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.766 . . . . 0.0 109.955 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.81 19.26 73.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.528 HG11 ' CGA' ' A' ' 83' ' ' HEM . 2.6 t -91.58 -67.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.596 -0.944 . . . . 0.0 109.459 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.575 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 88.6 m95 -119.41 -35.48 3.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.509 -0.744 . . . . 0.0 109.041 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.05 -174.29 23.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.485 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.39 11.44 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.426 1.417 . . . . 0.0 112.019 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.459 ' O ' HMD2 ' A' ' 83' ' ' HEM . 15.4 mt -109.11 87.06 4.42 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.659 -1.276 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.15 138.41 85.77 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.593 1.312 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.539 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.6 tmm? -79.02 126.68 81.6 Favored Pre-proline 0 C--N 1.299 -1.595 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.372 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HG2' HBC1 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -63.68 127.4 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.3 Cg_exo -55.18 132.99 55.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.241 1.127 . . . . 0.0 110.054 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.23 167.14 10.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.468 -0.77 . . . . 0.0 110.862 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.87 30.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.401 -0.812 . . . . 0.0 109.877 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 67' ' ' SER . 17.9 m -76.13 113.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 109.667 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -50.99 -176.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.778 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.09 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.019 -1.051 . . . . 0.0 110.087 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -52.86 -32.51 45.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mt-10 -68.97 -49.01 61.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -67.62 -17.45 64.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 109.239 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.41 -41.29 61.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.528 ' HA ' ' CG ' ' A' ' 76' ' ' LYS . 60.8 m -76.21 -23.39 54.62 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HB3' ' CMB' ' A' ' 83' ' ' HEM . 53.8 mt -75.9 -34.84 59.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.573 -0.704 . . . . 0.0 109.181 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.459 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -73.49 -48.3 34.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.081 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -66.02 -27.01 67.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.066 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.519 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 36.4 t90 -67.15 -41.46 86.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.413 -0.804 . . . . 0.0 109.355 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.583 HG12 ' CE1' ' A' ' 27' ' ' TYR . 16.2 mt -61.72 -50.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.381 -0.824 . . . . 0.0 109.521 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.466 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 1.6 mt -62.08 -25.35 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -33.68 73.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 81' ' ' GLN . 50.2 mm-40 -53.27 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.439 ' HB3' ' HG3' ' A' ' 28' ' ' LYS . 6.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.329 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.635 ' ND ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.333 0.587 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.27 153.86 66.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 110.156 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.2 Cg_exo -61.48 -14.95 38.06 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.664 1.349 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.71 -39.41 66.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.194 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 96.0 t -65.41 -54.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.857 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 2.2 pp -68.57 -24.16 64.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.349 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 3' ' ' PRO . . . -70.13 -33.54 71.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -84.59 -37.64 20.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.16 -35.59 77.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.501 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.455 ' HB3' ' H2A' ' A' ' 83' ' ' HEM . 1.0 OUTLIER -85.27 -10.49 56.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.045 -1.034 . . . . 0.0 110.589 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.44 58.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 20.4 m -62.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -1.234 . . . . 0.0 110.412 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mtp -85.51 10.68 12.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.893 . . . . 0.0 110.465 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.21 13.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 92.7 m -105.82 -21.57 13.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 110.711 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 14.8 m-70 -94.95 167.34 11.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 0.0 112.71 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -145.15 120.11 10.0 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CG2' ' HG3' ' A' ' 81' ' ' GLN . 7.8 mt -39.98 -25.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.221 -0.925 . . . . 0.0 111.15 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.9 p30 -147.52 -39.59 0.19 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.792 -1.192 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -70.51 153.93 42.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.013 . . . . 0.0 110.428 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -98.37 97.64 8.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.359 -0.838 . . . . 0.0 109.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.6 mtm -97.13 -121.58 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 64.3 t -70.4 -32.59 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.768 -1.208 . . . . 0.0 109.819 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.99 173.24 15.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.599 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.48 131.61 26.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.627 1.33 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 30' ' ' VAL . . . -47.01 153.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.873 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 16' ' ' HIS . 10.3 m-85 -66.81 -51.15 59.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -53.93 -49.88 67.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.534 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.68 -43.36 68.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.99 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.474 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 75.5 t -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 35' ' ' ALA . . . -72.92 -28.52 62.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.61 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -0.973 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.14 -42.9 10.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -88.28 0.85 55.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 31' ' ' ALA . . . -55.24 122.37 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.176 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.57 13.6 20.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.34 141.16 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -1.199 . . . . 0.0 110.214 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.37 52.89 2.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.76 48.03 0.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.83 -22.52 59.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -1.21 . . . . 0.0 110.092 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 3.3 pt-20 -71.3 -29.16 64.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.504 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -65.31 -53.06 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.674 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -70.09 -28.47 65.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 19.7 mt -68.67 -26.24 65.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 42' ' ' ALA . . . -73.14 -39.18 65.9 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.408 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -77.26 -23.13 51.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.542 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 19.5 mmt180 -90.13 -17.64 27.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.344 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.537 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 26.8 mt -85.32 -31.02 6.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -86.98 -11.97 48.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 110.1 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' GLY . 86.3 m-20 -121.04 -13.32 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 109.951 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 54.74 169.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 168.88 166.27 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.804 -1.41 . . . . 0.0 111.857 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.6 -173.9 2.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.777 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.0 9.92 54.93 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 HBA2 ' A' ' 83' ' ' HEM . 39.8 t -89.82 -50.96 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.398 -1.06 . . . . 0.0 109.459 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.599 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 92.5 m95 -129.22 -36.11 1.75 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.41 -166.53 24.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.2 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.411 1.408 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.525 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 10.3 mt -109.67 83.14 2.55 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.844 -1.16 . . . . 0.0 110.567 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.64 160.5 17.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.716 1.377 . . . . 0.0 111.1 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.569 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 54.0 ttp -96.91 131.21 28.28 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.501 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.431 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -67.59 132.33 26.78 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.653 1.344 . . . . 0.0 109.033 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.9 139.9 92.85 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.267 1.14 . . . . 0.0 110.344 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.481 ' HB2' HG12 ' A' ' 66' ' ' VAL . 10.9 m-80 -114.8 165.68 12.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 0.0 110.793 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.46 38.31 0.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.034 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 64' ' ' ASN . 27.3 m -71.31 116.41 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.312 -0.867 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 70' ' ' GLU . 29.1 m -51.62 178.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -59.15 5.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 109.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.6 -13.5 9.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mm-40 -82.29 -46.0 14.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.219 -0.926 . . . . 0.0 110.201 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.28 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.026 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -44.32 39.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.492 -0.755 . . . . 0.0 109.059 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 77' ' ' TRP . 35.5 m -74.44 -22.1 59.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.588 ' CD2' ' CMB' ' A' ' 83' ' ' HEM . 30.2 mt -75.5 -39.46 58.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.662 -0.649 . . . . 0.0 109.393 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . . . -72.06 -43.54 64.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.017 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 80' ' ' SER . 46.5 mttt -65.82 -30.83 71.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.216 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.568 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 33.4 t90 -66.55 -44.38 82.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.634 -0.666 . . . . 0.0 109.918 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.585 HG12 ' CD1' ' A' ' 27' ' ' TYR . 73.4 mt -61.43 -47.02 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.643 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.1 -12.73 60.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -0.824 . . . . 0.0 109.76 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -89.72 -19.94 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.091 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.523 ' HG2' ' CB ' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -40.65 -28.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 81' ' ' GLN . 2.2 tttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.416 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.588 ' CMB' ' CD2' ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.31 155.03 66.67 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.533 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_endo -60.61 -38.14 74.56 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.674 1.355 . . . . 0.0 110.296 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.84 -43.33 65.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 99.0 t -54.53 -37.82 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.298 -0.876 . . . . 0.0 109.432 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 3' ' ' PRO . 71.3 mt -65.0 -36.82 85.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.796 . . . . 0.0 109.759 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB1' ' CG ' ' A' ' 13' ' ' MET . . . -69.01 -23.25 64.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.2 -34.5 17.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.342 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.156 -0.965 . . . . 0.0 110.576 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HB3' ' CBB' ' A' ' 83' ' ' HEM . 0.0 OUTLIER -89.87 -13.33 36.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.599 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.86 17.93 52.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 35.4 m -63.38 -22.37 66.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -1.083 . . . . 0.0 110.715 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.527 ' CG ' ' HB1' ' A' ' 7' ' ' ALA . 5.6 mtp -90.82 8.79 33.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.822 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.37 -51.41 6.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.566 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 72.5 m -93.7 -16.29 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 110.94 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.582 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 15.1 m-70 -104.68 160.41 14.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.126 . . . . 0.0 112.289 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' CB ' ' SD ' ' A' ' 22' ' ' MET . . . -142.47 126.8 17.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' CG2' ' HG3' ' A' ' 81' ' ' GLN . 2.3 mp -38.72 -26.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.421 -0.799 . . . . 0.0 111.243 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 60.8 m-20 -152.19 -37.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.987 -1.071 . . . . 0.0 110.75 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -69.22 165.74 19.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -113.9 95.6 5.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.07 -1.019 . . . . 0.0 110.863 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.515 ' SD ' ' CB ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -85.05 -88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.688 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 71.8 t -104.46 -27.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 109.566 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.27 177.23 16.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.549 ' CG ' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -67.69 137.04 40.95 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.677 1.357 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' O ' ' CG2' ' A' ' 30' ' ' VAL . . . -44.9 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.584 ' CE1' HG12 ' A' ' 78' ' ' ILE . 3.0 m-85 -78.39 -46.69 19.32 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -56.86 -54.32 47.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -50.67 -36.61 36.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.257 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.571 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 94.7 t -61.5 -44.34 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.131 -0.981 . . . . 0.0 110.446 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -72.71 -23.81 60.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.403 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.79 -23.38 52.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -90.06 -42.27 11.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.48 3.82 38.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.039 -1.038 . . . . 0.0 110.09 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 31' ' ' ALA . . . -57.34 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.49 -39.01 0.86 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -49.21 138.74 12.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.106 -1.232 . . . . 0.0 110.354 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 50.49 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.392 -0.818 . . . . 0.0 110.121 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.69 42.46 0.05 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.494 ' O ' ' CG ' ' A' ' 44' ' ' LEU . . . -75.99 -18.78 59.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.269 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.519 ' HG2' ' CB ' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -75.06 -37.0 61.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.489 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.45 -52.03 50.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -65.91 -32.26 73.66 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 108.78 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.539 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 12.6 mt -64.57 -30.69 71.71 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.65 -34.47 74.05 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.655 -0.653 . . . . 0.0 109.581 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.8 -44.32 64.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.342 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.499 ' O ' ' HE2' ' A' ' 61' ' ' MET . 24.9 mmt180 -73.76 -20.33 60.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.132 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 47.5 mt -80.61 -31.53 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -88.41 -20.28 25.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' GLY . 20.2 t30 -113.73 -5.8 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 57.64 162.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.2 t 177.51 161.4 0.5 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.614 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.26 -175.07 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.836 -0.54 . . . . 0.0 109.951 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 69.09 16.58 70.95 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG13 ' CD1' ' A' ' 56' ' ' TRP . 89.4 t -97.96 -60.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.569 -0.96 . . . . 0.0 109.731 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.571 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 98.3 m95 -118.43 -39.8 2.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.48 -0.763 . . . . 0.0 109.46 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.73 -166.32 21.32 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.483 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.91 12.54 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.31 1.34 . . . . 0.0 111.902 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 8.7 mt -109.61 78.54 1.19 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.612 -1.305 . . . . 0.0 110.431 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.546 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.1 140.33 94.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.518 1.272 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.538 ' CE ' HBA1 ' A' ' 83' ' ' HEM . 7.6 ttp -72.89 135.45 80.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.489 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -69.36 135.11 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.798 1.42 . . . . 0.0 108.725 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.05 148.36 85.77 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.289 1.152 . . . . 0.0 110.392 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 1.7 m-80 -127.76 173.79 9.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.487 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.11 35.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 25.9 m -73.5 103.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.801 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -43.16 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.63 -68.08 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 0.0 110.13 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -21.0 1.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.305 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' CG ' ' NZ ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -73.86 -47.2 39.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 48' ' ' ILE . . . -71.14 -16.51 62.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.167 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -41.92 50.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -76.11 -27.6 57.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 24.1 mt -71.87 -34.17 69.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' HG2' ' A' ' 41' ' ' GLU . . . -70.37 -49.81 45.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.795 . . . . 0.0 109.397 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.2 OUTLIER -67.19 -24.71 65.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.896 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.533 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 54.3 t90 -71.27 -33.33 69.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 109.328 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.584 HG12 ' CE1' ' A' ' 27' ' ' TYR . 15.4 mt -69.88 -48.42 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.612 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 2.6 mp -72.39 -17.05 61.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.87 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 3.1 m -89.09 -13.86 37.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.213 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.51 ' HG3' ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -41.8 -46.84 4.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.327 -0.858 . . . . 0.0 110.449 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.285 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.579 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 1' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.299 0.571 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 6' ' ' LEU . 93.1 m-20 -77.1 163.29 65.96 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.867 . . . . 0.0 110.003 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.498 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 2.9 Cg_endo -59.61 -29.11 89.04 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' OE1' ' C ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -69.33 -31.37 69.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.316 -0.865 . . . . 0.0 108.743 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.8 t -70.76 -59.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.177 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 2' ' ' ASP . 0.3 OUTLIER -62.08 -21.49 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 109.536 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 3' ' ' PRO . . . -76.0 -29.33 58.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.364 -0.835 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 -27.82 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.807 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.2 m120 -72.34 -38.7 68.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.817 . . . . 0.0 110.33 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HB3' ' CBB' ' A' ' 83' ' ' HEM . 0.8 OUTLIER -83.09 -4.69 58.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.029 . . . . 0.0 110.193 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.52 18.01 65.02 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.438 ' HA ' ' C3B' ' A' ' 83' ' ' HEM . 23.8 m -63.82 -38.21 90.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.304 . . . . 0.0 110.44 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.76 7.09 13.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.576 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.43 -36.62 17.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.922 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.9 m -106.01 -17.68 14.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.2 m-70 -99.61 171.08 8.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.033 -1.042 . . . . 0.0 111.769 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -146.6 119.03 8.42 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.1 mp -37.78 -33.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.492 -0.755 . . . . 0.0 111.149 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.2 p30 -156.58 8.36 0.2 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.889 -1.132 . . . . 0.0 111.744 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -103.75 -176.1 2.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.708 -1.245 . . . . 0.0 109.921 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 9.8 mmtp -121.22 104.71 9.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.14 -0.975 . . . . 0.0 110.65 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.7 mtp -118.26 -106.55 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -89.07 -39.61 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.85 -1.157 . . . . 0.0 109.666 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.83 168.82 12.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.583 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -66.27 135.29 39.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.605 1.318 . . . . 0.0 110.502 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 17' ' ' ALA . . . -42.8 150.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -63.29 -59.91 4.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -0.938 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -47.59 -47.64 28.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.412 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' OD2' ' HE2' ' A' ' 21' ' ' LYS . 18.2 m-20 -57.33 -39.27 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 0.0 110.009 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 27' ' ' TYR . 73.3 t -57.08 -36.25 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 35' ' ' ALA . . . -79.68 -29.62 40.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.461 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.37 -24.18 62.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.438 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -90.2 -42.89 10.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -90.43 9.18 30.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 31' ' ' ALA . . . -55.83 140.89 40.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -12.0 67.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -54.06 147.25 13.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 110.353 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 49.15 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -0.841 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.82 53.24 0.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -73.47 -20.15 60.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -1.167 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 1.1 pt-20 -66.95 -23.25 65.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 0.0 109.966 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -72.92 -59.54 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.594 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.5 t80 -65.27 -25.7 67.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.927 . . . . 0.0 109.046 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 16.5 mt -66.75 -34.86 78.78 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.86 67.47 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -74.26 -37.12 63.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.11 -0.994 . . . . 0.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.1 mmt180 -84.55 -14.91 47.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.973 -1.08 . . . . 0.0 109.644 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.536 ' CD1' HMA3 ' A' ' 83' ' ' HEM . 30.2 mt -85.98 -25.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.029 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.36 -19.36 33.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.42 -0.8 . . . . 0.0 110.447 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 4.8 m120 -127.99 -4.02 5.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.454 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.14 173.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.7 167.85 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.825 -1.397 . . . . 0.0 111.594 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.578 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -100.21 177.86 4.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 109.921 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.44 21.96 79.06 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.547 HG12 ' CGA' ' A' ' 83' ' ' HEM . 10.5 t -95.17 -71.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.518 -0.989 . . . . 0.0 109.91 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.583 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 88.1 m95 -117.75 -34.88 4.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.053 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.45 -172.25 20.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.22 13.55 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.56 1.506 . . . . 0.0 112.231 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' HAD2 ' A' ' 83' ' ' HEM . 8.2 mt -110.63 93.35 16.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.615 -1.303 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -61.8 131.01 33.34 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.644 1.339 . . . . 0.0 110.811 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.533 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 5.4 tmm? -73.73 132.2 81.01 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -64.37 139.0 63.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.706 1.371 . . . . 0.0 108.702 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.5 Cg_endo -60.27 142.97 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.274 1.144 . . . . 0.0 110.274 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 2.8 m-80 -113.22 161.06 17.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.957 . . . . 0.0 110.529 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.49 34.1 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 28.6 m -80.87 114.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.768 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.0 m -50.52 -177.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.033 . . . . 0.0 109.597 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.1 -59.07 3.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.993 -1.067 . . . . 0.0 109.967 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -33.4 50.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.2 mm-40 -67.47 -50.14 60.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -64.23 -21.68 66.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -45.31 61.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.395 -0.816 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.6 m -72.59 -22.13 61.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.547 HD22 ' CMB' ' A' ' 83' ' ' HEM . 62.0 mt -73.0 -36.86 67.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.543 -0.723 . . . . 0.0 109.253 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -70.64 -50.72 33.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.7 OUTLIER -61.51 -24.16 66.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.838 . . . . 0.0 109.021 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.498 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 38.6 t90 -74.55 -41.19 61.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.496 -0.753 . . . . 0.0 109.863 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CD1' ' A' ' 27' ' ' TYR . 37.3 mt -60.51 -42.36 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.591 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -75.05 -13.53 60.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.511 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -100.06 -15.7 18.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 110.473 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.499 ' HA ' ' NE2' ' A' ' 81' ' ' GLN . 18.1 mm-40 -50.6 92.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 80' ' ' SER . 11.8 mmtp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.104 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.566 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.235 0.54 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -50.55 154.94 2.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.959 . . . . 0.0 109.961 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.467 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 2.8 Cg_endo -60.55 -26.76 83.54 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.663 1.349 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -38.33 79.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.206 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 50.8 t -62.65 -50.19 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.711 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 1.3 pp -72.08 -20.92 61.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.457 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.05 -37.51 87.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.782 . . . . 0.0 109.605 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -83.71 -38.06 21.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.823 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.482 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -60.21 -35.34 75.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.442 -0.786 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 46.3 mmtm -87.01 -14.05 42.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.59 10.29 56.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 19.5 m -62.62 -39.03 92.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.261 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 3.32 22.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 111.019 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.88 -43.51 14.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.032 . . . . 0.0 110.423 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 39.9 m -98.04 -23.09 15.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.534 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 30.1 m-70 -103.84 -175.18 2.73 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.362 1.077 . . . . 0.0 112.419 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.607 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -162.11 -171.6 2.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -86.41 -69.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.669 -1.27 . . . . 0.0 110.118 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' C ' ' HB1' ' A' ' 26' ' ' ALA . 4.5 t0 -110.08 -19.56 13.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 1.1 p -72.11 -169.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 5.3 pttt -150.51 87.46 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 mtm -79.88 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.92 . . . . 0.0 109.885 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 11.4 t -83.52 -29.61 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.0 171.48 14.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -65.33 144.05 78.99 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.488 1.257 . . . . 0.0 110.077 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 20' ' ' THR . . . -43.58 162.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.6 m-85 -77.29 -60.62 2.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -50.97 -37.77 46.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.7 m-20 -61.91 -46.29 90.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.802 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.462 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 68.7 t -52.17 -37.28 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.81 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' CB ' ' HA ' ' A' ' 79' ' ' LEU . . . -85.08 -21.07 29.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 110.299 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.8 -26.25 60.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 15.3 tppt? -87.21 -48.02 8.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.913 . . . . 0.0 110.092 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ALA . 13.9 m-85 -77.1 -13.11 60.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.02 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -43.15 109.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.74 34.3 0.7 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.466 ' CB ' ' HB1' ' A' ' 40' ' ' ALA . 2.5 mt-30 -125.93 144.37 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -1.22 . . . . 0.0 110.304 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.39 47.6 1.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.859 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.78 40.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.013 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' HB1' ' CB ' ' A' ' 37' ' ' GLN . . . -80.72 -31.39 36.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -1.133 . . . . 0.0 109.874 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -67.98 -22.93 64.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.457 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.47 -53.15 20.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.536 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.9 t80 -68.7 -24.87 64.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.546 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 8.9 mt -69.69 -32.52 71.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.56 68.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.94 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.24 -37.31 63.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.036 -1.04 . . . . 0.0 110.287 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.3 mmt-85 -78.18 -18.41 55.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.912 . . . . 0.0 109.569 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 30.7 mt -80.34 -36.04 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.702 . . . . 0.0 109.857 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -78.13 -31.08 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 110.431 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -109.28 -4.46 16.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 57.76 166.38 0.1 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 174.52 164.33 0.23 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.599 -1.53 . . . . 0.0 112.386 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.578 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -108.37 -171.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.626 -0.671 . . . . 0.0 109.848 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 20.58 76.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.636 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 78.7 t -102.81 -70.75 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.583 -0.951 . . . . 0.0 109.58 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.636 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 99.0 m95 -110.67 -41.07 4.39 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.5 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.23 -167.37 19.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.492 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.63 11.41 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.437 1.425 . . . . 0.0 111.895 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.422 ' O ' HMD1 ' A' ' 83' ' ' HEM . 10.4 mt -107.71 77.45 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.601 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.8 Cg_exo -56.38 139.05 86.03 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.535 1.281 . . . . 0.0 110.841 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.518 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 12.3 ttp -71.29 133.03 85.6 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.511 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -67.64 134.62 33.33 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.681 1.358 . . . . 0.0 108.992 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.32 136.04 69.47 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.269 1.141 . . . . 0.0 110.53 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-80 -113.75 170.47 8.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.474 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.83 34.95 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 67' ' ' SER . 16.0 m -78.15 114.42 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.12 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.7 t -50.84 -176.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -71.1 -42.11 69.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 110.324 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.05 -35.36 80.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.938 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.434 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mt-10 -72.97 -40.79 65.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 66' ' ' VAL . . . -73.74 -21.63 60.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -77.81 -43.35 30.81 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.261 -0.899 . . . . 0.0 108.577 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.8 m -72.87 -24.5 60.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.494 ' O ' HD11 ' A' ' 78' ' ' ILE . 23.6 mt -72.58 -46.17 55.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.459 ' HA ' HD13 ' A' ' 78' ' ' ILE . . . -64.19 -42.93 96.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.371 -0.83 . . . . 0.0 109.183 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.0 OUTLIER -69.56 -26.48 64.51 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 109.044 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 30.6 t90 -68.99 -43.08 75.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.298 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.585 HG12 ' CD1' ' A' ' 27' ' ' TYR . 6.0 mt -62.07 -43.57 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.021 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.533 ' HA ' ' CB ' ' A' ' 31' ' ' ALA . 2.0 mt -75.48 -14.12 60.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.351 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 47.9 t -83.5 -31.73 26.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.467 -0.771 . . . . 0.0 110.11 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 3.1 mm100 -52.54 157.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.012 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.2 tptt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.535 ' CMA' HD12 ' A' ' 78' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.151 0.501 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.402 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -74.76 167.26 38.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.458 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 3.0 Cg_endo -61.43 -17.82 55.77 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.618 1.325 . . . . 0.0 110.393 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.96 -32.95 65.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.372 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.69 -51.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.491 ' C ' ' CD1' ' A' ' 6' ' ' LEU . 2.5 pp -66.37 -31.28 71.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.398 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -56.45 -46.72 80.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -68.32 -37.53 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 0.0 109.736 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.88 -22.94 65.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.797 . . . . 0.0 110.229 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 45.5 mmtm -95.5 -25.17 16.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.812 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.57 13.12 28.9 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 24.6 m -64.69 -39.74 94.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.244 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 2.55 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.09 -48.27 16.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 97.0 m -100.31 -27.02 13.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.453 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.636 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 14.7 m-70 -97.62 168.32 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.211 1.005 . . . . 0.0 112.35 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -151.61 -166.79 2.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.6 mm -90.44 -75.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.781 -1.199 . . . . 0.0 110.145 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.14 -1.44 13.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.501 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 p -81.28 -168.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.958 . . . . 0.0 110.03 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.44 108.84 7.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.6 mtm -117.65 -119.52 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.046 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 42.7 t -77.75 -35.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.845 -1.159 . . . . 0.0 109.807 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.8 168.89 12.76 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.76 139.65 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.726 1.382 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -43.21 154.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.396 -0.815 . . . . 0.0 109.752 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.602 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.4 m-85 -70.51 -58.01 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' CG ' ' HA ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -48.04 -47.25 33.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -52.0 -45.56 64.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.413 -0.804 . . . . 0.0 109.929 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.585 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 81.3 t -55.45 -37.96 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' CB ' HD21 ' A' ' 79' ' ' LEU . . . -76.33 -25.48 54.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.38 -29.86 65.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -85.41 -42.12 14.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -90.63 7.09 41.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -61.03 118.28 6.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.384 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.38 -8.17 26.58 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.471 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -66.17 147.03 53.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -1.174 . . . . 0.0 110.098 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.22 56.17 3.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.02 46.63 0.3 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . . . -72.38 -16.03 61.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.408 ' HA ' HD11 ' A' ' 44' ' ' LEU . 2.7 mt-10 -70.17 -37.76 75.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.808 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -51.46 69.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 t80 -67.42 -31.82 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 108.953 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 24.0 mt -64.75 -25.17 67.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.4 -35.06 41.27 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.706 -0.621 . . . . 0.0 109.929 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -77.57 -24.52 49.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 11.8 mmp_? -89.46 -21.8 22.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 48.1 mt -84.6 -26.67 6.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.62 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -90.1 -8.06 52.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.397 -0.814 . . . . 0.0 110.484 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -133.14 -7.49 3.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.062 -1.023 . . . . 0.0 111.202 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 69.06 162.17 2.75 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -174.36 150.11 1.43 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.585 -1.538 . . . . 0.0 112.855 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.6 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.68 -173.71 2.3 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.694 -0.629 . . . . 0.0 109.558 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.25 16.29 53.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.638 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 98.0 t -93.13 -71.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.637 -0.919 . . . . 0.0 109.225 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.638 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 96.8 m95 -109.86 -39.57 5.04 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.718 0.771 . . . . 0.0 109.012 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.58 -178.03 28.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.518 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.91 8.09 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.498 1.466 . . . . 0.0 112.091 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.458 HD12 HG21 ' A' ' 59' ' ' ILE . 4.5 mt -107.12 80.04 0.78 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.674 -1.266 . . . . 0.0 109.651 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HG3' ' CB ' ' A' ' 53' ' ' GLN . 3.0 Cg_endo -55.37 148.9 49.13 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.854 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.577 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 7.9 ttp -76.79 131.97 72.57 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.057 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.533 ' CG ' HBC1 ' A' ' 83' ' ' HEM . 2.9 Cg_endo -65.9 134.57 37.83 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.617 1.325 . . . . 0.0 109.122 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.3 132.42 48.8 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.289 1.152 . . . . 0.0 110.075 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-80 -107.88 160.35 15.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 110.522 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.13 32.8 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.791 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 67' ' ' SER . 22.9 m -72.35 114.62 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 110.212 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' VAL . 33.6 m -47.74 174.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.53 -64.62 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.808 -1.183 . . . . 0.0 110.186 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -22.22 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 11.4 mm-40 -72.42 -52.54 15.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.21 -18.76 65.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.948 . . . . 0.0 108.785 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.93 -47.63 43.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.9 m -68.0 -24.49 65.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.534 ' O ' ' CD1' ' A' ' 78' ' ' ILE . 75.6 mt -73.19 -33.6 65.49 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.76 -51.46 40.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.61 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -60.98 -32.07 71.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 109.108 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.472 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 27.9 t90 -64.71 -48.08 75.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.716 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.595 HG12 ' CE1' ' A' ' 27' ' ' TYR . 1.6 mt -60.34 -56.35 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.448 -0.782 . . . . 0.0 110.028 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.514 HD21 ' CB ' ' A' ' 31' ' ' ALA . 1.5 mt -66.82 -11.74 56.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 39.9 t -95.95 -20.31 18.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 2.9 mm100 -46.34 -66.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.09 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.516 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 2.6 mttm . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.636 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.182 0.515 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 3.1 m-20 -66.66 164.1 36.08 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.999 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo -61.57 -45.48 17.62 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.697 1.367 . . . . 0.0 110.462 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 2' ' ' ASP . 7.2 pt-20 -48.65 -45.97 39.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 109.542 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 37.9 t -51.06 -47.12 31.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.9 . . . . 0.0 109.078 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 71.0 mt -56.06 -50.52 70.75 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.586 0.707 . . . . 0.0 109.801 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -51.94 -26.27 10.06 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.582 -0.698 . . . . 0.0 110.251 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -56.69 3.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 110.994 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 15.1 m-80 -64.44 -11.3 32.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.911 -1.118 . . . . 0.0 110.467 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 71.2 mmtt -101.42 -15.01 17.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 110.03 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.05 12.11 71.7 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 29.4 m -63.23 -40.46 97.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.245 . . . . 0.0 110.347 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -74.44 2.47 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.14 -50.55 12.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -99.64 -14.26 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 110.785 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.629 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 19.6 m-70 -105.34 174.13 6.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.076 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -149.87 -179.47 7.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.445 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.3 mp -90.66 -24.83 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.869 -1.144 . . . . 0.0 110.414 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 12.5 p-10 -157.77 -27.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 0.0 111.463 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 81.0 p -68.86 -173.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.772 -1.205 . . . . 0.0 110.115 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 104.64 8.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 111.011 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.88 -132.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.83 . . . . 0.0 109.112 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.4 -48.17 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.864 -1.147 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.03 167.79 21.89 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -67.0 143.32 65.4 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.572 1.301 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 25' ' ' PRO . . . -44.97 170.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.731 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.5 m-85 -86.93 -54.6 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.953 -1.092 . . . . 0.0 110.04 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HG3' ' HB3' ' A' ' 82' ' ' LYS . 1.1 tmmm? -50.54 -49.74 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.928 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -54.64 -42.81 71.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.073 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.537 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 53.5 t -56.07 -38.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 79' ' ' LEU . . . -76.5 -26.58 55.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.39 -29.11 65.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.2 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -84.64 -47.77 10.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 109.984 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -77.28 -3.71 41.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 31' ' ' ALA . . . -52.27 121.91 7.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.934 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.24 -37.45 2.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -63.17 126.28 26.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -1.082 . . . . 0.0 110.06 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.2 46.05 1.29 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.57 40.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -79.92 -12.74 59.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 109.908 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -75.11 -22.45 58.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.529 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -71.62 -51.52 22.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.664 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.556 ' CE1' ' NE ' ' A' ' 47' ' ' ARG . 45.5 t80 -69.64 -33.4 72.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 22.6 mt -61.38 -30.12 70.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.22 -38.85 60.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -19.44 60.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.051 -1.031 . . . . 0.0 109.845 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' NE ' ' CE1' ' A' ' 43' ' ' TYR . 6.5 mmt180 -90.17 -24.15 21.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.535 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 62.6 mt -86.71 -19.75 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.331 -0.856 . . . . 0.0 109.318 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -22.99 24.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 110.516 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 57.6 m-80 -126.21 -6.71 6.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 110.407 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.16 173.98 0.03 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 2.8 t 162.11 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.413 -1.051 . . . . 0.0 111.172 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.2 pm0 -100.16 -165.26 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 64.14 18.72 62.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.463 ' CG1' HBA2 ' A' ' 83' ' ' HEM . 2.4 t -95.5 -67.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.739 -0.859 . . . . 0.0 109.099 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.551 ' CB ' ' HG3' ' A' ' 25' ' ' PRO . 95.5 m95 -124.1 -36.38 2.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.65 -177.44 20.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.487 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -69.46 8.25 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.457 1.438 . . . . 0.0 112.038 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' O ' HAD2 ' A' ' 83' ' ' HEM . 6.3 mt -105.86 100.78 29.58 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.715 -1.241 . . . . 0.0 110.851 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' CB ' ' HB3' ' A' ' 53' ' ' GLN . 2.4 Cg_endo -64.63 133.41 36.68 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.457 1.24 . . . . 0.0 110.602 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.601 ' HE1' ' NA ' ' A' ' 83' ' ' HEM . 0.9 OUTLIER -71.87 135.6 83.0 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.487 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.0 Cg_endo -64.21 130.46 27.17 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.735 1.387 . . . . 0.0 109.456 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.23 135.79 64.29 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.401 1.211 . . . . 0.0 110.61 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.424 ' HB2' HG23 ' A' ' 66' ' ' VAL . 5.5 m-80 -109.05 163.83 12.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.67 36.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.969 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 66' ' ' VAL . 15.5 m -84.38 105.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.056 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 75.1 p -42.58 147.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.224 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' GLN . 8.0 p-10 -42.57 -31.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.45 -47.96 68.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.109 -0.994 . . . . 0.0 109.564 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 52.7 mt-10 -63.62 -48.05 78.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 110.161 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -67.27 -16.64 64.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 109.142 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.33 -45.62 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -27.74 63.39 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 49.6 mt -69.77 -34.96 74.48 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.46 -54.65 18.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 80' ' ' SER . 6.2 mttp -58.43 -25.12 61.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 108.871 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.468 ' HB3' ' O ' ' A' ' 74' ' ' LEU . 35.9 t90 -70.51 -43.11 70.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.61 -0.681 . . . . 0.0 109.515 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.596 HG12 ' CE1' ' A' ' 27' ' ' TYR . 4.9 mt -59.38 -50.91 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.739 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -73.72 -9.97 59.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 36.7 t -97.5 -16.46 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 110.326 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 22.5 mm-40 -43.7 -44.0 6.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 110.212 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 10.8 tttt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.629 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.62 164.79 0.39 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.101 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.1 Cg_exo -61.28 -27.22 83.04 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.678 1.357 . . . . 0.0 110.268 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.28 -33.92 73.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 108.626 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 98.0 t -64.45 -58.02 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.643 -0.661 . . . . 0.0 109.718 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 3.7 pp -64.16 -24.42 67.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -67.72 -29.49 68.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -52.16 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.322 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 15.1 m-80 -63.27 -16.48 60.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.091 -1.006 . . . . 0.0 110.383 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.498 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 34.2 mmtt -87.97 -18.8 28.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.63 13.53 53.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.444 ' HA ' ' C3B' ' A' ' 83' ' ' HEM . 57.4 m -69.72 -38.68 76.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -1.235 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mtp -82.36 6.0 18.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.782 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.52 -35.71 19.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 110.353 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 36.4 m -106.0 -22.95 12.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -0.819 . . . . 0.0 110.391 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 28.7 m-70 -103.35 153.84 20.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 111.415 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -129.89 123.93 31.96 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.476 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 35.7 mm -36.78 -29.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 111.014 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -153.45 -32.33 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.177 -0.952 . . . . 0.0 111.088 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.43 179.33 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.023 -1.048 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -117.69 120.42 37.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -0.872 . . . . 0.0 110.741 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 19.5 mtp -125.22 -108.08 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 25.3 t -86.32 -31.78 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 171.71 17.26 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -66.0 140.42 60.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.682 1.359 . . . . 0.0 110.383 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' O ' ' CG2' ' A' ' 30' ' ' VAL . . . -42.44 149.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 110.233 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 3.0 m-85 -63.43 -60.19 3.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.207 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -49.19 48.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.635 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -55.48 -40.07 71.21 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 110.027 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.603 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 95.5 t -57.84 -38.39 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.003 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 79' ' ' LEU . . . -75.92 -25.83 56.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 110.001 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -27.49 63.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 19.1 tttt -86.56 -43.75 12.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -82.82 -2.25 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 109.978 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.7 101.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.73 33.81 0.42 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.78 145.86 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.229 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.07 41.57 1.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.36 48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 44' ' ' LEU . . . -76.92 -33.66 57.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -1.168 . . . . 0.0 110.1 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HG2' ' CB ' ' A' ' 75' ' ' ALA . 3.0 tm-20 -64.29 -24.79 67.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.34 -51.6 23.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 1.3 t80 -71.32 -21.79 62.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.14 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 40' ' ' ALA . 3.5 mt -74.5 -26.67 60.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.24 46.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.636 -0.665 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.52 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -77.15 -34.66 56.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 75.5 mmt-85 -81.37 -22.11 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 44' ' ' LEU . 19.3 mt -80.98 -30.05 11.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.39 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.35 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -118.63 0.25 11.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.364 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 58.01 158.76 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.492 ' CB ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -177.32 158.63 1.47 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.546 -1.561 . . . . 0.0 112.595 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.34 -172.57 2.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.62 -0.675 . . . . 0.0 109.688 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.4 19.07 75.81 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG12 ' CD1' ' A' ' 56' ' ' TRP . 27.7 t -99.16 -74.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.632 -0.922 . . . . 0.0 109.814 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.603 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 97.5 m95 -106.91 -38.8 5.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.42 -165.74 18.82 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.484 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.05 13.44 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.383 1.389 . . . . 0.0 111.963 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.449 ' O ' ' CMD' ' A' ' 83' ' ' HEM . 6.3 mt -110.76 80.16 2.06 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.569 -1.332 . . . . 0.0 110.301 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -60.18 144.71 99.48 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.674 1.355 . . . . 0.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.563 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 5.9 ttp -73.93 134.55 77.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.661 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.469 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -69.77 139.26 39.75 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.668 1.352 . . . . 0.0 109.065 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 132.34 41.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.254 1.134 . . . . 0.0 110.133 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.4 m-80 -108.03 173.38 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.744 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.08 33.4 2.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.969 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 67' ' ' SER . 16.7 m -78.41 120.84 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 109.885 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 66' ' ' VAL . 6.2 m -49.68 -178.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.889 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.04 -58.2 4.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.694 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.86 -17.45 36.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.6 mm-40 -77.6 -50.23 12.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.42 -22.68 66.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.262 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -72.52 -44.61 61.97 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 3' ' ' PRO . 1.6 m -71.24 -24.05 62.11 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 27.1 mt -68.39 -38.21 81.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.494 ' CB ' ' HG2' ' A' ' 41' ' ' GLU . . . -69.79 -51.2 35.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.135 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 80' ' ' SER . 1.2 mttp -62.42 -23.34 66.8 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.309 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.493 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 33.9 t90 -73.64 -42.15 61.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.485 -0.759 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.572 HG12 ' CD1' ' A' ' 27' ' ' TYR . 96.7 mt -63.29 -56.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 75' ' ' ALA . 1.3 mp -65.78 -18.43 65.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.852 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 3.6 t -78.48 -29.81 46.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 110.148 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.536 ' OE1' ' CB ' ' A' ' 27' ' ' TYR . 12.0 mt-30 -57.61 -167.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.371 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.524 ' CGA' HG13 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.438 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -69.35 175.12 2.33 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 110.09 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 2.8 Cg_endo -62.1 -20.82 71.08 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.626 1.33 . . . . 0.0 110.577 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 4' ' ' GLU . 5.7 tm-20 -68.35 -44.64 74.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' CG1' ' HG3' ' A' ' 1' ' ' GLU . 25.9 t -58.77 -50.13 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 110.087 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.546 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -70.85 -22.6 62.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.351 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.46 ' N ' HD13 ' A' ' 6' ' ' LEU . . . -62.45 -38.95 91.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.571 -0.705 . . . . 0.0 109.392 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -41.14 34.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.9 m120 -62.95 -23.46 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HB3' HBB2 ' A' ' 83' ' ' HEM . 17.7 mmtt -91.14 -14.53 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.93 11.59 58.73 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 17.6 m -69.49 -38.58 77.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -1.202 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.35 6.78 9.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.25 -46.56 10.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.319 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 94.8 m -99.0 -16.56 18.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -0.811 . . . . 0.0 110.578 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.597 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.7 m-70 -110.07 178.63 4.34 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.387 1.089 . . . . 0.0 112.435 -177.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -155.29 -169.17 3.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 HD11 ' OE1' ' A' ' 81' ' ' GLN . 29.9 mm -90.8 -73.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.683 -1.261 . . . . 0.0 110.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -112.55 -10.14 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 110.004 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -77.4 -161.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 0.0 109.879 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 119.74 9.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.508 ' CE ' ' O ' ' A' ' 16' ' ' HIS . 15.4 mtm -121.58 -113.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.749 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 54.1 t -78.19 -32.78 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.801 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.78 175.33 16.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.513 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.63 142.12 69.41 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.617 1.325 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -42.6 157.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.936 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -73.41 -61.33 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.936 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' TYR . 5.8 tttt -46.29 -45.77 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 0.0 109.462 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -51.58 -45.56 63.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 109.811 179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 88.6 t -55.03 -45.21 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.94 -21.25 63.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.768 . . . . 0.0 110.155 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.68 42.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 110.531 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -35.14 15.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.119 -0.988 . . . . 0.0 110.084 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' ALA . 16.6 m-85 -85.9 -9.24 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -42.73 111.2 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.94 40.28 2.16 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.81 152.22 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 110.335 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.02 42.12 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.98 46.45 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' ' CG ' ' A' ' 44' ' ' LEU . . . -66.19 -29.68 70.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -1.107 . . . . 0.0 110.532 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -68.66 -32.22 71.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.19 -52.86 16.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.561 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 13.3 t80 -70.38 -19.39 63.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.276 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.563 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 10.8 mt -73.97 -33.82 64.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.75 69.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.735 -0.603 . . . . 0.0 109.5 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -43.75 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.561 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.51 -17.21 58.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.437 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 13.3 mt -83.19 -24.75 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 mtpp -85.34 -29.15 24.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.293 -0.879 . . . . 0.0 110.396 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 36.6 p30 -114.46 -5.15 12.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.634 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 59.05 172.1 0.42 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.62 163.5 0.12 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.705 -1.468 . . . . 0.0 112.422 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.584 ' CB ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -110.33 -178.91 3.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.433 -0.792 . . . . 0.0 109.876 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 74.51 20.22 79.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.584 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 71.3 t -103.91 -67.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.584 ' CD1' ' CG1' ' A' ' 55' ' ' VAL . 99.5 m95 -111.07 -40.13 4.56 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.338 -0.851 . . . . 0.0 110.114 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.54 -165.84 18.16 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.496 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.479 1.453 . . . . 0.0 111.619 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.413 ' O ' HMD3 ' A' ' 83' ' ' HEM . 7.1 mt -108.29 85.62 2.87 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.79 -1.194 . . . . 0.0 111.174 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.584 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.16 155.49 39.64 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.627 1.33 . . . . 0.0 110.275 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.585 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 49.9 ttp -87.92 134.85 34.44 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.465 ' HG2' HBC1 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -67.29 132.95 28.96 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.768 1.404 . . . . 0.0 109.172 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -59.04 136.09 70.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.269 1.142 . . . . 0.0 110.461 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.0 m-80 -112.03 163.25 14.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.401 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.8 36.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 67' ' ' SER . 16.0 m -77.71 108.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.374 -0.828 . . . . 0.0 110.421 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -43.72 146.22 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 67' ' ' SER . 7.7 p-10 -41.15 -40.91 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.104 -0.997 . . . . 0.0 110.872 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.35 -45.22 94.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 72.9 mm-40 -64.09 -42.38 96.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.97 -22.17 65.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.008 . . . . 0.0 109.699 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -72.15 -41.21 67.36 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' TRP . 1.2 m -73.96 -24.49 59.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 78' ' ' ILE . 41.8 mt -72.42 -37.86 68.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.557 -0.714 . . . . 0.0 109.18 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -71.83 -49.51 37.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.127 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 80' ' ' SER . 2.8 mttt -63.78 -25.15 68.05 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.353 -0.842 . . . . 0.0 108.816 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 24.7 t90 -70.39 -51.9 26.31 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.541 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 74' ' ' LEU . 4.3 mt -54.68 -49.66 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.15 -17.36 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.973 . . . . 0.0 109.847 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 11.9 t -93.34 -8.7 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.862 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.52 ' CG ' ' O ' ' A' ' 78' ' ' ILE . 15.1 mm-40 -40.62 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' SER . 28.2 mmmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.245 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.585 ' NA ' ' SD ' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 170.3 3.76 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.442 ' HB3' HG23 ' A' ' 73' ' ' THR . 3.0 Cg_exo -60.84 -40.05 56.97 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.644 1.339 . . . . 0.0 110.541 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 20.4 tt0 -56.89 -48.36 78.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.4 t -49.77 -34.26 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.406 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 39.8 mt -71.45 -38.38 71.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.629 ' CB ' ' CH2' ' A' ' 77' ' ' TRP . . . -58.47 -27.14 64.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.676 . . . . 0.0 110.141 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -90.0 -46.9 8.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.932 . . . . 0.0 110.528 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.0 m120 -63.99 -16.75 62.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.243 -0.911 . . . . 0.0 111.052 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 54.4 mmtt -104.46 -25.38 12.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.056 . . . . 0.0 110.487 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' O ' ' HB1' ' A' ' 14' ' ' ALA . . . 104.21 15.0 22.89 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 17.0 m -66.79 -35.05 79.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 0.0 110.2 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.446 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 56.8 mmm -79.71 5.96 12.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.914 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 11' ' ' GLY . . . -88.48 -37.21 15.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.109 -0.994 . . . . 0.0 110.482 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -105.33 -16.59 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.0 m-70 -105.16 166.78 10.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.903 -1.123 . . . . 0.0 112.082 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 20' ' ' THR . . . -146.91 120.13 8.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 17.9 mt -37.36 -29.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.3 p30 -151.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.077 -1.015 . . . . 0.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 17' ' ' ALA . 19.8 p -70.0 163.11 26.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -104.25 129.08 52.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 0.0 110.635 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.42 ' HE2' ' O ' ' A' ' 16' ' ' HIS . 10.3 mtm -127.27 -88.75 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.44 -33.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.47 174.5 16.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.506 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -64.71 129.65 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.56 1.294 . . . . 0.0 110.305 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -38.91 149.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.448 -0.782 . . . . 0.0 110.073 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 3.4 m-85 -65.4 -58.98 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 110.52 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -48.27 -47.12 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.954 -1.091 . . . . 0.0 109.623 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.13 -40.47 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 59.0 t -58.45 -39.9 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.34 -19.9 55.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.994 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.41 -28.71 46.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 0.0 110.057 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -89.6 -40.34 12.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.85 -11.46 59.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.0 103.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 109.985 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.7 33.82 0.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.75 128.49 42.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -1.198 . . . . 0.0 110.157 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.22 56.17 3.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.52 44.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' O ' HD13 ' A' ' 44' ' ' LEU . . . -74.41 -50.61 17.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.433 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 10.3 pt-20 -48.47 -35.62 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 110.527 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.85 -54.58 44.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 109.881 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.47 -38.11 88.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.932 . . . . 0.0 109.204 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.548 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -59.79 -27.45 66.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.51 -36.48 65.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.644 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -37.34 69.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 23.2 mmt180 -80.65 -16.49 53.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 49.9 mt -87.72 -23.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.709 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -19.95 30.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 51' ' ' GLY . 76.8 m-20 -136.28 2.25 2.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.544 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 50.64 175.33 0.02 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER 169.14 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.761 -1.435 . . . . 0.0 111.802 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.25 -177.72 3.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.8 21.44 79.29 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.57 ' CG1' ' CGA' ' A' ' 83' ' ' HEM . 8.0 t -99.38 -68.34 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.68 -0.894 . . . . 0.0 109.646 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.536 ' CD1' HG11 ' A' ' 55' ' ' VAL . 86.3 m95 -118.55 -36.71 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.749 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.36 -171.82 23.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.511 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.32 9.73 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 112.115 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.466 ' O ' ' CMD' ' A' ' 83' ' ' HEM . 6.3 mt -109.53 84.17 2.98 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.714 -1.241 . . . . 0.0 110.453 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.04 144.24 99.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.663 1.349 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.577 ' HE2' ' NA ' ' A' ' 83' ' ' HEM . 1.0 OUTLIER -77.18 134.88 66.86 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.6 Cg_endo -69.18 137.43 37.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 N-CA-C 108.395 -1.425 . . . . 0.0 108.395 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -56.89 156.51 23.36 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.224 1.118 . . . . 0.0 110.081 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 8.0 m-80 -128.62 164.38 22.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 111.059 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.66 34.9 0.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.512 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 66' ' ' VAL . 10.6 m -86.89 109.62 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.513 -0.742 . . . . 0.0 110.441 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 2.1 m -47.06 173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -57.3 13.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.98 -19.29 41.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 10.6 mt-10 -78.58 -45.74 21.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 110.427 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' CB ' HG23 ' A' ' 48' ' ' ILE . . . -70.7 -22.17 62.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.11 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -44.28 58.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.47 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 4.0 m -71.78 -25.2 61.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 71' ' ' ALA . 46.0 mt -77.33 -27.0 52.66 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.468 ' HA ' HD13 ' A' ' 78' ' ' ILE . . . -75.26 -52.58 10.53 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.549 -0.719 . . . . 0.0 109.215 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -59.75 -29.22 68.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 108.623 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.629 ' CH2' ' CB ' ' A' ' 7' ' ' ALA . 31.7 t90 -61.48 -53.34 57.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.61 -0.682 . . . . 0.0 109.507 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.567 HG12 ' CE1' ' A' ' 27' ' ' TYR . 7.2 mt -60.29 -40.98 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.159 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -76.88 -9.81 58.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.598 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 41.7 m -121.08 7.64 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 0.0 110.644 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.6 ' OE1' ' CD2' ' A' ' 77' ' ' TRP . 17.3 mm100 -42.64 -54.87 3.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.983 . . . . 0.0 110.416 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.358 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.577 ' NA ' ' HE2' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.242 0.544 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' HB2' HG21 ' A' ' 5' ' ' VAL . 2.0 m-20 -87.28 153.0 53.5 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 110.222 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo -61.34 -24.13 78.12 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.704 1.37 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.09 -32.14 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.861 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 2' ' ' ASP . 48.8 t -71.51 -45.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 1.4 pp -69.02 -31.4 70.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -59.68 -55.89 28.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -55.45 -42.59 74.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.1 m120 -59.9 -27.89 67.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 110.521 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 75.2 mmtt -93.32 -16.29 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 0.0 110.12 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.95 18.45 34.33 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 9.1 m -68.86 -42.34 77.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.54 5.11 16.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.45 -44.26 11.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 110.651 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 57.4 m -96.73 -19.84 18.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.593 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 26.5 m-70 -98.72 165.88 11.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.015 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.48 ' HB2' ' OG1' ' A' ' 20' ' ' THR . . . -136.82 114.27 10.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 2.5 mp -37.16 -35.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.49 -0.756 . . . . 0.0 110.89 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.78 9.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 111.191 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -112.69 -160.54 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.074 . . . . 0.0 109.889 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.71 131.38 35.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.015 -1.053 . . . . 0.0 110.591 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 mtp -140.83 -99.57 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 5.9 t -93.86 -31.28 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.025 -1.047 . . . . 0.0 109.22 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.76 171.77 18.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.587 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_endo -65.92 136.57 45.57 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.6 1.316 . . . . 0.0 110.381 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -42.6 152.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.047 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' A' ' 78' ' ' ILE . 3.6 m-85 -67.37 -57.45 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 0.0 110.213 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.64 -50.13 60.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.855 -1.153 . . . . 0.0 109.638 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.33 -44.14 71.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.357 -0.84 . . . . 0.0 109.992 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.476 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 23.1 t -54.16 -33.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 110.019 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.506 ' HB2' ' CD2' ' A' ' 79' ' ' LEU . . . -80.46 -26.35 38.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.373 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.25 -29.37 63.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.1 -38.02 19.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.88 . . . . 0.0 109.749 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -88.15 -4.08 58.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.69 109.04 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.31 -23.76 2.84 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -1.146 . . . . 0.0 110.018 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.85 39.45 0.93 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 110.401 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.49 43.28 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' LEU . . . -69.54 -15.0 63.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -1.176 . . . . 0.0 110.093 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.4 pt-20 -80.49 -34.24 35.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.081 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.512 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -65.04 -48.98 71.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -64.64 -46.0 84.38 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 20.2 mt -55.97 -21.3 20.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 42' ' ' ALA . . . -74.91 -43.11 56.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.945 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 43' ' ' TYR . 1.9 pt20 -75.6 -20.53 58.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' CE ' ' A' ' 61' ' ' MET . 8.7 mmt85 -90.54 -16.92 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.311 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.547 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 25.6 mt -85.91 -32.14 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.17 37.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.5 m120 -116.68 -11.45 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 60.84 161.19 0.11 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' GLY . 1.3 t -179.24 163.33 1.27 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.636 -1.508 . . . . 0.0 112.621 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.583 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -104.68 -178.0 3.53 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.49 20.41 78.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.53 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 44.2 t -96.88 -70.23 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.63 -0.923 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.587 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 98.9 m95 -114.68 -37.53 4.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.525 -0.734 . . . . 0.0 109.679 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.72 -169.45 20.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.21 11.41 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.566 1.511 . . . . 0.0 112.063 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.516 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 14.1 mt -109.59 86.04 4.23 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.651 -1.281 . . . . 0.0 110.586 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.579 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.3 Cg_exo -59.9 135.32 62.42 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.541 1.285 . . . . 0.0 111.013 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.562 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 52.5 ttp -71.75 130.8 86.58 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.458 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.08 138.52 47.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.648 1.341 . . . . 0.0 109.346 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.02 136.75 71.4 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.342 1.18 . . . . 0.0 110.054 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 3.2 m-80 -107.8 -174.65 2.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.02 . . . . 0.0 110.865 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.88 36.98 3.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.751 . . . . 0.0 110.018 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' SER . 25.8 m -81.37 114.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.044 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.474 ' HB2' ' OE1' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -46.8 174.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.77 -41.11 97.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.994 -1.066 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.17 -23.25 62.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.7 OUTLIER -81.1 -36.75 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 66' ' ' VAL . . . -76.31 -27.9 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.037 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.1 mt-30 -74.1 -41.97 60.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.528 ' HA ' ' CG ' ' A' ' 76' ' ' LYS . 85.8 m -73.8 -24.02 59.76 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 18.5 mt -74.51 -33.72 62.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.7 . . . . 0.0 109.124 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -72.53 -50.04 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -67.46 -23.26 65.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 178.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.465 ' HA ' ' OG ' ' A' ' 80' ' ' SER . 49.3 t90 -75.84 -36.74 59.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.606 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.591 HG12 ' CE1' ' A' ' 27' ' ' TYR . 17.3 mt -65.77 -46.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.805 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -74.12 -13.37 60.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 77' ' ' TRP . 89.2 p -102.29 -5.97 23.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.503 ' HA ' ' NE2' ' A' ' 81' ' ' GLN . 11.0 mm-40 -39.2 -46.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 110.736 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 4.8 tttt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.096 -1.002 . . . . 0.0 110.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.562 ' NA ' ' SD ' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.253 0.549 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -77.07 142.0 68.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.945 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.537 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.7 Cg_endo -63.42 -29.1 71.55 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.507 1.267 . . . . 0.0 110.629 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 18.9 pt-20 -73.0 -33.64 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.527 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 43.5 t -72.72 -46.69 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.0 pp -73.58 -22.74 59.96 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.209 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 3' ' ' PRO . . . -67.8 -40.96 83.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.706 . . . . 0.0 109.28 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.76 71.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.818 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.9 m120 -63.08 -26.08 68.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.286 -0.884 . . . . 0.0 110.664 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -92.96 -13.2 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 110.345 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.78 66.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 34.1 m -65.95 -15.09 62.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mtp -99.26 10.88 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.119 -0.988 . . . . 0.0 110.332 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.55 -49.73 6.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.494 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.4 m -97.35 -17.84 19.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.402 -0.811 . . . . 0.0 110.702 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.627 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 13.2 m-70 -102.87 174.08 6.03 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.138 -0.976 . . . . 0.0 112.169 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -156.29 -170.24 3.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mm -90.36 -62.49 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.72 -1.238 . . . . 0.0 110.272 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -124.76 -3.18 7.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.925 -1.109 . . . . 0.0 110.613 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 69.4 p -83.6 162.44 20.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.91 91.76 3.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.1 -1.0 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.22 -132.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 109.696 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.64 -33.03 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.922 -1.111 . . . . 0.0 109.26 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.92 163.84 12.15 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.511 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -63.8 142.74 83.96 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.706 1.372 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' CB ' ' OD2' ' A' ' 29' ' ' ASP . . . -46.02 153.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.7 m-85 -71.33 -60.74 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.705 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -48.0 -45.08 31.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.602 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.467 ' OD2' ' CB ' ' A' ' 26' ' ' ALA . 13.8 m-20 -55.44 -45.05 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.731 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.596 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 87.6 t -55.43 -33.81 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.144 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 35' ' ' ALA . . . -75.93 -37.66 58.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 110.511 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.67 66.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.3 -0.875 . . . . 0.0 110.424 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -84.24 -41.06 17.31 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -0.882 . . . . 0.0 109.968 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 15.5 m-85 -88.59 -0.96 57.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.809 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 31' ' ' ALA . . . -53.23 136.27 36.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.991 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.4 -35.24 5.19 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.2 mt-30 -54.02 129.04 32.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 50.63 2.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.72 55.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' HB3' ' OE1' ' A' ' 37' ' ' GLN . . . -90.03 -23.29 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.254 -1.145 . . . . 0.0 110.141 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.0 pt-20 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -68.98 -51.39 39.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.933 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 4.9 t80 -72.29 -27.9 62.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 108.962 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.543 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 21.4 mt -68.18 -26.94 66.0 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.08 -36.36 55.83 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.21 -26.66 59.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.2 mmt-85 -89.26 -17.55 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 37.1 mt -85.33 -26.61 6.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -85.84 -16.22 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.6 t30 -130.93 -1.62 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.095 -1.003 . . . . 0.0 110.584 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 53.83 168.75 0.03 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.6 170.42 0.12 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.605 -1.526 . . . . 0.0 112.084 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.584 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -110.25 -175.63 2.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.584 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.01 23.92 77.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.477 HG11 HBA2 ' A' ' 83' ' ' HEM . 34.1 t -105.89 -65.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.732 -0.864 . . . . 0.0 109.901 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.7 m95 -120.83 -37.59 2.97 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.29 -174.56 25.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.74 6.72 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.504 1.469 . . . . 0.0 111.793 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.482 ' O ' HBD1 ' A' ' 83' ' ' HEM . 7.3 mt -107.85 81.92 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.214 . . . . 0.0 110.301 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.6 Cg_exo -55.28 145.46 66.31 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.586 1.309 . . . . 0.0 111.295 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.525 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 40.9 ttp -79.17 133.9 60.11 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.603 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.427 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.6 Cg_endo -67.56 138.23 45.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.517 1.272 . . . . 0.0 108.99 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.26 140.11 93.08 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.372 1.196 . . . . 0.0 110.16 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.3 m-80 -113.01 170.93 7.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.797 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.53 48.86 0.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.416 -0.803 . . . . 0.0 109.84 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 66' ' ' VAL . 11.2 m -101.56 107.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 66' ' ' VAL . 1.8 m -42.07 148.41 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.847 . . . . 0.0 109.526 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' SER . 14.0 t0 -42.85 -37.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.993 -1.067 . . . . 0.0 110.734 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -64.93 -44.08 90.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.987 -1.071 . . . . 0.0 109.918 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 62.3 mt-10 -66.03 -46.64 77.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.355 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' A' ' 48' ' ' ILE . . . -69.61 -19.56 63.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 109.19 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.62 -44.32 57.34 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.8 m -70.53 -27.84 64.47 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.53 ' O ' ' CD1' ' A' ' 78' ' ' ILE . 47.3 mt -65.92 -43.28 88.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.584 -0.697 . . . . 0.0 109.249 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.79 -45.94 90.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 80' ' ' SER . 5.7 mttm -65.53 -23.88 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.458 ' HB3' ' O ' ' A' ' 74' ' ' LEU . 30.9 t90 -72.32 -46.11 57.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.753 . . . . 0.0 109.831 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.578 HG12 ' CE1' ' A' ' 27' ' ' TYR . 1.8 mp -59.59 -48.25 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.05 -22.68 61.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 109.846 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 82' ' ' LYS . 12.4 m -84.83 -16.38 41.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -45.07 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' SER . 9.8 tppt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.166 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.627 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.293 0.568 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.417 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 44.7 m-20 -77.6 164.54 57.29 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.425 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.2 Cg_exo -61.14 -43.59 28.61 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.805 1.424 . . . . 0.0 110.829 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -53.5 -45.9 69.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 66.0 t -55.52 -34.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -0.904 . . . . 0.0 109.374 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.19 -30.27 64.8 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.605 0.717 . . . . 0.0 109.548 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -66.87 -30.77 71.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.408 -0.807 . . . . 0.0 110.261 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -87.01 -43.73 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 110.385 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.4 m120 -66.4 -29.06 69.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.524 ' HB3' ' CBB' ' A' ' 83' ' ' HEM . 73.2 mmtt -96.15 -12.33 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.132 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.27 15.78 63.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 18.6 m -64.15 -21.75 66.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.467 ' HE3' HD13 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -93.69 15.24 16.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.482 -179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.55 -31.68 10.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.937 . . . . 0.0 110.373 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -112.0 -16.94 12.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 110.798 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.581 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 34.8 m-70 -110.81 160.98 16.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.787 -1.195 . . . . 0.0 112.432 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' CB ' ' OG1' ' A' ' 20' ' ' THR . . . -135.51 121.6 20.11 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 1.6 mp -38.65 -28.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 110.766 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -149.95 -32.1 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.205 -0.935 . . . . 0.0 111.11 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.533 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -68.9 -161.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.974 -1.079 . . . . 0.0 109.751 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 127.21 18.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -131.9 -100.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.474 HG12 ' HAC' ' A' ' 83' ' ' HEM . 40.9 t -90.93 -30.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.985 -1.072 . . . . 0.0 109.454 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.1 163.59 17.75 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' ALA . 3.0 Cg_exo -61.7 142.68 94.97 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.587 1.309 . . . . 0.0 110.584 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 20' ' ' THR . . . -43.24 147.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 2.7 m-85 -65.07 -61.48 2.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -47.3 -48.07 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.048 . . . . 0.0 109.336 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.81 -40.89 69.99 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.892 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.479 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 98.7 t -55.97 -44.82 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 110.156 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -30.1 69.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 110.395 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.16 -25.02 62.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.393 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.83 -37.33 14.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -93.63 -0.27 56.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.145 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.09 106.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.428 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.54 76.86 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 40' ' ' ALA . 1.9 mt-30 -145.85 167.96 21.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.59 42.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.55 46.0 0.59 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB3' ' OE1' ' A' ' 37' ' ' GLN . . . -63.12 -29.04 70.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -1.171 . . . . 0.0 110.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.82 -34.86 69.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.184 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.51 -51.16 61.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.302 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -67.6 -26.11 66.1 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.117 -0.99 . . . . 0.0 108.867 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' O ' ' CD1' ' A' ' 48' ' ' ILE . 13.5 mt -68.3 -25.26 65.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.69 -40.28 49.33 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.648 -0.657 . . . . 0.0 109.559 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -76.34 -21.43 56.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.859 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.474 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 5.4 mmm180 -89.05 -19.78 25.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.533 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 43.9 mt -84.98 -30.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.282 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 3.1 ttpm? -81.59 -25.94 35.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 m120 -119.41 -3.54 10.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 49.16 179.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.1 166.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.852 -1.381 . . . . 0.0 111.766 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -106.07 -175.82 2.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.394 -0.816 . . . . 0.0 109.792 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 19.88 76.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HB ' HBD1 ' A' ' 83' ' ' HEM . 17.2 t -96.87 -68.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.639 -0.918 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.479 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.3 m95 -117.57 -37.72 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.501 -0.75 . . . . 0.0 109.705 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.99 -172.24 21.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.73 8.04 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.438 1.426 . . . . 0.0 111.973 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.521 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 10.1 mt -109.06 89.59 6.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.651 -1.281 . . . . 0.0 110.411 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.95 145.4 98.42 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.551 1.29 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.533 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 2.7 tmm? -79.04 131.89 65.26 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.413 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -65.83 134.4 37.41 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.683 1.359 . . . . 0.0 108.973 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.43 135.16 65.99 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.208 1.11 . . . . 0.0 110.211 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.447 ' HB2' HG22 ' A' ' 66' ' ' VAL . 3.8 m-80 -106.65 161.9 14.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.9 43.66 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.087 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 67' ' ' SER . 16.7 m -96.64 114.76 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' VAL . 24.5 p -53.36 -171.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -76.84 -42.75 38.92 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.009 -1.057 . . . . 0.0 109.773 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -64.35 -36.76 85.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 0.0 109.304 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 51.6 mt-10 -69.08 -51.51 38.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -63.5 -18.13 63.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -47.98 49.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.418 HG22 ' HB3' ' A' ' 3' ' ' PRO . 5.1 m -68.41 -24.13 64.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 71' ' ' ALA . 88.7 mt -74.1 -34.51 63.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.613 -0.679 . . . . 0.0 109.349 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.27 -41.64 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.2 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 80' ' ' SER . 4.7 mttt -70.72 -26.8 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.459 -0.776 . . . . 0.0 109.058 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.602 ' CD2' ' OE1' ' A' ' 81' ' ' GLN . 35.8 t90 -71.84 -42.27 67.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.912 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 27' ' ' TYR . 11.5 mt -65.35 -48.57 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.31 -16.05 61.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.579 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' ' C ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -117.94 10.42 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.977 . . . . 0.0 110.574 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.602 ' OE1' ' CD2' ' A' ' 77' ' ' TRP . 4.0 mm100 -33.66 129.93 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.662 -0.649 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.146 179.849 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.524 ' CBB' ' HB3' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.413 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.3 pt-20 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.236 0.541 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -81.05 153.63 72.28 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.141 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.538 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_exo -60.38 -17.75 49.19 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.709 1.373 . . . . 0.0 110.355 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.53 -40.61 73.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.6 t -60.28 -54.69 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.429 -0.794 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 1.4 pp -63.29 -32.48 73.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.667 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -65.39 -22.42 66.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -82.35 -50.74 8.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.421 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 18.9 m-80 -63.86 -19.88 65.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 15.1 mmtt -85.04 -16.48 40.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.017 -1.052 . . . . 0.0 109.9 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.97 15.26 45.96 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 9.1 m -71.13 -48.67 50.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -1.213 . . . . 0.0 110.632 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.413 ' HB3' ' HE1' ' A' ' 13' ' ' MET . 81.0 mmm -72.49 3.31 5.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 0.0 110.98 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.14 22.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 0.0 110.425 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.7 m -111.74 -18.43 12.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.629 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.595 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 19.2 m-70 -99.14 165.64 11.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 112.043 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -141.6 117.48 10.49 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 22.5 mm -36.2 -29.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.542 -0.724 . . . . 0.0 111.035 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' ALA . 12.9 t70 -161.04 18.04 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.158 -0.964 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -112.01 -177.73 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 110.067 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -119.92 86.16 2.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 110.67 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.2 mtm -95.16 -112.93 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 109.686 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG12 ' HAC' ' A' ' 83' ' ' HEM . 55.7 t -88.39 -29.41 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.793 -1.192 . . . . 0.0 109.585 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.09 170.35 15.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.575 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -65.65 134.86 39.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.513 1.27 . . . . 0.0 110.326 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 17' ' ' ALA . . . -43.47 146.77 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.594 ' CE2' ' CH2' ' A' ' 77' ' ' TRP . 5.5 m-85 -57.52 -52.99 63.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.977 -1.077 . . . . 0.0 110.209 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.14 -50.63 58.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.421 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -56.39 -34.32 66.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.192 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.574 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 60.1 t -62.64 -36.87 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.107 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 35' ' ' ALA . . . -78.02 -24.42 47.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.93 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.3 -33.19 69.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.466 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -84.01 -35.51 23.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -90.72 -3.99 57.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 31' ' ' ALA . . . -53.83 128.6 30.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.75 71.86 1.27 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.456 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -145.64 144.1 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.82 46.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 110.627 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.8 42.45 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.456 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . . . -70.22 -21.0 63.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -1.126 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.5 mp0 -74.04 -36.74 64.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.552 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -46.85 82.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.343 -0.848 . . . . 0.0 109.682 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.499 ' OH ' ' NH2' ' A' ' 47' ' ' ARG . 51.5 t80 -73.76 -27.54 61.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.265 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.515 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . 11.3 mt -71.52 -24.92 62.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.83 -32.37 40.63 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -80.05 -24.32 40.79 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.44 -0.787 . . . . 0.0 109.182 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.499 ' NH2' ' OH ' ' A' ' 43' ' ' TYR . 34.5 mmt-85 -90.03 -17.02 28.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 109.088 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.538 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 25.2 mt -88.53 -29.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.722 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -120.09 -13.39 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.238 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.3 175.06 0.02 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.21 171.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.789 -1.418 . . . . 0.0 111.369 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.586 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -107.63 -171.93 1.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.486 -0.759 . . . . 0.0 109.995 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.586 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.22 12.63 61.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' CG1' ' CD1' ' A' ' 56' ' ' TRP . 24.9 t -93.97 -59.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.544 -0.974 . . . . 0.0 109.507 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.575 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 97.0 m95 -120.79 -38.92 2.78 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.578 0.704 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.94 -164.54 20.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.7 7.47 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.47 1.447 . . . . 0.0 111.718 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.4 mt -108.11 78.04 0.75 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.768 -1.207 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.572 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -56.63 140.11 89.52 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.567 ' HE3' ' NA ' ' A' ' 83' ' ' HEM . 0.8 OUTLIER -74.97 131.01 79.71 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.844 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.523 ' CG ' HBC1 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -67.03 128.66 19.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.642 1.338 . . . . 0.0 109.607 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.65 135.89 70.32 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.379 1.2 . . . . 0.0 110.243 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.28 170.26 8.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.878 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.41 35.18 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.386 -0.821 . . . . 0.0 109.645 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.47 HG13 ' HE3' ' A' ' 10' ' ' LYS . 34.9 m -86.31 105.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 110.151 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -42.41 153.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.251 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 67' ' ' SER . 3.3 m-20 -44.49 -37.57 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.705 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -41.28 90.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.021 -1.049 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 4.8 mm-40 -69.19 -36.99 77.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 66' ' ' VAL . . . -73.6 -20.28 60.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -76.34 -48.79 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -66.48 -25.78 66.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.548 ' CD1' HMB3 ' A' ' 83' ' ' HEM . 18.6 mt -71.14 -37.4 72.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' CB ' ' HB3' ' A' ' 44' ' ' LEU . . . -67.16 -53.07 33.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.519 -0.738 . . . . 0.0 109.434 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.415 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -63.67 -26.29 68.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.594 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 28.0 t90 -64.89 -36.47 84.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.583 HG12 ' CD1' ' A' ' 27' ' ' TYR . 12.1 mt -71.97 -46.49 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 109.625 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.7 mp -68.65 -11.35 60.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.27 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 m -95.34 -12.29 26.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.493 ' NE2' ' NE1' ' A' ' 77' ' ' TRP . 64.7 mm-40 -61.83 -27.44 68.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.95 . . . . 0.0 110.179 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.595 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.208 0.527 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.69 169.48 0.18 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.569 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.1 Cg_exo -61.99 -22.33 74.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.778 1.41 . . . . 0.0 110.494 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.54 -35.53 70.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.122 -0.986 . . . . 0.0 108.965 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 t -64.91 -53.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.394 -0.816 . . . . 0.0 109.643 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.569 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -68.61 -24.08 64.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' N ' HD11 ' A' ' 6' ' ' LEU . . . -68.13 -29.02 67.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -39.5 19.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.773 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -62.39 -27.75 69.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 110.677 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HB3' ' CBB' ' A' ' 83' ' ' HEM . 0.1 OUTLIER -88.51 -17.86 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.105 . . . . 0.0 110.413 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.22 13.29 39.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.436 ' HA ' ' C3B' ' A' ' 83' ' ' HEM . 14.1 m -66.26 -41.06 90.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -1.205 . . . . 0.0 110.317 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.5 5.93 16.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -0.88 . . . . 0.0 110.598 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.0 -26.51 16.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 110.569 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 m -112.45 -14.65 13.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.578 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 29.3 m-70 -111.88 158.33 19.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 111.824 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 19' ' ' ASP . . . -129.58 121.36 26.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 16.5 mt -39.73 -26.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.434 -0.791 . . . . 0.0 110.774 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.62 -35.34 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.956 -1.09 . . . . 0.0 111.01 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.06 -164.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.977 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -135.62 92.85 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.649 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -91.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.681 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -100.64 -45.91 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.924 . . . . 0.0 109.674 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.84 178.55 21.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ALA . 2.8 Cg_endo -65.87 137.68 50.1 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.69 1.363 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 30' ' ' VAL . . . -43.07 151.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CD1' HG12 ' A' ' 78' ' ' ILE . 3.3 m-85 -65.32 -59.4 4.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -53.52 -45.13 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.004 -1.06 . . . . 0.0 109.756 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.71 -39.41 77.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 110.021 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 72.2 t -57.98 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 110.116 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB1' ' HG ' ' A' ' 79' ' ' LEU . . . -72.06 -31.26 65.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 110.512 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.21 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 110.169 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -86.53 -48.86 8.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.492 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 8.5 m-85 -73.34 -5.44 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.55 109.94 0.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.16 -27.36 2.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.8 mt-30 -67.52 149.08 50.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -1.124 . . . . 0.0 110.178 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 52.61 2.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.47 50.17 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 37' ' ' GLN . . . -71.08 -25.48 62.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 110.042 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 75' ' ' ALA . 1.3 tt0 -67.02 -37.91 84.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 109.65 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.35 56.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.514 ' OH ' ' NE ' ' A' ' 47' ' ' ARG . 6.4 t80 -66.24 -24.15 66.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 109.086 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 13.9 mt -69.44 -30.31 68.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.12 67.42 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -77.07 -26.56 53.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.758 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' CE ' ' A' ' 61' ' ' MET . 4.0 mmt180 -89.77 -16.41 30.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.841 . . . . 0.0 109.242 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 31.2 mt -86.79 -28.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.73 -10.54 53.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.475 ' O ' ' O ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -125.48 -15.18 6.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 56.69 161.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.6 OUTLIER 171.72 167.91 0.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.534 -1.568 . . . . 0.0 112.039 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.583 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -103.75 -172.38 2.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.572 -0.705 . . . . 0.0 109.983 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.16 19.9 72.54 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' CGD' ' A' ' 83' ' ' HEM . 3.0 t -98.53 -68.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.794 -0.827 . . . . 0.0 109.631 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.6 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 83.0 m95 -116.45 -36.54 3.96 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.39 -0.819 . . . . 0.0 109.497 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.07 -166.48 19.01 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -71.29 15.26 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.405 1.403 . . . . 0.0 112.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.443 HG23 HMD2 ' A' ' 83' ' ' HEM . 5.4 mt -111.48 84.65 5.15 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 110.41 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.576 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.5 Cg_exo -60.81 134.69 55.22 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.648 1.341 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.577 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 52.5 ttp -75.37 133.72 74.24 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.335 -0.853 . . . . 0.0 110.166 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -69.69 134.2 27.57 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.521 1.274 . . . . 0.0 109.146 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.408 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.2 Cg_exo -58.17 142.65 97.31 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.202 1.107 . . . . 0.0 110.234 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -112.83 -174.8 2.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.902 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.31 34.17 5.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 7.8 m -74.28 118.74 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.768 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.453 ' C ' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -43.45 159.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 108.996 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -53.24 -50.22 65.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.878 -1.139 . . . . 0.0 110.442 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -21.87 66.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mm-40 -76.36 -40.13 52.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.917 . . . . 0.0 110.321 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.502 ' CB ' HG22 ' A' ' 66' ' ' VAL . . . -71.75 -26.1 62.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -68.85 -44.17 73.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -71.67 -24.42 61.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 38.5 mt -73.46 -33.13 64.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.281 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HB3' ' CG ' ' A' ' 41' ' ' GLU . . . -73.73 -50.73 19.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.139 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -26.94 68.63 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.36 -0.837 . . . . 0.0 109.044 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.464 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 40.6 t90 -68.72 -44.15 74.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.581 HG12 ' CD1' ' A' ' 27' ' ' TYR . 20.8 mt -56.99 -51.86 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.862 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.462 ' HG ' ' HB1' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -67.43 -21.74 65.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -77.75 -23.56 49.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 36.1 mm-40 -49.94 -177.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 110.336 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.577 ' NA ' ' SD ' ' A' ' 61' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.297 0.57 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.42 159.96 78.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.222 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.0 Cg_exo -60.75 -23.58 76.71 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.676 1.356 . . . . 0.0 110.664 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 12.7 pt-20 -68.23 -37.11 80.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.13 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 4' ' ' GLU . 59.9 t -64.97 -55.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.506 -0.746 . . . . 0.0 109.96 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 3' ' ' PRO . 4.0 pp -66.8 -21.89 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.599 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLU . . . -62.54 -47.89 81.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.504 -0.747 . . . . 0.0 109.526 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -40.87 80.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.835 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.7 m120 -65.52 -19.85 66.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.812 . . . . 0.0 110.645 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' CE ' ' OE1' ' A' ' 70' ' ' GLU . 50.9 mmtt -96.93 -19.69 18.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.058 -1.026 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 14' ' ' ALA . . . 95.63 11.74 54.83 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 37.6 m -67.2 -29.71 69.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.014 -1.286 . . . . 0.0 110.141 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mtp -84.8 7.77 19.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 11' ' ' GLY . . . -82.24 -49.49 10.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 110.391 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.6 m -102.9 -19.45 14.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 110.979 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.636 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 14.5 m-70 -101.61 173.71 6.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.837 -1.164 . . . . 0.0 112.069 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -153.84 -168.19 2.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.484 ' CD1' ' HG3' ' A' ' 81' ' ' GLN . 19.2 mm -90.27 -73.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.677 -1.264 . . . . 0.0 110.373 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 28' ' ' LYS . 17.2 p30 -116.03 -1.2 12.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 110.572 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 49.8 p -87.1 161.41 18.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 110.196 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -105.96 85.85 2.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 110.651 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mtm -88.54 -125.34 0.05 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 0.0 109.84 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 t -69.87 -39.46 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.757 -1.215 . . . . 0.0 109.649 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 173.35 14.91 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.06 136.88 50.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.719 1.379 . . . . 0.0 110.554 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.465 ' HB1' ' OD2' ' A' ' 29' ' ' ASP . . . -42.81 154.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.661 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.4 m-85 -70.11 -62.85 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.975 . . . . 0.0 109.836 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -47.48 -33.01 5.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.077 . . . . 0.0 109.392 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.465 ' OD2' ' HB1' ' A' ' 26' ' ' ALA . 7.2 m-20 -62.68 -46.65 87.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 109.59 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.577 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 49.9 t -57.43 -32.33 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.79 -24.37 38.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.467 -0.771 . . . . 0.0 110.082 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.36 62.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -40.22 12.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 110.098 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 23.3 m-85 -82.7 -7.04 59.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.15 134.74 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.21 5.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.495 ' CB ' ' HB3' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -122.58 138.38 54.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 110.083 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 51.31 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.686 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.07 41.78 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB3' ' CB ' ' A' ' 37' ' ' GLN . . . -79.69 -23.29 42.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.226 . . . . 0.0 110.018 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.36 -36.47 68.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.09 66.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.667 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.75 -28.07 66.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 11.5 mt -68.67 -25.08 64.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.38 40.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.49 -0.756 . . . . 0.0 109.559 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -77.71 -28.03 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.866 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.486 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 0.2 OUTLIER -86.48 -20.24 28.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.366 -0.834 . . . . 0.0 109.25 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.547 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 33.9 mt -84.79 -29.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.544 -0.722 . . . . 0.0 110.133 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -86.71 -17.16 34.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.062 -1.024 . . . . 0.0 110.133 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 51' ' ' GLY . 11.1 t-20 -119.0 -13.59 9.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 50.33 174.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 166.47 165.03 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.869 -1.371 . . . . 0.0 111.976 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -99.56 179.59 4.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.611 -0.681 . . . . 0.0 109.544 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.82 16.15 74.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.528 HG12 ' CGA' ' A' ' 83' ' ' HEM . 3.1 t -91.95 -64.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.566 -0.961 . . . . 0.0 109.373 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.577 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.6 m95 -118.89 -36.66 3.38 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.609 0.719 . . . . 0.0 109.414 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.66 -165.11 15.22 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.484 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.14 11.79 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.506 1.471 . . . . 0.0 112.138 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.41 ' O ' HAD2 ' A' ' 83' ' ' HEM . 6.1 mt -110.98 88.97 8.87 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.547 -1.346 . . . . 0.0 111.038 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -62.38 132.29 37.8 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.645 1.34 . . . . 0.0 110.821 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.1 tmm? -75.19 129.43 82.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.022 -1.049 . . . . 0.0 109.843 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HG2' HBC1 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -68.47 133.47 28.14 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.528 1.278 . . . . 0.0 108.884 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -57.59 140.85 94.7 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.206 1.108 . . . . 0.0 110.177 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-80 -109.25 164.84 12.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.91 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.45 32.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.832 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' SER . 15.5 m -73.94 120.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.514 -0.741 . . . . 0.0 109.915 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 66' ' ' VAL . 7.4 t -47.4 175.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.46 -69.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -21.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.467 ' OE1' ' CE ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -75.9 -48.39 21.54 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . . . -68.2 -18.95 64.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 108.72 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -48.59 46.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -27.05 68.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.545 ' O ' ' CD1' ' A' ' 78' ' ' ILE . 41.3 mt -66.13 -44.41 84.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -61.23 -52.79 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 1.1 mtpt -60.93 -19.52 60.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.576 ' CZ3' ' CE2' ' A' ' 27' ' ' TYR . 38.6 t90 -80.67 -41.31 23.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.77 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.583 HG12 ' CE1' ' A' ' 27' ' ' TYR . 1.6 mp -61.24 -52.16 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 109.833 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.21 -23.95 67.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 81' ' ' GLN . 0.6 OUTLIER -74.09 -28.46 61.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.395 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.518 ' HG2' ' CB ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -43.88 -53.65 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.105 -0.997 . . . . 0.0 110.277 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HEM . . . . . 0.636 ' NA ' ' NE2' ' A' ' 16' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.1 Cg_exo . . . . . 0 C--O 1.214 -0.718 0 N-CA-C 110.313 -0.687 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' HA ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 tt0 -52.0 -46.91 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 51.1 t -48.11 -40.39 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.384 -0.822 . . . . 0.0 108.962 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 65.4 mt -64.95 -40.01 94.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 109.734 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.652 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -58.23 -27.86 64.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.601 -0.687 . . . . 0.0 110.398 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -90.14 -36.57 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 110.777 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -70.57 -25.95 63.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.204 -0.935 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 22.7 mmtm -97.9 -26.35 14.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 110.202 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.43 18.47 14.52 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 14.1 m -65.0 -32.26 73.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.421 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 69.3 mmm -79.15 2.81 19.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.03 11.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 90.2 m -96.93 -15.6 21.08 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 110.961 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 8.6 m80 -104.42 172.39 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.96 -1.087 . . . . 0.0 112.047 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.88 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -152.77 124.4 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.4 mp -37.79 -27.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 111.266 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.587 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 2.0 p-10 -155.24 -32.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.996 -1.065 . . . . 0.0 111.404 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.88 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 17.9 p -69.65 151.7 45.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.965 -1.085 . . . . 0.0 109.847 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -93.38 117.76 30.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.671 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 2.3 mtm -123.02 -117.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.478 -0.764 . . . . 0.0 109.514 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 51.0 t -76.45 -34.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.833 -1.167 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.64 171.72 15.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.632 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.2 137.57 48.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.525 1.276 . . . . 0.0 110.072 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . . . -42.28 156.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.787 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.719 ' HD1' HG23 ' A' ' 78' ' ' ILE . 5.7 m-85 -69.06 -60.55 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.06 -42.27 65.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.038 -1.039 . . . . 0.0 109.011 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.818 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 59.2 m-20 -58.47 -40.86 83.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.865 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 26' ' ' ALA . 16.4 t -56.27 -38.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 109.318 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.853 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -74.0 -24.21 59.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.496 -0.753 . . . . 0.0 109.915 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.83 62.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -88.77 -35.44 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' HG2' ' A' ' 33' ' ' LYS . 3.9 m-30 -94.06 -1.75 53.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 109.84 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.853 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.05 130.23 37.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.177 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.15 -19.04 15.49 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 8.3 mm100 -66.58 145.78 55.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -1.089 . . . . 0.0 110.027 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.33 2.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.266 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 56.49 0.21 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.609 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -75.3 -13.16 60.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -1.161 . . . . 0.0 110.287 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.796 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -75.18 -30.05 60.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -70.61 -52.95 17.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.55 -34.64 78.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.911 . . . . 0.0 108.806 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 48' ' ' ILE . 11.5 mt -59.18 -36.6 75.62 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -65.94 -37.75 86.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 109.667 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -29.54 65.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.974 . . . . 0.0 110.08 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 29.2 mmt180 -88.42 -12.42 43.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.264 -0.898 . . . . 0.0 109.384 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 44' ' ' LEU . 38.7 mt -90.28 -25.16 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.452 -0.78 . . . . 0.0 109.446 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -85.53 -14.33 46.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.7 t30 -126.98 -11.71 5.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.55 174.64 0.02 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 163.87 167.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.169 -1.195 . . . . 0.0 111.414 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.0 pm0 -101.9 -161.14 0.83 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.435 -0.791 . . . . 0.0 109.925 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 56.4 19.39 25.61 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.864 HG12 ' CD1' ' A' ' 56' ' ' TRP . 60.5 t -104.54 -62.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.701 -0.882 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.864 ' CD1' HG12 ' A' ' 55' ' ' VAL . 88.2 m95 -120.0 -35.53 3.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.09 -175.93 31.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.94 6.83 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.379 1.386 . . . . 0.0 111.764 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.447 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 9.1 mt -106.05 85.37 1.59 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.84 -1.162 . . . . 0.0 109.829 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.7 Cg_endo -54.07 133.86 57.23 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.7 1.369 . . . . 0.0 110.834 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.57 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.2 tmm? -70.52 131.92 87.83 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.145 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.1 Cg_exo -64.38 130.24 26.26 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.73 1.384 . . . . 0.0 109.504 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.7 Cg_endo -59.38 138.24 83.12 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.478 1.251 . . . . 0.0 110.346 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -110.39 160.63 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.26 35.72 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 66' ' ' VAL . 19.8 m -79.86 119.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.393 -0.817 . . . . 0.0 110.028 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -46.39 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.569 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.93 -39.2 79.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.939 -1.1 . . . . 0.0 109.94 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.55 -34.77 74.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.871 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.4 mm-40 -71.71 -38.52 70.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 110.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.854 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -72.51 -22.82 60.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.221 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 7.2 mt-30 -71.73 -41.68 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.53 -25.84 61.53 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' A' ' 71' ' ' ALA . 41.6 mt -72.02 -30.99 65.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.796 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -73.29 -53.62 10.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.517 -0.739 . . . . 0.0 109.545 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 16.8 ptmt -64.87 -20.79 66.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.227 -0.921 . . . . 0.0 109.076 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.652 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 43.7 t90 -70.7 -43.55 68.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.304 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.719 HG23 ' HD1' ' A' ' 27' ' ' TYR . 13.1 mt -62.81 -48.78 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.918 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -69.19 -9.75 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.475 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 110.693 -179.719 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 110.519 -0.608 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -38.15 68.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.99 -52.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.884 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -61.77 -33.85 74.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.208 -0.932 . . . . 0.0 109.661 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.446 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -68.44 -21.92 64.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -49.91 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -65.31 -23.57 67.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.134 -0.978 . . . . 0.0 110.479 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 22.3 mmtm -84.52 -12.41 54.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 109.798 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.3 69.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 59.4 m -65.15 -31.7 73.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.252 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.2 mtp -88.41 7.62 31.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 110.301 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 -44.82 18.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 70.8 m -102.67 -17.61 15.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 110.887 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.612 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 11.1 m-70 -93.73 168.26 11.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.947 -1.096 . . . . 0.0 112.353 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.984 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -148.05 118.72 7.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.6 mp -38.66 -27.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.399 -0.813 . . . . 0.0 110.913 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.5 p-10 -148.65 -35.9 0.19 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.041 -1.037 . . . . 0.0 110.542 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.984 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.05 -179.29 1.47 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -129.83 89.07 2.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 110.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -78.82 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.006 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 70.7 t -97.75 -25.65 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.977 -1.077 . . . . 0.0 109.396 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.94 173.76 15.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.651 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -68.61 133.35 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.574 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -46.11 151.24 0.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.638 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -61.6 -64.39 0.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.115 -0.991 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -48.1 -46.02 33.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 2.8 m-20 -51.9 -47.1 64.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.486 -0.759 . . . . 0.0 110.147 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 26' ' ' ALA . 89.7 t -57.99 -34.25 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.9 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -75.78 -26.35 57.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.18 60.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -85.44 -37.35 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' GLY . 11.5 m-85 -97.8 -3.41 38.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -0.944 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.9 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -51.27 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 130.93 69.14 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.458 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.4 mt-30 -144.7 149.79 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.26 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.02 39.46 0.96 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.47 50.08 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -84.83 -42.46 15.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -1.175 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.781 ' HA ' HD12 ' A' ' 44' ' ' LEU . 10.0 mp0 -59.73 -38.09 80.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 109.926 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.89 84.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CZ ' ' HD2' ' A' ' 47' ' ' ARG . 28.6 t80 -70.68 -20.01 62.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.225 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.781 HD12 ' HA ' ' A' ' 41' ' ' GLU . 28.7 mt -72.86 -34.86 67.03 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.8 -31.97 59.66 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -28.13 51.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.863 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.589 ' HD2' ' CZ ' ' A' ' 43' ' ' TYR . 6.9 mmp_? -86.65 -16.81 35.47 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.377 -0.827 . . . . 0.0 109.547 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.551 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 58.8 mt -88.22 -28.97 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.459 -0.775 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -80.26 -20.77 43.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.2 m120 -120.86 -17.91 7.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.109 -0.994 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.74 169.48 0.02 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.6 OUTLIER 164.02 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.086 -1.243 . . . . 0.0 111.375 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -96.94 -160.97 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.313 -0.867 . . . . 0.0 110.44 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.46 19.04 59.59 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.849 HG12 ' CD1' ' A' ' 56' ' ' TRP . 9.4 t -98.28 -69.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.675 -0.897 . . . . 0.0 109.48 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.849 ' CD1' HG12 ' A' ' 55' ' ' VAL . 92.3 m95 -118.53 -38.25 3.17 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 108.953 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.51 -167.73 15.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.494 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.58 14.72 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.558 1.505 . . . . 0.0 112.07 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 mt -110.13 96.56 26.26 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.545 -1.347 . . . . 0.0 111.005 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.551 ' CB ' ' HB3' ' A' ' 53' ' ' GLN . 2.5 Cg_endo -65.01 128.64 21.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.615 1.324 . . . . 0.0 110.589 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.551 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tmm? -69.2 128.93 92.34 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.876 -1.14 . . . . 0.0 108.796 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.22 129.97 25.76 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.643 1.338 . . . . 0.0 109.5 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_exo -57.27 148.95 67.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.243 1.128 . . . . 0.0 109.972 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.73 163.45 18.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 111.047 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.5 36.37 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.7 m -84.4 108.62 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' VAL . 17.5 p -42.22 152.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.559 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -45.92 -48.76 16.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.797 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.84 -34.79 75.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.976 . . . . 0.0 110.46 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.97 -40.93 75.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -72.16 -21.47 61.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.02 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -70.27 -44.05 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 3' ' ' PRO . 18.9 m -70.84 -23.99 62.44 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.67 ' O ' HD12 ' A' ' 78' ' ' ILE . 31.7 mt -71.7 -37.45 70.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.47 58.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.452 -0.78 . . . . 0.0 109.159 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 80' ' ' SER . 13.2 mtmt -66.7 -22.2 66.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.239 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 62.0 t90 -78.01 -24.04 48.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 109.92 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 74' ' ' LEU . 7.2 mt -84.29 -61.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.898 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -49.74 -42.17 45.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 9.2 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.63 ' HA ' HD21 ' A' ' 6' ' ' LEU . 2.8 Cg_endo . . . . . 0 N--CA 1.484 0.924 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt-20 -65.09 -27.56 68.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 0.0 109.134 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 32.8 t -71.82 -59.25 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.535 -0.728 . . . . 0.0 109.404 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -62.67 -19.2 63.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.85 -53.85 23.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.932 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -29.78 69.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 110.463 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -67.17 -37.21 83.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.664 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 10.3 mmtp -82.31 -13.37 57.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.18 12.45 49.0 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 22.5 m -65.26 -38.62 90.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -1.23 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.85 7.26 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.469 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.88 -34.22 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.3 m -110.55 -14.86 14.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 110.745 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.631 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 7.2 m80 -102.98 154.38 19.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.895 -1.128 . . . . 0.0 111.846 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.858 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -132.47 121.32 23.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.846 HG22 ' HD2' ' A' ' 28' ' ' LYS . 11.2 mt -40.34 -26.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.957 . . . . 0.0 110.724 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 4.6 t70 -152.21 -35.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.858 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.81 163.68 25.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 110.518 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -103.44 89.31 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 110.559 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 mtm -85.49 -95.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.683 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.13 -39.35 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.68 -179.41 18.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.614 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.49 129.86 22.3 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.627 1.33 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.91 143.39 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.811 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.631 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 5.8 m-85 -53.92 -48.97 69.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.846 ' HD2' HG22 ' A' ' 18' ' ' ILE . 2.1 mtpp -57.43 -50.67 72.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.8 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.26 -27.13 63.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 110.242 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' ALA . 92.0 t -67.06 -43.09 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.047 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -74.47 -23.86 58.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 110.395 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.62 59.04 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.215 -0.928 . . . . 0.0 110.378 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -90.88 -41.7 11.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE2' ' CZ2' ' A' ' 56' ' ' TRP . 7.7 m-85 -78.35 -7.81 57.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.077 -1.015 . . . . 0.0 110.041 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.86 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 155.44 -45.14 0.54 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 5.4 mm-40 -42.24 157.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 57.58 3.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.663 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.05 57.96 0.39 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -70.7 -44.42 66.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -1.1 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 21.0 pt-20 -50.44 -37.79 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -60.8 -57.79 11.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 85.2 t80 -67.18 -13.86 62.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.557 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 18.8 mt -78.42 -29.39 47.11 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.46 64.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.597 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 2.3 mmt180 -81.42 -16.67 51.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.21 -0.932 . . . . 0.0 109.521 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.557 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 9.7 mt -81.08 -34.43 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.34 -12.41 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 110.685 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.32 -8.84 8.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 110.654 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 62.01 160.55 0.16 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 11.5 t -179.2 154.82 0.68 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.639 -1.507 . . . . 0.0 112.54 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.11 -176.31 3.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.679 -0.638 . . . . 0.0 109.703 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 66.05 10.77 52.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 53' ' ' GLN . 2.1 t -89.41 -62.25 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.482 -1.011 . . . . 0.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.614 ' CD2' ' CG ' ' A' ' 25' ' ' PRO . 73.9 m95 -115.65 -33.72 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.497 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.36 -167.31 25.76 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.7 Cg_endo -69.44 6.87 1.04 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.376 1.384 . . . . 0.0 111.695 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 15.6 mt -110.59 90.17 10.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 120.805 -1.185 . . . . 0.0 110.5 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -61.88 141.34 89.45 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.786 1.414 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.555 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 32.4 ttp -71.92 128.48 89.31 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.902 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.0 130.94 30.7 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.589 1.31 . . . . 0.0 109.379 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.1 131.2 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.322 1.169 . . . . 0.0 109.928 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -105.55 163.89 12.31 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 110.537 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 30.32 1.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.842 . . . . 0.0 109.733 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' CG ' ' A' ' 49' ' ' LYS . 15.8 m -74.16 116.06 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -48.85 179.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.695 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -65.5 -68.89 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -45.83 -32.19 2.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.364 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -68.3 -51.35 45.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.351 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.963 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -63.67 -21.07 66.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -71.44 -47.32 56.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.389 -0.819 . . . . 0.0 108.815 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -68.16 -24.43 64.98 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.982 ' O ' HD12 ' A' ' 78' ' ' ILE . 70.4 mt -68.99 -41.33 77.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.581 -0.699 . . . . 0.0 109.381 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.7 -48.75 65.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.379 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -63.68 -19.2 64.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.394 -0.817 . . . . 0.0 109.458 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -78.51 -46.18 20.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 110.098 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.982 HD12 ' O ' ' A' ' 74' ' ' LEU . 3.1 mt -63.06 -48.36 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.532 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -13.71 61.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.767 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -33.0 57.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.246 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.8 t -66.4 -48.74 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.572 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.4 pp -69.36 -30.57 68.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.268 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.6 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -58.14 -55.42 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -43.77 82.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.83 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -55.13 -29.45 57.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 16.7 mmtm -90.69 -22.32 21.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.903 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.62 14.44 27.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 19.8 m -66.36 -36.05 81.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -1.198 . . . . 0.0 110.407 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 mtp -82.16 6.82 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 110.882 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.87 -43.87 13.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 89.9 m -101.71 -18.13 15.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.3 m-70 -101.0 167.45 10.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 111.969 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -147.26 122.8 10.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.55 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.1 mp -37.45 -27.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.424 -0.798 . . . . 0.0 111.075 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.576 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -155.68 -34.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 110.863 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.931 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 62.4 p -69.62 154.53 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.199 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.66 122.72 39.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mtm -124.73 -98.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 68.1 t -94.2 -36.32 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 109.317 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.25 178.17 16.4 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -69.23 133.2 25.94 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.656 1.346 . . . . 0.0 110.485 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.43 150.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.057 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 8.2 m-85 -60.73 -56.95 15.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.247 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 -49.81 52.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.753 -1.217 . . . . 0.0 109.448 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 6.5 m-20 -53.33 -41.75 66.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 26' ' ' ALA . 49.5 t -53.98 -42.44 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.846 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -73.65 -23.42 59.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.965 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 29' ' ' ASP . . . -66.64 -34.07 77.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' CZ3' ' A' ' 56' ' ' TRP . 3.2 ttmt -86.92 -49.97 7.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -76.46 1.22 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.846 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -59.01 126.72 28.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.439 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.36 28.67 4.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.48 138.83 50.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 110.24 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.42 41.12 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.95 55.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.647 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -87.15 -17.27 33.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.149 -1.207 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.697 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 2.3 mt-10 -75.63 -33.71 60.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.887 . . . . 0.0 109.611 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.68 63.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.554 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.73 -31.65 68.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.087 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 40' ' ' ALA . 15.4 mt -67.46 -26.99 66.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . . . -75.61 -33.41 60.52 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.574 -0.704 . . . . 0.0 109.834 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.36 -36.36 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.424 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 33.5 mmt-85 -82.18 -15.76 52.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 44' ' ' LEU . 24.9 mt -85.99 -29.6 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.24 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -84.84 -17.75 37.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.4 t30 -126.8 -0.04 6.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.111 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 51.27 -173.76 0.13 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.2 p 167.42 158.72 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.038 -1.272 . . . . 0.0 111.871 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.681 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -106.15 -164.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 0.0 109.959 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 53.39 18.98 7.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 53' ' ' GLN . 6.7 t -94.72 -69.25 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -1.103 . . . . 0.0 109.17 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.61 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 98.4 m95 -110.41 -39.03 5.06 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.736 0.779 . . . . 0.0 108.941 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.88 -174.0 24.32 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -70.02 8.15 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.349 1.366 . . . . 0.0 111.506 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 11.3 mt -107.34 82.37 1.21 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -55.42 145.67 66.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.667 1.351 . . . . 0.0 111.563 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.549 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.6 ttm -74.95 132.42 77.3 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.808 . . . . 0.0 109.406 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.59 129.14 19.37 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.624 1.328 . . . . 0.0 109.036 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -56.68 133.92 61.11 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.179 1.094 . . . . 0.0 110.146 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -105.9 -177.99 3.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.19 35.41 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 66' ' ' VAL . 27.1 m -87.09 103.14 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.8 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 40.3 t -43.61 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 109.345 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 67' ' ' SER . 1.5 m-20 -42.78 -47.51 5.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.507 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -59.17 -41.42 88.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 17.8 mt-10 -65.87 -38.94 90.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.817 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 45' ' ' ALA . . . -70.45 -19.92 62.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.091 -1.006 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -49.05 30.41 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -27.94 66.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 78' ' ' ILE . 51.1 mt -69.53 -36.12 76.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.697 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -67.46 -53.4 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -0.756 . . . . 0.0 109.505 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 10.4 mttt -61.98 -24.07 66.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.591 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 40.9 t90 -72.03 -35.44 69.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.511 -0.743 . . . . 0.0 109.57 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -74.8 -38.96 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 4.3 mt -74.21 -11.96 60.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.367 -0.833 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.422 -179.746 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.73 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.798 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 8.9 pt-20 -70.19 -39.09 75.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.259 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.55 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 57.8 t -64.32 -54.93 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 3' ' ' PRO . 3.8 pp -67.95 -22.66 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.876 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.92 -33.36 74.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -37.86 33.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -65.11 -30.99 71.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.883 . . . . 0.0 110.877 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 6.3 mmtm -83.82 -18.09 38.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.887 -1.133 . . . . 0.0 109.772 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.8 12.34 43.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 15.0 m -68.03 -35.83 78.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.268 . . . . 0.0 110.417 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 1.69 41.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -38.64 15.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.005 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -101.24 -26.41 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 110.444 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.625 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 11.0 m80 -106.36 166.79 10.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 22' ' ' MET . . . -135.21 -176.16 4.17 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 45.3 mm -91.32 -26.01 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 110.402 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 2.8 p30 -162.22 19.35 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.976 -1.077 . . . . 0.0 111.06 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -114.93 -166.4 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.954 -1.091 . . . . 0.0 110.194 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 87.81 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 110.765 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.581 ' HE2' ' HB2' ' A' ' 17' ' ' ALA . 31.3 mtm -97.89 -98.43 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 109.598 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.9 t -88.87 -45.58 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 0.0 109.231 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.7 172.74 14.4 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HG3' ' HB3' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.23 143.04 82.4 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.469 1.247 . . . . 0.0 110.275 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -41.42 163.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -81.44 -53.14 6.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.13 -42.11 63.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 5.0 m-20 -58.05 -38.48 76.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.541 -0.724 . . . . 0.0 109.681 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 26' ' ' ALA . 91.1 t -58.55 -46.45 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.825 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.86 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.88 -19.93 61.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.552 -0.717 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -32.43 62.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -43.07 13.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.932 . . . . 0.0 109.822 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -78.81 -5.76 54.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.854 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.86 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -62.21 89.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.13 -20.94 0.57 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 mt-30 -71.48 149.91 45.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.101 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.15 40.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 110.428 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.7 56.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.645 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -90.28 -20.16 23.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.242 . . . . 0.0 110.45 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.93 -34.84 66.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 109.503 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.35 -50.93 63.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.721 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.526 ' CE1' ' CG ' ' A' ' 47' ' ' ARG . 1.2 t80 -68.11 -30.3 69.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 109.106 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 48' ' ' ILE . 9.2 mt -65.13 -29.7 70.57 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.92 66.31 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.597 -0.689 . . . . 0.0 110.008 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -76.38 -27.4 56.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 110.363 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' CG ' ' CE1' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -87.72 -15.26 37.55 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 44' ' ' LEU . 35.2 mt -86.61 -32.31 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.382 -0.824 . . . . 0.0 109.618 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -85.06 -10.48 56.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 3.1 m-20 -124.16 -12.8 7.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 51.14 175.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 166.28 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.047 -1.267 . . . . 0.0 111.462 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.568 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -102.37 179.67 4.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.766 . . . . 0.0 109.955 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.81 19.26 73.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 56' ' ' TRP . 2.6 t -91.58 -67.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.596 -0.944 . . . . 0.0 109.459 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.592 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 88.6 m95 -119.41 -35.48 3.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.509 -0.744 . . . . 0.0 109.041 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.05 -174.29 23.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.39 11.44 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.426 1.417 . . . . 0.0 112.019 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 15.4 mt -109.11 87.06 4.42 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.659 -1.276 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.15 138.41 85.77 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.593 1.312 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.555 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.6 tmm? -79.02 126.68 81.6 Favored Pre-proline 0 C--N 1.299 -1.595 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.372 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.68 127.4 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.3 Cg_exo -55.18 132.99 55.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.241 1.127 . . . . 0.0 110.054 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -102.23 167.14 10.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.468 -0.77 . . . . 0.0 110.862 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.87 30.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.401 -0.812 . . . . 0.0 109.877 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 66' ' ' VAL . 17.9 m -76.13 113.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 109.667 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -50.99 -176.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.778 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.09 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.019 -1.051 . . . . 0.0 110.087 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -52.86 -32.51 45.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mt-10 -68.97 -49.01 61.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -67.62 -17.45 64.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 109.239 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -74.41 -41.29 61.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 3' ' ' PRO . 60.8 m -76.21 -23.39 54.62 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 53.8 mt -75.9 -34.84 59.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.573 -0.704 . . . . 0.0 109.181 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.781 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -73.49 -48.3 34.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.081 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.576 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -66.02 -27.01 67.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.066 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.526 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 36.4 t90 -67.15 -41.46 86.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.413 -0.804 . . . . 0.0 109.355 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 75' ' ' ALA . 16.2 mt -61.72 -50.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.381 -0.824 . . . . 0.0 109.521 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.6 mt -62.08 -25.35 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.759 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.2 Cg_exo . . . . . 0 C--O 1.211 -0.846 0 N-CA-C 110.608 -0.574 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.71 -39.41 66.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.194 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 96.0 t -65.41 -54.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.857 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 3' ' ' PRO . 2.2 pp -68.57 -24.16 64.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.349 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -70.13 -33.54 71.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -84.59 -37.64 20.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.16 -35.59 77.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.501 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.27 -10.49 56.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.045 -1.034 . . . . 0.0 110.589 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.44 58.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 20.4 m -62.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -1.234 . . . . 0.0 110.412 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mtp -85.51 10.68 12.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.893 . . . . 0.0 110.465 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.21 13.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 92.7 m -105.82 -21.57 13.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 110.711 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 14.8 m-70 -94.95 167.34 11.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 0.0 112.71 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.948 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -145.15 120.11 10.0 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG22 ' HE3' ' A' ' 28' ' ' LYS . 7.8 mt -39.98 -25.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.221 -0.925 . . . . 0.0 111.15 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.9 p30 -147.52 -39.59 0.19 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.792 -1.192 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.948 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -70.51 153.93 42.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.013 . . . . 0.0 110.428 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -98.37 97.64 8.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.359 -0.838 . . . . 0.0 109.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.573 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 16.6 mtm -97.13 -121.58 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 64.3 t -70.4 -32.59 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.768 -1.208 . . . . 0.0 109.819 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.99 173.24 15.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.632 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.48 131.61 26.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.627 1.33 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -47.01 153.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.873 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 16' ' ' HIS . 10.3 m-85 -66.81 -51.15 59.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HE3' HG22 ' A' ' 18' ' ' ILE . 10.8 mttt -53.93 -49.88 67.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.534 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.68 -43.36 68.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.99 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 26' ' ' ALA . 75.5 t -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.92 -28.52 62.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.61 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -0.973 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.14 -42.9 10.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -88.28 0.85 55.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.24 122.37 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.176 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.57 13.6 20.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.642 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.34 141.16 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -1.199 . . . . 0.0 110.214 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.37 52.89 2.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.76 48.03 0.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -73.83 -22.52 59.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -1.21 . . . . 0.0 110.092 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 3.3 pt-20 -71.3 -29.16 64.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -65.31 -53.06 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.674 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -70.09 -28.47 65.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 48' ' ' ILE . 19.7 mt -68.67 -26.24 65.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -73.14 -39.18 65.9 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.408 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -77.26 -23.13 51.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.542 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 19.5 mmt180 -90.13 -17.64 27.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.344 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 44' ' ' LEU . 26.8 mt -85.32 -31.02 6.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -86.98 -11.97 48.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 110.1 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 86.3 m-20 -121.04 -13.32 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 109.951 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 54.74 169.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 168.88 166.27 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.804 -1.41 . . . . 0.0 111.857 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -105.6 -173.9 2.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.777 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.567 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.0 9.92 54.93 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.712 HG12 ' CD1' ' A' ' 56' ' ' TRP . 39.8 t -89.82 -50.96 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.398 -1.06 . . . . 0.0 109.459 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.712 ' CD1' HG12 ' A' ' 55' ' ' VAL . 92.5 m95 -129.22 -36.11 1.75 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.41 -166.53 24.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.2 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.411 1.408 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -109.67 83.14 2.55 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.844 -1.16 . . . . 0.0 110.567 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.64 160.5 17.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.716 1.377 . . . . 0.0 111.1 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.568 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 54.0 ttp -96.91 131.21 28.28 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.501 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.9 Cg_endo -67.59 132.33 26.78 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.653 1.344 . . . . 0.0 109.033 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.9 139.9 92.85 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.267 1.14 . . . . 0.0 110.344 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -114.8 165.68 12.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 0.0 110.793 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.46 38.31 0.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.034 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 66' ' ' VAL . 27.3 m -71.31 116.41 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.312 -0.867 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.451 ' N ' ' HB2' ' A' ' 70' ' ' GLU . 29.1 m -51.62 178.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -59.15 5.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 109.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.6 -13.5 9.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mm-40 -82.29 -46.0 14.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.219 -0.926 . . . . 0.0 110.201 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.28 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.026 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -44.32 39.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.492 -0.755 . . . . 0.0 109.059 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 3' ' ' PRO . 35.5 m -74.44 -22.1 59.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 30.2 mt -75.5 -39.46 58.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.662 -0.649 . . . . 0.0 109.393 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -72.06 -43.54 64.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.017 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 46.5 mttt -65.82 -30.83 71.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.216 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.568 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 33.4 t90 -66.55 -44.38 82.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.634 -0.666 . . . . 0.0 109.918 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.613 HG23 ' CD1' ' A' ' 27' ' ' TYR . 73.4 mt -61.43 -47.02 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.643 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.1 -12.73 60.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -0.824 . . . . 0.0 109.76 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.091 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.562 ' HA ' HD12 ' A' ' 6' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.296 -0.694 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.84 -43.33 65.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 99.0 t -54.53 -37.82 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.298 -0.876 . . . . 0.0 109.432 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 3' ' ' PRO . 71.3 mt -65.0 -36.82 85.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.796 . . . . 0.0 109.759 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -69.01 -23.25 64.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.2 -34.5 17.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.342 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.156 -0.965 . . . . 0.0 110.576 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.798 ' HG2' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -89.87 -13.33 36.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.599 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.86 17.93 52.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 35.4 m -63.38 -22.37 66.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -1.083 . . . . 0.0 110.715 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.6 mtp -90.82 8.79 33.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.822 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.37 -51.41 6.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.566 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 72.5 m -93.7 -16.29 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 110.94 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 15.1 m-70 -104.68 160.41 14.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.126 . . . . 0.0 112.289 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.012 ' HB2' ' SD ' ' A' ' 22' ' ' MET . . . -142.47 126.8 17.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.3 mp -38.72 -26.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.421 -0.799 . . . . 0.0 111.243 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.541 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 60.8 m-20 -152.19 -37.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.987 -1.071 . . . . 0.0 110.75 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.79 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -69.22 165.74 19.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -113.9 95.6 5.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.07 -1.019 . . . . 0.0 110.863 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 1.012 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -85.05 -88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.688 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 71.8 t -104.46 -27.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 109.566 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.27 177.23 16.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -67.69 137.04 40.95 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.677 1.357 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.932 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -44.9 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.795 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.0 m-85 -78.39 -46.69 19.32 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -56.86 -54.32 47.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -50.67 -36.61 36.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.257 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 26' ' ' ALA . 94.7 t -61.5 -44.34 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.131 -0.981 . . . . 0.0 110.446 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . . . -72.71 -23.81 60.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.403 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.79 -23.38 52.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -90.06 -42.27 11.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.48 3.82 38.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.039 -1.038 . . . . 0.0 110.09 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.34 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.49 -39.01 0.86 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 mm-40 -49.21 138.74 12.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.106 -1.232 . . . . 0.0 110.354 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 50.49 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.392 -0.818 . . . . 0.0 110.121 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.69 42.46 0.05 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -75.99 -18.78 59.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.269 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.654 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -75.06 -37.0 61.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.489 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -66.45 -52.03 50.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -65.91 -32.26 73.66 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 108.78 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.641 ' O ' HD12 ' A' ' 48' ' ' ILE . 12.6 mt -64.57 -30.69 71.71 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -69.65 -34.47 74.05 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.655 -0.653 . . . . 0.0 109.581 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.8 -44.32 64.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.342 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.76 -20.33 60.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 44' ' ' LEU . 47.5 mt -80.61 -31.53 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -88.41 -20.28 25.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' GLY . 20.2 t30 -113.73 -5.8 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 57.64 162.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.2 t 177.51 161.4 0.5 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.614 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.26 -175.07 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.836 -0.54 . . . . 0.0 109.951 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 69.09 16.58 70.95 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.818 HG12 ' CD1' ' A' ' 56' ' ' TRP . 89.4 t -97.96 -60.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.569 -0.96 . . . . 0.0 109.731 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.818 ' CD1' HG12 ' A' ' 55' ' ' VAL . 98.3 m95 -118.43 -39.8 2.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.48 -0.763 . . . . 0.0 109.46 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.73 -166.32 21.32 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.91 12.54 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.31 1.34 . . . . 0.0 111.902 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.61 78.54 1.19 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.612 -1.305 . . . . 0.0 110.431 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.1 140.33 94.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.518 1.272 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.557 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 7.6 ttp -72.89 135.45 80.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.489 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.8 Cg_endo -69.36 135.11 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.798 1.42 . . . . 0.0 108.725 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.05 148.36 85.77 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.289 1.152 . . . . 0.0 110.392 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.467 ' HB2' HG13 ' A' ' 66' ' ' VAL . 4.2 m120 -127.76 173.79 9.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.487 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.11 35.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.798 HG12 ' HG2' ' A' ' 10' ' ' LYS . 25.9 m -73.5 103.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.801 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -43.16 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.63 -68.08 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 0.0 110.13 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -21.0 1.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.305 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' CG ' ' NZ ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -73.86 -47.2 39.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -71.14 -16.51 62.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.167 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -41.92 50.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -76.11 -27.6 57.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.663 HD11 ' HE3' ' A' ' 10' ' ' LYS . 24.1 mt -71.87 -34.17 69.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -70.37 -49.81 45.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.795 . . . . 0.0 109.397 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.2 OUTLIER -67.19 -24.71 65.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.896 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.54 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 54.3 t90 -71.27 -33.33 69.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 109.328 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' A' ' 75' ' ' ALA . 15.4 mt -69.88 -48.42 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.612 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.733 HD12 ' O ' ' A' ' 75' ' ' ALA . 2.6 mp -72.39 -17.05 61.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.87 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 3.1 m . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.213 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HA ' HD11 ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 C--O 1.212 -0.781 0 N-CA-C 110.141 -0.753 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' OE1' ' C ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -69.33 -31.37 69.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.316 -0.865 . . . . 0.0 108.743 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.8 t -70.76 -59.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.177 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.673 HD11 ' HA ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -62.08 -21.49 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 109.536 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -76.0 -29.33 58.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.364 -0.835 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 -27.82 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.807 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.2 m120 -72.34 -38.7 68.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.817 . . . . 0.0 110.33 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -83.09 -4.69 58.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.029 . . . . 0.0 110.193 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.52 18.01 65.02 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 m -63.82 -38.21 90.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.304 . . . . 0.0 110.44 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.76 7.09 13.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.576 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.43 -36.62 17.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.922 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.9 m -106.01 -17.68 14.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 7.9 m80 -99.61 171.08 8.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.033 -1.042 . . . . 0.0 111.769 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.863 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -146.6 119.03 8.42 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.1 mp -37.78 -33.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.492 -0.755 . . . . 0.0 111.149 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 1.2 p30 -156.58 8.36 0.2 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.889 -1.132 . . . . 0.0 111.744 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.863 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -103.75 -176.1 2.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.708 -1.245 . . . . 0.0 109.921 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 9.8 mmtp -121.22 104.71 9.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.14 -0.975 . . . . 0.0 110.65 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 21.7 mtp -118.26 -106.55 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -89.07 -39.61 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.85 -1.157 . . . . 0.0 109.666 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.83 168.82 12.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -66.27 135.29 39.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.605 1.318 . . . . 0.0 110.502 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.865 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.8 150.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -63.29 -59.91 4.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -0.938 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -47.59 -47.64 28.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.412 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 18.2 m-20 -57.33 -39.27 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 0.0 110.009 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 26' ' ' ALA . 73.3 t -57.08 -36.25 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -79.68 -29.62 40.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.461 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.37 -24.18 62.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.438 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -90.2 -42.89 10.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -90.43 9.18 30.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.83 140.89 40.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -12.0 67.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 3.8 mm-40 -54.06 147.25 13.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 110.353 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 49.15 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -0.841 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.82 53.24 0.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -73.47 -20.15 60.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -1.167 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.576 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 1.1 pt-20 -66.95 -23.25 65.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 0.0 109.966 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -72.92 -59.54 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.5 t80 -65.27 -25.7 67.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.927 . . . . 0.0 109.046 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 48' ' ' ILE . 16.5 mt -66.75 -34.86 78.78 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.86 67.47 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -74.26 -37.12 63.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.11 -0.994 . . . . 0.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.1 mmt180 -84.55 -14.91 47.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.973 -1.08 . . . . 0.0 109.644 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 44' ' ' LEU . 30.2 mt -85.98 -25.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.029 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.678 ' HG2' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.36 -19.36 33.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.42 -0.8 . . . . 0.0 110.447 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 4.8 m120 -127.99 -4.02 5.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.454 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.14 173.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.7 167.85 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.825 -1.397 . . . . 0.0 111.594 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -100.21 177.86 4.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 109.921 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.44 21.96 79.06 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 56' ' ' TRP . 10.5 t -95.17 -71.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.518 -0.989 . . . . 0.0 109.91 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.755 ' CD1' HG12 ' A' ' 55' ' ' VAL . 88.1 m95 -117.75 -34.88 4.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.053 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.45 -172.25 20.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.22 13.55 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.56 1.506 . . . . 0.0 112.231 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 59' ' ' ILE . 8.2 mt -110.63 93.35 16.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.615 -1.303 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.545 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -61.8 131.01 33.34 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.644 1.339 . . . . 0.0 110.811 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.545 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 5.4 tmm? -73.73 132.2 81.01 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 2.8 Cg_endo -64.37 139.0 63.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.706 1.371 . . . . 0.0 108.702 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.5 Cg_endo -60.27 142.97 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.274 1.144 . . . . 0.0 110.274 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -113.22 161.06 17.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.957 . . . . 0.0 110.529 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.49 34.1 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' HG2' ' A' ' 49' ' ' LYS . 28.6 m -80.87 114.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.768 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.0 m -50.52 -177.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.033 . . . . 0.0 109.597 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.1 -59.07 3.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.993 -1.067 . . . . 0.0 109.967 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -33.4 50.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.2 mm-40 -67.47 -50.14 60.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.839 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -64.23 -21.68 66.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -45.31 61.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.395 -0.816 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 3' ' ' PRO . 57.6 m -72.59 -22.13 61.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 71' ' ' ALA . 62.0 mt -73.0 -36.86 67.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.543 -0.723 . . . . 0.0 109.253 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -70.64 -50.72 33.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.7 OUTLIER -61.51 -24.16 66.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.838 . . . . 0.0 109.021 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.509 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 38.6 t90 -74.55 -41.19 61.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.496 -0.753 . . . . 0.0 109.863 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.622 HG21 HG11 ' A' ' 30' ' ' VAL . 37.3 mt -60.51 -42.36 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.591 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.767 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -75.05 -13.53 60.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.511 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 110.473 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HB3' HG22 ' A' ' 73' ' ' THR . 2.8 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 110.302 -0.692 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -68.95 -38.33 79.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.206 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.438 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 50.8 t -62.65 -50.19 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.711 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.75 HD11 HD21 ' A' ' 74' ' ' LEU . 1.3 pp -72.08 -20.92 61.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.457 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -65.05 -37.51 87.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.782 . . . . 0.0 109.605 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -83.71 -38.06 21.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.823 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.482 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -60.21 -35.34 75.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.442 -0.786 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 46.3 mmtm -87.01 -14.05 42.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.59 10.29 56.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 19.5 m -62.62 -39.03 92.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.261 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 3.32 22.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 111.019 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.88 -43.51 14.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.032 . . . . 0.0 110.423 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 39.9 m -98.04 -23.09 15.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.555 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 30.1 m-70 -103.84 -175.18 2.73 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.362 1.077 . . . . 0.0 112.419 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.607 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -162.11 -171.6 2.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 23.7 mm -86.41 -69.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.669 -1.27 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -110.08 -19.56 13.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.802 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.1 p -72.11 -169.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 5.3 pttt -150.51 87.46 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 mtm -79.88 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.92 . . . . 0.0 109.885 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 11.4 t -83.52 -29.61 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.0 171.48 14.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -65.33 144.05 78.99 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.488 1.257 . . . . 0.0 110.077 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.83 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.58 162.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.6 m-85 -77.29 -60.62 2.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.97 -37.77 46.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.599 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.7 m-20 -61.91 -46.29 90.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.802 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 26' ' ' ALA . 68.7 t -52.17 -37.28 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.81 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.669 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . -85.08 -21.07 29.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 110.299 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.8 -26.25 60.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -87.21 -48.02 8.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.913 . . . . 0.0 110.092 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ALA . 13.9 m-85 -77.1 -13.11 60.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.02 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -43.15 109.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.74 34.3 0.7 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 2.5 mt-30 -125.93 144.37 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -1.22 . . . . 0.0 110.304 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.39 47.6 1.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.859 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.78 40.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.013 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -80.72 -31.39 36.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -1.133 . . . . 0.0 109.874 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -67.98 -22.93 64.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.457 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.47 -53.15 20.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.536 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.9 t80 -68.7 -24.87 64.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 48' ' ' ILE . 8.9 mt -69.69 -32.52 71.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.56 68.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.94 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.24 -37.31 63.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.036 -1.04 . . . . 0.0 110.287 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.3 mmt-85 -78.18 -18.41 55.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.912 . . . . 0.0 109.569 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 44' ' ' LEU . 30.7 mt -80.34 -36.04 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.702 . . . . 0.0 109.857 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -78.13 -31.08 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 110.431 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.8 m-80 -109.28 -4.46 16.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.561 ' HA2' ' HE3' ' A' ' 61' ' ' MET . . . 57.76 166.38 0.1 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 174.52 164.33 0.23 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.599 -1.53 . . . . 0.0 112.386 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -108.37 -171.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.626 -0.671 . . . . 0.0 109.848 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 20.58 76.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.005 HG12 ' CD1' ' A' ' 56' ' ' TRP . 78.7 t -102.81 -70.75 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.583 -0.951 . . . . 0.0 109.58 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 1.005 ' CD1' HG12 ' A' ' 55' ' ' VAL . 99.0 m95 -110.67 -41.07 4.39 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.5 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.23 -167.37 19.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.63 11.41 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.437 1.425 . . . . 0.0 111.895 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 mt -107.71 77.45 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.601 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.8 Cg_exo -56.38 139.05 86.03 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.535 1.281 . . . . 0.0 110.841 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.561 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 12.3 ttp -71.29 133.03 85.6 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.511 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.8 Cg_endo -67.64 134.62 33.33 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.681 1.358 . . . . 0.0 108.992 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_endo -59.32 136.04 69.47 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.269 1.141 . . . . 0.0 110.53 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -113.75 170.47 8.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.474 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.83 34.95 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.0 m -78.15 114.42 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.12 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.7 t -50.84 -176.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -71.1 -42.11 69.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 110.324 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.05 -35.36 80.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.938 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mt-10 -72.97 -40.79 65.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.74 -21.63 60.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -77.81 -43.35 30.81 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.261 -0.899 . . . . 0.0 108.577 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 3' ' ' PRO . 19.8 m -72.87 -24.5 60.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.75 HD21 HD11 ' A' ' 6' ' ' LEU . 23.6 mt -72.58 -46.17 55.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -64.19 -42.93 96.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.371 -0.83 . . . . 0.0 109.183 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.0 OUTLIER -69.56 -26.48 64.51 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 109.044 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 30.6 t90 -68.99 -43.08 75.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.298 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 75' ' ' ALA . 6.0 mt -62.07 -43.57 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.021 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.669 HD23 ' HB1' ' A' ' 31' ' ' ALA . 2.0 mt -75.48 -14.12 60.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.351 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 47.9 t . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.467 -0.771 . . . . 0.0 110.11 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.96 -32.95 65.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.372 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.69 -51.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 6' ' ' LEU . 2.5 pp -66.37 -31.28 71.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.398 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -56.45 -46.72 80.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -68.32 -37.53 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 0.0 109.736 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.88 -22.94 65.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.797 . . . . 0.0 110.229 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 45.5 mmtm -95.5 -25.17 16.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.812 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.57 13.12 28.9 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 24.6 m -64.69 -39.74 94.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.244 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 2.55 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.09 -48.27 16.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 97.0 m -100.31 -27.02 13.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.453 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 4.4 m80 -97.62 168.32 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.211 1.005 . . . . 0.0 112.35 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -151.61 -166.79 2.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 27.6 mm -90.44 -75.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.781 -1.199 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.14 -1.44 13.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.501 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 4.9 p -81.28 -168.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.958 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.44 108.84 7.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.6 mtm -117.65 -119.52 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.046 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 42.7 t -77.75 -35.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.845 -1.159 . . . . 0.0 109.807 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.8 168.89 12.76 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.76 139.65 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.726 1.382 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -43.21 154.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.396 -0.815 . . . . 0.0 109.752 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.624 ' CE1' HG12 ' A' ' 78' ' ' ILE . 1.4 m-85 -70.51 -58.01 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -47.25 33.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 22.4 m-20 -52.0 -45.56 64.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.413 -0.804 . . . . 0.0 109.929 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 26' ' ' ALA . 81.3 t -55.45 -37.96 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.818 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -76.33 -25.48 54.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.38 -29.86 65.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -85.41 -42.12 14.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -90.63 7.09 41.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -61.03 118.28 6.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.384 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.38 -8.17 26.58 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.536 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -66.17 147.03 53.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -1.174 . . . . 0.0 110.098 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.22 56.17 3.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.02 46.63 0.3 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -72.38 -16.03 61.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HA ' HD12 ' A' ' 44' ' ' LEU . 2.7 mt-10 -70.17 -37.76 75.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.808 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -51.46 69.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 t80 -67.42 -31.82 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 108.953 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 41' ' ' GLU . 24.0 mt -64.75 -25.17 67.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.4 -35.06 41.27 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.706 -0.621 . . . . 0.0 109.929 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -77.57 -24.52 49.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.587 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 11.8 mmp_? -89.46 -21.8 22.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.541 HG22 HG21 ' A' ' 66' ' ' VAL . 48.1 mt -84.6 -26.67 6.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.62 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -90.1 -8.06 52.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.397 -0.814 . . . . 0.0 110.484 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -133.14 -7.49 3.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.062 -1.023 . . . . 0.0 111.202 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 69.06 162.17 2.75 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -174.36 150.11 1.43 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.585 -1.538 . . . . 0.0 112.855 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.68 -173.71 2.3 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.694 -0.629 . . . . 0.0 109.558 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.25 16.29 53.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.961 HG12 ' CD1' ' A' ' 56' ' ' TRP . 98.0 t -93.13 -71.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.637 -0.919 . . . . 0.0 109.225 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.961 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.8 m95 -109.86 -39.57 5.04 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.718 0.771 . . . . 0.0 109.012 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.58 -178.03 28.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.91 8.09 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.498 1.466 . . . . 0.0 112.091 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.12 80.04 0.78 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.674 -1.266 . . . . 0.0 109.651 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.0 Cg_endo -55.37 148.9 49.13 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.854 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.584 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 7.9 ttp -76.79 131.97 72.57 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.057 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.9 134.57 37.83 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.617 1.325 . . . . 0.0 109.122 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.3 132.42 48.8 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.289 1.152 . . . . 0.0 110.075 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -107.88 160.35 15.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 110.522 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.13 32.8 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.791 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.684 ' O ' HG23 ' A' ' 66' ' ' VAL . 22.9 m -72.35 114.62 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 110.212 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' VAL . 33.6 m -47.74 174.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.53 -64.62 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.808 -1.183 . . . . 0.0 110.186 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -22.22 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 11.4 mm-40 -72.42 -52.54 15.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -67.21 -18.76 65.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.948 . . . . 0.0 108.785 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.93 -47.63 43.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 3' ' ' PRO . 3.9 m -68.0 -24.49 65.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.063 ' O ' HD12 ' A' ' 78' ' ' ILE . 75.6 mt -73.19 -33.6 65.49 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.76 -51.46 40.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.61 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -60.98 -32.07 71.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 109.108 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -64.71 -48.08 75.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.716 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.063 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.6 mt -60.34 -56.35 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.448 -0.782 . . . . 0.0 110.028 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 31' ' ' ALA . 1.5 mt -66.82 -11.74 56.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 39.9 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 110.413 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.795 0 N-CA-C 110.462 -0.63 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -48.65 -45.97 39.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 109.542 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.9 t -51.06 -47.12 31.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.9 . . . . 0.0 109.078 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 71.0 mt -56.06 -50.52 70.75 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.586 0.707 . . . . 0.0 109.801 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -51.94 -26.27 10.06 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.582 -0.698 . . . . 0.0 110.251 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -56.69 3.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 110.994 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -64.44 -11.3 32.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.911 -1.118 . . . . 0.0 110.467 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.527 ' HD2' HG12 ' A' ' 66' ' ' VAL . 71.2 mmtt -101.42 -15.01 17.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 110.03 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.05 12.11 71.7 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 29.4 m -63.23 -40.46 97.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.245 . . . . 0.0 110.347 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.434 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -74.44 2.47 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.14 -50.55 12.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -99.64 -14.26 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 110.785 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 19.6 m-70 -105.34 174.13 6.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.076 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -149.87 -179.47 7.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.3 mp -90.66 -24.83 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.869 -1.144 . . . . 0.0 110.414 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 12.5 p-10 -157.77 -27.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 0.0 111.463 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 81.0 p -68.86 -173.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.772 -1.205 . . . . 0.0 110.115 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 104.64 8.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 111.011 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.431 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -107.88 -132.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.83 . . . . 0.0 109.112 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.4 -48.17 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.864 -1.147 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.03 167.79 21.89 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.579 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -67.0 143.32 65.4 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.572 1.301 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.723 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -44.97 170.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.731 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.5 m-85 -86.93 -54.6 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.953 -1.092 . . . . 0.0 110.04 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 1.1 tmmm? -50.54 -49.74 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.928 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -54.64 -42.81 71.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.073 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 26' ' ' ALA . 53.5 t -56.07 -38.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.63 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -76.5 -26.58 55.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.39 -29.11 65.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.2 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -84.64 -47.77 10.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 109.984 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -77.28 -3.71 41.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -52.27 121.91 7.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.934 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.24 -37.45 2.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.9 mm100 -63.17 126.28 26.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -1.082 . . . . 0.0 110.06 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.2 46.05 1.29 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.57 40.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -79.92 -12.74 59.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 109.908 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.538 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -75.11 -22.45 58.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -71.62 -51.52 22.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.664 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.556 ' CE1' ' NE ' ' A' ' 47' ' ' ARG . 45.5 t80 -69.64 -33.4 72.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.605 ' O ' HD12 ' A' ' 48' ' ' ILE . 22.6 mt -61.38 -30.12 70.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.22 -38.85 60.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -73.94 -19.44 60.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.051 -1.031 . . . . 0.0 109.845 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' NE ' ' CE1' ' A' ' 43' ' ' TYR . 6.5 mmt180 -90.17 -24.15 21.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 44' ' ' LEU . 62.6 mt -86.71 -19.75 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.331 -0.856 . . . . 0.0 109.318 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -22.99 24.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 110.516 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 57.6 m-80 -126.21 -6.71 6.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 110.407 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.16 173.98 0.03 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 2.8 t 162.11 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.413 -1.051 . . . . 0.0 111.172 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.2 pm0 -100.16 -165.26 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 64.14 18.72 62.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 56' ' ' TRP . 2.4 t -95.5 -67.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.739 -0.859 . . . . 0.0 109.099 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.579 ' CB ' ' HG3' ' A' ' 25' ' ' PRO . 95.5 m95 -124.1 -36.38 2.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.65 -177.44 20.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.514 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -69.46 8.25 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.457 1.438 . . . . 0.0 112.038 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.86 100.78 29.58 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.715 -1.241 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.4 Cg_endo -64.63 133.41 36.68 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.457 1.24 . . . . 0.0 110.602 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.54 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -71.87 135.6 83.0 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.0 Cg_endo -64.21 130.46 27.17 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.735 1.387 . . . . 0.0 109.456 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.23 135.79 64.29 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.401 1.211 . . . . 0.0 110.61 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -109.05 163.83 12.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.67 36.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.969 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 66' ' ' VAL . 15.5 m -84.38 105.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.056 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 75.1 p -42.58 147.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.224 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 72' ' ' GLN . 8.0 p-10 -42.57 -31.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.45 -47.96 68.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.109 -0.994 . . . . 0.0 109.564 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.496 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 52.7 mt-10 -63.62 -48.05 78.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 110.161 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -67.27 -16.64 64.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 109.142 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.33 -45.62 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -27.74 63.39 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 71' ' ' ALA . 49.6 mt -69.77 -34.96 74.48 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -67.46 -54.65 18.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' SER . 6.2 mttp -58.43 -25.12 61.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 108.871 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' LEU . 35.9 t90 -70.51 -43.11 70.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.61 -0.681 . . . . 0.0 109.515 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' A' ' 27' ' ' TYR . 4.9 mt -59.38 -50.91 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.739 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -73.72 -9.97 59.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 36.7 t . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 110.326 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.763 0 N-CA-C 110.268 -0.705 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.28 -33.92 73.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 108.626 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.45 -58.02 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.643 -0.661 . . . . 0.0 109.718 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.7 pp -64.16 -24.42 67.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.536 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -67.72 -29.49 68.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -52.16 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.322 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -63.27 -16.48 60.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.091 -1.006 . . . . 0.0 110.383 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.562 ' HE3' HG12 ' A' ' 66' ' ' VAL . 34.2 mmtt -87.97 -18.8 28.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.63 13.53 53.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.414 ' C ' ' HH ' ' A' ' 27' ' ' TYR . 57.4 m -69.72 -38.68 76.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -1.235 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mtp -82.36 6.0 18.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.782 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.52 -35.71 19.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 110.353 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 36.4 m -106.0 -22.95 12.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -0.819 . . . . 0.0 110.391 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 28.7 m-70 -103.35 153.84 20.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 111.415 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.891 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -129.89 123.93 31.96 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.525 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 35.7 mm -36.78 -29.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 111.014 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.606 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -153.45 -32.33 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.177 -0.952 . . . . 0.0 111.088 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.891 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.43 179.33 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.023 -1.048 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -117.69 120.42 37.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -0.872 . . . . 0.0 110.741 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 19.5 mtp -125.22 -108.08 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 25.3 t -86.32 -31.78 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 171.71 17.26 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -66.0 140.42 60.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.682 1.359 . . . . 0.0 110.383 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.032 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.44 149.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 110.233 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 3.0 m-85 -63.43 -60.19 3.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.207 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -49.19 48.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.635 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 12.8 m-20 -55.48 -40.07 71.21 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 110.027 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.032 HG23 ' O ' ' A' ' 26' ' ' ALA . 95.5 t -57.84 -38.39 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.003 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -75.92 -25.83 56.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 110.001 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -27.49 63.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 19.1 tttt -86.56 -43.75 12.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -82.82 -2.25 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 109.978 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.7 101.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.73 33.81 0.42 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.494 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -116.78 145.86 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.229 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.07 41.57 1.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.36 48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.94 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -76.92 -33.66 57.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -1.168 . . . . 0.0 110.1 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.642 ' HG2' ' HB3' ' A' ' 75' ' ' ALA . 3.0 tm-20 -64.29 -24.79 67.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.34 -51.6 23.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.617 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 1.3 t80 -71.32 -21.79 62.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.14 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.94 HD12 ' O ' ' A' ' 40' ' ' ALA . 3.5 mt -74.5 -26.67 60.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.24 46.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.636 -0.665 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.544 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -77.15 -34.66 56.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.617 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 75.5 mmt-85 -81.37 -22.11 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 19.3 mt -80.98 -30.05 11.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.39 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.35 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -118.63 0.25 11.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.364 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 58.01 158.76 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.511 ' CB ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -177.32 158.63 1.47 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.546 -1.561 . . . . 0.0 112.595 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.34 -172.57 2.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.62 -0.675 . . . . 0.0 109.688 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.4 19.07 75.81 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.749 HG12 ' CD1' ' A' ' 56' ' ' TRP . 27.7 t -99.16 -74.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.632 -0.922 . . . . 0.0 109.814 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.756 ' HZ2' HG13 ' A' ' 30' ' ' VAL . 97.5 m95 -106.91 -38.8 5.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.42 -165.74 18.82 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.05 13.44 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.383 1.389 . . . . 0.0 111.963 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.76 80.16 2.06 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.569 -1.332 . . . . 0.0 110.301 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -60.18 144.71 99.48 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.674 1.355 . . . . 0.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.592 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 5.9 ttp -73.93 134.55 77.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.661 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.7 Cg_endo -69.77 139.26 39.75 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.668 1.352 . . . . 0.0 109.065 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 132.34 41.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.254 1.134 . . . . 0.0 110.133 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -108.03 173.38 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.744 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.08 33.4 2.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.969 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.562 HG12 ' HE3' ' A' ' 10' ' ' LYS . 16.7 m -78.41 120.84 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 109.885 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 66' ' ' VAL . 6.2 m -49.68 -178.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.889 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.04 -58.2 4.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.694 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.86 -17.45 36.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.6 mm-40 -77.6 -50.23 12.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -66.42 -22.68 66.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.262 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -72.52 -44.61 61.97 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 3' ' ' PRO . 1.6 m -71.24 -24.05 62.11 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 71' ' ' ALA . 27.1 mt -68.39 -38.21 81.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.642 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . . . -69.79 -51.2 35.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.135 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 80' ' ' SER . 1.2 mttp -62.42 -23.34 66.8 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.309 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.536 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 33.9 t90 -73.64 -42.15 61.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.485 -0.759 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.569 HG12 ' CD1' ' A' ' 27' ' ' TYR . 96.7 mt -63.29 -56.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 31' ' ' ALA . 1.3 mp -65.78 -18.43 65.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.852 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 3.6 t . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 110.148 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.61 ' HA ' HD21 ' A' ' 6' ' ' LEU . 2.8 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 110.577 -0.586 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 5.7 tm-20 -68.35 -44.64 74.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.9 t -58.77 -50.13 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 110.087 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 7' ' ' ALA . 4.2 pp -70.85 -22.6 62.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.351 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.792 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -62.45 -38.95 91.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.571 -0.705 . . . . 0.0 109.392 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -41.14 34.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -62.95 -23.46 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 17.7 mmtt -91.14 -14.53 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.93 11.59 58.73 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 17.6 m -69.49 -38.58 77.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -1.202 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.35 6.78 9.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.25 -46.56 10.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.319 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 94.8 m -99.0 -16.56 18.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -0.811 . . . . 0.0 110.578 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.623 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 7.1 m170 -110.07 178.63 4.34 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.387 1.089 . . . . 0.0 112.435 -177.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -155.29 -169.17 3.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 mm -90.8 -73.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.683 -1.261 . . . . 0.0 110.242 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -112.55 -10.14 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 110.004 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.73 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.3 p -77.4 -161.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 0.0 109.879 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 119.74 9.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.508 ' CE ' ' O ' ' A' ' 16' ' ' HIS . 15.4 mtm -121.58 -113.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.749 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 54.1 t -78.19 -32.78 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.801 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.78 175.33 16.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.539 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.63 142.12 69.41 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.617 1.325 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -42.6 157.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.936 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -73.41 -61.33 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.936 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' TYR . 5.8 tttt -46.29 -45.77 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 0.0 109.462 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -51.58 -45.56 63.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 109.811 179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' ALA . 88.6 t -55.03 -45.21 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -69.94 -21.25 63.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.768 . . . . 0.0 110.155 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.68 42.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 110.531 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -35.14 15.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.119 -0.988 . . . . 0.0 110.084 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' ALA . 16.6 m-85 -85.9 -9.24 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -42.73 111.2 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.94 40.28 2.16 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.785 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -102.81 152.22 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 110.335 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.02 42.12 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.98 46.45 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -66.19 -29.68 70.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -1.107 . . . . 0.0 110.532 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -68.66 -32.22 71.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.19 -52.86 16.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 13.3 t80 -70.38 -19.39 63.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.276 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.8 mt -73.97 -33.82 64.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.75 69.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.735 -0.603 . . . . 0.0 109.5 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -43.75 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.51 -17.21 58.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.437 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 44' ' ' LEU . 13.3 mt -83.19 -24.75 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.442 ' HG3' HG23 ' A' ' 66' ' ' VAL . 3.0 mtpp -85.34 -29.15 24.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.293 -0.879 . . . . 0.0 110.396 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 36.6 p30 -114.46 -5.15 12.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.634 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 59.05 172.1 0.42 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.62 163.5 0.12 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.705 -1.468 . . . . 0.0 112.422 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.581 ' CB ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -110.33 -178.91 3.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.433 -0.792 . . . . 0.0 109.876 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 74.51 20.22 79.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.947 HG12 ' CD1' ' A' ' 56' ' ' TRP . 71.3 t -103.91 -67.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.947 ' CD1' HG12 ' A' ' 55' ' ' VAL . 99.5 m95 -111.07 -40.13 4.56 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.338 -0.851 . . . . 0.0 110.114 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.54 -165.84 18.16 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.479 1.453 . . . . 0.0 111.619 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.29 85.62 2.87 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.79 -1.194 . . . . 0.0 111.174 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.581 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.16 155.49 39.64 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.627 1.33 . . . . 0.0 110.275 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.554 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 49.9 ttp -87.92 134.85 34.44 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.7 Cg_endo -67.29 132.95 28.96 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.768 1.404 . . . . 0.0 109.172 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -59.04 136.09 70.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.269 1.142 . . . . 0.0 110.461 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -112.03 163.25 14.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.401 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.8 36.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.527 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.0 m -77.71 108.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.374 -0.828 . . . . 0.0 110.421 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -43.72 146.22 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 67' ' ' SER . 7.7 p-10 -41.15 -40.91 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.104 -0.997 . . . . 0.0 110.872 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.35 -45.22 94.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 72.9 mm-40 -64.09 -42.38 96.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -66.97 -22.17 65.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.008 . . . . 0.0 109.699 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -72.15 -41.21 67.36 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' TRP . 1.2 m -73.96 -24.49 59.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.915 ' O ' HD12 ' A' ' 78' ' ' ILE . 41.8 mt -72.42 -37.86 68.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.557 -0.714 . . . . 0.0 109.18 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -71.83 -49.51 37.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.127 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 80' ' ' SER . 2.8 mttt -63.78 -25.15 68.05 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.353 -0.842 . . . . 0.0 108.816 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.595 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 24.7 t90 -70.39 -51.9 26.31 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.541 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 74' ' ' LEU . 4.3 mt -54.68 -49.66 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.15 -17.36 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.973 . . . . 0.0 109.847 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 11.9 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.862 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.541 -0.6 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.89 -48.36 78.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.4 t -49.77 -34.26 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.511 HD12 ' CG2' ' A' ' 73' ' ' THR . 39.8 mt -71.45 -38.38 71.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -58.47 -27.14 64.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.676 . . . . 0.0 110.141 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -90.0 -46.9 8.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.932 . . . . 0.0 110.528 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.0 m120 -63.99 -16.75 62.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.243 -0.911 . . . . 0.0 111.052 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 54.4 mmtt -104.46 -25.38 12.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.056 . . . . 0.0 110.487 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.21 15.0 22.89 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 17.0 m -66.79 -35.05 79.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 0.0 110.2 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mmm -79.71 5.96 12.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.914 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.48 -37.21 15.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.109 -0.994 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -105.33 -16.59 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.624 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 6.7 m80 -105.16 166.78 10.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.903 -1.123 . . . . 0.0 112.082 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -146.91 120.13 8.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 17.9 mt -37.36 -29.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.573 ' OD1' HG23 ' A' ' 20' ' ' THR . 2.3 p30 -151.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.077 -1.015 . . . . 0.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.923 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 19.8 p -70.0 163.11 26.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -104.25 129.08 52.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 0.0 110.635 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.455 ' HE3' ' O ' ' A' ' 16' ' ' HIS . 10.3 mtm -127.27 -88.75 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.44 -33.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.47 174.5 16.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.529 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -64.71 129.65 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.56 1.294 . . . . 0.0 110.305 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.874 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -38.91 149.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.448 -0.782 . . . . 0.0 110.073 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.787 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.4 m-85 -65.4 -58.98 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 110.52 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -48.27 -47.12 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.954 -1.091 . . . . 0.0 109.623 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.13 -40.47 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 26' ' ' ALA . 59.0 t -58.45 -39.9 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -77.34 -19.9 55.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.41 -28.71 46.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 0.0 110.057 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -40.34 12.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.85 -11.46 59.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.0 103.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 109.985 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.7 33.82 0.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.75 128.49 42.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -1.198 . . . . 0.0 110.157 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.22 56.17 3.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.52 44.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -74.41 -50.61 17.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 10.3 pt-20 -48.47 -35.62 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 110.527 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -56.85 -54.58 44.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 109.881 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.47 -38.11 88.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.932 . . . . 0.0 109.204 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -59.79 -27.45 66.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -73.51 -36.48 65.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.644 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -37.34 69.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.473 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 23.2 mmt180 -80.65 -16.49 53.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.664 HG22 HG21 ' A' ' 66' ' ' VAL . 49.9 mt -87.72 -23.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.709 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -19.95 30.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 76.8 m-20 -136.28 2.25 2.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.544 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 50.64 175.33 0.02 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER 169.14 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.761 -1.435 . . . . 0.0 111.802 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -109.25 -177.72 3.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.8 21.44 79.29 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.823 HG12 ' CD1' ' A' ' 56' ' ' TRP . 8.0 t -99.38 -68.34 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.68 -0.894 . . . . 0.0 109.646 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.823 ' CD1' HG12 ' A' ' 55' ' ' VAL . 86.3 m95 -118.55 -36.71 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.749 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.36 -171.82 23.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.555 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.32 9.73 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 112.115 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -109.53 84.17 2.98 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.714 -1.241 . . . . 0.0 110.453 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.04 144.24 99.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.663 1.349 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.551 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -77.18 134.88 66.86 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.481 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 2.6 Cg_endo -69.18 137.43 37.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 N-CA-C 108.395 -1.425 . . . . 0.0 108.395 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -56.89 156.51 23.36 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.224 1.118 . . . . 0.0 110.081 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -128.62 164.38 22.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 111.059 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.66 34.9 0.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.512 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.664 HG21 HG22 ' A' ' 48' ' ' ILE . 10.6 m -86.89 109.62 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.513 -0.742 . . . . 0.0 110.441 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.474 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 2.1 m -47.06 173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -57.3 13.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.98 -19.29 41.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 66' ' ' VAL . 10.6 mt-10 -78.58 -45.74 21.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 110.427 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -70.7 -22.17 62.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.11 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -44.28 58.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.511 ' CG2' HD12 ' A' ' 6' ' ' LEU . 4.0 m -71.78 -25.2 61.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 71' ' ' ALA . 46.0 mt -77.33 -27.0 52.66 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -75.26 -52.58 10.53 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.549 -0.719 . . . . 0.0 109.215 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -59.75 -29.22 68.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 108.623 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.728 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 31.7 t90 -61.48 -53.34 57.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.61 -0.682 . . . . 0.0 109.507 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.787 HG23 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -60.29 -40.98 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.159 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -76.88 -9.81 58.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.598 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 41.7 m . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 0.0 110.644 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 110.28 -0.7 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.09 -32.14 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.861 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 48.8 t -71.51 -45.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.705 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -69.02 -31.4 70.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -59.68 -55.89 28.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -55.45 -42.59 74.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.1 m120 -59.9 -27.89 67.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 110.521 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 75.2 mmtt -93.32 -16.29 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 0.0 110.12 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.95 18.45 34.33 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 9.1 m -68.86 -42.34 77.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.54 5.11 16.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.45 -44.26 11.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 110.651 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 57.4 m -96.73 -19.84 18.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.593 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 8.4 m80 -98.72 165.88 11.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.015 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.802 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -136.82 114.27 10.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.5 mp -37.16 -35.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.49 -0.756 . . . . 0.0 110.89 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.78 9.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 111.191 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.802 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -112.69 -160.54 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.074 . . . . 0.0 109.889 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.71 131.38 35.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.015 -1.053 . . . . 0.0 110.591 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 mtp -140.83 -99.57 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 5.9 t -93.86 -31.28 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.025 -1.047 . . . . 0.0 109.22 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.76 171.77 18.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_endo -65.92 136.57 45.57 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.6 1.316 . . . . 0.0 110.381 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -42.6 152.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.047 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.633 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.6 m-85 -67.37 -57.45 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 0.0 110.213 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.64 -50.13 60.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.855 -1.153 . . . . 0.0 109.638 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 3.8 m-20 -54.33 -44.14 71.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.357 -0.84 . . . . 0.0 109.992 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' ALA . 23.1 t -54.16 -33.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 110.019 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -80.46 -26.35 38.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.373 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.25 -29.37 63.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.1 -38.02 19.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.88 . . . . 0.0 109.749 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -88.15 -4.08 58.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.69 109.04 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.31 -23.76 2.84 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 1.5 mm-40 -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -1.146 . . . . 0.0 110.018 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.85 39.45 0.93 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 110.401 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.49 43.28 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -69.54 -15.0 63.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -1.176 . . . . 0.0 110.093 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.526 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.4 pt-20 -80.49 -34.24 35.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.081 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.794 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -65.04 -48.98 71.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.495 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -64.64 -46.0 84.38 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.647 ' O ' HD12 ' A' ' 48' ' ' ILE . 20.2 mt -55.97 -21.3 20.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -74.91 -43.11 56.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.945 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 43' ' ' TYR . 1.9 pt20 -75.6 -20.53 58.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' CE ' ' A' ' 61' ' ' MET . 8.7 mmt85 -90.54 -16.92 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.311 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.647 HD12 ' O ' ' A' ' 44' ' ' LEU . 25.6 mt -85.91 -32.14 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.17 37.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.5 m120 -116.68 -11.45 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 60.84 161.19 0.11 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.3 t -179.24 163.33 1.27 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.636 -1.508 . . . . 0.0 112.621 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -104.68 -178.0 3.53 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.49 20.41 78.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.918 HG12 ' CD1' ' A' ' 56' ' ' TRP . 44.2 t -96.88 -70.23 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.63 -0.923 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.918 ' CD1' HG12 ' A' ' 55' ' ' VAL . 98.9 m95 -114.68 -37.53 4.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.525 -0.734 . . . . 0.0 109.679 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.72 -169.45 20.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.21 11.41 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.566 1.511 . . . . 0.0 112.063 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 mt -109.59 86.04 4.23 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.651 -1.281 . . . . 0.0 110.586 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.3 Cg_exo -59.9 135.32 62.42 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.541 1.285 . . . . 0.0 111.013 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.565 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 52.5 ttp -71.75 130.8 86.58 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.458 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.08 138.52 47.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.648 1.341 . . . . 0.0 109.346 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.02 136.75 71.4 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.342 1.18 . . . . 0.0 110.054 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -107.8 -174.65 2.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.02 . . . . 0.0 110.865 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.88 36.98 3.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.751 . . . . 0.0 110.018 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 66' ' ' VAL . 25.8 m -81.37 114.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.044 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB2' ' OE1' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -46.8 174.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.77 -41.11 97.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.994 -1.066 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.17 -23.25 62.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.56 ' HG2' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -81.1 -36.75 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB2' HG23 ' A' ' 66' ' ' VAL . . . -76.31 -27.9 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.037 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.1 mt-30 -74.1 -41.97 60.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.558 ' HA ' ' CG ' ' A' ' 76' ' ' LYS . 85.8 m -73.8 -24.02 59.76 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.539 ' O ' HD12 ' A' ' 78' ' ' ILE . 18.5 mt -74.51 -33.72 62.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.7 . . . . 0.0 109.124 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.53 -50.04 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.558 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -67.46 -23.26 65.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 178.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.512 ' HA ' ' OG ' ' A' ' 80' ' ' SER . 49.3 t90 -75.84 -36.74 59.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.606 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.633 HG23 ' CD1' ' A' ' 27' ' ' TYR . 17.3 mt -65.77 -46.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.805 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.686 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -74.12 -13.37 60.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 77' ' ' TRP . 89.2 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.456 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.662 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 2.7 Cg_endo . . . . . 0 N--CA 1.482 0.821 0 N-CA-C 110.629 -0.566 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 18.9 pt-20 -73.0 -33.64 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.527 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 43.5 t -72.72 -46.69 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.761 ' C ' HD12 ' A' ' 6' ' ' LEU . 4.0 pp -73.58 -22.74 59.96 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.209 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.8 -40.96 83.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.706 . . . . 0.0 109.28 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.76 71.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.818 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.08 -26.08 68.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.286 -0.884 . . . . 0.0 110.664 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 74.8 mmtt -92.96 -13.2 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 110.345 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.78 66.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 34.1 m -65.95 -15.09 62.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mtp -99.26 10.88 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.119 -0.988 . . . . 0.0 110.332 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.55 -49.73 6.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.494 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.4 m -97.35 -17.84 19.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.402 -0.811 . . . . 0.0 110.702 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.616 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 4.1 m80 -102.87 174.08 6.03 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.138 -0.976 . . . . 0.0 112.169 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -156.29 -170.24 3.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.432 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 28.1 mm -90.36 -62.49 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.72 -1.238 . . . . 0.0 110.272 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 3.0 p30 -124.76 -3.18 7.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.925 -1.109 . . . . 0.0 110.613 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 69.4 p -83.6 162.44 20.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.91 91.76 3.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.1 -1.0 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 1.7 mtm -97.22 -132.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 109.696 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.64 -33.03 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.922 -1.111 . . . . 0.0 109.26 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.92 163.84 12.15 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -63.8 142.74 83.96 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.706 1.372 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.901 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -46.02 153.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.7 m-85 -71.33 -60.74 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.705 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.0 -45.08 31.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.602 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.691 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 13.8 m-20 -55.44 -45.05 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.731 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 26' ' ' ALA . 87.6 t -55.43 -33.81 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.144 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -75.93 -37.66 58.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 110.511 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.67 66.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.3 -0.875 . . . . 0.0 110.424 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -84.24 -41.06 17.31 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -0.882 . . . . 0.0 109.968 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 15.5 m-85 -88.59 -0.96 57.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.809 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -53.23 136.27 36.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.991 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.4 -35.24 5.19 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.2 mt-30 -54.02 129.04 32.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 50.63 2.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.72 55.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.03 -23.29 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.254 -1.145 . . . . 0.0 110.141 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.0 pt-20 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -68.98 -51.39 39.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.933 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 4.9 t80 -72.29 -27.9 62.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 108.962 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 48' ' ' ILE . 21.4 mt -68.18 -26.94 66.0 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.08 -36.36 55.83 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.21 -26.66 59.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.2 mmt-85 -89.26 -17.55 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 44' ' ' LEU . 37.1 mt -85.33 -26.61 6.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -85.84 -16.22 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.6 t30 -130.93 -1.62 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.095 -1.003 . . . . 0.0 110.584 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.58 ' HA2' ' HE3' ' A' ' 61' ' ' MET . . . 53.83 168.75 0.03 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.6 170.42 0.12 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.605 -1.526 . . . . 0.0 112.084 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -110.25 -175.63 2.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.01 23.92 77.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.851 HG12 ' CD1' ' A' ' 56' ' ' TRP . 34.1 t -105.89 -65.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.732 -0.864 . . . . 0.0 109.901 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.851 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.7 m95 -120.83 -37.59 2.97 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.29 -174.56 25.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.537 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.74 6.72 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.504 1.469 . . . . 0.0 111.793 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 mt -107.85 81.92 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.214 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.6 Cg_exo -55.28 145.46 66.31 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.586 1.309 . . . . 0.0 111.295 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.58 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 40.9 ttp -79.17 133.9 60.11 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.603 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.6 Cg_endo -67.56 138.23 45.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.517 1.272 . . . . 0.0 108.99 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.26 140.11 93.08 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.372 1.196 . . . . 0.0 110.16 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -113.01 170.93 7.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.797 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.53 48.86 0.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.416 -0.803 . . . . 0.0 109.84 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 71' ' ' ALA . 11.2 m -101.56 107.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 66' ' ' VAL . 1.8 m -42.07 148.41 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.847 . . . . 0.0 109.526 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' SER . 14.0 t0 -42.85 -37.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.993 -1.067 . . . . 0.0 110.734 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -64.93 -44.08 90.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.987 -1.071 . . . . 0.0 109.918 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 62.3 mt-10 -66.03 -46.64 77.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.355 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -69.61 -19.56 63.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 109.19 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.62 -44.32 57.34 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.8 m -70.53 -27.84 64.47 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.06 ' O ' HD12 ' A' ' 78' ' ' ILE . 47.3 mt -65.92 -43.28 88.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.584 -0.697 . . . . 0.0 109.249 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -62.79 -45.94 90.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 80' ' ' SER . 5.7 mttm -65.53 -23.88 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 30.9 t90 -72.32 -46.11 57.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.753 . . . . 0.0 109.831 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.06 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -59.59 -48.25 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.05 -22.68 61.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 109.846 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 12.4 m . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.2 Cg_exo . . . . . 0 N--CA 1.483 0.864 0 N-CA-C 110.829 -0.489 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -53.5 -45.9 69.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 66.0 t -55.52 -34.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -0.904 . . . . 0.0 109.374 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 3' ' ' PRO . 62.5 mt -72.19 -30.27 64.8 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.605 0.717 . . . . 0.0 109.548 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 12' ' ' CYS . . . -66.87 -30.77 71.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.408 -0.807 . . . . 0.0 110.261 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -87.01 -43.73 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 110.385 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.4 m120 -66.4 -29.06 69.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HD2' HG12 ' A' ' 66' ' ' VAL . 73.2 mmtt -96.15 -12.33 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.132 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.27 15.78 63.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 18.6 m -64.15 -21.75 66.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.429 ' CG ' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -93.69 15.24 16.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.482 -179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.55 -31.68 10.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.937 . . . . 0.0 110.373 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -112.0 -16.94 12.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 110.798 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 34.8 m-70 -110.81 160.98 16.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.787 -1.195 . . . . 0.0 112.432 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.989 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -135.51 121.6 20.11 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 1.6 mp -38.65 -28.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 110.766 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -149.95 -32.1 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.205 -0.935 . . . . 0.0 111.11 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.989 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -68.9 -161.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.974 -1.079 . . . . 0.0 109.751 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 127.21 18.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.887 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -131.9 -100.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.93 -30.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.985 -1.072 . . . . 0.0 109.454 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.1 163.59 17.75 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' ALA . 3.0 Cg_exo -61.7 142.68 94.97 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.587 1.309 . . . . 0.0 110.584 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.955 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.24 147.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.726 ' CD1' HG23 ' A' ' 78' ' ' ILE . 2.7 m-85 -65.07 -61.48 2.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -47.3 -48.07 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.048 . . . . 0.0 109.336 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.4 m-20 -54.81 -40.89 69.99 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.892 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 26' ' ' ALA . 98.7 t -55.97 -44.82 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 110.156 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -67.92 -30.1 69.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.16 -25.02 62.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.393 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.83 -37.33 14.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -93.63 -0.27 56.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.145 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.09 106.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.428 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.54 76.86 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.591 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mt-30 -145.85 167.96 21.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.59 42.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.55 46.0 0.59 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -63.12 -29.04 70.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -1.171 . . . . 0.0 110.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.82 -34.86 69.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.184 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -65.51 -51.16 61.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.302 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -67.6 -26.11 66.1 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.117 -0.99 . . . . 0.0 108.867 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 48' ' ' ILE . 13.5 mt -68.3 -25.26 65.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -76.69 -40.28 49.33 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.648 -0.657 . . . . 0.0 109.559 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -76.34 -21.43 56.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.859 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 5.4 mmm180 -89.05 -19.78 25.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 44' ' ' LEU . 43.9 mt -84.98 -30.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.282 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 3.1 ttpm? -81.59 -25.94 35.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.584 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 m120 -119.41 -3.54 10.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 49.16 179.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.1 166.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.852 -1.381 . . . . 0.0 111.766 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -106.07 -175.82 2.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.394 -0.816 . . . . 0.0 109.792 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 19.88 76.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.85 HG12 ' CD1' ' A' ' 56' ' ' TRP . 17.2 t -96.87 -68.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.639 -0.918 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.85 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.3 m95 -117.57 -37.72 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.501 -0.75 . . . . 0.0 109.705 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.99 -172.24 21.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.547 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.73 8.04 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.438 1.426 . . . . 0.0 111.973 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -109.06 89.59 6.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.651 -1.281 . . . . 0.0 110.411 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.95 145.4 98.42 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.551 1.29 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.541 ' HE1' ' HA ' ' A' ' 48' ' ' ILE . 2.7 tmm? -79.04 131.89 65.26 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.83 134.4 37.41 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.683 1.359 . . . . 0.0 108.973 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.43 135.16 65.99 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.208 1.11 . . . . 0.0 110.211 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -106.65 161.9 14.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.9 43.66 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.087 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.61 HG21 HG22 ' A' ' 48' ' ' ILE . 16.7 m -96.64 114.76 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' VAL . 24.5 p -53.36 -171.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -76.84 -42.75 38.92 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.009 -1.057 . . . . 0.0 109.773 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -64.35 -36.76 85.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 0.0 109.304 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 51.6 mt-10 -69.08 -51.51 38.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.897 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -63.5 -18.13 63.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -47.98 49.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 3' ' ' PRO . 5.1 m -68.41 -24.13 64.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 71' ' ' ALA . 88.7 mt -74.1 -34.51 63.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.613 -0.679 . . . . 0.0 109.349 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.27 -41.64 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.2 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 80' ' ' SER . 4.7 mttt -70.72 -26.8 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.459 -0.776 . . . . 0.0 109.058 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 35.8 t90 -71.84 -42.27 67.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.912 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.726 HG23 ' CD1' ' A' ' 27' ' ' TYR . 11.5 mt -65.35 -48.57 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.638 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.31 -16.05 61.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.579 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.977 . . . . 0.0 110.574 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_exo . . . . . 0 N--CA 1.481 0.756 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.53 -40.61 73.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.6 t -60.28 -54.69 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.429 -0.794 . . . . 0.0 110.003 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -63.29 -32.48 73.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.667 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.44 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -65.39 -22.42 66.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -82.35 -50.74 8.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.421 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -63.86 -19.88 65.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 0.0 110.698 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.837 ' HE3' HG12 ' A' ' 66' ' ' VAL . 15.1 mmtt -85.04 -16.48 40.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.017 -1.052 . . . . 0.0 109.9 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.97 15.26 45.96 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 9.1 m -71.13 -48.67 50.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -1.213 . . . . 0.0 110.632 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.0 mmm -72.49 3.31 5.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 0.0 110.98 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.14 22.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 0.0 110.425 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.7 m -111.74 -18.43 12.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.629 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.6 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 19.2 m-70 -99.14 165.64 11.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 112.043 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.654 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -141.6 117.48 10.49 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 22.5 mm -36.2 -29.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.542 -0.724 . . . . 0.0 111.035 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' ALA . 12.9 t70 -161.04 18.04 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.158 -0.964 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.664 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -112.01 -177.73 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 110.067 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -119.92 86.16 2.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 110.67 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 1.2 mtm -95.16 -112.93 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 109.686 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.39 -29.41 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.793 -1.192 . . . . 0.0 109.585 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.09 170.35 15.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -65.65 134.86 39.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.513 1.27 . . . . 0.0 110.326 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.938 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.47 146.77 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 5.5 m-85 -57.52 -52.99 63.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.977 -1.077 . . . . 0.0 110.209 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.14 -50.63 58.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.421 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -56.39 -34.32 66.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.192 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 26' ' ' ALA . 60.1 t -62.64 -36.87 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.107 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -78.02 -24.42 47.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.93 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.3 -33.19 69.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.466 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -84.01 -35.51 23.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -90.72 -3.99 57.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -53.83 128.6 30.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.75 71.86 1.27 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.672 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -145.64 144.1 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.82 46.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 110.627 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.8 42.45 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -70.22 -21.0 63.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -1.126 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.5 mp0 -74.04 -36.74 64.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.552 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -46.85 82.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.343 -0.848 . . . . 0.0 109.682 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.502 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 51.5 t80 -73.76 -27.54 61.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.265 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . 11.3 mt -71.52 -24.92 62.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 72' ' ' GLN . . . -79.83 -32.37 40.63 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -80.05 -24.32 40.79 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.44 -0.787 . . . . 0.0 109.182 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 34.5 mmt-85 -90.03 -17.02 28.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 109.088 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 25.2 mt -88.53 -29.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.722 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.585 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -120.09 -13.39 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.238 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.3 175.06 0.02 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.21 171.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.789 -1.418 . . . . 0.0 111.369 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.589 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.63 -171.93 1.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.486 -0.759 . . . . 0.0 109.995 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.585 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.22 12.63 61.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.81 HG12 ' CD1' ' A' ' 56' ' ' TRP . 24.9 t -93.97 -59.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.544 -0.974 . . . . 0.0 109.507 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.81 ' CD1' HG12 ' A' ' 55' ' ' VAL . 97.0 m95 -120.79 -38.92 2.78 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.578 0.704 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.94 -164.54 20.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.7 7.47 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.47 1.447 . . . . 0.0 111.718 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.4 mt -108.11 78.04 0.75 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.768 -1.207 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -56.63 140.11 89.52 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -74.97 131.01 79.71 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.844 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.7 Cg_endo -67.03 128.66 19.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.642 1.338 . . . . 0.0 109.607 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.65 135.89 70.32 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.379 1.2 . . . . 0.0 110.243 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -107.28 170.26 8.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.878 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.41 35.18 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.386 -0.821 . . . . 0.0 109.645 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.837 HG12 ' HE3' ' A' ' 10' ' ' LYS . 34.9 m -86.31 105.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 110.151 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -42.41 153.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.251 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' OD1' ' HD3' ' A' ' 49' ' ' LYS . 3.3 m-20 -44.49 -37.57 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.705 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -41.28 90.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.021 -1.049 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 4.8 mm-40 -69.19 -36.99 77.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.524 ' HB2' HG23 ' A' ' 66' ' ' VAL . . . -73.6 -20.28 60.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 5.1 tt0 -76.34 -48.79 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -66.48 -25.78 66.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 6' ' ' LEU . 18.6 mt -71.14 -37.4 72.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.774 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -67.16 -53.07 33.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.519 -0.738 . . . . 0.0 109.434 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -63.67 -26.29 68.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.594 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 28.0 t90 -64.89 -36.47 84.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.774 HD12 ' HA ' ' A' ' 75' ' ' ALA . 12.1 mt -71.97 -46.49 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 109.625 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 75' ' ' ALA . 1.7 mp -68.65 -11.35 60.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.27 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.716 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.793 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.54 -35.53 70.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.122 -0.986 . . . . 0.0 108.965 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 t -64.91 -53.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.394 -0.816 . . . . 0.0 109.643 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.716 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -68.61 -24.08 64.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -68.13 -29.02 67.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -39.5 19.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.773 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -62.39 -27.75 69.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 110.677 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' HG2' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -88.51 -17.86 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.105 . . . . 0.0 110.413 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.22 13.29 39.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.26 -41.06 90.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -1.205 . . . . 0.0 110.317 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.5 5.93 16.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -0.88 . . . . 0.0 110.598 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.0 -26.51 16.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 110.569 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 m -112.45 -14.65 13.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 29.3 m-70 -111.88 158.33 19.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 111.824 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.866 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -129.58 121.36 26.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 16.5 mt -39.73 -26.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.434 -0.791 . . . . 0.0 110.774 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.62 -35.34 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.956 -1.09 . . . . 0.0 111.01 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.866 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.06 -164.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.977 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -135.62 92.85 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.649 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -91.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.681 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -100.64 -45.91 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.924 . . . . 0.0 109.674 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.84 178.55 21.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.87 137.68 50.1 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.69 1.363 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.008 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.07 151.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.662 ' HD1' HG23 ' A' ' 78' ' ' ILE . 3.3 m-85 -65.32 -59.4 4.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -53.52 -45.13 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.004 -1.06 . . . . 0.0 109.756 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.6 m-20 -57.71 -39.41 77.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 110.021 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 26' ' ' ALA . 72.2 t -57.98 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 110.116 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.06 -31.26 65.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 110.512 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.21 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 110.169 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -86.53 -48.86 8.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.492 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 8.5 m-85 -73.34 -5.44 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.55 109.94 0.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.16 -27.36 2.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 1.8 mt-30 -67.52 149.08 50.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -1.124 . . . . 0.0 110.178 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 52.61 2.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.47 50.17 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -71.08 -25.48 62.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 110.042 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 75' ' ' ALA . 1.3 tt0 -67.02 -37.91 84.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 109.65 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.35 56.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.514 ' OH ' ' NE ' ' A' ' 47' ' ' ARG . 6.4 t80 -66.24 -24.15 66.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 109.086 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 48' ' ' ILE . 13.9 mt -69.44 -30.31 68.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.12 67.42 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -77.07 -26.56 53.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.758 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' CE ' ' A' ' 61' ' ' MET . 4.0 mmt180 -89.77 -16.41 30.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.841 . . . . 0.0 109.242 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 44' ' ' LEU . 31.2 mt -86.79 -28.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.73 -10.54 53.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 t-20 -125.48 -15.18 6.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 56.69 161.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER 171.72 167.91 0.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.534 -1.568 . . . . 0.0 112.039 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.588 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -103.75 -172.38 2.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.572 -0.705 . . . . 0.0 109.983 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.16 19.9 72.54 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG12 ' CD1' ' A' ' 56' ' ' TRP . 3.0 t -98.53 -68.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.794 -0.827 . . . . 0.0 109.631 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.642 ' CZ2' HG13 ' A' ' 30' ' ' VAL . 83.0 m95 -116.45 -36.54 3.96 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.39 -0.819 . . . . 0.0 109.497 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.07 -166.48 19.01 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -71.29 15.26 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.405 1.403 . . . . 0.0 112.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 59' ' ' ILE . 5.4 mt -111.48 84.65 5.15 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 110.41 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.5 Cg_exo -60.81 134.69 55.22 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.648 1.341 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.566 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 52.5 ttp -75.37 133.72 74.24 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.335 -0.853 . . . . 0.0 110.166 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.6 Cg_endo -69.69 134.2 27.57 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.521 1.274 . . . . 0.0 109.146 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.2 Cg_exo -58.17 142.65 97.31 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.202 1.107 . . . . 0.0 110.234 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -112.83 -174.8 2.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.902 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.31 34.17 5.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.731 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 7.8 m -74.28 118.74 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.768 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.468 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -43.45 159.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 108.996 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -53.24 -50.22 65.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.878 -1.139 . . . . 0.0 110.442 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -21.87 66.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.482 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mm-40 -76.36 -40.13 52.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.917 . . . . 0.0 110.321 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB2' ' CG2' ' A' ' 66' ' ' VAL . . . -71.75 -26.1 62.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -68.85 -44.17 73.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -71.67 -24.42 61.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 71' ' ' ALA . 38.5 mt -73.46 -33.13 64.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.281 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -73.73 -50.73 19.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.139 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -26.94 68.63 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.36 -0.837 . . . . 0.0 109.044 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 40.6 t90 -68.72 -44.15 74.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 75' ' ' ALA . 20.8 mt -56.99 -51.86 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.862 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -67.43 -21.74 65.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 77' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.719 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.664 -0.552 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 5' ' ' VAL . 12.7 pt-20 -68.23 -37.11 80.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.13 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 4' ' ' GLU . 59.9 t -64.97 -55.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.506 -0.746 . . . . 0.0 109.96 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.719 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.0 pp -66.8 -21.89 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.599 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -62.54 -47.89 81.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.504 -0.747 . . . . 0.0 109.526 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -40.87 80.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.835 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.52 -19.85 66.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.812 . . . . 0.0 110.645 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' HE2' ' OE1' ' A' ' 70' ' ' GLU . 50.9 mmtt -96.93 -19.69 18.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.058 -1.026 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.63 11.74 54.83 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 37.6 m -67.2 -29.71 69.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.014 -1.286 . . . . 0.0 110.141 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mtp -84.8 7.77 19.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.24 -49.49 10.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 110.391 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.6 m -102.9 -19.45 14.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 110.979 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 4.8 m80 -101.61 173.71 6.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.837 -1.164 . . . . 0.0 112.069 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -153.84 -168.19 2.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 19.2 mm -90.27 -73.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.677 -1.264 . . . . 0.0 110.373 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB3' ' HG2' ' A' ' 28' ' ' LYS . 17.2 p30 -116.03 -1.2 12.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 110.572 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.451 HG23 ' OD1' ' A' ' 19' ' ' ASP . 49.8 p -87.1 161.41 18.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 110.196 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -105.96 85.85 2.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 110.651 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.415 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 1.5 mtm -88.54 -125.34 0.05 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 0.0 109.84 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 t -69.87 -39.46 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.757 -1.215 . . . . 0.0 109.649 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 173.35 14.91 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.504 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.06 136.88 50.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.719 1.379 . . . . 0.0 110.554 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.742 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . . . -42.81 154.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.661 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.4 m-85 -70.11 -62.85 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.975 . . . . 0.0 109.836 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -47.48 -33.01 5.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.077 . . . . 0.0 109.392 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.742 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 7.2 m-20 -62.68 -46.65 87.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 109.59 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.593 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 49.9 t -57.43 -32.33 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -80.79 -24.37 38.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.467 -0.771 . . . . 0.0 110.082 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.36 62.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -40.22 12.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 110.098 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.47 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 23.3 m-85 -82.7 -7.04 59.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -47.15 134.74 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.21 5.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.482 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -122.58 138.38 54.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 110.083 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 51.31 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.686 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.07 41.78 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.482 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -79.69 -23.29 42.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.226 . . . . 0.0 110.018 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.36 -36.47 68.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.09 66.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.667 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.75 -28.07 66.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 48' ' ' ILE . 11.5 mt -68.67 -25.08 64.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.38 40.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.49 -0.756 . . . . 0.0 109.559 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -77.71 -28.03 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.866 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' O ' ' HE3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -86.48 -20.24 28.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.366 -0.834 . . . . 0.0 109.25 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 44' ' ' LEU . 33.9 mt -84.79 -29.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.544 -0.722 . . . . 0.0 110.133 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HG3' HG23 ' A' ' 66' ' ' VAL . 13.3 mtpt -86.71 -17.16 34.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.062 -1.024 . . . . 0.0 110.133 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.1 t-20 -119.0 -13.59 9.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 50.33 174.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 166.47 165.03 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.869 -1.371 . . . . 0.0 111.976 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -99.56 179.59 4.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.611 -0.681 . . . . 0.0 109.544 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.82 16.15 74.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.95 -64.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.566 -0.961 . . . . 0.0 109.373 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.593 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.6 m95 -118.89 -36.66 3.38 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.609 0.719 . . . . 0.0 109.414 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.66 -165.11 15.22 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.14 11.79 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.506 1.471 . . . . 0.0 112.138 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mt -110.98 88.97 8.87 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.547 -1.346 . . . . 0.0 111.038 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -62.38 132.29 37.8 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.645 1.34 . . . . 0.0 110.821 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.1 tmm? -75.19 129.43 82.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.022 -1.049 . . . . 0.0 109.843 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.47 133.47 28.14 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.528 1.278 . . . . 0.0 108.884 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -57.59 140.85 94.7 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.206 1.108 . . . . 0.0 110.177 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.25 164.84 12.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.91 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.45 32.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.832 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' SER . 15.5 m -73.94 120.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.514 -0.741 . . . . 0.0 109.915 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 66' ' ' VAL . 7.4 t -47.4 175.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.46 -69.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -21.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -75.9 -48.39 21.54 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.855 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -68.2 -18.95 64.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 108.72 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -48.59 46.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -27.05 68.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.057 ' O ' HD12 ' A' ' 78' ' ' ILE . 41.3 mt -66.13 -44.41 84.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -61.23 -52.79 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 1.1 mtpt -60.93 -19.52 60.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.576 ' CZ3' ' CE2' ' A' ' 27' ' ' TYR . 38.6 t90 -80.67 -41.31 23.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.77 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.057 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.6 mp -61.24 -52.16 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 109.833 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -64.21 -23.95 67.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.395 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.242 0.544 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 1.6 m-20 -48.68 159.97 0.5 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.17 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.1 Cg_exo -60.98 -49.92 7.26 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.609 1.32 . . . . 0.0 110.313 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' HA ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 tt0 -52.0 -46.91 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 51.1 t -48.11 -40.39 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.384 -0.822 . . . . 0.0 108.962 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 65.4 mt -64.95 -40.01 94.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 109.734 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.652 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -58.23 -27.86 64.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.601 -0.687 . . . . 0.0 110.398 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -90.14 -36.57 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 110.777 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -70.57 -25.95 63.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.204 -0.935 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.683 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 22.7 mmtm -97.9 -26.35 14.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 110.202 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.43 18.47 14.52 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 14.1 m -65.0 -32.26 73.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.421 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 69.3 mmm -79.15 2.81 19.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.03 11.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 90.2 m -96.93 -15.6 21.08 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 110.961 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.4 m-70 -104.42 172.39 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.96 -1.087 . . . . 0.0 112.047 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.88 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -152.77 124.4 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.634 HG23 ' HB3' ' A' ' 81' ' ' GLN . 3.4 mp -37.79 -27.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 111.266 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.587 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 2.0 p-10 -155.24 -32.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.996 -1.065 . . . . 0.0 111.404 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.88 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 17.9 p -69.65 151.7 45.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.965 -1.085 . . . . 0.0 109.847 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -93.38 117.76 30.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.671 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 2.3 mtm -123.02 -117.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.478 -0.764 . . . . 0.0 109.514 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.485 HG11 ' HAC' ' A' ' 83' ' ' HEM . 51.0 t -76.45 -34.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.833 -1.167 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.64 171.72 15.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.632 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.2 137.57 48.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.525 1.276 . . . . 0.0 110.072 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . . . -42.28 156.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.787 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.719 ' HD1' HG23 ' A' ' 78' ' ' ILE . 5.7 m-85 -69.06 -60.55 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -53.06 -42.27 65.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.038 -1.039 . . . . 0.0 109.011 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.818 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 59.2 m-20 -58.47 -40.86 83.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.865 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 26' ' ' ALA . 16.4 t -56.27 -38.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 109.318 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.853 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -74.0 -24.21 59.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.496 -0.753 . . . . 0.0 109.915 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.83 62.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -88.77 -35.44 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' HG2' ' A' ' 33' ' ' LYS . 3.9 m-30 -94.06 -1.75 53.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 109.84 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.853 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.05 130.23 37.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.177 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.15 -19.04 15.49 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 8.3 mm100 -66.58 145.78 55.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -1.089 . . . . 0.0 110.027 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.33 2.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.266 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 56.49 0.21 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.609 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -75.3 -13.16 60.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -1.161 . . . . 0.0 110.287 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.796 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -75.18 -30.05 60.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -70.61 -52.95 17.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.55 -34.64 78.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.911 . . . . 0.0 108.806 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 48' ' ' ILE . 11.5 mt -59.18 -36.6 75.62 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -65.94 -37.75 86.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 109.667 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -29.54 65.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.974 . . . . 0.0 110.08 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.498 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 29.2 mmt180 -88.42 -12.42 43.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.264 -0.898 . . . . 0.0 109.384 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.879 HD11 HMA1 ' A' ' 83' ' ' HEM . 38.7 mt -90.28 -25.16 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.452 -0.78 . . . . 0.0 109.446 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -85.53 -14.33 46.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.7 t30 -126.98 -11.71 5.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.55 174.64 0.02 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 163.87 167.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.169 -1.195 . . . . 0.0 111.414 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.0 pm0 -101.9 -161.14 0.83 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.435 -0.791 . . . . 0.0 109.925 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 56.4 19.39 25.61 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.864 HG12 ' CD1' ' A' ' 56' ' ' TRP . 60.5 t -104.54 -62.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.701 -0.882 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.864 ' CD1' HG12 ' A' ' 55' ' ' VAL . 88.2 m95 -120.0 -35.53 3.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.09 -175.93 31.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.94 6.83 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.379 1.386 . . . . 0.0 111.764 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.546 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 9.1 mt -106.05 85.37 1.59 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.84 -1.162 . . . . 0.0 109.829 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.7 Cg_endo -54.07 133.86 57.23 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.7 1.369 . . . . 0.0 110.834 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.598 ' HE3' ' HA ' ' A' ' 48' ' ' ILE . 3.2 tmm? -70.52 131.92 87.83 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.145 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.1 Cg_exo -64.38 130.24 26.26 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.73 1.384 . . . . 0.0 109.504 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.7 Cg_endo -59.38 138.24 83.12 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.478 1.251 . . . . 0.0 110.346 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -110.39 160.63 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.26 35.72 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 66' ' ' VAL . 19.8 m -79.86 119.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.393 -0.817 . . . . 0.0 110.028 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -46.39 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.569 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.93 -39.2 79.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.939 -1.1 . . . . 0.0 109.94 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.55 -34.77 74.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.871 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.4 mm-40 -71.71 -38.52 70.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 110.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.854 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -72.51 -22.82 60.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.221 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 7.2 mt-30 -71.73 -41.68 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.53 -25.84 61.53 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' A' ' 71' ' ' ALA . 41.6 mt -72.02 -30.99 65.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.796 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -73.29 -53.62 10.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.517 -0.739 . . . . 0.0 109.545 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 16.8 ptmt -64.87 -20.79 66.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.227 -0.921 . . . . 0.0 109.076 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.652 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 43.7 t90 -70.7 -43.55 68.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.304 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.719 HG23 ' HD1' ' A' ' 27' ' ' TYR . 13.1 mt -62.81 -48.78 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.918 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -69.19 -9.75 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.475 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 81' ' ' GLN . 13.4 t -108.21 -5.13 17.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.634 ' HB3' HG23 ' A' ' 18' ' ' ILE . 13.3 mm-40 -50.51 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.026 . . . . 0.0 110.046 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.259 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.879 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.215 0.531 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.94 153.76 80.32 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_endo -60.38 -15.22 34.16 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.726 1.382 . . . . 0.0 110.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -38.15 68.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -62.99 -52.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.884 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -61.77 -33.85 74.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.208 -0.932 . . . . 0.0 109.661 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.446 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -68.44 -21.92 64.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -49.91 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -65.31 -23.57 67.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.134 -0.978 . . . . 0.0 110.479 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 22.3 mmtm -84.52 -12.41 54.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 109.798 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.3 69.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.534 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 59.4 m -65.15 -31.7 73.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.252 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.2 mtp -88.41 7.62 31.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 110.301 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 -44.82 18.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 70.8 m -102.67 -17.61 15.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 110.887 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.645 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 11.1 m-70 -93.73 168.26 11.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.947 -1.096 . . . . 0.0 112.353 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.984 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -148.05 118.72 7.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.6 mp -38.66 -27.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.399 -0.813 . . . . 0.0 110.913 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.5 p-10 -148.65 -35.9 0.19 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.041 -1.037 . . . . 0.0 110.542 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.984 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.05 -179.29 1.47 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -129.83 89.07 2.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 110.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -78.82 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.006 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 70.7 t -97.75 -25.65 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.977 -1.077 . . . . 0.0 109.396 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.94 173.76 15.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.651 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -68.61 133.35 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.574 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -46.11 151.24 0.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.638 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -61.6 -64.39 0.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.115 -0.991 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -48.1 -46.02 33.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 2.8 m-20 -51.9 -47.1 64.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.486 -0.759 . . . . 0.0 110.147 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 26' ' ' ALA . 89.7 t -57.99 -34.25 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.9 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -75.78 -26.35 57.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.18 60.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -85.44 -37.35 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' GLY . 11.5 m-85 -97.8 -3.41 38.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -0.944 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.9 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -51.27 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 130.93 69.14 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.458 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.4 mt-30 -144.7 149.79 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.26 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.02 39.46 0.96 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.47 50.08 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -84.83 -42.46 15.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -1.175 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.781 ' HA ' HD12 ' A' ' 44' ' ' LEU . 10.0 mp0 -59.73 -38.09 80.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 109.926 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.89 84.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CZ ' ' HD2' ' A' ' 47' ' ' ARG . 28.6 t80 -70.68 -20.01 62.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.225 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.781 HD12 ' HA ' ' A' ' 41' ' ' GLU . 28.7 mt -72.86 -34.86 67.03 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.8 -31.97 59.66 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -28.13 51.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.863 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.589 ' HD2' ' CZ ' ' A' ' 43' ' ' TYR . 6.9 mmp_? -86.65 -16.81 35.47 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.377 -0.827 . . . . 0.0 109.547 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.928 HD11 HMA1 ' A' ' 83' ' ' HEM . 58.8 mt -88.22 -28.97 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.459 -0.775 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -80.26 -20.77 43.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.2 m120 -120.86 -17.91 7.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.109 -0.994 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.74 169.48 0.02 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.6 OUTLIER 164.02 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.086 -1.243 . . . . 0.0 111.375 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -96.94 -160.97 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.313 -0.867 . . . . 0.0 110.44 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.46 19.04 59.59 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.849 HG12 ' CD1' ' A' ' 56' ' ' TRP . 9.4 t -98.28 -69.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.675 -0.897 . . . . 0.0 109.48 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.849 ' CD1' HG12 ' A' ' 55' ' ' VAL . 92.3 m95 -118.53 -38.25 3.17 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 108.953 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.51 -167.73 15.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.494 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.58 14.72 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.558 1.505 . . . . 0.0 112.07 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 8.9 mt -110.13 96.56 26.26 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.545 -1.347 . . . . 0.0 111.005 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.551 ' CB ' ' HB3' ' A' ' 53' ' ' GLN . 2.5 Cg_endo -65.01 128.64 21.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.615 1.324 . . . . 0.0 110.589 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.551 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tmm? -69.2 128.93 92.34 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.876 -1.14 . . . . 0.0 108.796 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -64.22 129.97 25.76 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.643 1.338 . . . . 0.0 109.5 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_exo -57.27 148.95 67.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.243 1.128 . . . . 0.0 109.972 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.73 163.45 18.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 111.047 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.5 36.37 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.7 m -84.4 108.62 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' VAL . 17.5 p -42.22 152.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.559 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -45.92 -48.76 16.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.797 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.84 -34.79 75.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.976 . . . . 0.0 110.46 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.97 -40.93 75.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -72.16 -21.47 61.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.02 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -70.27 -44.05 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 3' ' ' PRO . 18.9 m -70.84 -23.99 62.44 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.979 HD13 HMB1 ' A' ' 83' ' ' HEM . 31.7 mt -71.7 -37.45 70.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.47 58.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.452 -0.78 . . . . 0.0 109.159 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 80' ' ' SER . 13.2 mtmt -66.7 -22.2 66.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.239 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 62.0 t90 -78.01 -24.04 48.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 109.92 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 74' ' ' LEU . 7.2 mt -84.29 -61.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.898 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -49.74 -42.17 45.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 9.2 m -86.58 -42.25 13.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.551 ' HG3' ' CB ' ' A' ' 27' ' ' TYR . 0.7 OUTLIER 37.83 -155.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.1 tpmt? . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.159 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.979 HMB1 HD13 ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 1' ' ' GLU . 8.2 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 3.3 m-20 -54.0 145.99 30.96 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.957 . . . . 0.0 110.123 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.63 ' HA ' HD21 ' A' ' 6' ' ' LEU . 2.8 Cg_endo -61.93 -33.32 84.16 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.544 1.286 . . . . 0.0 110.716 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt-20 -65.09 -27.56 68.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 0.0 109.134 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 2' ' ' ASP . 32.8 t -71.82 -59.25 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.535 -0.728 . . . . 0.0 109.404 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -62.67 -19.2 63.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.85 -53.85 23.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.932 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -29.78 69.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 110.463 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -67.17 -37.21 83.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.664 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.579 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 10.3 mmtp -82.31 -13.37 57.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.18 12.45 49.0 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.636 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 22.5 m -65.26 -38.62 90.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -1.23 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.85 7.26 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.469 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.88 -34.22 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.3 m -110.55 -14.86 14.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 110.745 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.631 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.7 m-70 -102.98 154.38 19.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.895 -1.128 . . . . 0.0 111.846 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.858 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -132.47 121.32 23.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.846 HG22 ' HD2' ' A' ' 28' ' ' LYS . 11.2 mt -40.34 -26.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.957 . . . . 0.0 110.724 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 4.6 t70 -152.21 -35.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.858 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.81 163.68 25.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 110.518 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -103.44 89.31 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 110.559 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 mtm -85.49 -95.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.683 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.13 -39.35 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.68 -179.41 18.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.614 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.49 129.86 22.3 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.627 1.33 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.91 143.39 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.811 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.631 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 5.8 m-85 -53.92 -48.97 69.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.846 ' HD2' HG22 ' A' ' 18' ' ' ILE . 2.1 mtpp -57.43 -50.67 72.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.8 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.26 -27.13 63.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 110.242 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' ALA . 92.0 t -67.06 -43.09 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.047 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -74.47 -23.86 58.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 110.395 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.62 59.04 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.215 -0.928 . . . . 0.0 110.378 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -90.88 -41.7 11.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE2' ' CZ2' ' A' ' 56' ' ' TRP . 7.7 m-85 -78.35 -7.81 57.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.077 -1.015 . . . . 0.0 110.041 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.86 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 155.44 -45.14 0.54 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 5.4 mm-40 -42.24 157.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 57.58 3.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.663 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.05 57.96 0.39 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -70.7 -44.42 66.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -1.1 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 21.0 pt-20 -50.44 -37.79 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -60.8 -57.79 11.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 85.2 t80 -67.18 -13.86 62.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD22 HMA1 ' A' ' 83' ' ' HEM . 18.8 mt -78.42 -29.39 47.11 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.46 64.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.597 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 2.3 mmt180 -81.42 -16.67 51.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.21 -0.932 . . . . 0.0 109.521 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 HMA3 ' A' ' 83' ' ' HEM . 9.7 mt -81.08 -34.43 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.34 -12.41 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 110.685 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.32 -8.84 8.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 110.654 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 62.01 160.55 0.16 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 11.5 t -179.2 154.82 0.68 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.639 -1.507 . . . . 0.0 112.54 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.11 -176.31 3.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.679 -0.638 . . . . 0.0 109.703 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 66.05 10.77 52.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.974 HG11 HBA2 ' A' ' 83' ' ' HEM . 2.1 t -89.41 -62.25 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.482 -1.011 . . . . 0.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.614 ' CD2' ' CG ' ' A' ' 25' ' ' PRO . 73.9 m95 -115.65 -33.72 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.497 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.36 -167.31 25.76 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.7 Cg_endo -69.44 6.87 1.04 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.376 1.384 . . . . 0.0 111.695 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.549 ' O ' HMD1 ' A' ' 83' ' ' HEM . 15.6 mt -110.59 90.17 10.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 120.805 -1.185 . . . . 0.0 110.5 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -61.88 141.34 89.45 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.786 1.414 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.592 ' HE3' ' O ' ' A' ' 47' ' ' ARG . 32.4 ttp -71.92 128.48 89.31 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.902 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -63.0 130.94 30.7 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.589 1.31 . . . . 0.0 109.379 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.1 131.2 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.322 1.169 . . . . 0.0 109.928 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -105.55 163.89 12.31 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 110.537 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 30.32 1.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.842 . . . . 0.0 109.733 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' CG ' ' A' ' 49' ' ' LYS . 15.8 m -74.16 116.06 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -48.85 179.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.695 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -65.5 -68.89 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -45.83 -32.19 2.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.364 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -68.3 -51.35 45.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.351 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.963 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -63.67 -21.07 66.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -71.44 -47.32 56.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.389 -0.819 . . . . 0.0 108.815 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -68.16 -24.43 64.98 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.982 ' O ' HD12 ' A' ' 78' ' ' ILE . 70.4 mt -68.99 -41.33 77.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.581 -0.699 . . . . 0.0 109.381 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.7 -48.75 65.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.379 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -63.68 -19.2 64.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.394 -0.817 . . . . 0.0 109.458 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -78.51 -46.18 20.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 110.098 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.982 HD12 ' O ' ' A' ' 74' ' ' LEU . 3.1 mt -63.06 -48.36 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.532 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -13.71 61.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -82.35 -31.79 29.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.652 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 65.1 mm-40 -43.09 -54.74 4.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.332 -0.855 . . . . 0.0 110.083 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.974 HBA2 HG11 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.181 0.515 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.3 156.88 83.43 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo -60.99 -15.12 36.92 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.678 1.357 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -33.0 57.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.246 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.8 t -66.4 -48.74 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.572 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.4 pp -69.36 -30.57 68.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.268 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -58.14 -55.42 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -43.77 82.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.83 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -55.13 -29.45 57.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.606 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 16.7 mmtm -90.69 -22.32 21.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.903 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.62 14.44 27.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.69 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 19.8 m -66.36 -36.05 81.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -1.198 . . . . 0.0 110.407 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 mtp -82.16 6.82 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 110.882 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.87 -43.87 13.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 89.9 m -101.71 -18.13 15.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.3 m-70 -101.0 167.45 10.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 111.969 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -147.26 122.8 10.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.55 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.1 mp -37.45 -27.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.424 -0.798 . . . . 0.0 111.075 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.576 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -155.68 -34.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 110.863 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.931 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 62.4 p -69.62 154.53 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.199 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.66 122.72 39.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mtm -124.73 -98.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 68.1 t -94.2 -36.32 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 109.317 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.25 178.17 16.4 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -69.23 133.2 25.94 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.656 1.346 . . . . 0.0 110.485 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.43 150.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.057 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 8.2 m-85 -60.73 -56.95 15.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.247 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HE2' ' HD3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -50.32 -49.81 52.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.753 -1.217 . . . . 0.0 109.448 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 6.5 m-20 -53.33 -41.75 66.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 26' ' ' ALA . 49.5 t -53.98 -42.44 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.846 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -73.65 -23.42 59.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.965 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 29' ' ' ASP . . . -66.64 -34.07 77.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' CZ3' ' A' ' 56' ' ' TRP . 3.2 ttmt -86.92 -49.97 7.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -76.46 1.22 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.846 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -59.01 126.72 28.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.439 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.36 28.67 4.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.48 138.83 50.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 110.24 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.42 41.12 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.95 55.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.647 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -87.15 -17.27 33.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.149 -1.207 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.697 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 2.3 mt-10 -75.63 -33.71 60.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.887 . . . . 0.0 109.611 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.68 63.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.554 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.73 -31.65 68.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.087 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 40' ' ' ALA . 15.4 mt -67.46 -26.99 66.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . . . -75.61 -33.41 60.52 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.574 -0.704 . . . . 0.0 109.834 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.36 -36.36 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.424 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 33.5 mmt-85 -82.18 -15.76 52.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.961 HD11 HMA1 ' A' ' 83' ' ' HEM . 24.9 mt -85.99 -29.6 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.24 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -84.84 -17.75 37.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.4 t30 -126.8 -0.04 6.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.111 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 51.27 -173.76 0.13 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.2 p 167.42 158.72 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.038 -1.272 . . . . 0.0 111.871 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.681 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -106.15 -164.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 0.0 109.959 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 53.39 18.98 7.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 53' ' ' GLN . 6.7 t -94.72 -69.25 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -1.103 . . . . 0.0 109.17 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.61 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 98.4 m95 -110.41 -39.03 5.06 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.736 0.779 . . . . 0.0 108.941 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.88 -174.0 24.32 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -70.02 8.15 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.349 1.366 . . . . 0.0 111.506 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 11.3 mt -107.34 82.37 1.21 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -55.42 145.67 66.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.667 1.351 . . . . 0.0 111.563 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.549 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.6 ttm -74.95 132.42 77.3 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.808 . . . . 0.0 109.406 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.715 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -67.59 129.14 19.37 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.624 1.328 . . . . 0.0 109.036 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -56.68 133.92 61.11 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.179 1.094 . . . . 0.0 110.146 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -105.9 -177.99 3.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.19 35.41 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.77 ' O ' HG23 ' A' ' 66' ' ' VAL . 27.1 m -87.09 103.14 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.8 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 40.3 t -43.61 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 109.345 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 67' ' ' SER . 1.5 m-20 -42.78 -47.51 5.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.507 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -59.17 -41.42 88.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 17.8 mt-10 -65.87 -38.94 90.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.817 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 45' ' ' ALA . . . -70.45 -19.92 62.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.091 -1.006 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -49.05 30.41 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -27.94 66.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.66 HD22 ' CMB' ' A' ' 83' ' ' HEM . 51.1 mt -69.53 -36.12 76.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.697 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -67.46 -53.4 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -0.756 . . . . 0.0 109.505 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 10.4 mttt -61.98 -24.07 66.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.591 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 40.9 t90 -72.03 -35.44 69.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.511 -0.743 . . . . 0.0 109.57 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.735 HD13 HMA3 ' A' ' 83' ' ' HEM . 7.2 mt -74.8 -38.96 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 4.3 mt -74.21 -11.96 60.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.367 -0.833 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.5 p -91.65 -24.24 19.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.422 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 81.9 mm-40 -55.82 125.9 23.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' HD3' ' HE2' ' A' ' 28' ' ' LYS . 2.4 tppp? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.141 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.961 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.162 0.506 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' OD2' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -80.41 162.44 61.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 109.901 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.73 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.0 Cg_endo -60.43 -19.32 58.29 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.645 1.34 . . . . 0.0 110.673 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 8.9 pt-20 -70.19 -39.09 75.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.259 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.55 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 57.8 t -64.32 -54.93 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 3' ' ' PRO . 3.8 pp -67.95 -22.66 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.876 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.92 -33.36 74.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -37.86 33.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -65.11 -30.99 71.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.883 . . . . 0.0 110.877 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.596 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 6.3 mmtm -83.82 -18.09 38.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.887 -1.133 . . . . 0.0 109.772 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.8 12.34 43.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.731 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 15.0 m -68.03 -35.83 78.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.268 . . . . 0.0 110.417 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 1.69 41.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -38.64 15.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.005 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -101.24 -26.41 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 110.444 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.635 ' NE2' ' ND ' ' A' ' 83' ' ' HEM . 32.9 m-70 -106.36 166.79 10.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 22' ' ' MET . . . -135.21 -176.16 4.17 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.603 HG23 ' HB3' ' A' ' 81' ' ' GLN . 45.3 mm -91.32 -26.01 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 110.402 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 2.8 p30 -162.22 19.35 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.976 -1.077 . . . . 0.0 111.06 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -114.93 -166.4 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.954 -1.091 . . . . 0.0 110.194 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 87.81 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 110.765 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.581 ' HE2' ' HB2' ' A' ' 17' ' ' ALA . 31.3 mtm -97.89 -98.43 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 109.598 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.624 HG11 ' HAC' ' A' ' 83' ' ' HEM . 94.9 t -88.87 -45.58 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 0.0 109.231 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.7 172.74 14.4 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HG3' ' HB3' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.23 143.04 82.4 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.469 1.247 . . . . 0.0 110.275 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -41.42 163.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -81.44 -53.14 6.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -52.13 -42.11 63.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 5.0 m-20 -58.05 -38.48 76.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.541 -0.724 . . . . 0.0 109.681 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 26' ' ' ALA . 91.1 t -58.55 -46.45 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.825 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.86 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.88 -19.93 61.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.552 -0.717 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -32.43 62.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -43.07 13.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.932 . . . . 0.0 109.822 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -78.81 -5.76 54.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.854 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.86 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -62.21 89.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.13 -20.94 0.57 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 mt-30 -71.48 149.91 45.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.101 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.15 40.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 110.428 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.7 56.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.645 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -90.28 -20.16 23.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.242 . . . . 0.0 110.45 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.93 -34.84 66.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 109.503 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.35 -50.93 63.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.721 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.526 ' CE1' ' CG ' ' A' ' 47' ' ' ARG . 1.2 t80 -68.11 -30.3 69.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 109.106 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 48' ' ' ILE . 9.2 mt -65.13 -29.7 70.57 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.92 66.31 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.597 -0.689 . . . . 0.0 110.008 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -76.38 -27.4 56.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 110.363 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 0.2 OUTLIER -87.72 -15.26 37.55 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.787 HD11 HMA1 ' A' ' 83' ' ' HEM . 35.2 mt -86.61 -32.31 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.382 -0.824 . . . . 0.0 109.618 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -85.06 -10.48 56.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 3.1 m-20 -124.16 -12.8 7.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 51.14 175.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 166.28 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.047 -1.267 . . . . 0.0 111.462 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.568 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -102.37 179.67 4.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.766 . . . . 0.0 109.955 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.81 19.26 73.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.771 HG11 ' CGA' ' A' ' 83' ' ' HEM . 2.6 t -91.58 -67.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.596 -0.944 . . . . 0.0 109.459 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.592 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 88.6 m95 -119.41 -35.48 3.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.509 -0.744 . . . . 0.0 109.041 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.05 -174.29 23.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.39 11.44 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.426 1.417 . . . . 0.0 112.019 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.556 ' O ' HMD3 ' A' ' 83' ' ' HEM . 15.4 mt -109.11 87.06 4.42 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.659 -1.276 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.15 138.41 85.77 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.593 1.312 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.555 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.6 tmm? -79.02 126.68 81.6 Favored Pre-proline 0 C--N 1.299 -1.595 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.372 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.68 127.4 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.3 Cg_exo -55.18 132.99 55.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.241 1.127 . . . . 0.0 110.054 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -102.23 167.14 10.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.468 -0.77 . . . . 0.0 110.862 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.87 30.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.401 -0.812 . . . . 0.0 109.877 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 66' ' ' VAL . 17.9 m -76.13 113.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 109.667 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -50.99 -176.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.778 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.09 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.019 -1.051 . . . . 0.0 110.087 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -52.86 -32.51 45.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mt-10 -68.97 -49.01 61.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -67.62 -17.45 64.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 109.239 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -74.41 -41.29 61.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 3' ' ' PRO . 60.8 m -76.21 -23.39 54.62 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.702 HD13 HMB1 ' A' ' 83' ' ' HEM . 53.8 mt -75.9 -34.84 59.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.573 -0.704 . . . . 0.0 109.181 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.781 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -73.49 -48.3 34.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.081 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.576 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -66.02 -27.01 67.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.066 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.526 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 36.4 t90 -67.15 -41.46 86.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.413 -0.804 . . . . 0.0 109.355 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 75' ' ' ALA . 16.2 mt -61.72 -50.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.381 -0.824 . . . . 0.0 109.521 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.6 mt -62.08 -25.35 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -33.68 73.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.603 ' HB3' HG23 ' A' ' 18' ' ' ILE . 50.2 mm-40 -53.27 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.471 ' HB3' ' HG3' ' A' ' 28' ' ' LYS . 6.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.329 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.787 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.333 0.587 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.2 m-20 -83.27 153.86 66.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 110.156 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.759 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.2 Cg_exo -61.48 -14.95 38.06 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.664 1.349 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.71 -39.41 66.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.194 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 96.0 t -65.41 -54.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.857 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 3' ' ' PRO . 2.2 pp -68.57 -24.16 64.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.349 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -70.13 -33.54 71.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -84.59 -37.64 20.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.16 -35.59 77.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.501 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.845 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 1.0 OUTLIER -85.27 -10.49 56.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.045 -1.034 . . . . 0.0 110.589 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.44 58.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.599 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 20.4 m -62.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -1.234 . . . . 0.0 110.412 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mtp -85.51 10.68 12.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.893 . . . . 0.0 110.465 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.21 13.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 92.7 m -105.82 -21.57 13.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 110.711 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 14.8 m-70 -94.95 167.34 11.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 0.0 112.71 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.948 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -145.15 120.11 10.0 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG23 ' HG3' ' A' ' 81' ' ' GLN . 7.8 mt -39.98 -25.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.221 -0.925 . . . . 0.0 111.15 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.9 p30 -147.52 -39.59 0.19 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.792 -1.192 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.948 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -70.51 153.93 42.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.013 . . . . 0.0 110.428 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -98.37 97.64 8.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.359 -0.838 . . . . 0.0 109.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.573 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 16.6 mtm -97.13 -121.58 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 64.3 t -70.4 -32.59 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.768 -1.208 . . . . 0.0 109.819 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.99 173.24 15.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.632 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.48 131.61 26.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.627 1.33 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -47.01 153.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.873 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 16' ' ' HIS . 10.3 m-85 -66.81 -51.15 59.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HE3' HG22 ' A' ' 18' ' ' ILE . 10.8 mttt -53.93 -49.88 67.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.534 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.68 -43.36 68.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.99 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 26' ' ' ALA . 75.5 t -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.92 -28.52 62.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.61 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -0.973 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.14 -42.9 10.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -88.28 0.85 55.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.24 122.37 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.176 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.57 13.6 20.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.642 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.34 141.16 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -1.199 . . . . 0.0 110.214 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.37 52.89 2.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.76 48.03 0.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -73.83 -22.52 59.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -1.21 . . . . 0.0 110.092 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 3.3 pt-20 -71.3 -29.16 64.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -65.31 -53.06 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.674 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -70.09 -28.47 65.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 48' ' ' ILE . 19.7 mt -68.67 -26.24 65.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -73.14 -39.18 65.9 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.408 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -77.26 -23.13 51.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.542 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 19.5 mmt180 -90.13 -17.64 27.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.344 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.776 HD11 HMA1 ' A' ' 83' ' ' HEM . 26.8 mt -85.32 -31.02 6.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -86.98 -11.97 48.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 110.1 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 86.3 m-20 -121.04 -13.32 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 109.951 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 54.74 169.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 168.88 166.27 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.804 -1.41 . . . . 0.0 111.857 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -105.6 -173.9 2.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.777 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.567 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.0 9.92 54.93 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.712 HG12 ' CD1' ' A' ' 56' ' ' TRP . 39.8 t -89.82 -50.96 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.398 -1.06 . . . . 0.0 109.459 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.712 ' CD1' HG12 ' A' ' 55' ' ' VAL . 92.5 m95 -129.22 -36.11 1.75 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.41 -166.53 24.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.2 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.411 1.408 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG22 HMD3 ' A' ' 83' ' ' HEM . 10.3 mt -109.67 83.14 2.55 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.844 -1.16 . . . . 0.0 110.567 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.64 160.5 17.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.716 1.377 . . . . 0.0 111.1 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.569 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 54.0 ttp -96.91 131.21 28.28 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.501 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.9 Cg_endo -67.59 132.33 26.78 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.653 1.344 . . . . 0.0 109.033 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.9 139.9 92.85 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.267 1.14 . . . . 0.0 110.344 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -114.8 165.68 12.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 0.0 110.793 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.46 38.31 0.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.034 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 66' ' ' VAL . 27.3 m -71.31 116.41 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.312 -0.867 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.451 ' N ' ' HB2' ' A' ' 70' ' ' GLU . 29.1 m -51.62 178.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -59.15 5.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 109.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.6 -13.5 9.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mm-40 -82.29 -46.0 14.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.219 -0.926 . . . . 0.0 110.201 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.28 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.026 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -44.32 39.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.492 -0.755 . . . . 0.0 109.059 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 3' ' ' PRO . 35.5 m -74.44 -22.1 59.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.116 HD22 ' CMB' ' A' ' 83' ' ' HEM . 30.2 mt -75.5 -39.46 58.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.662 -0.649 . . . . 0.0 109.393 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -72.06 -43.54 64.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.017 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 46.5 mttt -65.82 -30.83 71.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.216 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.568 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 33.4 t90 -66.55 -44.38 82.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.634 -0.666 . . . . 0.0 109.918 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.623 HD11 ' HHB' ' A' ' 83' ' ' HEM . 73.4 mt -61.43 -47.02 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.643 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.1 -12.73 60.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -0.824 . . . . 0.0 109.76 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -89.72 -19.94 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.091 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.983 ' HG3' HG23 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -40.65 -28.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 81' ' ' GLN . 2.2 tttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.416 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 1.116 ' CMB' HD22 ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.31 155.03 66.67 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.562 ' HA ' HD12 ' A' ' 6' ' ' LEU . 3.0 Cg_endo -60.61 -38.14 74.56 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.674 1.355 . . . . 0.0 110.296 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.84 -43.33 65.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 99.0 t -54.53 -37.82 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.298 -0.876 . . . . 0.0 109.432 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 3' ' ' PRO . 71.3 mt -65.0 -36.82 85.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.796 . . . . 0.0 109.759 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -69.01 -23.25 64.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.2 -34.5 17.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.342 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.156 -0.965 . . . . 0.0 110.576 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.875 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 0.0 OUTLIER -89.87 -13.33 36.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.599 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.86 17.93 52.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 35.4 m -63.38 -22.37 66.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -1.083 . . . . 0.0 110.715 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.6 mtp -90.82 8.79 33.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.822 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.37 -51.41 6.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.566 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 72.5 m -93.7 -16.29 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 110.94 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 15.1 m-70 -104.68 160.41 14.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.126 . . . . 0.0 112.289 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.012 ' HB2' ' SD ' ' A' ' 22' ' ' MET . . . -142.47 126.8 17.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.914 HG23 ' HG3' ' A' ' 81' ' ' GLN . 2.3 mp -38.72 -26.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.421 -0.799 . . . . 0.0 111.243 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.541 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 60.8 m-20 -152.19 -37.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.987 -1.071 . . . . 0.0 110.75 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.79 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -69.22 165.74 19.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -113.9 95.6 5.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.07 -1.019 . . . . 0.0 110.863 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 1.012 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -85.05 -88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.688 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 71.8 t -104.46 -27.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 109.566 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.27 177.23 16.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -67.69 137.04 40.95 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.677 1.357 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.932 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -44.9 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.795 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.0 m-85 -78.39 -46.69 19.32 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -56.86 -54.32 47.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -50.67 -36.61 36.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.257 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 26' ' ' ALA . 94.7 t -61.5 -44.34 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.131 -0.981 . . . . 0.0 110.446 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . . . -72.71 -23.81 60.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.403 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.79 -23.38 52.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -90.06 -42.27 11.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.48 3.82 38.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.039 -1.038 . . . . 0.0 110.09 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.34 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.49 -39.01 0.86 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 mm-40 -49.21 138.74 12.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.106 -1.232 . . . . 0.0 110.354 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 50.49 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.392 -0.818 . . . . 0.0 110.121 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.69 42.46 0.05 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -75.99 -18.78 59.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.269 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.654 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -75.06 -37.0 61.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.489 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -66.45 -52.03 50.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -65.91 -32.26 73.66 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 108.78 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.641 ' O ' HD12 ' A' ' 48' ' ' ILE . 12.6 mt -64.57 -30.69 71.71 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -69.65 -34.47 74.05 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.655 -0.653 . . . . 0.0 109.581 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.8 -44.32 64.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.342 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.76 -20.33 60.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.734 HD11 HMA1 ' A' ' 83' ' ' HEM . 47.5 mt -80.61 -31.53 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -88.41 -20.28 25.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' GLY . 20.2 t30 -113.73 -5.8 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 57.64 162.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.2 t 177.51 161.4 0.5 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.614 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.26 -175.07 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.836 -0.54 . . . . 0.0 109.951 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 69.09 16.58 70.95 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.818 HG12 ' CD1' ' A' ' 56' ' ' TRP . 89.4 t -97.96 -60.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.569 -0.96 . . . . 0.0 109.731 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.818 ' CD1' HG12 ' A' ' 55' ' ' VAL . 98.3 m95 -118.43 -39.8 2.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.48 -0.763 . . . . 0.0 109.46 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.73 -166.32 21.32 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.91 12.54 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.31 1.34 . . . . 0.0 111.902 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG22 HMD3 ' A' ' 83' ' ' HEM . 8.7 mt -109.61 78.54 1.19 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.612 -1.305 . . . . 0.0 110.431 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.1 140.33 94.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.518 1.272 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.652 ' HE2' HBA1 ' A' ' 83' ' ' HEM . 7.6 ttp -72.89 135.45 80.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.489 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -69.36 135.11 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.798 1.42 . . . . 0.0 108.725 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.05 148.36 85.77 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.289 1.152 . . . . 0.0 110.392 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.467 ' HB2' HG13 ' A' ' 66' ' ' VAL . 4.2 m120 -127.76 173.79 9.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.487 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.11 35.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.798 HG12 ' HG2' ' A' ' 10' ' ' LYS . 25.9 m -73.5 103.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.801 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -43.16 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.63 -68.08 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 0.0 110.13 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -21.0 1.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.305 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' CG ' ' NZ ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -73.86 -47.2 39.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -71.14 -16.51 62.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.167 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -41.92 50.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -76.11 -27.6 57.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.009 HD13 HMB1 ' A' ' 83' ' ' HEM . 24.1 mt -71.87 -34.17 69.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -70.37 -49.81 45.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.795 . . . . 0.0 109.397 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.2 OUTLIER -67.19 -24.71 65.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.896 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.54 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 54.3 t90 -71.27 -33.33 69.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 109.328 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' A' ' 75' ' ' ALA . 15.4 mt -69.88 -48.42 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.612 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.733 HD12 ' O ' ' A' ' 75' ' ' ALA . 2.6 mp -72.39 -17.05 61.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.87 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 3.1 m -89.09 -13.86 37.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.213 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.914 ' HG3' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -41.8 -46.84 4.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.327 -0.858 . . . . 0.0 110.449 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.486 ' HB3' ' HG3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.285 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 1.009 HMB1 HD13 ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 1' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.299 0.571 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 6' ' ' LEU . 93.1 m-20 -77.1 163.29 65.96 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.867 . . . . 0.0 110.003 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HA ' HD11 ' A' ' 6' ' ' LEU . 2.9 Cg_endo -59.61 -29.11 89.04 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' OE1' ' C ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -69.33 -31.37 69.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.316 -0.865 . . . . 0.0 108.743 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.8 t -70.76 -59.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.177 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.673 HD11 ' HA ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -62.08 -21.49 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 109.536 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -76.0 -29.33 58.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.364 -0.835 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 -27.82 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.807 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.2 m120 -72.34 -38.7 68.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.817 . . . . 0.0 110.33 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.911 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 0.8 OUTLIER -83.09 -4.69 58.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.029 . . . . 0.0 110.193 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.52 18.01 65.02 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.516 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 23.8 m -63.82 -38.21 90.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.304 . . . . 0.0 110.44 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.76 7.09 13.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.576 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.43 -36.62 17.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.922 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.9 m -106.01 -17.68 14.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.2 m-70 -99.61 171.08 8.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.033 -1.042 . . . . 0.0 111.769 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.863 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -146.6 119.03 8.42 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.1 mp -37.78 -33.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.492 -0.755 . . . . 0.0 111.149 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 1.2 p30 -156.58 8.36 0.2 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.889 -1.132 . . . . 0.0 111.744 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.863 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -103.75 -176.1 2.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.708 -1.245 . . . . 0.0 109.921 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 9.8 mmtp -121.22 104.71 9.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.14 -0.975 . . . . 0.0 110.65 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 21.7 mtp -118.26 -106.55 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.418 HG11 ' HAC' ' A' ' 83' ' ' HEM . 78.6 t -89.07 -39.61 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.85 -1.157 . . . . 0.0 109.666 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.83 168.82 12.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -66.27 135.29 39.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.605 1.318 . . . . 0.0 110.502 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.865 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.8 150.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -63.29 -59.91 4.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -0.938 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -47.59 -47.64 28.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.412 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 18.2 m-20 -57.33 -39.27 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 0.0 110.009 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 26' ' ' ALA . 73.3 t -57.08 -36.25 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -79.68 -29.62 40.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.461 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.37 -24.18 62.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.438 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -90.2 -42.89 10.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -90.43 9.18 30.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.83 140.89 40.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -12.0 67.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 3.8 mm-40 -54.06 147.25 13.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 110.353 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 49.15 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -0.841 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.82 53.24 0.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -73.47 -20.15 60.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -1.167 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.576 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 1.1 pt-20 -66.95 -23.25 65.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 0.0 109.966 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -72.92 -59.54 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.5 t80 -65.27 -25.7 67.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.927 . . . . 0.0 109.046 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 48' ' ' ILE . 16.5 mt -66.75 -34.86 78.78 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.86 67.47 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -74.26 -37.12 63.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.11 -0.994 . . . . 0.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.1 mmt180 -84.55 -14.91 47.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.973 -1.08 . . . . 0.0 109.644 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.952 HD11 HMA1 ' A' ' 83' ' ' HEM . 30.2 mt -85.98 -25.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.029 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.678 ' HG2' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.36 -19.36 33.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.42 -0.8 . . . . 0.0 110.447 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 4.8 m120 -127.99 -4.02 5.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.454 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.14 173.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.7 167.85 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.825 -1.397 . . . . 0.0 111.594 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -100.21 177.86 4.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 109.921 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.44 21.96 79.06 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 56' ' ' TRP . 10.5 t -95.17 -71.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.518 -0.989 . . . . 0.0 109.91 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.755 ' CD1' HG12 ' A' ' 55' ' ' VAL . 88.1 m95 -117.75 -34.88 4.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.053 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.45 -172.25 20.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.22 13.55 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.56 1.506 . . . . 0.0 112.231 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' O ' HAD2 ' A' ' 83' ' ' HEM . 8.2 mt -110.63 93.35 16.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.615 -1.303 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.545 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -61.8 131.01 33.34 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.644 1.339 . . . . 0.0 110.811 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.545 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 5.4 tmm? -73.73 132.2 81.01 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 2.8 Cg_endo -64.37 139.0 63.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.706 1.371 . . . . 0.0 108.702 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.5 Cg_endo -60.27 142.97 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.274 1.144 . . . . 0.0 110.274 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.448 ' ND2' ' CBB' ' A' ' 83' ' ' HEM . 8.2 m120 -113.22 161.06 17.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.957 . . . . 0.0 110.529 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.49 34.1 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' HG2' ' A' ' 49' ' ' LYS . 28.6 m -80.87 114.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.768 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.0 m -50.52 -177.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.033 . . . . 0.0 109.597 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.1 -59.07 3.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.993 -1.067 . . . . 0.0 109.967 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -33.4 50.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.2 mm-40 -67.47 -50.14 60.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.839 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -64.23 -21.68 66.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -45.31 61.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.395 -0.816 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 3' ' ' PRO . 57.6 m -72.59 -22.13 61.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 71' ' ' ALA . 62.0 mt -73.0 -36.86 67.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.543 -0.723 . . . . 0.0 109.253 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -70.64 -50.72 33.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.7 OUTLIER -61.51 -24.16 66.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.838 . . . . 0.0 109.021 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.509 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 38.6 t90 -74.55 -41.19 61.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.496 -0.753 . . . . 0.0 109.863 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.736 HD13 HMA3 ' A' ' 83' ' ' HEM . 37.3 mt -60.51 -42.36 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.591 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.767 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -75.05 -13.53 60.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.511 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -100.06 -15.7 18.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 110.473 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.507 ' HB3' HG23 ' A' ' 18' ' ' ILE . 18.1 mm-40 -50.6 92.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 80' ' ' SER . 11.8 mmtp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.104 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.952 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.235 0.54 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -50.55 154.94 2.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.959 . . . . 0.0 109.961 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HB3' HG22 ' A' ' 73' ' ' THR . 2.8 Cg_endo -60.55 -26.76 83.54 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.663 1.349 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -68.95 -38.33 79.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.206 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 50.8 t -62.65 -50.19 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.711 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.75 HD11 HD21 ' A' ' 74' ' ' LEU . 1.3 pp -72.08 -20.92 61.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.457 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -65.05 -37.51 87.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.782 . . . . 0.0 109.605 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -83.71 -38.06 21.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.823 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.482 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -60.21 -35.34 75.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.442 -0.786 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.689 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 46.3 mmtm -87.01 -14.05 42.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.59 10.29 56.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.657 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 19.5 m -62.62 -39.03 92.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.261 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 3.32 22.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 111.019 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.88 -43.51 14.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.032 . . . . 0.0 110.423 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 39.9 m -98.04 -23.09 15.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.555 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 30.1 m-70 -103.84 -175.18 2.73 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.362 1.077 . . . . 0.0 112.419 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.607 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -162.11 -171.6 2.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 23.7 mm -86.41 -69.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.669 -1.27 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -110.08 -19.56 13.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.802 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.1 p -72.11 -169.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 5.3 pttt -150.51 87.46 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 mtm -79.88 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.92 . . . . 0.0 109.885 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 11.4 t -83.52 -29.61 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.0 171.48 14.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -65.33 144.05 78.99 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.488 1.257 . . . . 0.0 110.077 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.83 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.58 162.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.6 m-85 -77.29 -60.62 2.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' HG3' ' HA ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -50.97 -37.77 46.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.599 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.7 m-20 -61.91 -46.29 90.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.802 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 26' ' ' ALA . 68.7 t -52.17 -37.28 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.81 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.669 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . -85.08 -21.07 29.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 110.299 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.8 -26.25 60.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -87.21 -48.02 8.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.913 . . . . 0.0 110.092 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ALA . 13.9 m-85 -77.1 -13.11 60.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.02 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -43.15 109.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.74 34.3 0.7 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 2.5 mt-30 -125.93 144.37 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -1.22 . . . . 0.0 110.304 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.39 47.6 1.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.859 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.78 40.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.013 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -80.72 -31.39 36.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -1.133 . . . . 0.0 109.874 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -67.98 -22.93 64.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.457 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.47 -53.15 20.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.536 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.9 t80 -68.7 -24.87 64.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 48' ' ' ILE . 8.9 mt -69.69 -32.52 71.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.56 68.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.94 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.24 -37.31 63.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.036 -1.04 . . . . 0.0 110.287 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.3 mmt-85 -78.18 -18.41 55.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.912 . . . . 0.0 109.569 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.938 HD11 HMA1 ' A' ' 83' ' ' HEM . 30.7 mt -80.34 -36.04 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.702 . . . . 0.0 109.857 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -78.13 -31.08 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 110.431 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.8 m-80 -109.28 -4.46 16.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.545 ' HA2' ' HE3' ' A' ' 61' ' ' MET . . . 57.76 166.38 0.1 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 174.52 164.33 0.23 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.599 -1.53 . . . . 0.0 112.386 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -108.37 -171.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.626 -0.671 . . . . 0.0 109.848 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 20.58 76.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.005 HG12 ' CD1' ' A' ' 56' ' ' TRP . 78.7 t -102.81 -70.75 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.583 -0.951 . . . . 0.0 109.58 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 1.005 ' CD1' HG12 ' A' ' 55' ' ' VAL . 99.0 m95 -110.67 -41.07 4.39 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.5 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.23 -167.37 19.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.63 11.41 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.437 1.425 . . . . 0.0 111.895 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.407 ' O ' HMD3 ' A' ' 83' ' ' HEM . 10.4 mt -107.71 77.45 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.601 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.8 Cg_exo -56.38 139.05 86.03 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.535 1.281 . . . . 0.0 110.841 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.655 ' HE2' HBA1 ' A' ' 83' ' ' HEM . 12.3 ttp -71.29 133.03 85.6 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.511 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.556 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -67.64 134.62 33.33 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.681 1.358 . . . . 0.0 108.992 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_endo -59.32 136.04 69.47 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.269 1.141 . . . . 0.0 110.53 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -113.75 170.47 8.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.474 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.83 34.95 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.0 m -78.15 114.42 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.12 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.7 t -50.84 -176.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -71.1 -42.11 69.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 110.324 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.05 -35.36 80.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.938 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mt-10 -72.97 -40.79 65.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.74 -21.63 60.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -77.81 -43.35 30.81 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.261 -0.899 . . . . 0.0 108.577 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 3' ' ' PRO . 19.8 m -72.87 -24.5 60.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.859 HD22 ' CMB' ' A' ' 83' ' ' HEM . 23.6 mt -72.58 -46.17 55.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -64.19 -42.93 96.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.371 -0.83 . . . . 0.0 109.183 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.0 OUTLIER -69.56 -26.48 64.51 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 109.044 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 30.6 t90 -68.99 -43.08 75.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.298 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.789 HD13 HMA3 ' A' ' 83' ' ' HEM . 6.0 mt -62.07 -43.57 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.021 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.669 HD23 ' HB1' ' A' ' 31' ' ' ALA . 2.0 mt -75.48 -14.12 60.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.351 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 47.9 t -83.5 -31.73 26.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.467 -0.771 . . . . 0.0 110.11 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 3.1 mm100 -52.54 157.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.012 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.525 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.2 tptt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.938 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.151 0.501 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -74.76 167.26 38.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.0 Cg_endo -61.43 -17.82 55.77 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.618 1.325 . . . . 0.0 110.393 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.96 -32.95 65.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.372 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.69 -51.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 6' ' ' LEU . 2.5 pp -66.37 -31.28 71.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.398 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -56.45 -46.72 80.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -68.32 -37.53 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 0.0 109.736 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.88 -22.94 65.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.797 . . . . 0.0 110.229 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 45.5 mmtm -95.5 -25.17 16.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.812 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.57 13.12 28.9 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.507 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 24.6 m -64.69 -39.74 94.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.244 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 2.55 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.09 -48.27 16.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 97.0 m -100.31 -27.02 13.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.453 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.636 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 14.7 m-70 -97.62 168.32 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.211 1.005 . . . . 0.0 112.35 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -151.61 -166.79 2.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 27.6 mm -90.44 -75.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.781 -1.199 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.14 -1.44 13.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.501 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 4.9 p -81.28 -168.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.958 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.44 108.84 7.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.6 mtm -117.65 -119.52 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.046 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.603 HG11 ' HAC' ' A' ' 83' ' ' HEM . 42.7 t -77.75 -35.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.845 -1.159 . . . . 0.0 109.807 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.8 168.89 12.76 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.76 139.65 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.726 1.382 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -43.21 154.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.396 -0.815 . . . . 0.0 109.752 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.624 ' CE1' HG12 ' A' ' 78' ' ' ILE . 1.4 m-85 -70.51 -58.01 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' CG ' ' HA ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -48.04 -47.25 33.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 22.4 m-20 -52.0 -45.56 64.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.413 -0.804 . . . . 0.0 109.929 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 26' ' ' ALA . 81.3 t -55.45 -37.96 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.818 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -76.33 -25.48 54.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.38 -29.86 65.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -85.41 -42.12 14.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -90.63 7.09 41.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -61.03 118.28 6.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.384 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.38 -8.17 26.58 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.536 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -66.17 147.03 53.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -1.174 . . . . 0.0 110.098 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.22 56.17 3.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.02 46.63 0.3 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -72.38 -16.03 61.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HA ' HD12 ' A' ' 44' ' ' LEU . 2.7 mt-10 -70.17 -37.76 75.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.808 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -51.46 69.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 t80 -67.42 -31.82 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 108.953 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 41' ' ' GLU . 24.0 mt -64.75 -25.17 67.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.4 -35.06 41.27 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.706 -0.621 . . . . 0.0 109.929 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -77.57 -24.52 49.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.587 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 11.8 mmp_? -89.46 -21.8 22.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.541 HG22 HG21 ' A' ' 66' ' ' VAL . 48.1 mt -84.6 -26.67 6.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.62 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -90.1 -8.06 52.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.397 -0.814 . . . . 0.0 110.484 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -133.14 -7.49 3.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.062 -1.023 . . . . 0.0 111.202 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 69.06 162.17 2.75 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -174.36 150.11 1.43 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.585 -1.538 . . . . 0.0 112.855 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.68 -173.71 2.3 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.694 -0.629 . . . . 0.0 109.558 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.25 16.29 53.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.961 HG12 ' CD1' ' A' ' 56' ' ' TRP . 98.0 t -93.13 -71.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.637 -0.919 . . . . 0.0 109.225 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.961 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.8 m95 -109.86 -39.57 5.04 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.718 0.771 . . . . 0.0 109.012 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.58 -178.03 28.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.91 8.09 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.498 1.466 . . . . 0.0 112.091 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.575 ' O ' HMD3 ' A' ' 83' ' ' HEM . 4.5 mt -107.12 80.04 0.78 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.674 -1.266 . . . . 0.0 109.651 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.0 Cg_endo -55.37 148.9 49.13 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.854 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.659 ' HE2' HBA1 ' A' ' 83' ' ' HEM . 7.9 ttp -76.79 131.97 72.57 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.057 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.469 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.9 Cg_endo -65.9 134.57 37.83 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.617 1.325 . . . . 0.0 109.122 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.3 132.42 48.8 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.289 1.152 . . . . 0.0 110.075 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -107.88 160.35 15.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 110.522 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.13 32.8 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.791 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.684 ' O ' HG23 ' A' ' 66' ' ' VAL . 22.9 m -72.35 114.62 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 110.212 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' VAL . 33.6 m -47.74 174.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.53 -64.62 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.808 -1.183 . . . . 0.0 110.186 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -22.22 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 11.4 mm-40 -72.42 -52.54 15.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -67.21 -18.76 65.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.948 . . . . 0.0 108.785 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.93 -47.63 43.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 3' ' ' PRO . 3.9 m -68.0 -24.49 65.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.063 ' O ' HD12 ' A' ' 78' ' ' ILE . 75.6 mt -73.19 -33.6 65.49 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.76 -51.46 40.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.61 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -60.98 -32.07 71.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 109.108 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.466 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 27.9 t90 -64.71 -48.08 75.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.716 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.063 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.6 mt -60.34 -56.35 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.448 -0.782 . . . . 0.0 110.028 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 31' ' ' ALA . 1.5 mt -66.82 -11.74 56.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 39.9 t -95.95 -20.31 18.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 2.9 mm100 -46.34 -66.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.09 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 2.6 mttm . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.855 ' CGA' HG11 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.182 0.515 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 3.1 m-20 -66.66 164.1 36.08 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.999 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo -61.57 -45.48 17.62 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.697 1.367 . . . . 0.0 110.462 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 2' ' ' ASP . 7.2 pt-20 -48.65 -45.97 39.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 109.542 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 2' ' ' ASP . 37.9 t -51.06 -47.12 31.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.9 . . . . 0.0 109.078 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 71.0 mt -56.06 -50.52 70.75 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.586 0.707 . . . . 0.0 109.801 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -51.94 -26.27 10.06 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.582 -0.698 . . . . 0.0 110.251 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -56.69 3.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 110.994 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -64.44 -11.3 32.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.911 -1.118 . . . . 0.0 110.467 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.732 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 71.2 mmtt -101.42 -15.01 17.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 110.03 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.05 12.11 71.7 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.569 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 29.4 m -63.23 -40.46 97.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.245 . . . . 0.0 110.347 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.434 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -74.44 2.47 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.14 -50.55 12.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -99.64 -14.26 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 110.785 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.629 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 19.6 m-70 -105.34 174.13 6.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.076 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -149.87 -179.47 7.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.3 mp -90.66 -24.83 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.869 -1.144 . . . . 0.0 110.414 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 12.5 p-10 -157.77 -27.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 0.0 111.463 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 81.0 p -68.86 -173.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.772 -1.205 . . . . 0.0 110.115 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 104.64 8.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 111.011 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.431 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -107.88 -132.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.83 . . . . 0.0 109.112 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.4 -48.17 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.864 -1.147 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.03 167.79 21.89 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.579 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -67.0 143.32 65.4 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.572 1.301 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.723 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -44.97 170.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.731 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.5 m-85 -86.93 -54.6 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.953 -1.092 . . . . 0.0 110.04 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 82' ' ' LYS . 1.1 tmmm? -50.54 -49.74 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.928 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -54.64 -42.81 71.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.073 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 26' ' ' ALA . 53.5 t -56.07 -38.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.63 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -76.5 -26.58 55.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.39 -29.11 65.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.2 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -84.64 -47.77 10.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 109.984 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -77.28 -3.71 41.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -52.27 121.91 7.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.934 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.24 -37.45 2.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.9 mm100 -63.17 126.28 26.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -1.082 . . . . 0.0 110.06 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.2 46.05 1.29 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.57 40.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -79.92 -12.74 59.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 109.908 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.538 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -75.11 -22.45 58.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -71.62 -51.52 22.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.664 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.556 ' CE1' ' NE ' ' A' ' 47' ' ' ARG . 45.5 t80 -69.64 -33.4 72.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.605 ' O ' HD12 ' A' ' 48' ' ' ILE . 22.6 mt -61.38 -30.12 70.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.22 -38.85 60.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -73.94 -19.44 60.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.051 -1.031 . . . . 0.0 109.845 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' NE ' ' CE1' ' A' ' 43' ' ' TYR . 6.5 mmt180 -90.17 -24.15 21.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.613 HD11 HMA1 ' A' ' 83' ' ' HEM . 62.6 mt -86.71 -19.75 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.331 -0.856 . . . . 0.0 109.318 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -22.99 24.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 110.516 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 57.6 m-80 -126.21 -6.71 6.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 110.407 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.16 173.98 0.03 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 2.8 t 162.11 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.413 -1.051 . . . . 0.0 111.172 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.2 pm0 -100.16 -165.26 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 64.14 18.72 62.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.808 HG11 ' CBA' ' A' ' 83' ' ' HEM . 2.4 t -95.5 -67.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.739 -0.859 . . . . 0.0 109.099 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.579 ' CB ' ' HG3' ' A' ' 25' ' ' PRO . 95.5 m95 -124.1 -36.38 2.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.65 -177.44 20.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.514 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -69.46 8.25 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.457 1.438 . . . . 0.0 112.038 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.479 ' O ' HAD2 ' A' ' 83' ' ' HEM . 6.3 mt -105.86 100.78 29.58 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.715 -1.241 . . . . 0.0 110.851 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.4 Cg_endo -64.63 133.41 36.68 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.457 1.24 . . . . 0.0 110.602 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.647 ' HE2' ' NA ' ' A' ' 83' ' ' HEM . 0.9 OUTLIER -71.87 135.6 83.0 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.0 Cg_endo -64.21 130.46 27.17 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.735 1.387 . . . . 0.0 109.456 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.23 135.79 64.29 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.401 1.211 . . . . 0.0 110.61 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -109.05 163.83 12.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.67 36.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.969 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 66' ' ' VAL . 15.5 m -84.38 105.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.056 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 75.1 p -42.58 147.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.224 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 72' ' ' GLN . 8.0 p-10 -42.57 -31.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.45 -47.96 68.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.109 -0.994 . . . . 0.0 109.564 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.496 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 52.7 mt-10 -63.62 -48.05 78.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 110.161 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -67.27 -16.64 64.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 109.142 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.33 -45.62 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -27.74 63.39 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 71' ' ' ALA . 49.6 mt -69.77 -34.96 74.48 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -67.46 -54.65 18.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' SER . 6.2 mttp -58.43 -25.12 61.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 108.871 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' LEU . 35.9 t90 -70.51 -43.11 70.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.61 -0.681 . . . . 0.0 109.515 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' A' ' 27' ' ' TYR . 4.9 mt -59.38 -50.91 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.739 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -73.72 -9.97 59.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 36.7 t -97.5 -16.46 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 110.326 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HG3' ' HB3' ' A' ' 27' ' ' TYR . 22.5 mm-40 -43.7 -44.0 6.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 110.212 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 10.8 tttt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.808 ' CBA' HG11 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.62 164.79 0.39 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.101 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.1 Cg_exo -61.28 -27.22 83.04 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.678 1.357 . . . . 0.0 110.268 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.28 -33.92 73.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 108.626 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -64.45 -58.02 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.643 -0.661 . . . . 0.0 109.718 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.7 pp -64.16 -24.42 67.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.536 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -67.72 -29.49 68.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -52.16 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.322 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -63.27 -16.48 60.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.091 -1.006 . . . . 0.0 110.383 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.562 ' HE3' HG12 ' A' ' 66' ' ' VAL . 34.2 mmtt -87.97 -18.8 28.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.63 13.53 53.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.618 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 57.4 m -69.72 -38.68 76.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -1.235 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mtp -82.36 6.0 18.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.782 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.52 -35.71 19.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 110.353 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 36.4 m -106.0 -22.95 12.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -0.819 . . . . 0.0 110.391 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 28.7 m-70 -103.35 153.84 20.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 111.415 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.891 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -129.89 123.93 31.96 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.655 HD13 ' OE1' ' A' ' 81' ' ' GLN . 35.7 mm -36.78 -29.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 111.014 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.606 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -153.45 -32.33 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.177 -0.952 . . . . 0.0 111.088 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.891 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.43 179.33 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.023 -1.048 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -117.69 120.42 37.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -0.872 . . . . 0.0 110.741 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 19.5 mtp -125.22 -108.08 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 25.3 t -86.32 -31.78 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 171.71 17.26 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -66.0 140.42 60.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.682 1.359 . . . . 0.0 110.383 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.032 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.44 149.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 110.233 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 3.0 m-85 -63.43 -60.19 3.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.207 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -49.68 -49.19 48.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.635 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 12.8 m-20 -55.48 -40.07 71.21 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 110.027 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.032 HG23 ' O ' ' A' ' 26' ' ' ALA . 95.5 t -57.84 -38.39 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.003 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -75.92 -25.83 56.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 110.001 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -27.49 63.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 19.1 tttt -86.56 -43.75 12.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -82.82 -2.25 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 109.978 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.7 101.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.73 33.81 0.42 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -116.78 145.86 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.229 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.07 41.57 1.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.36 48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.94 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -76.92 -33.66 57.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -1.168 . . . . 0.0 110.1 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.642 ' HG2' ' HB3' ' A' ' 75' ' ' ALA . 3.0 tm-20 -64.29 -24.79 67.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.34 -51.6 23.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.617 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 1.3 t80 -71.32 -21.79 62.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.14 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.94 HD12 ' O ' ' A' ' 40' ' ' ALA . 3.5 mt -74.5 -26.67 60.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.24 46.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.636 -0.665 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.544 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -77.15 -34.66 56.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.617 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 75.5 mmt-85 -81.37 -22.11 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.778 HD11 ' CMA' ' A' ' 83' ' ' HEM . 19.3 mt -80.98 -30.05 11.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.39 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.35 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -118.63 0.25 11.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.364 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 58.01 158.76 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.511 ' CB ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -177.32 158.63 1.47 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.546 -1.561 . . . . 0.0 112.595 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.34 -172.57 2.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.62 -0.675 . . . . 0.0 109.688 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.4 19.07 75.81 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.749 HG12 ' CD1' ' A' ' 56' ' ' TRP . 27.7 t -99.16 -74.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.632 -0.922 . . . . 0.0 109.814 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.756 ' HZ2' HG13 ' A' ' 30' ' ' VAL . 97.5 m95 -106.91 -38.8 5.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.42 -165.74 18.82 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.05 13.44 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.383 1.389 . . . . 0.0 111.963 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.647 ' O ' HMD3 ' A' ' 83' ' ' HEM . 6.3 mt -110.76 80.16 2.06 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.569 -1.332 . . . . 0.0 110.301 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -60.18 144.71 99.48 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.674 1.355 . . . . 0.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.622 ' HE2' HBA1 ' A' ' 83' ' ' HEM . 5.9 ttp -73.93 134.55 77.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.661 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.701 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -69.77 139.26 39.75 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.668 1.352 . . . . 0.0 109.065 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 132.34 41.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.254 1.134 . . . . 0.0 110.133 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -108.03 173.38 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.744 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.08 33.4 2.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.969 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG12 ' HE3' ' A' ' 10' ' ' LYS . 16.7 m -78.41 120.84 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 109.885 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 66' ' ' VAL . 6.2 m -49.68 -178.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.889 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.04 -58.2 4.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.694 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.86 -17.45 36.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.6 mm-40 -77.6 -50.23 12.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -66.42 -22.68 66.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.262 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -72.52 -44.61 61.97 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 3' ' ' PRO . 1.6 m -71.24 -24.05 62.11 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.809 HD13 HMB1 ' A' ' 83' ' ' HEM . 27.1 mt -68.39 -38.21 81.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.642 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . . . -69.79 -51.2 35.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.135 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 80' ' ' SER . 1.2 mttp -62.42 -23.34 66.8 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.309 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.536 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 33.9 t90 -73.64 -42.15 61.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.485 -0.759 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.898 ' CD1' HMA2 ' A' ' 83' ' ' HEM . 96.7 mt -63.29 -56.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 31' ' ' ALA . 1.3 mp -65.78 -18.43 65.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.852 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 3.6 t -78.48 -29.81 46.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 110.148 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.655 ' OE1' HD13 ' A' ' 18' ' ' ILE . 12.0 mt-30 -57.61 -167.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.371 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.898 HMA2 ' CD1' ' A' ' 78' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.686 ' HG3' HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -69.35 175.12 2.33 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 110.09 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.61 ' HA ' HD21 ' A' ' 6' ' ' LEU . 2.8 Cg_endo -62.1 -20.82 71.08 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.626 1.33 . . . . 0.0 110.577 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 5.7 tm-20 -68.35 -44.64 74.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.686 HG11 ' HG3' ' A' ' 1' ' ' GLU . 25.9 t -58.77 -50.13 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 110.087 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 7' ' ' ALA . 4.2 pp -70.85 -22.6 62.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.351 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.792 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -62.45 -38.95 91.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.571 -0.705 . . . . 0.0 109.392 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -41.14 34.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -62.95 -23.46 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 17.7 mmtt -91.14 -14.53 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.93 11.59 58.73 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.615 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 17.6 m -69.49 -38.58 77.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -1.202 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.35 6.78 9.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.25 -46.56 10.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.319 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 94.8 m -99.0 -16.56 18.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -0.811 . . . . 0.0 110.578 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.623 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.7 m-70 -110.07 178.63 4.34 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.387 1.089 . . . . 0.0 112.435 -177.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -155.29 -169.17 3.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.536 HD13 ' OE1' ' A' ' 81' ' ' GLN . 29.9 mm -90.8 -73.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.683 -1.261 . . . . 0.0 110.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -112.55 -10.14 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 110.004 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.73 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.3 p -77.4 -161.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 0.0 109.879 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 119.74 9.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.508 ' CE ' ' O ' ' A' ' 16' ' ' HIS . 15.4 mtm -121.58 -113.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.749 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 54.1 t -78.19 -32.78 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.801 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.78 175.33 16.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.539 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.63 142.12 69.41 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.617 1.325 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -42.6 157.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.936 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -73.41 -61.33 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.936 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' TYR . 5.8 tttt -46.29 -45.77 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 0.0 109.462 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -51.58 -45.56 63.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 109.811 179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' ALA . 88.6 t -55.03 -45.21 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -69.94 -21.25 63.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.768 . . . . 0.0 110.155 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.68 42.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 110.531 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -35.14 15.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.119 -0.988 . . . . 0.0 110.084 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' ALA . 16.6 m-85 -85.9 -9.24 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -42.73 111.2 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.94 40.28 2.16 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.785 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -102.81 152.22 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 110.335 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.02 42.12 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.98 46.45 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -66.19 -29.68 70.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -1.107 . . . . 0.0 110.532 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -68.66 -32.22 71.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.19 -52.86 16.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 13.3 t80 -70.38 -19.39 63.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.276 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.683 HD22 HMA2 ' A' ' 83' ' ' HEM . 10.8 mt -73.97 -33.82 64.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.75 69.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.735 -0.603 . . . . 0.0 109.5 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -43.75 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.51 -17.21 58.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.437 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.986 HD11 HMA1 ' A' ' 83' ' ' HEM . 13.3 mt -83.19 -24.75 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.442 ' HG3' HG23 ' A' ' 66' ' ' VAL . 3.0 mtpp -85.34 -29.15 24.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.293 -0.879 . . . . 0.0 110.396 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 36.6 p30 -114.46 -5.15 12.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.634 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 59.05 172.1 0.42 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.62 163.5 0.12 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.705 -1.468 . . . . 0.0 112.422 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.581 ' CB ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -110.33 -178.91 3.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.433 -0.792 . . . . 0.0 109.876 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 74.51 20.22 79.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.947 HG12 ' CD1' ' A' ' 56' ' ' TRP . 71.3 t -103.91 -67.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.947 ' CD1' HG12 ' A' ' 55' ' ' VAL . 99.5 m95 -111.07 -40.13 4.56 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.338 -0.851 . . . . 0.0 110.114 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.54 -165.84 18.16 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.479 1.453 . . . . 0.0 111.619 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.772 HG22 ' CMD' ' A' ' 83' ' ' HEM . 7.1 mt -108.29 85.62 2.87 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.79 -1.194 . . . . 0.0 111.174 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.581 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.16 155.49 39.64 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.627 1.33 . . . . 0.0 110.275 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.585 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 49.9 ttp -87.92 134.85 34.44 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.791 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -67.29 132.95 28.96 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.768 1.404 . . . . 0.0 109.172 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -59.04 136.09 70.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.269 1.142 . . . . 0.0 110.461 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -112.03 163.25 14.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.401 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.8 36.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.527 ' O ' HG23 ' A' ' 66' ' ' VAL . 16.0 m -77.71 108.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.374 -0.828 . . . . 0.0 110.421 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -43.72 146.22 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 67' ' ' SER . 7.7 p-10 -41.15 -40.91 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.104 -0.997 . . . . 0.0 110.872 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.35 -45.22 94.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 72.9 mm-40 -64.09 -42.38 96.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -66.97 -22.17 65.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.008 . . . . 0.0 109.699 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -72.15 -41.21 67.36 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' TRP . 1.2 m -73.96 -24.49 59.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.915 ' O ' HD12 ' A' ' 78' ' ' ILE . 41.8 mt -72.42 -37.86 68.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.557 -0.714 . . . . 0.0 109.18 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -71.83 -49.51 37.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.127 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 80' ' ' SER . 2.8 mttt -63.78 -25.15 68.05 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.353 -0.842 . . . . 0.0 108.816 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.595 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 24.7 t90 -70.39 -51.9 26.31 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.541 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 74' ' ' LEU . 4.3 mt -54.68 -49.66 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.15 -17.36 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.973 . . . . 0.0 109.847 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 11.9 t -93.34 -8.7 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.862 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.536 ' OE1' HD13 ' A' ' 18' ' ' ILE . 15.1 mm-40 -40.62 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' SER . 28.2 mmmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.245 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.986 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 170.3 3.76 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.84 -40.05 56.97 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.644 1.339 . . . . 0.0 110.541 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.89 -48.36 78.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.4 t -49.77 -34.26 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.511 HD12 ' CG2' ' A' ' 73' ' ' THR . 39.8 mt -71.45 -38.38 71.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -58.47 -27.14 64.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.676 . . . . 0.0 110.141 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -90.0 -46.9 8.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.932 . . . . 0.0 110.528 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.0 m120 -63.99 -16.75 62.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.243 -0.911 . . . . 0.0 111.052 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.643 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 54.4 mmtt -104.46 -25.38 12.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.056 . . . . 0.0 110.487 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.21 15.0 22.89 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 17.0 m -66.79 -35.05 79.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 0.0 110.2 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mmm -79.71 5.96 12.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.914 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.48 -37.21 15.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.109 -0.994 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -105.33 -16.59 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.624 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 22.0 m-70 -105.16 166.78 10.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.903 -1.123 . . . . 0.0 112.082 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -146.91 120.13 8.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 17.9 mt -37.36 -29.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' OD1' HG23 ' A' ' 20' ' ' THR . 2.3 p30 -151.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.077 -1.015 . . . . 0.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.923 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 19.8 p -70.0 163.11 26.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -104.25 129.08 52.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 0.0 110.635 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.455 ' HE3' ' O ' ' A' ' 16' ' ' HIS . 10.3 mtm -127.27 -88.75 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.44 -33.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.47 174.5 16.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.529 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -64.71 129.65 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.56 1.294 . . . . 0.0 110.305 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.874 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -38.91 149.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.448 -0.782 . . . . 0.0 110.073 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.787 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.4 m-85 -65.4 -58.98 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 110.52 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -48.27 -47.12 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.954 -1.091 . . . . 0.0 109.623 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.13 -40.47 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 26' ' ' ALA . 59.0 t -58.45 -39.9 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -77.34 -19.9 55.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.41 -28.71 46.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 0.0 110.057 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -40.34 12.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.85 -11.46 59.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.0 103.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 109.985 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.7 33.82 0.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.75 128.49 42.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -1.198 . . . . 0.0 110.157 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.22 56.17 3.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.52 44.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -74.41 -50.61 17.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 10.3 pt-20 -48.47 -35.62 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 110.527 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -56.85 -54.58 44.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 109.881 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.47 -38.11 88.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.932 . . . . 0.0 109.204 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.81 HD23 HMA3 ' A' ' 83' ' ' HEM . 0.9 OUTLIER -59.79 -27.45 66.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -73.51 -36.48 65.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.644 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -37.34 69.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 23.2 mmt180 -80.65 -16.49 53.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.933 HD11 HMA1 ' A' ' 83' ' ' HEM . 49.9 mt -87.72 -23.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.709 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -19.95 30.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 76.8 m-20 -136.28 2.25 2.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.544 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 50.64 175.33 0.02 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER 169.14 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.761 -1.435 . . . . 0.0 111.802 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -109.25 -177.72 3.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.8 21.44 79.29 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG12 ' CD1' ' A' ' 56' ' ' TRP . 8.0 t -99.38 -68.34 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.68 -0.894 . . . . 0.0 109.646 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.823 ' CD1' HG12 ' A' ' 55' ' ' VAL . 86.3 m95 -118.55 -36.71 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.749 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.36 -171.82 23.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.555 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.32 9.73 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 112.115 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.717 ' O ' HMD3 ' A' ' 83' ' ' HEM . 6.3 mt -109.53 84.17 2.98 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.714 -1.241 . . . . 0.0 110.453 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.04 144.24 99.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.663 1.349 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.583 ' HE2' ' NA ' ' A' ' 83' ' ' HEM . 1.0 OUTLIER -77.18 134.88 66.86 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.743 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.6 Cg_endo -69.18 137.43 37.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 N-CA-C 108.395 -1.425 . . . . 0.0 108.395 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -56.89 156.51 23.36 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.224 1.118 . . . . 0.0 110.081 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.489 ' ND2' ' CBB' ' A' ' 83' ' ' HEM . 9.8 m120 -128.62 164.38 22.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 111.059 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.66 34.9 0.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.512 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.664 HG21 HG22 ' A' ' 48' ' ' ILE . 10.6 m -86.89 109.62 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.513 -0.742 . . . . 0.0 110.441 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.474 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 2.1 m -47.06 173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -57.3 13.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.98 -19.29 41.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 66' ' ' VAL . 10.6 mt-10 -78.58 -45.74 21.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 110.427 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -70.7 -22.17 62.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.11 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -44.28 58.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.511 ' CG2' HD12 ' A' ' 6' ' ' LEU . 4.0 m -71.78 -25.2 61.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 71' ' ' ALA . 46.0 mt -77.33 -27.0 52.66 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -75.26 -52.58 10.53 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.549 -0.719 . . . . 0.0 109.215 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -59.75 -29.22 68.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 108.623 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.728 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 31.7 t90 -61.48 -53.34 57.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.61 -0.682 . . . . 0.0 109.507 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.787 HG23 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -60.29 -40.98 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.159 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -76.88 -9.81 58.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.598 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 41.7 m -121.08 7.64 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 0.0 110.644 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.6 ' OE1' ' CD2' ' A' ' 77' ' ' TRP . 17.3 mm100 -42.64 -54.87 3.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.983 . . . . 0.0 110.416 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.358 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.933 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.242 0.544 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -87.28 153.0 53.5 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo -61.34 -24.13 78.12 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.704 1.37 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.09 -32.14 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.861 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 48.8 t -71.51 -45.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.705 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -69.02 -31.4 70.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -59.68 -55.89 28.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -55.45 -42.59 74.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.1 m120 -59.9 -27.89 67.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 110.521 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 1.024 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 75.2 mmtt -93.32 -16.29 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 0.0 110.12 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.95 18.45 34.33 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.668 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 9.1 m -68.86 -42.34 77.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.54 5.11 16.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.45 -44.26 11.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 110.651 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 57.4 m -96.73 -19.84 18.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.593 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 26.5 m-70 -98.72 165.88 11.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.015 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.802 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -136.82 114.27 10.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 81' ' ' GLN . 2.5 mp -37.16 -35.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.49 -0.756 . . . . 0.0 110.89 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.78 9.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 111.191 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.802 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -112.69 -160.54 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.074 . . . . 0.0 109.889 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.71 131.38 35.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.015 -1.053 . . . . 0.0 110.591 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 mtp -140.83 -99.57 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 5.9 t -93.86 -31.28 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.025 -1.047 . . . . 0.0 109.22 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.76 171.77 18.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_endo -65.92 136.57 45.57 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.6 1.316 . . . . 0.0 110.381 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -42.6 152.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.047 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.633 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.6 m-85 -67.37 -57.45 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 0.0 110.213 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.64 -50.13 60.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.855 -1.153 . . . . 0.0 109.638 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 3.8 m-20 -54.33 -44.14 71.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.357 -0.84 . . . . 0.0 109.992 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' ALA . 23.1 t -54.16 -33.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 110.019 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -80.46 -26.35 38.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.373 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.25 -29.37 63.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.1 -38.02 19.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.88 . . . . 0.0 109.749 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -88.15 -4.08 58.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.69 109.04 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.31 -23.76 2.84 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 1.5 mm-40 -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -1.146 . . . . 0.0 110.018 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.85 39.45 0.93 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 110.401 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.49 43.28 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -69.54 -15.0 63.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -1.176 . . . . 0.0 110.093 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.526 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.4 pt-20 -80.49 -34.24 35.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.081 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.794 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -65.04 -48.98 71.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.495 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -64.64 -46.0 84.38 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.769 HD22 HMA2 ' A' ' 83' ' ' HEM . 20.2 mt -55.97 -21.3 20.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -74.91 -43.11 56.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.945 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 43' ' ' TYR . 1.9 pt20 -75.6 -20.53 58.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' CE ' ' A' ' 61' ' ' MET . 8.7 mmt85 -90.54 -16.92 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.311 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.037 HD11 HMA1 ' A' ' 83' ' ' HEM . 25.6 mt -85.91 -32.14 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.17 37.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.5 m120 -116.68 -11.45 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 60.84 161.19 0.11 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.3 t -179.24 163.33 1.27 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.636 -1.508 . . . . 0.0 112.621 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -104.68 -178.0 3.53 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.49 20.41 78.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.918 HG12 ' CD1' ' A' ' 56' ' ' TRP . 44.2 t -96.88 -70.23 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.63 -0.923 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.918 ' CD1' HG12 ' A' ' 55' ' ' VAL . 98.9 m95 -114.68 -37.53 4.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.525 -0.734 . . . . 0.0 109.679 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.72 -169.45 20.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.21 11.41 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.566 1.511 . . . . 0.0 112.063 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.516 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 14.1 mt -109.59 86.04 4.23 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.651 -1.281 . . . . 0.0 110.586 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.3 Cg_exo -59.9 135.32 62.42 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.541 1.285 . . . . 0.0 111.013 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.565 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 52.5 ttp -71.75 130.8 86.58 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.458 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.08 138.52 47.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.648 1.341 . . . . 0.0 109.346 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.02 136.75 71.4 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.342 1.18 . . . . 0.0 110.054 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -107.8 -174.65 2.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.02 . . . . 0.0 110.865 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.88 36.98 3.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.751 . . . . 0.0 110.018 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 66' ' ' VAL . 25.8 m -81.37 114.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.044 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB2' ' OE1' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -46.8 174.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.77 -41.11 97.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.994 -1.066 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.17 -23.25 62.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.56 ' HG2' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -81.1 -36.75 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB2' HG23 ' A' ' 66' ' ' VAL . . . -76.31 -27.9 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.037 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.1 mt-30 -74.1 -41.97 60.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.558 ' HA ' ' CG ' ' A' ' 76' ' ' LYS . 85.8 m -73.8 -24.02 59.76 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.946 HD22 ' CMB' ' A' ' 83' ' ' HEM . 18.5 mt -74.51 -33.72 62.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.7 . . . . 0.0 109.124 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.53 -50.04 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.558 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -67.46 -23.26 65.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 178.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.512 ' HA ' ' OG ' ' A' ' 80' ' ' SER . 49.3 t90 -75.84 -36.74 59.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.606 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.673 HD13 HMA3 ' A' ' 83' ' ' HEM . 17.3 mt -65.77 -46.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.805 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.686 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -74.12 -13.37 60.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 77' ' ' TRP . 89.2 p -102.29 -5.97 23.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.528 ' HB3' HG23 ' A' ' 18' ' ' ILE . 11.0 mm-40 -39.2 -46.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 110.736 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 4.8 tttt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.096 -1.002 . . . . 0.0 110.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 1.037 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.253 0.549 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.503 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -77.07 142.0 68.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.945 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 2.7 Cg_endo -63.42 -29.1 71.55 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.507 1.267 . . . . 0.0 110.629 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 18.9 pt-20 -73.0 -33.64 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.527 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 43.5 t -72.72 -46.69 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.761 ' C ' HD12 ' A' ' 6' ' ' LEU . 4.0 pp -73.58 -22.74 59.96 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.209 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.8 -40.96 83.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.706 . . . . 0.0 109.28 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.76 71.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.818 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -63.08 -26.08 68.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.286 -0.884 . . . . 0.0 110.664 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 74.8 mmtt -92.96 -13.2 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 110.345 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.78 66.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.513 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 34.1 m -65.95 -15.09 62.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mtp -99.26 10.88 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.119 -0.988 . . . . 0.0 110.332 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.55 -49.73 6.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.494 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.4 m -97.35 -17.84 19.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.402 -0.811 . . . . 0.0 110.702 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.627 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 13.2 m-70 -102.87 174.08 6.03 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.138 -0.976 . . . . 0.0 112.169 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -156.29 -170.24 3.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.432 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 28.1 mm -90.36 -62.49 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.72 -1.238 . . . . 0.0 110.272 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 3.0 p30 -124.76 -3.18 7.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.925 -1.109 . . . . 0.0 110.613 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 69.4 p -83.6 162.44 20.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.91 91.76 3.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.1 -1.0 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 1.7 mtm -97.22 -132.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 109.696 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' HMD3 ' A' ' 83' ' ' HEM . 72.8 t -69.64 -33.03 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.922 -1.111 . . . . 0.0 109.26 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.92 163.84 12.15 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -63.8 142.74 83.96 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.706 1.372 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.901 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -46.02 153.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.7 m-85 -71.33 -60.74 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.705 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -48.0 -45.08 31.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.602 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.691 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 13.8 m-20 -55.44 -45.05 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.731 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 26' ' ' ALA . 87.6 t -55.43 -33.81 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.144 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -75.93 -37.66 58.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 110.511 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.67 66.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.3 -0.875 . . . . 0.0 110.424 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -84.24 -41.06 17.31 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -0.882 . . . . 0.0 109.968 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 15.5 m-85 -88.59 -0.96 57.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.809 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -53.23 136.27 36.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.991 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.4 -35.24 5.19 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.2 mt-30 -54.02 129.04 32.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 50.63 2.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.72 55.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.03 -23.29 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.254 -1.145 . . . . 0.0 110.141 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.0 pt-20 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -68.98 -51.39 39.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.933 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 4.9 t80 -72.29 -27.9 62.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 108.962 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.699 HD22 HMA2 ' A' ' 83' ' ' HEM . 21.4 mt -68.18 -26.94 66.0 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.08 -36.36 55.83 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.21 -26.66 59.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.2 mmt-85 -89.26 -17.55 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.703 HD11 HMA1 ' A' ' 83' ' ' HEM . 37.1 mt -85.33 -26.61 6.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -85.84 -16.22 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.6 t30 -130.93 -1.62 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.095 -1.003 . . . . 0.0 110.584 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 53.83 168.75 0.03 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.6 170.42 0.12 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.605 -1.526 . . . . 0.0 112.084 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -110.25 -175.63 2.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.01 23.92 77.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.851 HG12 ' CD1' ' A' ' 56' ' ' TRP . 34.1 t -105.89 -65.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.732 -0.864 . . . . 0.0 109.901 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.851 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.7 m95 -120.83 -37.59 2.97 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.29 -174.56 25.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.537 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.74 6.72 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.504 1.469 . . . . 0.0 111.793 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' O ' HBD1 ' A' ' 83' ' ' HEM . 7.3 mt -107.85 81.92 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.214 . . . . 0.0 110.301 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.6 Cg_exo -55.28 145.46 66.31 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.586 1.309 . . . . 0.0 111.295 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.541 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 40.9 ttp -79.17 133.9 60.11 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.603 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.6 Cg_endo -67.56 138.23 45.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.517 1.272 . . . . 0.0 108.99 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.26 140.11 93.08 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.372 1.196 . . . . 0.0 110.16 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -113.01 170.93 7.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.797 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.53 48.86 0.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.416 -0.803 . . . . 0.0 109.84 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 71' ' ' ALA . 11.2 m -101.56 107.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 66' ' ' VAL . 1.8 m -42.07 148.41 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.847 . . . . 0.0 109.526 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' SER . 14.0 t0 -42.85 -37.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.993 -1.067 . . . . 0.0 110.734 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -64.93 -44.08 90.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.987 -1.071 . . . . 0.0 109.918 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 62.3 mt-10 -66.03 -46.64 77.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.355 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -69.61 -19.56 63.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 109.19 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.62 -44.32 57.34 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.8 m -70.53 -27.84 64.47 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.06 ' O ' HD12 ' A' ' 78' ' ' ILE . 47.3 mt -65.92 -43.28 88.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.584 -0.697 . . . . 0.0 109.249 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -62.79 -45.94 90.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 80' ' ' SER . 5.7 mttm -65.53 -23.88 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 30.9 t90 -72.32 -46.11 57.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.753 . . . . 0.0 109.831 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.06 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -59.59 -48.25 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.05 -22.68 61.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 109.846 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 82' ' ' LYS . 12.4 m -84.83 -16.38 41.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -45.07 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' SER . 9.8 tppt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.166 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.845 HBA2 HG11 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.293 0.568 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.402 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 44.7 m-20 -77.6 164.54 57.29 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.2 Cg_exo -61.14 -43.59 28.61 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.805 1.424 . . . . 0.0 110.829 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -53.5 -45.9 69.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 66.0 t -55.52 -34.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -0.904 . . . . 0.0 109.374 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 3' ' ' PRO . 62.5 mt -72.19 -30.27 64.8 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.605 0.717 . . . . 0.0 109.548 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 12' ' ' CYS . . . -66.87 -30.77 71.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.408 -0.807 . . . . 0.0 110.261 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -87.01 -43.73 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 110.385 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.4 m120 -66.4 -29.06 69.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 1.022 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 73.2 mmtt -96.15 -12.33 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.132 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.27 15.78 63.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.708 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 18.6 m -64.15 -21.75 66.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.429 ' CG ' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -93.69 15.24 16.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.482 -179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.55 -31.68 10.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.937 . . . . 0.0 110.373 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -112.0 -16.94 12.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 110.798 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 34.8 m-70 -110.81 160.98 16.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.787 -1.195 . . . . 0.0 112.432 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.989 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -135.51 121.6 20.11 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 1.6 mp -38.65 -28.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 110.766 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -149.95 -32.1 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.205 -0.935 . . . . 0.0 111.11 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.989 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -68.9 -161.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.974 -1.079 . . . . 0.0 109.751 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 127.21 18.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.887 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -131.9 -100.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.93 -30.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.985 -1.072 . . . . 0.0 109.454 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.1 163.59 17.75 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' ALA . 3.0 Cg_exo -61.7 142.68 94.97 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.587 1.309 . . . . 0.0 110.584 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.955 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.24 147.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.726 ' CD1' HG23 ' A' ' 78' ' ' ILE . 2.7 m-85 -65.07 -61.48 2.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -47.3 -48.07 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.048 . . . . 0.0 109.336 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.4 m-20 -54.81 -40.89 69.99 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.892 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 26' ' ' ALA . 98.7 t -55.97 -44.82 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 110.156 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -67.92 -30.1 69.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.16 -25.02 62.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.393 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.83 -37.33 14.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -93.63 -0.27 56.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.145 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.09 106.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.428 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.54 76.86 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.591 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mt-30 -145.85 167.96 21.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.59 42.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.55 46.0 0.59 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -63.12 -29.04 70.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -1.171 . . . . 0.0 110.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.82 -34.86 69.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.184 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -65.51 -51.16 61.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.302 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -67.6 -26.11 66.1 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.117 -0.99 . . . . 0.0 108.867 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 48' ' ' ILE . 13.5 mt -68.3 -25.26 65.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -76.69 -40.28 49.33 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.648 -0.657 . . . . 0.0 109.559 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -76.34 -21.43 56.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.859 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 5.4 mmm180 -89.05 -19.78 25.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.849 HD11 HMA1 ' A' ' 83' ' ' HEM . 43.9 mt -84.98 -30.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.282 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 3.1 ttpm? -81.59 -25.94 35.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.584 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 m120 -119.41 -3.54 10.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 49.16 179.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.1 166.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.852 -1.381 . . . . 0.0 111.766 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -106.07 -175.82 2.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.394 -0.816 . . . . 0.0 109.792 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 19.88 76.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.85 HG12 ' CD1' ' A' ' 56' ' ' TRP . 17.2 t -96.87 -68.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.639 -0.918 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.85 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.3 m95 -117.57 -37.72 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.501 -0.75 . . . . 0.0 109.705 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.99 -172.24 21.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.547 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.73 8.04 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.438 1.426 . . . . 0.0 111.973 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.521 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 10.1 mt -109.06 89.59 6.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.651 -1.281 . . . . 0.0 110.411 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.95 145.4 98.42 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.551 1.29 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.535 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 2.7 tmm? -79.04 131.89 65.26 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -65.83 134.4 37.41 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.683 1.359 . . . . 0.0 108.973 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.43 135.16 65.99 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.208 1.11 . . . . 0.0 110.211 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -106.65 161.9 14.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.9 43.66 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.087 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.61 HG21 HG22 ' A' ' 48' ' ' ILE . 16.7 m -96.64 114.76 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' VAL . 24.5 p -53.36 -171.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -76.84 -42.75 38.92 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.009 -1.057 . . . . 0.0 109.773 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -64.35 -36.76 85.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 0.0 109.304 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 51.6 mt-10 -69.08 -51.51 38.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.897 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -63.5 -18.13 63.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -47.98 49.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 3' ' ' PRO . 5.1 m -68.41 -24.13 64.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 71' ' ' ALA . 88.7 mt -74.1 -34.51 63.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.613 -0.679 . . . . 0.0 109.349 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.27 -41.64 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.2 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 80' ' ' SER . 4.7 mttt -70.72 -26.8 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.459 -0.776 . . . . 0.0 109.058 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.752 ' CD2' ' NE2' ' A' ' 81' ' ' GLN . 35.8 t90 -71.84 -42.27 67.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.912 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.726 HG23 ' CD1' ' A' ' 27' ' ' TYR . 11.5 mt -65.35 -48.57 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.638 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.31 -16.05 61.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.579 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' ' C ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -117.94 10.42 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.977 . . . . 0.0 110.574 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.752 ' NE2' ' CD2' ' A' ' 77' ' ' TRP . 35.1 mm-40 -33.66 129.93 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.662 -0.649 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.146 179.849 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 1.022 HBB1 ' HB3' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.3 pt-20 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.236 0.541 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -81.05 153.63 72.28 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.141 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_exo -60.38 -17.75 49.19 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.709 1.373 . . . . 0.0 110.355 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.53 -40.61 73.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.416 ' HB ' ' HG3' ' A' ' 1' ' ' GLU . 76.6 t -60.28 -54.69 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.429 -0.794 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -63.29 -32.48 73.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.667 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.44 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -65.39 -22.42 66.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -82.35 -50.74 8.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.421 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -63.86 -19.88 65.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 0.0 110.698 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.837 ' HE3' HG12 ' A' ' 66' ' ' VAL . 15.1 mmtt -85.04 -16.48 40.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.017 -1.052 . . . . 0.0 109.9 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.97 15.26 45.96 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 9.1 m -71.13 -48.67 50.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -1.213 . . . . 0.0 110.632 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.0 mmm -72.49 3.31 5.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 0.0 110.98 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.14 22.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 0.0 110.425 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.7 m -111.74 -18.43 12.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.629 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.6 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 19.2 m-70 -99.14 165.64 11.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 112.043 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.654 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -141.6 117.48 10.49 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 22.5 mm -36.2 -29.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.542 -0.724 . . . . 0.0 111.035 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' ALA . 12.9 t70 -161.04 18.04 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.158 -0.964 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.664 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -112.01 -177.73 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 110.067 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -119.92 86.16 2.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 110.67 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 1.2 mtm -95.16 -112.93 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 109.686 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.503 HG12 HMD1 ' A' ' 83' ' ' HEM . 55.7 t -88.39 -29.41 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.793 -1.192 . . . . 0.0 109.585 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.09 170.35 15.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -65.65 134.86 39.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.513 1.27 . . . . 0.0 110.326 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.938 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.47 146.77 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 5.5 m-85 -57.52 -52.99 63.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.977 -1.077 . . . . 0.0 110.209 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.14 -50.63 58.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.421 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -56.39 -34.32 66.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.192 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 26' ' ' ALA . 60.1 t -62.64 -36.87 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.107 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -78.02 -24.42 47.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.93 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.3 -33.19 69.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.466 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -84.01 -35.51 23.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -90.72 -3.99 57.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -53.83 128.6 30.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.75 71.86 1.27 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.672 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -145.64 144.1 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.82 46.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 110.627 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.8 42.45 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -70.22 -21.0 63.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -1.126 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.5 mp0 -74.04 -36.74 64.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.552 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -46.85 82.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.343 -0.848 . . . . 0.0 109.682 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.502 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 51.5 t80 -73.76 -27.54 61.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.265 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . 11.3 mt -71.52 -24.92 62.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 72' ' ' GLN . . . -79.83 -32.37 40.63 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -80.05 -24.32 40.79 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.44 -0.787 . . . . 0.0 109.182 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 34.5 mmt-85 -90.03 -17.02 28.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 109.088 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.94 HD11 HMA1 ' A' ' 83' ' ' HEM . 25.2 mt -88.53 -29.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.722 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.585 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -120.09 -13.39 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.238 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.3 175.06 0.02 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.21 171.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.789 -1.418 . . . . 0.0 111.369 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.589 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.63 -171.93 1.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.486 -0.759 . . . . 0.0 109.995 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.585 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.22 12.63 61.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.81 HG12 ' CD1' ' A' ' 56' ' ' TRP . 24.9 t -93.97 -59.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.544 -0.974 . . . . 0.0 109.507 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.81 ' CD1' HG12 ' A' ' 55' ' ' VAL . 97.0 m95 -120.79 -38.92 2.78 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.578 0.704 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.94 -164.54 20.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.7 7.47 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.47 1.447 . . . . 0.0 111.718 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.478 HG22 HMD3 ' A' ' 83' ' ' HEM . 15.4 mt -108.11 78.04 0.75 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.768 -1.207 . . . . 0.0 110.545 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -56.63 140.11 89.52 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.605 ' HE2' ' NA ' ' A' ' 83' ' ' HEM . 0.8 OUTLIER -74.97 131.01 79.71 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.844 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -67.03 128.66 19.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.642 1.338 . . . . 0.0 109.607 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.65 135.89 70.32 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.379 1.2 . . . . 0.0 110.243 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -107.28 170.26 8.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.878 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.41 35.18 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.386 -0.821 . . . . 0.0 109.645 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.837 HG12 ' HE3' ' A' ' 10' ' ' LYS . 34.9 m -86.31 105.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 110.151 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -42.41 153.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.251 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' OD1' ' HD3' ' A' ' 49' ' ' LYS . 3.3 m-20 -44.49 -37.57 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.705 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -41.28 90.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.021 -1.049 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 4.8 mm-40 -69.19 -36.99 77.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.524 ' HB2' HG23 ' A' ' 66' ' ' VAL . . . -73.6 -20.28 60.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 5.1 tt0 -76.34 -48.79 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -66.48 -25.78 66.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.958 HD13 HMB1 ' A' ' 83' ' ' HEM . 18.6 mt -71.14 -37.4 72.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.774 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -67.16 -53.07 33.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.519 -0.738 . . . . 0.0 109.434 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -63.67 -26.29 68.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.594 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 28.0 t90 -64.89 -36.47 84.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.856 HD13 HMA3 ' A' ' 83' ' ' HEM . 12.1 mt -71.97 -46.49 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 109.625 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 75' ' ' ALA . 1.7 mp -68.65 -11.35 60.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.27 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 m -95.34 -12.29 26.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.493 ' NE2' ' NE1' ' A' ' 77' ' ' TRP . 64.7 mm-40 -61.83 -27.44 68.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.95 . . . . 0.0 110.179 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.958 HMB1 HD13 ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.71 ' HG2' HG11 ' A' ' 5' ' ' VAL . 1.1 mp0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.208 0.527 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.69 169.48 0.18 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.716 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.1 Cg_exo -61.99 -22.33 74.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.778 1.41 . . . . 0.0 110.494 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.54 -35.53 70.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.122 -0.986 . . . . 0.0 108.965 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG11 ' HG2' ' A' ' 1' ' ' GLU . 3.8 t -64.91 -53.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.394 -0.816 . . . . 0.0 109.643 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.716 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -68.61 -24.08 64.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -68.13 -29.02 67.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -39.5 19.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.773 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -62.39 -27.75 69.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 110.677 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.934 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 0.1 OUTLIER -88.51 -17.86 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.105 . . . . 0.0 110.413 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.22 13.29 39.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.691 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 14.1 m -66.26 -41.06 90.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -1.205 . . . . 0.0 110.317 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.5 5.93 16.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -0.88 . . . . 0.0 110.598 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.0 -26.51 16.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 110.569 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 m -112.45 -14.65 13.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 29.3 m-70 -111.88 158.33 19.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 111.824 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.866 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -129.58 121.36 26.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.58 HG23 ' HB3' ' A' ' 81' ' ' GLN . 16.5 mt -39.73 -26.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.434 -0.791 . . . . 0.0 110.774 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.62 -35.34 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.956 -1.09 . . . . 0.0 111.01 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.866 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.06 -164.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.977 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -135.62 92.85 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.649 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -91.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.681 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -100.64 -45.91 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.924 . . . . 0.0 109.674 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.84 178.55 21.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.87 137.68 50.1 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.69 1.363 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.008 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.07 151.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.662 ' HD1' HG23 ' A' ' 78' ' ' ILE . 3.3 m-85 -65.32 -59.4 4.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.5 ' CD ' ' HA ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -53.52 -45.13 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.004 -1.06 . . . . 0.0 109.756 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.6 m-20 -57.71 -39.41 77.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 110.021 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 26' ' ' ALA . 72.2 t -57.98 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 110.116 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.06 -31.26 65.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 110.512 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.21 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 110.169 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -86.53 -48.86 8.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.492 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 8.5 m-85 -73.34 -5.44 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.55 109.94 0.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.16 -27.36 2.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 1.8 mt-30 -67.52 149.08 50.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -1.124 . . . . 0.0 110.178 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 52.61 2.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.47 50.17 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -71.08 -25.48 62.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 110.042 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 75' ' ' ALA . 1.3 tt0 -67.02 -37.91 84.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 109.65 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.35 56.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.514 ' OH ' ' NE ' ' A' ' 47' ' ' ARG . 6.4 t80 -66.24 -24.15 66.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 109.086 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.726 HD22 HMA2 ' A' ' 83' ' ' HEM . 13.9 mt -69.44 -30.31 68.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.12 67.42 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -77.07 -26.56 53.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.758 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' CE ' ' A' ' 61' ' ' MET . 4.0 mmt180 -89.77 -16.41 30.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.841 . . . . 0.0 109.242 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.975 HD11 HMA1 ' A' ' 83' ' ' HEM . 31.2 mt -86.79 -28.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.73 -10.54 53.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 t-20 -125.48 -15.18 6.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 56.69 161.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER 171.72 167.91 0.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.534 -1.568 . . . . 0.0 112.039 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.588 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -103.75 -172.38 2.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.572 -0.705 . . . . 0.0 109.983 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.16 19.9 72.54 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.768 HG11 ' CGA' ' A' ' 83' ' ' HEM . 3.0 t -98.53 -68.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.794 -0.827 . . . . 0.0 109.631 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.642 ' CZ2' HG13 ' A' ' 30' ' ' VAL . 83.0 m95 -116.45 -36.54 3.96 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.39 -0.819 . . . . 0.0 109.497 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.07 -166.48 19.01 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -71.29 15.26 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.405 1.403 . . . . 0.0 112.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 59' ' ' ILE . 5.4 mt -111.48 84.65 5.15 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 110.41 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.5 Cg_exo -60.81 134.69 55.22 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.648 1.341 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.577 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 52.5 ttp -75.37 133.72 74.24 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.335 -0.853 . . . . 0.0 110.166 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.6 Cg_endo -69.69 134.2 27.57 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.521 1.274 . . . . 0.0 109.146 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.2 Cg_exo -58.17 142.65 97.31 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.202 1.107 . . . . 0.0 110.234 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -112.83 -174.8 2.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.902 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.31 34.17 5.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.731 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 7.8 m -74.28 118.74 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.768 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.468 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -43.45 159.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 108.996 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -53.24 -50.22 65.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.878 -1.139 . . . . 0.0 110.442 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -21.87 66.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.482 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mm-40 -76.36 -40.13 52.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.917 . . . . 0.0 110.321 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB2' ' CG2' ' A' ' 66' ' ' VAL . . . -71.75 -26.1 62.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -68.85 -44.17 73.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -71.67 -24.42 61.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.707 HD22 ' CMB' ' A' ' 83' ' ' HEM . 38.5 mt -73.46 -33.13 64.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.281 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -73.73 -50.73 19.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.139 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -26.94 68.63 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.36 -0.837 . . . . 0.0 109.044 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 40.6 t90 -68.72 -44.15 74.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.806 HD13 HMA3 ' A' ' 83' ' ' HEM . 20.8 mt -56.99 -51.86 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.862 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -67.43 -21.74 65.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -77.75 -23.56 49.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.58 ' HB3' HG23 ' A' ' 18' ' ' ILE . 36.1 mm-40 -49.94 -177.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 110.336 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 0.975 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.297 0.57 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.42 159.96 78.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.222 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.719 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.0 Cg_exo -60.75 -23.58 76.71 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.676 1.356 . . . . 0.0 110.664 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 5' ' ' VAL . 12.7 pt-20 -68.23 -37.11 80.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.13 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 4' ' ' GLU . 59.9 t -64.97 -55.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.506 -0.746 . . . . 0.0 109.96 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.719 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.0 pp -66.8 -21.89 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.599 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -62.54 -47.89 81.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.504 -0.747 . . . . 0.0 109.526 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -40.87 80.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.835 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -65.52 -19.85 66.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.812 . . . . 0.0 110.645 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' HE2' ' OE1' ' A' ' 70' ' ' GLU . 50.9 mmtt -96.93 -19.69 18.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.058 -1.026 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.63 11.74 54.83 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.63 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 37.6 m -67.2 -29.71 69.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.014 -1.286 . . . . 0.0 110.141 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mtp -84.8 7.77 19.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.24 -49.49 10.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 110.391 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.6 m -102.9 -19.45 14.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 110.979 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.636 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 14.5 m-70 -101.61 173.71 6.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.837 -1.164 . . . . 0.0 112.069 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -153.84 -168.19 2.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 81' ' ' GLN . 19.2 mm -90.27 -73.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.677 -1.264 . . . . 0.0 110.373 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB3' ' HG2' ' A' ' 28' ' ' LYS . 17.2 p30 -116.03 -1.2 12.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 110.572 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.451 HG23 ' OD1' ' A' ' 19' ' ' ASP . 49.8 p -87.1 161.41 18.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 110.196 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -105.96 85.85 2.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 110.651 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.415 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 1.5 mtm -88.54 -125.34 0.05 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 0.0 109.84 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 t -69.87 -39.46 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.757 -1.215 . . . . 0.0 109.649 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 173.35 14.91 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HD3' HBD1 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -65.06 136.88 50.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.719 1.379 . . . . 0.0 110.554 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.742 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . . . -42.81 154.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.661 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.4 m-85 -70.11 -62.85 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.975 . . . . 0.0 109.836 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -47.48 -33.01 5.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.077 . . . . 0.0 109.392 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.742 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 7.2 m-20 -62.68 -46.65 87.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 109.59 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.593 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 49.9 t -57.43 -32.33 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -80.79 -24.37 38.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.467 -0.771 . . . . 0.0 110.082 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.36 62.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -40.22 12.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 110.098 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.47 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 23.3 m-85 -82.7 -7.04 59.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -47.15 134.74 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.21 5.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.482 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -122.58 138.38 54.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 110.083 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 51.31 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.686 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.07 41.78 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.482 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -79.69 -23.29 42.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.226 . . . . 0.0 110.018 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.36 -36.47 68.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.09 66.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.667 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.75 -28.07 66.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 48' ' ' ILE . 11.5 mt -68.67 -25.08 64.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.38 40.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.49 -0.756 . . . . 0.0 109.559 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -77.71 -28.03 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.866 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 0.2 OUTLIER -86.48 -20.24 28.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.366 -0.834 . . . . 0.0 109.25 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.02 HD11 HMA1 ' A' ' 83' ' ' HEM . 33.9 mt -84.79 -29.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.544 -0.722 . . . . 0.0 110.133 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HG3' HG23 ' A' ' 66' ' ' VAL . 13.3 mtpt -86.71 -17.16 34.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.062 -1.024 . . . . 0.0 110.133 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.1 t-20 -119.0 -13.59 9.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 50.33 174.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 166.47 165.03 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.869 -1.371 . . . . 0.0 111.976 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -99.56 179.59 4.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.611 -0.681 . . . . 0.0 109.544 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.82 16.15 74.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.872 HG11 ' CGA' ' A' ' 83' ' ' HEM . 3.1 t -91.95 -64.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.566 -0.961 . . . . 0.0 109.373 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.593 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.6 m95 -118.89 -36.66 3.38 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.609 0.719 . . . . 0.0 109.414 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.66 -165.11 15.22 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.14 11.79 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.506 1.471 . . . . 0.0 112.138 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.512 HG22 HMD3 ' A' ' 83' ' ' HEM . 6.1 mt -110.98 88.97 8.87 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.547 -1.346 . . . . 0.0 111.038 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -62.38 132.29 37.8 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.645 1.34 . . . . 0.0 110.821 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.1 tmm? -75.19 129.43 82.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.022 -1.049 . . . . 0.0 109.843 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.47 133.47 28.14 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.528 1.278 . . . . 0.0 108.884 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -57.59 140.85 94.7 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.206 1.108 . . . . 0.0 110.177 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.25 164.84 12.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.91 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.45 32.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.832 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' SER . 15.5 m -73.94 120.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.514 -0.741 . . . . 0.0 109.915 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 66' ' ' VAL . 7.4 t -47.4 175.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.46 -69.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -21.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -75.9 -48.39 21.54 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.855 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -68.2 -18.95 64.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 108.72 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -48.59 46.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -27.05 68.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.057 ' O ' HD12 ' A' ' 78' ' ' ILE . 41.3 mt -66.13 -44.41 84.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -61.23 -52.79 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 1.1 mtpt -60.93 -19.52 60.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.576 ' CZ3' ' CE2' ' A' ' 27' ' ' TYR . 38.6 t90 -80.67 -41.31 23.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.77 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.057 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.6 mp -61.24 -52.16 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 109.833 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -64.21 -23.95 67.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 81' ' ' GLN . 0.6 OUTLIER -74.09 -28.46 61.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.395 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.784 ' HG3' HD12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -43.88 -53.65 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.105 -0.997 . . . . 0.0 110.277 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HEM . . . . . 1.02 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.1 Cg_exo . . . . . 0 C--O 1.214 -0.718 0 N-CA-C 110.313 -0.687 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' HA ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 tt0 -52.0 -46.91 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 51.1 t -48.11 -40.39 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.384 -0.822 . . . . 0.0 108.962 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 65.4 mt -64.95 -40.01 94.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 109.734 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.652 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -58.23 -27.86 64.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.601 -0.687 . . . . 0.0 110.398 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -90.14 -36.57 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 110.777 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -70.57 -25.95 63.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.204 -0.935 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 22.7 mmtm -97.9 -26.35 14.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 110.202 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.43 18.47 14.52 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 14.1 m -65.0 -32.26 73.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.421 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 69.3 mmm -79.15 2.81 19.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.03 11.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 90.2 m -96.93 -15.6 21.08 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 110.961 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.4 m-70 -104.42 172.39 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.96 -1.087 . . . . 0.0 112.047 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.88 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -152.77 124.4 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.4 mp -37.79 -27.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 111.266 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.587 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 2.0 p-10 -155.24 -32.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.996 -1.065 . . . . 0.0 111.404 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.88 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 17.9 p -69.65 151.7 45.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.965 -1.085 . . . . 0.0 109.847 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -93.38 117.76 30.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.671 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 2.3 mtm -123.02 -117.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.478 -0.764 . . . . 0.0 109.514 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 51.0 t -76.45 -34.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.833 -1.167 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.64 171.72 15.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.632 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.2 137.57 48.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.525 1.276 . . . . 0.0 110.072 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . . . -42.28 156.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.787 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.719 ' HD1' HG23 ' A' ' 78' ' ' ILE . 5.7 m-85 -69.06 -60.55 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.06 -42.27 65.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.038 -1.039 . . . . 0.0 109.011 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.818 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 59.2 m-20 -58.47 -40.86 83.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.865 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 26' ' ' ALA . 16.4 t -56.27 -38.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 109.318 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.853 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -74.0 -24.21 59.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.496 -0.753 . . . . 0.0 109.915 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.83 62.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -88.77 -35.44 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' HG2' ' A' ' 33' ' ' LYS . 3.9 m-30 -94.06 -1.75 53.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 109.84 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.853 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.05 130.23 37.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.177 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.15 -19.04 15.49 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 8.3 mm100 -66.58 145.78 55.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -1.089 . . . . 0.0 110.027 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.33 2.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.266 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 56.49 0.21 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.609 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -75.3 -13.16 60.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -1.161 . . . . 0.0 110.287 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.796 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -75.18 -30.05 60.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -70.61 -52.95 17.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.55 -34.64 78.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.911 . . . . 0.0 108.806 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 48' ' ' ILE . 11.5 mt -59.18 -36.6 75.62 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -65.94 -37.75 86.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 109.667 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -29.54 65.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.974 . . . . 0.0 110.08 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 29.2 mmt180 -88.42 -12.42 43.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.264 -0.898 . . . . 0.0 109.384 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.638 HD12 ' O ' ' A' ' 44' ' ' LEU . 38.7 mt -90.28 -25.16 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.452 -0.78 . . . . 0.0 109.446 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -85.53 -14.33 46.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.7 t30 -126.98 -11.71 5.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.55 174.64 0.02 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 163.87 167.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.169 -1.195 . . . . 0.0 111.414 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.0 pm0 -101.9 -161.14 0.83 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.435 -0.791 . . . . 0.0 109.925 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 56.4 19.39 25.61 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.864 HG12 ' CD1' ' A' ' 56' ' ' TRP . 60.5 t -104.54 -62.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.701 -0.882 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.864 ' CD1' HG12 ' A' ' 55' ' ' VAL . 88.2 m95 -120.0 -35.53 3.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.09 -175.93 31.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.94 6.83 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.379 1.386 . . . . 0.0 111.764 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.447 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 9.1 mt -106.05 85.37 1.59 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.84 -1.162 . . . . 0.0 109.829 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.7 Cg_endo -54.07 133.86 57.23 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.7 1.369 . . . . 0.0 110.834 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.57 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.2 tmm? -70.52 131.92 87.83 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.145 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.1 Cg_exo -64.38 130.24 26.26 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.73 1.384 . . . . 0.0 109.504 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.7 Cg_endo -59.38 138.24 83.12 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.478 1.251 . . . . 0.0 110.346 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-80 -110.39 160.63 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.26 35.72 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 66' ' ' VAL . 19.8 m -79.86 119.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.393 -0.817 . . . . 0.0 110.028 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -46.39 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.569 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.93 -39.2 79.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.939 -1.1 . . . . 0.0 109.94 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.55 -34.77 74.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.871 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.4 mm-40 -71.71 -38.52 70.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 110.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.854 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -72.51 -22.82 60.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.221 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 7.2 mt-30 -71.73 -41.68 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.53 -25.84 61.53 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' A' ' 71' ' ' ALA . 41.6 mt -72.02 -30.99 65.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.796 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -73.29 -53.62 10.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.517 -0.739 . . . . 0.0 109.545 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 16.8 ptmt -64.87 -20.79 66.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.227 -0.921 . . . . 0.0 109.076 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.652 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 43.7 t90 -70.7 -43.55 68.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.304 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.719 HG23 ' HD1' ' A' ' 27' ' ' TYR . 13.1 mt -62.81 -48.78 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.918 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -69.19 -9.75 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.475 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 110.693 -179.719 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 110.519 -0.608 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -38.15 68.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 4.1 t -62.99 -52.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.884 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -61.77 -33.85 74.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.208 -0.932 . . . . 0.0 109.661 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.446 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -68.44 -21.92 64.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -49.91 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 12.6 m-80 -65.31 -23.57 67.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.134 -0.978 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 22.3 mmtm -84.52 -12.41 54.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 109.798 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.3 69.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 59.4 m -65.15 -31.7 73.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.252 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.2 mtp -88.41 7.62 31.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 110.301 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 -44.82 18.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 70.8 m -102.67 -17.61 15.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 110.887 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.612 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 11.1 m-70 -93.73 168.26 11.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.947 -1.096 . . . . 0.0 112.353 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.984 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -148.05 118.72 7.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.6 mp -38.66 -27.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.399 -0.813 . . . . 0.0 110.913 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.5 p-10 -148.65 -35.9 0.19 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.041 -1.037 . . . . 0.0 110.542 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.984 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.05 -179.29 1.47 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -129.83 89.07 2.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 110.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -78.82 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.006 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 70.7 t -97.75 -25.65 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.977 -1.077 . . . . 0.0 109.396 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.94 173.76 15.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.651 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -68.61 133.35 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.574 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -46.11 151.24 0.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.638 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -61.6 -64.39 0.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.115 -0.991 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -48.1 -46.02 33.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 2.8 m-20 -51.9 -47.1 64.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.486 -0.759 . . . . 0.0 110.147 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 26' ' ' ALA . 89.7 t -57.99 -34.25 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.9 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -75.78 -26.35 57.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.18 60.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -85.44 -37.35 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' GLY . 11.5 m-85 -97.8 -3.41 38.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -0.944 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.9 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -51.27 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 130.93 69.14 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.458 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.4 mt-30 -144.7 149.79 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.26 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.02 39.46 0.96 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.47 50.08 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -84.83 -42.46 15.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -1.175 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.781 ' HA ' HD12 ' A' ' 44' ' ' LEU . 10.0 mp0 -59.73 -38.09 80.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 109.926 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.89 84.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CZ ' ' HD2' ' A' ' 47' ' ' ARG . 28.6 t80 -70.68 -20.01 62.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.225 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.781 HD12 ' HA ' ' A' ' 41' ' ' GLU . 28.7 mt -72.86 -34.86 67.03 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.8 -31.97 59.66 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -28.13 51.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.863 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.589 ' HD2' ' CZ ' ' A' ' 43' ' ' TYR . 6.9 mmp_? -86.65 -16.81 35.47 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.377 -0.827 . . . . 0.0 109.547 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.551 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 58.8 mt -88.22 -28.97 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.459 -0.775 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -80.26 -20.77 43.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.2 m120 -120.86 -17.91 7.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.109 -0.994 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.74 169.48 0.02 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.6 OUTLIER 164.02 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.086 -1.243 . . . . 0.0 111.375 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -96.94 -160.97 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.313 -0.867 . . . . 0.0 110.44 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.46 19.04 59.59 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.849 HG12 ' CD1' ' A' ' 56' ' ' TRP . 9.4 t -98.28 -69.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.675 -0.897 . . . . 0.0 109.48 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.849 ' CD1' HG12 ' A' ' 55' ' ' VAL . 92.3 m95 -118.53 -38.25 3.17 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 108.953 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.51 -167.73 15.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.494 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.58 14.72 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.558 1.505 . . . . 0.0 112.07 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.9 mt -110.13 96.56 26.26 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.545 -1.347 . . . . 0.0 111.005 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.551 ' CB ' ' HB3' ' A' ' 53' ' ' GLN . 2.5 Cg_endo -65.01 128.64 21.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.615 1.324 . . . . 0.0 110.589 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.551 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tmm? -69.2 128.93 92.34 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.876 -1.14 . . . . 0.0 108.796 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.22 129.97 25.76 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.643 1.338 . . . . 0.0 109.5 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_exo -57.27 148.95 67.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.243 1.128 . . . . 0.0 109.972 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -120.73 163.45 18.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 111.047 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.5 36.37 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 66' ' ' VAL . 16.7 m -84.4 108.62 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' VAL . 17.5 p -42.22 152.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.559 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -45.92 -48.76 16.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.797 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.84 -34.79 75.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.976 . . . . 0.0 110.46 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.97 -40.93 75.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -72.16 -21.47 61.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.02 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -70.27 -44.05 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 3' ' ' PRO . 18.9 m -70.84 -23.99 62.44 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.67 ' O ' HD12 ' A' ' 78' ' ' ILE . 31.7 mt -71.7 -37.45 70.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.47 58.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.452 -0.78 . . . . 0.0 109.159 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 80' ' ' SER . 13.2 mtmt -66.7 -22.2 66.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.239 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 62.0 t90 -78.01 -24.04 48.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 109.92 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 74' ' ' LEU . 7.2 mt -84.29 -61.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.898 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -49.74 -42.17 45.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 9.2 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.63 ' HA ' HD21 ' A' ' 6' ' ' LEU . 2.8 Cg_endo . . . . . 0 N--CA 1.484 0.924 0 N-CA-C 110.716 -0.532 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt-20 -65.09 -27.56 68.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 0.0 109.134 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 32.8 t -71.82 -59.25 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.535 -0.728 . . . . 0.0 109.404 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -62.67 -19.2 63.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.85 -53.85 23.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.932 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -29.78 69.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 110.463 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -67.17 -37.21 83.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.664 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 10.3 mmtp -82.31 -13.37 57.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.18 12.45 49.0 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 22.5 m -65.26 -38.62 90.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -1.23 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.85 7.26 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.469 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.88 -34.22 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.3 m -110.55 -14.86 14.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 110.745 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.631 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.7 m-70 -102.98 154.38 19.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.895 -1.128 . . . . 0.0 111.846 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.858 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -132.47 121.32 23.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.846 HG22 ' HD2' ' A' ' 28' ' ' LYS . 11.2 mt -40.34 -26.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.957 . . . . 0.0 110.724 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 4.6 t70 -152.21 -35.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.858 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.81 163.68 25.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 110.518 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -103.44 89.31 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 110.559 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 mtm -85.49 -95.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.683 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.13 -39.35 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.68 -179.41 18.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.614 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.49 129.86 22.3 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.627 1.33 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.91 143.39 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.811 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.631 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 5.8 m-85 -53.92 -48.97 69.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.846 ' HD2' HG22 ' A' ' 18' ' ' ILE . 2.1 mtpp -57.43 -50.67 72.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.8 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.26 -27.13 63.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 110.242 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' ALA . 92.0 t -67.06 -43.09 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.047 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -74.47 -23.86 58.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 110.395 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.62 59.04 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.215 -0.928 . . . . 0.0 110.378 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -90.88 -41.7 11.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE2' ' CZ2' ' A' ' 56' ' ' TRP . 7.7 m-85 -78.35 -7.81 57.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.077 -1.015 . . . . 0.0 110.041 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.86 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 155.44 -45.14 0.54 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 5.4 mm-40 -42.24 157.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 57.58 3.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.663 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.05 57.96 0.39 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -70.7 -44.42 66.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -1.1 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 21.0 pt-20 -50.44 -37.79 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -60.8 -57.79 11.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 85.2 t80 -67.18 -13.86 62.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.557 ' O ' ' CG1' ' A' ' 48' ' ' ILE . 18.8 mt -78.42 -29.39 47.11 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.46 64.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.597 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 2.3 mmt180 -81.42 -16.67 51.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.21 -0.932 . . . . 0.0 109.521 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.557 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 9.7 mt -81.08 -34.43 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.34 -12.41 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 110.685 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.32 -8.84 8.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 110.654 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 62.01 160.55 0.16 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 11.5 t -179.2 154.82 0.68 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.639 -1.507 . . . . 0.0 112.54 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.11 -176.31 3.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.679 -0.638 . . . . 0.0 109.703 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 66.05 10.77 52.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 53' ' ' GLN . 2.1 t -89.41 -62.25 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.482 -1.011 . . . . 0.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.614 ' CD2' ' CG ' ' A' ' 25' ' ' PRO . 73.9 m95 -115.65 -33.72 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.497 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.36 -167.31 25.76 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.7 Cg_endo -69.44 6.87 1.04 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.376 1.384 . . . . 0.0 111.695 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 15.6 mt -110.59 90.17 10.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 120.805 -1.185 . . . . 0.0 110.5 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -61.88 141.34 89.45 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.786 1.414 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.555 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 32.4 ttp -71.92 128.48 89.31 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.902 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.471 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -63.0 130.94 30.7 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.589 1.31 . . . . 0.0 109.379 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.1 131.2 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.322 1.169 . . . . 0.0 109.928 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.1 m-80 -105.55 163.89 12.31 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 110.537 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 30.32 1.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.842 . . . . 0.0 109.733 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' CG ' ' A' ' 49' ' ' LYS . 15.8 m -74.16 116.06 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -48.85 179.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.695 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -65.5 -68.89 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -45.83 -32.19 2.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.364 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -68.3 -51.35 45.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.351 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.963 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -63.67 -21.07 66.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -71.44 -47.32 56.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.389 -0.819 . . . . 0.0 108.815 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -68.16 -24.43 64.98 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.982 ' O ' HD12 ' A' ' 78' ' ' ILE . 70.4 mt -68.99 -41.33 77.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.581 -0.699 . . . . 0.0 109.381 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.7 -48.75 65.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.379 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -63.68 -19.2 64.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.394 -0.817 . . . . 0.0 109.458 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -78.51 -46.18 20.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 110.098 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.982 HD12 ' O ' ' A' ' 74' ' ' LEU . 3.1 mt -63.06 -48.36 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.532 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -13.71 61.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.767 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -33.0 57.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.246 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.8 t -66.4 -48.74 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.572 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.4 pp -69.36 -30.57 68.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.268 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.6 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -58.14 -55.42 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -43.77 82.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.83 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -55.13 -29.45 57.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 16.7 mmtm -90.69 -22.32 21.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.903 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.62 14.44 27.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 19.8 m -66.36 -36.05 81.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -1.198 . . . . 0.0 110.407 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 mtp -82.16 6.82 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 110.882 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.87 -43.87 13.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 89.9 m -101.71 -18.13 15.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.3 m-70 -101.0 167.45 10.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 111.969 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -147.26 122.8 10.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.55 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.1 mp -37.45 -27.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.424 -0.798 . . . . 0.0 111.075 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.576 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -155.68 -34.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 110.863 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.931 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 62.4 p -69.62 154.53 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.199 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.66 122.72 39.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mtm -124.73 -98.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 68.1 t -94.2 -36.32 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 109.317 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.25 178.17 16.4 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -69.23 133.2 25.94 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.656 1.346 . . . . 0.0 110.485 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.43 150.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.057 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 8.2 m-85 -60.73 -56.95 15.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.247 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.32 -49.81 52.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.753 -1.217 . . . . 0.0 109.448 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 6.5 m-20 -53.33 -41.75 66.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 26' ' ' ALA . 49.5 t -53.98 -42.44 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.846 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -73.65 -23.42 59.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.965 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 29' ' ' ASP . . . -66.64 -34.07 77.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' CZ3' ' A' ' 56' ' ' TRP . 3.2 ttmt -86.92 -49.97 7.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -76.46 1.22 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.846 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -59.01 126.72 28.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.439 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.36 28.67 4.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.48 138.83 50.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 110.24 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.42 41.12 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.95 55.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.647 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -87.15 -17.27 33.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.149 -1.207 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.697 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 2.3 mt-10 -75.63 -33.71 60.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.887 . . . . 0.0 109.611 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.68 63.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.554 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.73 -31.65 68.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.087 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 40' ' ' ALA . 15.4 mt -67.46 -26.99 66.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . . . -75.61 -33.41 60.52 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.574 -0.704 . . . . 0.0 109.834 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -75.36 -36.36 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.424 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 33.5 mmt-85 -82.18 -15.76 52.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.601 HD12 ' O ' ' A' ' 44' ' ' LEU . 24.9 mt -85.99 -29.6 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.24 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -84.84 -17.75 37.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.4 t30 -126.8 -0.04 6.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.111 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 51.27 -173.76 0.13 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.2 p 167.42 158.72 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.038 -1.272 . . . . 0.0 111.871 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.681 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -106.15 -164.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 0.0 109.959 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 53.39 18.98 7.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 53' ' ' GLN . 6.7 t -94.72 -69.25 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -1.103 . . . . 0.0 109.17 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.61 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 98.4 m95 -110.41 -39.03 5.06 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.736 0.779 . . . . 0.0 108.941 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.88 -174.0 24.32 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -70.02 8.15 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.349 1.366 . . . . 0.0 111.506 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 11.3 mt -107.34 82.37 1.21 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -55.42 145.67 66.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.667 1.351 . . . . 0.0 111.563 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.549 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.6 ttm -74.95 132.42 77.3 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.808 . . . . 0.0 109.406 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -67.59 129.14 19.37 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.624 1.328 . . . . 0.0 109.036 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -56.68 133.92 61.11 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.179 1.094 . . . . 0.0 110.146 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.0 m-80 -105.9 -177.99 3.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.19 35.41 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 66' ' ' VAL . 27.1 m -87.09 103.14 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.8 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 40.3 t -43.61 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 109.345 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 67' ' ' SER . 1.5 m-20 -42.78 -47.51 5.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.507 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -59.17 -41.42 88.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 17.8 mt-10 -65.87 -38.94 90.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.817 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 45' ' ' ALA . . . -70.45 -19.92 62.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.091 -1.006 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -49.05 30.41 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -27.94 66.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 78' ' ' ILE . 51.1 mt -69.53 -36.12 76.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.697 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -67.46 -53.4 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -0.756 . . . . 0.0 109.505 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 10.4 mttt -61.98 -24.07 66.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.591 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 40.9 t90 -72.03 -35.44 69.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.511 -0.743 . . . . 0.0 109.57 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -74.8 -38.96 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 4.3 mt -74.21 -11.96 60.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.367 -0.833 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.422 -179.746 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.73 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.798 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 8.9 pt-20 -70.19 -39.09 75.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.259 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.55 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 57.8 t -64.32 -54.93 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 3' ' ' PRO . 3.8 pp -67.95 -22.66 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.876 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.92 -33.36 74.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -37.86 33.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.8 m120 -65.11 -30.99 71.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.883 . . . . 0.0 110.877 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 6.3 mmtm -83.82 -18.09 38.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.887 -1.133 . . . . 0.0 109.772 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.8 12.34 43.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 15.0 m -68.03 -35.83 78.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.268 . . . . 0.0 110.417 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 1.69 41.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -38.64 15.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.005 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -101.24 -26.41 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 110.444 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.625 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 32.9 m-70 -106.36 166.79 10.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 22' ' ' MET . . . -135.21 -176.16 4.17 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 45.3 mm -91.32 -26.01 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 110.402 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 2.8 p30 -162.22 19.35 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.976 -1.077 . . . . 0.0 111.06 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -114.93 -166.4 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.954 -1.091 . . . . 0.0 110.194 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 87.81 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 110.765 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.581 ' HE2' ' HB2' ' A' ' 17' ' ' ALA . 31.3 mtm -97.89 -98.43 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 109.598 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.9 t -88.87 -45.58 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 0.0 109.231 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.7 172.74 14.4 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HG3' ' HB3' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.23 143.04 82.4 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.469 1.247 . . . . 0.0 110.275 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -41.42 163.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -81.44 -53.14 6.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -52.13 -42.11 63.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 5.0 m-20 -58.05 -38.48 76.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.541 -0.724 . . . . 0.0 109.681 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 26' ' ' ALA . 91.1 t -58.55 -46.45 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.825 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.86 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.88 -19.93 61.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.552 -0.717 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -32.43 62.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -43.07 13.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.932 . . . . 0.0 109.822 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -78.81 -5.76 54.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.854 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.86 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -62.21 89.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.13 -20.94 0.57 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 mt-30 -71.48 149.91 45.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.101 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.15 40.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 110.428 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.7 56.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.645 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -90.28 -20.16 23.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.242 . . . . 0.0 110.45 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.93 -34.84 66.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 109.503 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.35 -50.93 63.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.721 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.526 ' CE1' ' CG ' ' A' ' 47' ' ' ARG . 1.2 t80 -68.11 -30.3 69.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 109.106 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 48' ' ' ILE . 9.2 mt -65.13 -29.7 70.57 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.92 66.31 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.597 -0.689 . . . . 0.0 110.008 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -76.38 -27.4 56.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 110.363 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' CG ' ' CE1' ' A' ' 43' ' ' TYR . 0.2 OUTLIER -87.72 -15.26 37.55 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 44' ' ' LEU . 35.2 mt -86.61 -32.31 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.382 -0.824 . . . . 0.0 109.618 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -85.06 -10.48 56.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 3.1 m-20 -124.16 -12.8 7.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 51.14 175.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 166.28 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.047 -1.267 . . . . 0.0 111.462 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.568 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -102.37 179.67 4.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.766 . . . . 0.0 109.955 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.81 19.26 73.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 56' ' ' TRP . 2.6 t -91.58 -67.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.596 -0.944 . . . . 0.0 109.459 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.592 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 88.6 m95 -119.41 -35.48 3.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.509 -0.744 . . . . 0.0 109.041 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.05 -174.29 23.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.39 11.44 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.426 1.417 . . . . 0.0 112.019 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 15.4 mt -109.11 87.06 4.42 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.659 -1.276 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.15 138.41 85.77 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.593 1.312 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.555 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.6 tmm? -79.02 126.68 81.6 Favored Pre-proline 0 C--N 1.299 -1.595 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.372 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.68 127.4 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.3 Cg_exo -55.18 132.99 55.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.241 1.127 . . . . 0.0 110.054 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.23 167.14 10.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.468 -0.77 . . . . 0.0 110.862 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.87 30.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.401 -0.812 . . . . 0.0 109.877 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 66' ' ' VAL . 17.9 m -76.13 113.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 109.667 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -50.99 -176.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.778 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.09 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.019 -1.051 . . . . 0.0 110.087 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -52.86 -32.51 45.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mt-10 -68.97 -49.01 61.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -67.62 -17.45 64.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 109.239 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.41 -41.29 61.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 3' ' ' PRO . 60.8 m -76.21 -23.39 54.62 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 53.8 mt -75.9 -34.84 59.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.573 -0.704 . . . . 0.0 109.181 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.781 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -73.49 -48.3 34.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.081 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.576 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -66.02 -27.01 67.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.066 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.526 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 36.4 t90 -67.15 -41.46 86.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.413 -0.804 . . . . 0.0 109.355 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 75' ' ' ALA . 16.2 mt -61.72 -50.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.381 -0.824 . . . . 0.0 109.521 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.6 mt -62.08 -25.35 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.759 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.2 Cg_exo . . . . . 0 C--O 1.211 -0.846 0 N-CA-C 110.608 -0.574 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.71 -39.41 66.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.194 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 96.0 t -65.41 -54.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.857 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 3' ' ' PRO . 2.2 pp -68.57 -24.16 64.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.349 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -70.13 -33.54 71.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -84.59 -37.64 20.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.16 -35.59 77.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.501 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.27 -10.49 56.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.045 -1.034 . . . . 0.0 110.589 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.44 58.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 20.4 m -62.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -1.234 . . . . 0.0 110.412 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mtp -85.51 10.68 12.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.893 . . . . 0.0 110.465 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.21 13.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 92.7 m -105.82 -21.57 13.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 110.711 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 14.8 m-70 -94.95 167.34 11.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 0.0 112.71 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.948 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -145.15 120.11 10.0 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG22 ' HE3' ' A' ' 28' ' ' LYS . 7.8 mt -39.98 -25.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.221 -0.925 . . . . 0.0 111.15 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.9 p30 -147.52 -39.59 0.19 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.792 -1.192 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.948 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -70.51 153.93 42.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.013 . . . . 0.0 110.428 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -98.37 97.64 8.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.359 -0.838 . . . . 0.0 109.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.573 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 16.6 mtm -97.13 -121.58 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 64.3 t -70.4 -32.59 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.768 -1.208 . . . . 0.0 109.819 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.99 173.24 15.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.632 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.48 131.61 26.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.627 1.33 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -47.01 153.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.873 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 16' ' ' HIS . 10.3 m-85 -66.81 -51.15 59.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HE3' HG22 ' A' ' 18' ' ' ILE . 10.8 mttt -53.93 -49.88 67.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.534 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.68 -43.36 68.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.99 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 26' ' ' ALA . 75.5 t -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.92 -28.52 62.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.61 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -0.973 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.14 -42.9 10.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -88.28 0.85 55.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.24 122.37 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.176 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.57 13.6 20.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.642 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.34 141.16 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -1.199 . . . . 0.0 110.214 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.37 52.89 2.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.76 48.03 0.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -73.83 -22.52 59.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -1.21 . . . . 0.0 110.092 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 3.3 pt-20 -71.3 -29.16 64.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -65.31 -53.06 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.674 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -70.09 -28.47 65.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 48' ' ' ILE . 19.7 mt -68.67 -26.24 65.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -73.14 -39.18 65.9 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.408 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -77.26 -23.13 51.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.542 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 19.5 mmt180 -90.13 -17.64 27.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.344 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 44' ' ' LEU . 26.8 mt -85.32 -31.02 6.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -86.98 -11.97 48.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 110.1 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 86.3 m-20 -121.04 -13.32 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 109.951 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 54.74 169.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 168.88 166.27 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.804 -1.41 . . . . 0.0 111.857 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -105.6 -173.9 2.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.777 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.567 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.0 9.92 54.93 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.712 HG12 ' CD1' ' A' ' 56' ' ' TRP . 39.8 t -89.82 -50.96 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.398 -1.06 . . . . 0.0 109.459 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.712 ' CD1' HG12 ' A' ' 55' ' ' VAL . 92.5 m95 -129.22 -36.11 1.75 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.41 -166.53 24.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.2 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.411 1.408 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 mt -109.67 83.14 2.55 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.844 -1.16 . . . . 0.0 110.567 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.64 160.5 17.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.716 1.377 . . . . 0.0 111.1 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.568 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 54.0 ttp -96.91 131.21 28.28 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.501 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.431 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -67.59 132.33 26.78 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.653 1.344 . . . . 0.0 109.033 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.9 139.9 92.85 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.267 1.14 . . . . 0.0 110.344 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 10.9 m-80 -114.8 165.68 12.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 0.0 110.793 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.46 38.31 0.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.034 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 66' ' ' VAL . 27.3 m -71.31 116.41 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.312 -0.867 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.451 ' N ' ' HB2' ' A' ' 70' ' ' GLU . 29.1 m -51.62 178.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -59.15 5.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 109.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.6 -13.5 9.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mm-40 -82.29 -46.0 14.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.219 -0.926 . . . . 0.0 110.201 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.28 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.026 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -44.32 39.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.492 -0.755 . . . . 0.0 109.059 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 3' ' ' PRO . 35.5 m -74.44 -22.1 59.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 70' ' ' GLU . 30.2 mt -75.5 -39.46 58.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.662 -0.649 . . . . 0.0 109.393 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -72.06 -43.54 64.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.017 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 46.5 mttt -65.82 -30.83 71.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.216 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.568 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 33.4 t90 -66.55 -44.38 82.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.634 -0.666 . . . . 0.0 109.918 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.613 HG23 ' CD1' ' A' ' 27' ' ' TYR . 73.4 mt -61.43 -47.02 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.643 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.1 -12.73 60.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -0.824 . . . . 0.0 109.76 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.091 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.562 ' HA ' HD12 ' A' ' 6' ' ' LEU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.296 -0.694 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.84 -43.33 65.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 99.0 t -54.53 -37.82 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.298 -0.876 . . . . 0.0 109.432 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 3' ' ' PRO . 71.3 mt -65.0 -36.82 85.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.796 . . . . 0.0 109.759 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -69.01 -23.25 64.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.2 -34.5 17.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.342 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.156 -0.965 . . . . 0.0 110.576 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.798 ' HG2' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -89.87 -13.33 36.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.599 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.86 17.93 52.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 35.4 m -63.38 -22.37 66.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -1.083 . . . . 0.0 110.715 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.6 mtp -90.82 8.79 33.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.822 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.37 -51.41 6.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.566 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 72.5 m -93.7 -16.29 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 110.94 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 15.1 m-70 -104.68 160.41 14.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.126 . . . . 0.0 112.289 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.012 ' HB2' ' SD ' ' A' ' 22' ' ' MET . . . -142.47 126.8 17.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.3 mp -38.72 -26.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.421 -0.799 . . . . 0.0 111.243 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.541 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 60.8 m-20 -152.19 -37.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.987 -1.071 . . . . 0.0 110.75 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.79 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -69.22 165.74 19.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -113.9 95.6 5.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.07 -1.019 . . . . 0.0 110.863 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 1.012 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -85.05 -88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.688 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 71.8 t -104.46 -27.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 109.566 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.27 177.23 16.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -67.69 137.04 40.95 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.677 1.357 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.932 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -44.9 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.795 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.0 m-85 -78.39 -46.69 19.32 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -56.86 -54.32 47.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -50.67 -36.61 36.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.257 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 26' ' ' ALA . 94.7 t -61.5 -44.34 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.131 -0.981 . . . . 0.0 110.446 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . . . -72.71 -23.81 60.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.403 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.79 -23.38 52.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -90.06 -42.27 11.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.48 3.82 38.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.039 -1.038 . . . . 0.0 110.09 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.34 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.49 -39.01 0.86 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 mm-40 -49.21 138.74 12.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.106 -1.232 . . . . 0.0 110.354 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 50.49 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.392 -0.818 . . . . 0.0 110.121 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.69 42.46 0.05 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -75.99 -18.78 59.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.269 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.654 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -75.06 -37.0 61.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.489 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -66.45 -52.03 50.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -65.91 -32.26 73.66 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 108.78 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.641 ' O ' HD12 ' A' ' 48' ' ' ILE . 12.6 mt -64.57 -30.69 71.71 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -69.65 -34.47 74.05 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.655 -0.653 . . . . 0.0 109.581 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.8 -44.32 64.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.342 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.76 -20.33 60.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.641 HD12 ' O ' ' A' ' 44' ' ' LEU . 47.5 mt -80.61 -31.53 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -88.41 -20.28 25.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' GLY . 20.2 t30 -113.73 -5.8 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 57.64 162.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.2 t 177.51 161.4 0.5 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.614 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.26 -175.07 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.836 -0.54 . . . . 0.0 109.951 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 69.09 16.58 70.95 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.818 HG12 ' CD1' ' A' ' 56' ' ' TRP . 89.4 t -97.96 -60.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.569 -0.96 . . . . 0.0 109.731 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.818 ' CD1' HG12 ' A' ' 55' ' ' VAL . 98.3 m95 -118.43 -39.8 2.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.48 -0.763 . . . . 0.0 109.46 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.73 -166.32 21.32 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.91 12.54 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.31 1.34 . . . . 0.0 111.902 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.61 78.54 1.19 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.612 -1.305 . . . . 0.0 110.431 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.1 140.33 94.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.518 1.272 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.557 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 7.6 ttp -72.89 135.45 80.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.489 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.8 Cg_endo -69.36 135.11 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.798 1.42 . . . . 0.0 108.725 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.05 148.36 85.77 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.289 1.152 . . . . 0.0 110.392 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.467 ' HB2' HG13 ' A' ' 66' ' ' VAL . 1.7 m-80 -127.76 173.79 9.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.487 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.11 35.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.798 HG12 ' HG2' ' A' ' 10' ' ' LYS . 25.9 m -73.5 103.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.801 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -43.16 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.63 -68.08 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 0.0 110.13 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -21.0 1.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.305 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' CG ' ' NZ ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -73.86 -47.2 39.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -71.14 -16.51 62.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.167 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -41.92 50.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -76.11 -27.6 57.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.663 HD11 ' HE3' ' A' ' 10' ' ' LYS . 24.1 mt -71.87 -34.17 69.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -70.37 -49.81 45.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.795 . . . . 0.0 109.397 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.2 OUTLIER -67.19 -24.71 65.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.896 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.54 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 54.3 t90 -71.27 -33.33 69.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 109.328 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' A' ' 75' ' ' ALA . 15.4 mt -69.88 -48.42 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.612 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.733 HD12 ' O ' ' A' ' 75' ' ' ALA . 2.6 mp -72.39 -17.05 61.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.87 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 3.1 m . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.213 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HA ' HD11 ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 C--O 1.212 -0.781 0 N-CA-C 110.141 -0.753 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' C ' ' OE1' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -69.33 -31.37 69.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.316 -0.865 . . . . 0.0 108.743 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.8 t -70.76 -59.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.177 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.673 HD11 ' HA ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -62.08 -21.49 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 109.536 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -76.0 -29.33 58.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.364 -0.835 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 -27.82 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.807 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.2 m120 -72.34 -38.7 68.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.817 . . . . 0.0 110.33 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -83.09 -4.69 58.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.029 . . . . 0.0 110.193 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.52 18.01 65.02 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 m -63.82 -38.21 90.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.304 . . . . 0.0 110.44 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.76 7.09 13.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.576 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.43 -36.62 17.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.922 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.9 m -106.01 -17.68 14.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.2 m-70 -99.61 171.08 8.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.033 -1.042 . . . . 0.0 111.769 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.863 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -146.6 119.03 8.42 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.1 mp -37.78 -33.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.492 -0.755 . . . . 0.0 111.149 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 1.2 p30 -156.58 8.36 0.2 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.889 -1.132 . . . . 0.0 111.744 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.863 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -103.75 -176.1 2.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.708 -1.245 . . . . 0.0 109.921 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 9.8 mmtp -121.22 104.71 9.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.14 -0.975 . . . . 0.0 110.65 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 21.7 mtp -118.26 -106.55 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.6 t -89.07 -39.61 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.85 -1.157 . . . . 0.0 109.666 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.83 168.82 12.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -66.27 135.29 39.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.605 1.318 . . . . 0.0 110.502 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.865 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.8 150.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -63.29 -59.91 4.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -0.938 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -47.59 -47.64 28.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.412 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 18.2 m-20 -57.33 -39.27 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 0.0 110.009 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 26' ' ' ALA . 73.3 t -57.08 -36.25 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -79.68 -29.62 40.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.461 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.37 -24.18 62.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.438 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -90.2 -42.89 10.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -90.43 9.18 30.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.83 140.89 40.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -12.0 67.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 3.8 mm-40 -54.06 147.25 13.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 110.353 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 49.15 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -0.841 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.82 53.24 0.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -73.47 -20.15 60.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -1.167 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.576 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 1.1 pt-20 -66.95 -23.25 65.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 0.0 109.966 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -72.92 -59.54 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.5 t80 -65.27 -25.7 67.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.927 . . . . 0.0 109.046 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 48' ' ' ILE . 16.5 mt -66.75 -34.86 78.78 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.86 67.47 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -74.26 -37.12 63.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.11 -0.994 . . . . 0.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.1 mmt180 -84.55 -14.91 47.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.973 -1.08 . . . . 0.0 109.644 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 44' ' ' LEU . 30.2 mt -85.98 -25.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.029 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.678 ' HG2' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.36 -19.36 33.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.42 -0.8 . . . . 0.0 110.447 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 4.8 m120 -127.99 -4.02 5.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.454 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.14 173.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.7 167.85 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.825 -1.397 . . . . 0.0 111.594 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -100.21 177.86 4.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 109.921 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.44 21.96 79.06 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 56' ' ' TRP . 10.5 t -95.17 -71.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.518 -0.989 . . . . 0.0 109.91 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.755 ' CD1' HG12 ' A' ' 55' ' ' VAL . 88.1 m95 -117.75 -34.88 4.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.053 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.45 -172.25 20.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.22 13.55 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.56 1.506 . . . . 0.0 112.231 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 59' ' ' ILE . 8.2 mt -110.63 93.35 16.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.615 -1.303 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.545 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -61.8 131.01 33.34 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.644 1.339 . . . . 0.0 110.811 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.545 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 5.4 tmm? -73.73 132.2 81.01 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -64.37 139.0 63.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.706 1.371 . . . . 0.0 108.702 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.5 Cg_endo -60.27 142.97 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.274 1.144 . . . . 0.0 110.274 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 2.8 m-80 -113.22 161.06 17.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.957 . . . . 0.0 110.529 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.49 34.1 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' HG2' ' A' ' 49' ' ' LYS . 28.6 m -80.87 114.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.768 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.0 m -50.52 -177.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.033 . . . . 0.0 109.597 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.1 -59.07 3.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.993 -1.067 . . . . 0.0 109.967 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -33.4 50.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.2 mm-40 -67.47 -50.14 60.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.839 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -64.23 -21.68 66.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -45.31 61.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.395 -0.816 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 3' ' ' PRO . 57.6 m -72.59 -22.13 61.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 71' ' ' ALA . 62.0 mt -73.0 -36.86 67.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.543 -0.723 . . . . 0.0 109.253 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -70.64 -50.72 33.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.7 OUTLIER -61.51 -24.16 66.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.838 . . . . 0.0 109.021 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.509 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 38.6 t90 -74.55 -41.19 61.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.496 -0.753 . . . . 0.0 109.863 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.622 HG21 HG11 ' A' ' 30' ' ' VAL . 37.3 mt -60.51 -42.36 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.591 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.767 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -75.05 -13.53 60.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.511 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 110.473 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HB3' HG22 ' A' ' 73' ' ' THR . 2.8 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 110.302 -0.692 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -68.95 -38.33 79.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.206 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.438 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 50.8 t -62.65 -50.19 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.711 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.75 HD11 HD21 ' A' ' 74' ' ' LEU . 1.3 pp -72.08 -20.92 61.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.457 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -65.05 -37.51 87.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.782 . . . . 0.0 109.605 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -83.71 -38.06 21.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.823 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.482 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -60.21 -35.34 75.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.442 -0.786 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 46.3 mmtm -87.01 -14.05 42.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.59 10.29 56.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 19.5 m -62.62 -39.03 92.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.261 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 3.32 22.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 111.019 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.88 -43.51 14.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.032 . . . . 0.0 110.423 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 39.9 m -98.04 -23.09 15.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.555 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 30.1 m-70 -103.84 -175.18 2.73 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.362 1.077 . . . . 0.0 112.419 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.607 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -162.11 -171.6 2.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 23.7 mm -86.41 -69.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.669 -1.27 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -110.08 -19.56 13.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.802 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.1 p -72.11 -169.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 5.3 pttt -150.51 87.46 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 mtm -79.88 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.92 . . . . 0.0 109.885 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 11.4 t -83.52 -29.61 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.0 171.48 14.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -65.33 144.05 78.99 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.488 1.257 . . . . 0.0 110.077 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.83 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.58 162.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.6 m-85 -77.29 -60.62 2.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.97 -37.77 46.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.599 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.7 m-20 -61.91 -46.29 90.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.802 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 26' ' ' ALA . 68.7 t -52.17 -37.28 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.81 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.669 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . -85.08 -21.07 29.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 110.299 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.8 -26.25 60.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -87.21 -48.02 8.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.913 . . . . 0.0 110.092 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ALA . 13.9 m-85 -77.1 -13.11 60.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.02 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -43.15 109.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.74 34.3 0.7 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 2.5 mt-30 -125.93 144.37 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -1.22 . . . . 0.0 110.304 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.39 47.6 1.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.859 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.78 40.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.013 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -80.72 -31.39 36.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -1.133 . . . . 0.0 109.874 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -67.98 -22.93 64.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.457 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.47 -53.15 20.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.536 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.9 t80 -68.7 -24.87 64.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 48' ' ' ILE . 8.9 mt -69.69 -32.52 71.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.56 68.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.94 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.24 -37.31 63.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.036 -1.04 . . . . 0.0 110.287 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.3 mmt-85 -78.18 -18.41 55.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.912 . . . . 0.0 109.569 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 44' ' ' LEU . 30.7 mt -80.34 -36.04 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.702 . . . . 0.0 109.857 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -78.13 -31.08 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 110.431 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.8 m-80 -109.28 -4.46 16.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.561 ' HA2' ' HE3' ' A' ' 61' ' ' MET . . . 57.76 166.38 0.1 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 174.52 164.33 0.23 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.599 -1.53 . . . . 0.0 112.386 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -108.37 -171.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.626 -0.671 . . . . 0.0 109.848 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 20.58 76.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.005 HG12 ' CD1' ' A' ' 56' ' ' TRP . 78.7 t -102.81 -70.75 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.583 -0.951 . . . . 0.0 109.58 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 1.005 ' CD1' HG12 ' A' ' 55' ' ' VAL . 99.0 m95 -110.67 -41.07 4.39 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.5 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.23 -167.37 19.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.63 11.41 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.437 1.425 . . . . 0.0 111.895 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 mt -107.71 77.45 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.601 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.8 Cg_exo -56.38 139.05 86.03 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.535 1.281 . . . . 0.0 110.841 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.561 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 12.3 ttp -71.29 133.03 85.6 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.511 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -67.64 134.62 33.33 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.681 1.358 . . . . 0.0 108.992 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_endo -59.32 136.04 69.47 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.269 1.141 . . . . 0.0 110.53 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-80 -113.75 170.47 8.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.474 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.83 34.95 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 66' ' ' VAL . 16.0 m -78.15 114.42 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.12 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.7 t -50.84 -176.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -71.1 -42.11 69.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 110.324 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.05 -35.36 80.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.938 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mt-10 -72.97 -40.79 65.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.74 -21.63 60.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -77.81 -43.35 30.81 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.261 -0.899 . . . . 0.0 108.577 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 3' ' ' PRO . 19.8 m -72.87 -24.5 60.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.75 HD21 HD11 ' A' ' 6' ' ' LEU . 23.6 mt -72.58 -46.17 55.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -64.19 -42.93 96.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.371 -0.83 . . . . 0.0 109.183 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.0 OUTLIER -69.56 -26.48 64.51 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 109.044 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 30.6 t90 -68.99 -43.08 75.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.298 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 75' ' ' ALA . 6.0 mt -62.07 -43.57 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.021 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.669 HD23 ' HB1' ' A' ' 31' ' ' ALA . 2.0 mt -75.48 -14.12 60.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.351 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 47.9 t . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.467 -0.771 . . . . 0.0 110.11 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.0 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 110.393 -0.657 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.96 -32.95 65.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.372 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.69 -51.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 6' ' ' LEU . 2.5 pp -66.37 -31.28 71.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.398 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -56.45 -46.72 80.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -68.32 -37.53 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 0.0 109.736 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.88 -22.94 65.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.797 . . . . 0.0 110.229 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 45.5 mmtm -95.5 -25.17 16.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.812 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.57 13.12 28.9 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 24.6 m -64.69 -39.74 94.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.244 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 2.55 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.09 -48.27 16.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 97.0 m -100.31 -27.02 13.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.453 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.7 m-70 -97.62 168.32 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.211 1.005 . . . . 0.0 112.35 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -151.61 -166.79 2.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 27.6 mm -90.44 -75.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.781 -1.199 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.14 -1.44 13.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.501 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 4.9 p -81.28 -168.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.958 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.44 108.84 7.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.6 mtm -117.65 -119.52 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.046 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 42.7 t -77.75 -35.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.845 -1.159 . . . . 0.0 109.807 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.8 168.89 12.76 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.76 139.65 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.726 1.382 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -43.21 154.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.396 -0.815 . . . . 0.0 109.752 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.624 ' CE1' HG12 ' A' ' 78' ' ' ILE . 1.4 m-85 -70.51 -58.01 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -47.25 33.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 22.4 m-20 -52.0 -45.56 64.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.413 -0.804 . . . . 0.0 109.929 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 26' ' ' ALA . 81.3 t -55.45 -37.96 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.818 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -76.33 -25.48 54.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.38 -29.86 65.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -85.41 -42.12 14.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -90.63 7.09 41.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -61.03 118.28 6.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.384 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.38 -8.17 26.58 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.536 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -66.17 147.03 53.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -1.174 . . . . 0.0 110.098 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.22 56.17 3.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.02 46.63 0.3 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -72.38 -16.03 61.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HA ' HD12 ' A' ' 44' ' ' LEU . 2.7 mt-10 -70.17 -37.76 75.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.808 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -51.46 69.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 t80 -67.42 -31.82 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 108.953 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 41' ' ' GLU . 24.0 mt -64.75 -25.17 67.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.4 -35.06 41.27 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.706 -0.621 . . . . 0.0 109.929 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -77.57 -24.52 49.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.587 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 11.8 mmp_? -89.46 -21.8 22.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.541 HG22 HG21 ' A' ' 66' ' ' VAL . 48.1 mt -84.6 -26.67 6.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.62 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -90.1 -8.06 52.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.397 -0.814 . . . . 0.0 110.484 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -133.14 -7.49 3.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.062 -1.023 . . . . 0.0 111.202 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 69.06 162.17 2.75 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -174.36 150.11 1.43 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.585 -1.538 . . . . 0.0 112.855 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.68 -173.71 2.3 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.694 -0.629 . . . . 0.0 109.558 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.25 16.29 53.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.961 HG12 ' CD1' ' A' ' 56' ' ' TRP . 98.0 t -93.13 -71.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.637 -0.919 . . . . 0.0 109.225 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.961 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.8 m95 -109.86 -39.57 5.04 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.718 0.771 . . . . 0.0 109.012 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.58 -178.03 28.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.91 8.09 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.498 1.466 . . . . 0.0 112.091 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.12 80.04 0.78 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.674 -1.266 . . . . 0.0 109.651 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.0 Cg_endo -55.37 148.9 49.13 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.854 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.584 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 7.9 ttp -76.79 131.97 72.57 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.057 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -65.9 134.57 37.83 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.617 1.325 . . . . 0.0 109.122 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.3 132.42 48.8 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.289 1.152 . . . . 0.0 110.075 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-80 -107.88 160.35 15.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 110.522 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.13 32.8 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.791 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 66' ' ' VAL . 22.9 m -72.35 114.62 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 110.212 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' VAL . 33.6 m -47.74 174.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.53 -64.62 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.808 -1.183 . . . . 0.0 110.186 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -22.22 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 11.4 mm-40 -72.42 -52.54 15.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -67.21 -18.76 65.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.948 . . . . 0.0 108.785 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.93 -47.63 43.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 3' ' ' PRO . 3.9 m -68.0 -24.49 65.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.063 ' O ' HD12 ' A' ' 78' ' ' ILE . 75.6 mt -73.19 -33.6 65.49 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.76 -51.46 40.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.61 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -60.98 -32.07 71.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 109.108 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -64.71 -48.08 75.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.716 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.063 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.6 mt -60.34 -56.35 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.448 -0.782 . . . . 0.0 110.028 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 31' ' ' ALA . 1.5 mt -66.82 -11.74 56.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 39.9 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 110.413 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.795 0 N-CA-C 110.462 -0.63 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -48.65 -45.97 39.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 109.542 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 37.9 t -51.06 -47.12 31.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.9 . . . . 0.0 109.078 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 71.0 mt -56.06 -50.52 70.75 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.586 0.707 . . . . 0.0 109.801 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -51.94 -26.27 10.06 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.582 -0.698 . . . . 0.0 110.251 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -56.69 3.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 110.994 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 15.1 m-80 -64.44 -11.3 32.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.911 -1.118 . . . . 0.0 110.467 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.527 ' HD2' HG12 ' A' ' 66' ' ' VAL . 71.2 mmtt -101.42 -15.01 17.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 110.03 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.05 12.11 71.7 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 29.4 m -63.23 -40.46 97.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.245 . . . . 0.0 110.347 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.434 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -74.44 2.47 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.14 -50.55 12.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -99.64 -14.26 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 110.785 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 19.6 m-70 -105.34 174.13 6.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.076 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -149.87 -179.47 7.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.3 mp -90.66 -24.83 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.869 -1.144 . . . . 0.0 110.414 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 12.5 p-10 -157.77 -27.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 0.0 111.463 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 81.0 p -68.86 -173.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.772 -1.205 . . . . 0.0 110.115 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 104.64 8.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 111.011 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.431 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -107.88 -132.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.83 . . . . 0.0 109.112 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.4 -48.17 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.864 -1.147 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.03 167.79 21.89 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.579 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -67.0 143.32 65.4 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.572 1.301 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.723 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -44.97 170.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.731 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.5 m-85 -86.93 -54.6 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.953 -1.092 . . . . 0.0 110.04 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 1.1 tmmm? -50.54 -49.74 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.928 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -54.64 -42.81 71.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.073 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 26' ' ' ALA . 53.5 t -56.07 -38.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.63 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -76.5 -26.58 55.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.39 -29.11 65.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.2 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -84.64 -47.77 10.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 109.984 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -77.28 -3.71 41.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -52.27 121.91 7.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.934 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.24 -37.45 2.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.9 mm100 -63.17 126.28 26.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -1.082 . . . . 0.0 110.06 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.2 46.05 1.29 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.57 40.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -79.92 -12.74 59.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 109.908 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.538 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -75.11 -22.45 58.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -71.62 -51.52 22.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.664 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.556 ' CE1' ' NE ' ' A' ' 47' ' ' ARG . 45.5 t80 -69.64 -33.4 72.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.605 ' O ' HD12 ' A' ' 48' ' ' ILE . 22.6 mt -61.38 -30.12 70.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.22 -38.85 60.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -19.44 60.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.051 -1.031 . . . . 0.0 109.845 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' NE ' ' CE1' ' A' ' 43' ' ' TYR . 6.5 mmt180 -90.17 -24.15 21.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.605 HD12 ' O ' ' A' ' 44' ' ' LEU . 62.6 mt -86.71 -19.75 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.331 -0.856 . . . . 0.0 109.318 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -22.99 24.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 110.516 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 57.6 m-80 -126.21 -6.71 6.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 110.407 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.16 173.98 0.03 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 2.8 t 162.11 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.413 -1.051 . . . . 0.0 111.172 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.2 pm0 -100.16 -165.26 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 64.14 18.72 62.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 56' ' ' TRP . 2.4 t -95.5 -67.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.739 -0.859 . . . . 0.0 109.099 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.579 ' CB ' ' HG3' ' A' ' 25' ' ' PRO . 95.5 m95 -124.1 -36.38 2.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.65 -177.44 20.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.514 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -69.46 8.25 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.457 1.438 . . . . 0.0 112.038 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -105.86 100.78 29.58 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.715 -1.241 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.553 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.4 Cg_endo -64.63 133.41 36.68 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.457 1.24 . . . . 0.0 110.602 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.54 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -71.87 135.6 83.0 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.0 Cg_endo -64.21 130.46 27.17 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.735 1.387 . . . . 0.0 109.456 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.23 135.79 64.29 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.401 1.211 . . . . 0.0 110.61 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -109.05 163.83 12.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.67 36.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.969 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' VAL . 15.5 m -84.38 105.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.056 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 75.1 p -42.58 147.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.224 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 72' ' ' GLN . 8.0 p-10 -42.57 -31.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.45 -47.96 68.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.109 -0.994 . . . . 0.0 109.564 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.496 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 52.7 mt-10 -63.62 -48.05 78.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 110.161 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -67.27 -16.64 64.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 109.142 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.33 -45.62 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -27.74 63.39 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 71' ' ' ALA . 49.6 mt -69.77 -34.96 74.48 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -67.46 -54.65 18.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' SER . 6.2 mttp -58.43 -25.12 61.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 108.871 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' LEU . 35.9 t90 -70.51 -43.11 70.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.61 -0.681 . . . . 0.0 109.515 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' A' ' 27' ' ' TYR . 4.9 mt -59.38 -50.91 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.739 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -73.72 -9.97 59.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 36.7 t . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 110.326 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.763 0 N-CA-C 110.268 -0.705 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.28 -33.92 73.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 108.626 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 98.0 t -64.45 -58.02 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.643 -0.661 . . . . 0.0 109.718 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.7 pp -64.16 -24.42 67.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.536 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -67.72 -29.49 68.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -52.16 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.322 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 15.1 m-80 -63.27 -16.48 60.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.091 -1.006 . . . . 0.0 110.383 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.562 ' HE3' HG12 ' A' ' 66' ' ' VAL . 34.2 mmtt -87.97 -18.8 28.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.63 13.53 53.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.414 ' C ' ' HH ' ' A' ' 27' ' ' TYR . 57.4 m -69.72 -38.68 76.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -1.235 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mtp -82.36 6.0 18.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.782 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.52 -35.71 19.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 110.353 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 36.4 m -106.0 -22.95 12.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -0.819 . . . . 0.0 110.391 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 28.7 m-70 -103.35 153.84 20.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 111.415 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.891 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -129.89 123.93 31.96 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.525 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 35.7 mm -36.78 -29.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 111.014 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.606 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -153.45 -32.33 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.177 -0.952 . . . . 0.0 111.088 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.891 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.43 179.33 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.023 -1.048 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -117.69 120.42 37.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -0.872 . . . . 0.0 110.741 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 19.5 mtp -125.22 -108.08 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 25.3 t -86.32 -31.78 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 171.71 17.26 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -66.0 140.42 60.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.682 1.359 . . . . 0.0 110.383 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.032 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.44 149.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 110.233 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 3.0 m-85 -63.43 -60.19 3.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.207 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -49.19 48.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.635 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 12.8 m-20 -55.48 -40.07 71.21 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 110.027 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.032 HG23 ' O ' ' A' ' 26' ' ' ALA . 95.5 t -57.84 -38.39 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.003 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -75.92 -25.83 56.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 110.001 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -27.49 63.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 19.1 tttt -86.56 -43.75 12.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -82.82 -2.25 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 109.978 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.7 101.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.73 33.81 0.42 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.494 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -116.78 145.86 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.229 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.07 41.57 1.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.36 48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.94 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -76.92 -33.66 57.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -1.168 . . . . 0.0 110.1 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.642 ' HG2' ' HB3' ' A' ' 75' ' ' ALA . 3.0 tm-20 -64.29 -24.79 67.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.34 -51.6 23.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.617 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 1.3 t80 -71.32 -21.79 62.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.14 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.94 HD12 ' O ' ' A' ' 40' ' ' ALA . 3.5 mt -74.5 -26.67 60.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.24 46.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.636 -0.665 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.544 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -77.15 -34.66 56.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.617 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 75.5 mmt-85 -81.37 -22.11 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.476 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 19.3 mt -80.98 -30.05 11.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.39 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.35 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -118.63 0.25 11.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.364 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 58.01 158.76 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.511 ' CB ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -177.32 158.63 1.47 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.546 -1.561 . . . . 0.0 112.595 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.34 -172.57 2.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.62 -0.675 . . . . 0.0 109.688 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.4 19.07 75.81 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.749 HG12 ' CD1' ' A' ' 56' ' ' TRP . 27.7 t -99.16 -74.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.632 -0.922 . . . . 0.0 109.814 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.756 ' HZ2' HG13 ' A' ' 30' ' ' VAL . 97.5 m95 -106.91 -38.8 5.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.42 -165.74 18.82 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.05 13.44 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.383 1.389 . . . . 0.0 111.963 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -110.76 80.16 2.06 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.569 -1.332 . . . . 0.0 110.301 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -60.18 144.71 99.48 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.674 1.355 . . . . 0.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.592 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 5.9 ttp -73.93 134.55 77.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.661 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.469 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -69.77 139.26 39.75 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.668 1.352 . . . . 0.0 109.065 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 132.34 41.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.254 1.134 . . . . 0.0 110.133 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.4 m-80 -108.03 173.38 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.744 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.08 33.4 2.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.969 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.562 HG12 ' HE3' ' A' ' 10' ' ' LYS . 16.7 m -78.41 120.84 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 109.885 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 66' ' ' VAL . 6.2 m -49.68 -178.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.889 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.04 -58.2 4.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.694 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.86 -17.45 36.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.6 mm-40 -77.6 -50.23 12.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -66.42 -22.68 66.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.262 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -72.52 -44.61 61.97 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 3' ' ' PRO . 1.6 m -71.24 -24.05 62.11 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 71' ' ' ALA . 27.1 mt -68.39 -38.21 81.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.642 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . . . -69.79 -51.2 35.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.135 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 80' ' ' SER . 1.2 mttp -62.42 -23.34 66.8 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.309 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.536 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 33.9 t90 -73.64 -42.15 61.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.485 -0.759 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.569 HG12 ' CD1' ' A' ' 27' ' ' TYR . 96.7 mt -63.29 -56.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 31' ' ' ALA . 1.3 mp -65.78 -18.43 65.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.852 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 3.6 t . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 110.148 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.61 ' HA ' HD21 ' A' ' 6' ' ' LEU . 2.8 Cg_endo . . . . . 0 N--CA 1.481 0.773 0 N-CA-C 110.577 -0.586 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 5.7 tm-20 -68.35 -44.64 74.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.9 t -58.77 -50.13 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 110.087 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 7' ' ' ALA . 4.2 pp -70.85 -22.6 62.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.351 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.792 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -62.45 -38.95 91.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.571 -0.705 . . . . 0.0 109.392 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -41.14 34.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.504 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.9 m120 -62.95 -23.46 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 17.7 mmtt -91.14 -14.53 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.93 11.59 58.73 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 17.6 m -69.49 -38.58 77.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -1.202 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.35 6.78 9.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.25 -46.56 10.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.319 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 94.8 m -99.0 -16.56 18.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -0.811 . . . . 0.0 110.578 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.623 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.7 m-70 -110.07 178.63 4.34 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.387 1.089 . . . . 0.0 112.435 -177.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -155.29 -169.17 3.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 mm -90.8 -73.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.683 -1.261 . . . . 0.0 110.242 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -112.55 -10.14 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 110.004 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.73 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.3 p -77.4 -161.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 0.0 109.879 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 119.74 9.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.508 ' CE ' ' O ' ' A' ' 16' ' ' HIS . 15.4 mtm -121.58 -113.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.749 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 54.1 t -78.19 -32.78 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.801 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.78 175.33 16.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.539 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.63 142.12 69.41 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.617 1.325 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -42.6 157.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.936 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -73.41 -61.33 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.936 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' TYR . 5.8 tttt -46.29 -45.77 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 0.0 109.462 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -51.58 -45.56 63.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 109.811 179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' ALA . 88.6 t -55.03 -45.21 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -69.94 -21.25 63.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.768 . . . . 0.0 110.155 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.68 42.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 110.531 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -35.14 15.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.119 -0.988 . . . . 0.0 110.084 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' ALA . 16.6 m-85 -85.9 -9.24 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -42.73 111.2 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.94 40.28 2.16 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.785 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -102.81 152.22 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 110.335 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.02 42.12 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.98 46.45 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -66.19 -29.68 70.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -1.107 . . . . 0.0 110.532 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -68.66 -32.22 71.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.19 -52.86 16.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 13.3 t80 -70.38 -19.39 63.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.276 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 48' ' ' ILE . 10.8 mt -73.97 -33.82 64.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.75 69.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.735 -0.603 . . . . 0.0 109.5 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -43.75 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.51 -17.21 58.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.437 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 44' ' ' LEU . 13.3 mt -83.19 -24.75 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.442 ' HG3' HG23 ' A' ' 66' ' ' VAL . 3.0 mtpp -85.34 -29.15 24.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.293 -0.879 . . . . 0.0 110.396 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 36.6 p30 -114.46 -5.15 12.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.634 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 59.05 172.1 0.42 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.62 163.5 0.12 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.705 -1.468 . . . . 0.0 112.422 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.581 ' CB ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -110.33 -178.91 3.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.433 -0.792 . . . . 0.0 109.876 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.565 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 74.51 20.22 79.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.947 HG12 ' CD1' ' A' ' 56' ' ' TRP . 71.3 t -103.91 -67.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.947 ' CD1' HG12 ' A' ' 55' ' ' VAL . 99.5 m95 -111.07 -40.13 4.56 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.338 -0.851 . . . . 0.0 110.114 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.54 -165.84 18.16 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.479 1.453 . . . . 0.0 111.619 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 mt -108.29 85.62 2.87 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.79 -1.194 . . . . 0.0 111.174 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.581 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.16 155.49 39.64 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.627 1.33 . . . . 0.0 110.275 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.554 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 49.9 ttp -87.92 134.85 34.44 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.7 Cg_endo -67.29 132.95 28.96 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.768 1.404 . . . . 0.0 109.172 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -59.04 136.09 70.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.269 1.142 . . . . 0.0 110.461 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.0 m-80 -112.03 163.25 14.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.401 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.8 36.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 66' ' ' VAL . 16.0 m -77.71 108.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.374 -0.828 . . . . 0.0 110.421 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -43.72 146.22 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 67' ' ' SER . 7.7 p-10 -41.15 -40.91 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.104 -0.997 . . . . 0.0 110.872 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.35 -45.22 94.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 72.9 mm-40 -64.09 -42.38 96.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -66.97 -22.17 65.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.008 . . . . 0.0 109.699 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -72.15 -41.21 67.36 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' TRP . 1.2 m -73.96 -24.49 59.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.915 ' O ' HD12 ' A' ' 78' ' ' ILE . 41.8 mt -72.42 -37.86 68.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.557 -0.714 . . . . 0.0 109.18 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -71.83 -49.51 37.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.127 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 80' ' ' SER . 2.8 mttt -63.78 -25.15 68.05 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.353 -0.842 . . . . 0.0 108.816 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.595 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 24.7 t90 -70.39 -51.9 26.31 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.541 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 74' ' ' LEU . 4.3 mt -54.68 -49.66 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.15 -17.36 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.973 . . . . 0.0 109.847 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 11.9 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.862 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.541 -0.6 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.89 -48.36 78.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.4 t -49.77 -34.26 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.511 HD12 ' CG2' ' A' ' 73' ' ' THR . 39.8 mt -71.45 -38.38 71.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -58.47 -27.14 64.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.676 . . . . 0.0 110.141 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -90.0 -46.9 8.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.932 . . . . 0.0 110.528 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.0 m120 -63.99 -16.75 62.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.243 -0.911 . . . . 0.0 111.052 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 54.4 mmtt -104.46 -25.38 12.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.056 . . . . 0.0 110.487 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.21 15.0 22.89 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 17.0 m -66.79 -35.05 79.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 0.0 110.2 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mmm -79.71 5.96 12.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.914 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.48 -37.21 15.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.109 -0.994 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -105.33 -16.59 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.624 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 22.0 m-70 -105.16 166.78 10.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.903 -1.123 . . . . 0.0 112.082 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -146.91 120.13 8.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 17.9 mt -37.36 -29.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.573 ' OD1' HG23 ' A' ' 20' ' ' THR . 2.3 p30 -151.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.077 -1.015 . . . . 0.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.923 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 19.8 p -70.0 163.11 26.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -104.25 129.08 52.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 0.0 110.635 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.455 ' HE3' ' O ' ' A' ' 16' ' ' HIS . 10.3 mtm -127.27 -88.75 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.44 -33.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.47 174.5 16.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.529 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -64.71 129.65 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.56 1.294 . . . . 0.0 110.305 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.874 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -38.91 149.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.448 -0.782 . . . . 0.0 110.073 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.787 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.4 m-85 -65.4 -58.98 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 110.52 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -48.27 -47.12 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.954 -1.091 . . . . 0.0 109.623 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.13 -40.47 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 26' ' ' ALA . 59.0 t -58.45 -39.9 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -77.34 -19.9 55.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.41 -28.71 46.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 0.0 110.057 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -40.34 12.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.85 -11.46 59.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.0 103.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 109.985 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.7 33.82 0.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.75 128.49 42.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -1.198 . . . . 0.0 110.157 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.22 56.17 3.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.52 44.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -74.41 -50.61 17.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 10.3 pt-20 -48.47 -35.62 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 110.527 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -56.85 -54.58 44.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 109.881 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.47 -38.11 88.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.932 . . . . 0.0 109.204 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -59.79 -27.45 66.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -73.51 -36.48 65.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.644 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -37.34 69.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.473 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 23.2 mmt180 -80.65 -16.49 53.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.664 HG22 HG21 ' A' ' 66' ' ' VAL . 49.9 mt -87.72 -23.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.709 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -19.95 30.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 76.8 m-20 -136.28 2.25 2.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.544 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 50.64 175.33 0.02 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER 169.14 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.761 -1.435 . . . . 0.0 111.802 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -109.25 -177.72 3.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.8 21.44 79.29 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.823 HG12 ' CD1' ' A' ' 56' ' ' TRP . 8.0 t -99.38 -68.34 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.68 -0.894 . . . . 0.0 109.646 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.823 ' CD1' HG12 ' A' ' 55' ' ' VAL . 86.3 m95 -118.55 -36.71 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.749 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.36 -171.82 23.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.555 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.32 9.73 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 112.115 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.3 mt -109.53 84.17 2.98 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.714 -1.241 . . . . 0.0 110.453 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.04 144.24 99.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.663 1.349 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.551 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.0 OUTLIER -77.18 134.88 66.86 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.6 Cg_endo -69.18 137.43 37.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 N-CA-C 108.395 -1.425 . . . . 0.0 108.395 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -56.89 156.51 23.36 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.224 1.118 . . . . 0.0 110.081 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 8.0 m-80 -128.62 164.38 22.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 111.059 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.66 34.9 0.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.512 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.664 HG21 HG22 ' A' ' 48' ' ' ILE . 10.6 m -86.89 109.62 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.513 -0.742 . . . . 0.0 110.441 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.474 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 2.1 m -47.06 173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -57.3 13.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.98 -19.29 41.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 66' ' ' VAL . 10.6 mt-10 -78.58 -45.74 21.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 110.427 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -70.7 -22.17 62.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.11 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -44.28 58.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.511 ' CG2' HD12 ' A' ' 6' ' ' LEU . 4.0 m -71.78 -25.2 61.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 71' ' ' ALA . 46.0 mt -77.33 -27.0 52.66 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -75.26 -52.58 10.53 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.549 -0.719 . . . . 0.0 109.215 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -59.75 -29.22 68.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 108.623 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.728 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 31.7 t90 -61.48 -53.34 57.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.61 -0.682 . . . . 0.0 109.507 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.787 HG23 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -60.29 -40.98 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.159 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -76.88 -9.81 58.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.598 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 41.7 m . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 0.0 110.644 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 110.28 -0.7 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.09 -32.14 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.861 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 48.8 t -71.51 -45.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.705 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -69.02 -31.4 70.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -59.68 -55.89 28.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -55.45 -42.59 74.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.1 m120 -59.9 -27.89 67.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 110.521 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 75.2 mmtt -93.32 -16.29 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 0.0 110.12 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.95 18.45 34.33 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 9.1 m -68.86 -42.34 77.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.54 5.11 16.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.45 -44.26 11.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 110.651 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 57.4 m -96.73 -19.84 18.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.593 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 26.5 m-70 -98.72 165.88 11.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.015 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.802 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -136.82 114.27 10.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.5 mp -37.16 -35.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.49 -0.756 . . . . 0.0 110.89 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.78 9.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 111.191 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.802 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -112.69 -160.54 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.074 . . . . 0.0 109.889 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.71 131.38 35.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.015 -1.053 . . . . 0.0 110.591 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 mtp -140.83 -99.57 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 5.9 t -93.86 -31.28 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.025 -1.047 . . . . 0.0 109.22 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.76 171.77 18.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_endo -65.92 136.57 45.57 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.6 1.316 . . . . 0.0 110.381 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -42.6 152.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.047 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.633 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.6 m-85 -67.37 -57.45 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 0.0 110.213 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.64 -50.13 60.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.855 -1.153 . . . . 0.0 109.638 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 3.8 m-20 -54.33 -44.14 71.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.357 -0.84 . . . . 0.0 109.992 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' ALA . 23.1 t -54.16 -33.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 110.019 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -80.46 -26.35 38.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.373 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.25 -29.37 63.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.1 -38.02 19.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.88 . . . . 0.0 109.749 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -88.15 -4.08 58.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.69 109.04 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.31 -23.76 2.84 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 1.5 mm-40 -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -1.146 . . . . 0.0 110.018 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.85 39.45 0.93 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 110.401 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.49 43.28 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -69.54 -15.0 63.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -1.176 . . . . 0.0 110.093 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.526 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.4 pt-20 -80.49 -34.24 35.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.081 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.794 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -65.04 -48.98 71.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.495 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -64.64 -46.0 84.38 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.647 ' O ' HD12 ' A' ' 48' ' ' ILE . 20.2 mt -55.97 -21.3 20.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -74.91 -43.11 56.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.945 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 43' ' ' TYR . 1.9 pt20 -75.6 -20.53 58.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' CE ' ' A' ' 61' ' ' MET . 8.7 mmt85 -90.54 -16.92 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.311 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.647 HD12 ' O ' ' A' ' 44' ' ' LEU . 25.6 mt -85.91 -32.14 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.17 37.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.5 m120 -116.68 -11.45 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 60.84 161.19 0.11 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.3 t -179.24 163.33 1.27 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.636 -1.508 . . . . 0.0 112.621 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -104.68 -178.0 3.53 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.49 20.41 78.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.918 HG12 ' CD1' ' A' ' 56' ' ' TRP . 44.2 t -96.88 -70.23 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.63 -0.923 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.918 ' CD1' HG12 ' A' ' 55' ' ' VAL . 98.9 m95 -114.68 -37.53 4.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.525 -0.734 . . . . 0.0 109.679 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.72 -169.45 20.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.21 11.41 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.566 1.511 . . . . 0.0 112.063 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 mt -109.59 86.04 4.23 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.651 -1.281 . . . . 0.0 110.586 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.3 Cg_exo -59.9 135.32 62.42 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.541 1.285 . . . . 0.0 111.013 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.565 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 52.5 ttp -71.75 130.8 86.58 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.458 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.08 138.52 47.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.648 1.341 . . . . 0.0 109.346 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.02 136.75 71.4 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.342 1.18 . . . . 0.0 110.054 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 3.2 m-80 -107.8 -174.65 2.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.02 . . . . 0.0 110.865 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.88 36.98 3.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.751 . . . . 0.0 110.018 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 66' ' ' VAL . 25.8 m -81.37 114.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.044 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB2' ' OE1' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -46.8 174.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.77 -41.11 97.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.994 -1.066 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.17 -23.25 62.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.56 ' HG2' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -81.1 -36.75 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB2' HG23 ' A' ' 66' ' ' VAL . . . -76.31 -27.9 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.037 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.1 mt-30 -74.1 -41.97 60.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.558 ' HA ' ' CG ' ' A' ' 76' ' ' LYS . 85.8 m -73.8 -24.02 59.76 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.539 ' O ' HD12 ' A' ' 78' ' ' ILE . 18.5 mt -74.51 -33.72 62.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.7 . . . . 0.0 109.124 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.53 -50.04 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.558 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -67.46 -23.26 65.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 178.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.512 ' HA ' ' OG ' ' A' ' 80' ' ' SER . 49.3 t90 -75.84 -36.74 59.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.606 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.633 HG23 ' CD1' ' A' ' 27' ' ' TYR . 17.3 mt -65.77 -46.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.805 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.686 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -74.12 -13.37 60.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 77' ' ' TRP . 89.2 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.456 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.662 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 2.7 Cg_endo . . . . . 0 N--CA 1.482 0.821 0 N-CA-C 110.629 -0.566 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 18.9 pt-20 -73.0 -33.64 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.527 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 43.5 t -72.72 -46.69 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.761 ' C ' HD12 ' A' ' 6' ' ' LEU . 4.0 pp -73.58 -22.74 59.96 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.209 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.8 -40.96 83.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.706 . . . . 0.0 109.28 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.76 71.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.818 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.9 m120 -63.08 -26.08 68.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.286 -0.884 . . . . 0.0 110.664 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 74.8 mmtt -92.96 -13.2 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 110.345 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.78 66.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 34.1 m -65.95 -15.09 62.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mtp -99.26 10.88 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.119 -0.988 . . . . 0.0 110.332 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.55 -49.73 6.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.494 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.4 m -97.35 -17.84 19.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.402 -0.811 . . . . 0.0 110.702 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.616 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 13.2 m-70 -102.87 174.08 6.03 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.138 -0.976 . . . . 0.0 112.169 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -156.29 -170.24 3.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.432 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 28.1 mm -90.36 -62.49 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.72 -1.238 . . . . 0.0 110.272 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 3.0 p30 -124.76 -3.18 7.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.925 -1.109 . . . . 0.0 110.613 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 69.4 p -83.6 162.44 20.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.91 91.76 3.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.1 -1.0 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 1.7 mtm -97.22 -132.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 109.696 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.64 -33.03 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.922 -1.111 . . . . 0.0 109.26 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.92 163.84 12.15 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -63.8 142.74 83.96 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.706 1.372 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.901 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -46.02 153.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.7 m-85 -71.33 -60.74 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.705 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.0 -45.08 31.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.602 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.691 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 13.8 m-20 -55.44 -45.05 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.731 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 26' ' ' ALA . 87.6 t -55.43 -33.81 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.144 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -75.93 -37.66 58.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 110.511 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.67 66.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.3 -0.875 . . . . 0.0 110.424 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -84.24 -41.06 17.31 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -0.882 . . . . 0.0 109.968 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 15.5 m-85 -88.59 -0.96 57.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.809 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -53.23 136.27 36.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.991 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.4 -35.24 5.19 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.2 mt-30 -54.02 129.04 32.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 50.63 2.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.72 55.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.03 -23.29 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.254 -1.145 . . . . 0.0 110.141 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.0 pt-20 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -68.98 -51.39 39.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.933 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 4.9 t80 -72.29 -27.9 62.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 108.962 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 48' ' ' ILE . 21.4 mt -68.18 -26.94 66.0 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.08 -36.36 55.83 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.21 -26.66 59.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.2 mmt-85 -89.26 -17.55 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 44' ' ' LEU . 37.1 mt -85.33 -26.61 6.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -85.84 -16.22 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.6 t30 -130.93 -1.62 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.095 -1.003 . . . . 0.0 110.584 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.58 ' HA2' ' HE3' ' A' ' 61' ' ' MET . . . 53.83 168.75 0.03 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.6 170.42 0.12 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.605 -1.526 . . . . 0.0 112.084 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -110.25 -175.63 2.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.01 23.92 77.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.851 HG12 ' CD1' ' A' ' 56' ' ' TRP . 34.1 t -105.89 -65.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.732 -0.864 . . . . 0.0 109.901 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.851 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.7 m95 -120.83 -37.59 2.97 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.29 -174.56 25.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.537 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.74 6.72 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.504 1.469 . . . . 0.0 111.793 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.3 mt -107.85 81.92 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.214 . . . . 0.0 110.301 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.6 Cg_exo -55.28 145.46 66.31 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.586 1.309 . . . . 0.0 111.295 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.58 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 40.9 ttp -79.17 133.9 60.11 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.603 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.6 Cg_endo -67.56 138.23 45.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.517 1.272 . . . . 0.0 108.99 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.26 140.11 93.08 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.372 1.196 . . . . 0.0 110.16 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.3 m-80 -113.01 170.93 7.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.797 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.53 48.86 0.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.416 -0.803 . . . . 0.0 109.84 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 71' ' ' ALA . 11.2 m -101.56 107.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 66' ' ' VAL . 1.8 m -42.07 148.41 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.847 . . . . 0.0 109.526 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' SER . 14.0 t0 -42.85 -37.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.993 -1.067 . . . . 0.0 110.734 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -64.93 -44.08 90.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.987 -1.071 . . . . 0.0 109.918 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 62.3 mt-10 -66.03 -46.64 77.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.355 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -69.61 -19.56 63.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 109.19 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.62 -44.32 57.34 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.8 m -70.53 -27.84 64.47 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.06 ' O ' HD12 ' A' ' 78' ' ' ILE . 47.3 mt -65.92 -43.28 88.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.584 -0.697 . . . . 0.0 109.249 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -62.79 -45.94 90.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 80' ' ' SER . 5.7 mttm -65.53 -23.88 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 30.9 t90 -72.32 -46.11 57.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.753 . . . . 0.0 109.831 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.06 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -59.59 -48.25 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.05 -22.68 61.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 109.846 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 12.4 m . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.2 Cg_exo . . . . . 0 N--CA 1.483 0.864 0 N-CA-C 110.829 -0.489 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -53.5 -45.9 69.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 66.0 t -55.52 -34.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -0.904 . . . . 0.0 109.374 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 3' ' ' PRO . 62.5 mt -72.19 -30.27 64.8 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.605 0.717 . . . . 0.0 109.548 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 12' ' ' CYS . . . -66.87 -30.77 71.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.408 -0.807 . . . . 0.0 110.261 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -87.01 -43.73 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 110.385 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.4 m120 -66.4 -29.06 69.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' HD2' HG12 ' A' ' 66' ' ' VAL . 73.2 mmtt -96.15 -12.33 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.132 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.27 15.78 63.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 18.6 m -64.15 -21.75 66.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.429 ' CG ' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -93.69 15.24 16.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.482 -179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.55 -31.68 10.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.937 . . . . 0.0 110.373 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -112.0 -16.94 12.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 110.798 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 34.8 m-70 -110.81 160.98 16.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.787 -1.195 . . . . 0.0 112.432 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.989 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -135.51 121.6 20.11 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 1.6 mp -38.65 -28.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 110.766 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -149.95 -32.1 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.205 -0.935 . . . . 0.0 111.11 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.989 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -68.9 -161.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.974 -1.079 . . . . 0.0 109.751 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 127.21 18.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.887 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -131.9 -100.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.93 -30.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.985 -1.072 . . . . 0.0 109.454 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.1 163.59 17.75 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' ALA . 3.0 Cg_exo -61.7 142.68 94.97 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.587 1.309 . . . . 0.0 110.584 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.955 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.24 147.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.726 ' CD1' HG23 ' A' ' 78' ' ' ILE . 2.7 m-85 -65.07 -61.48 2.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -47.3 -48.07 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.048 . . . . 0.0 109.336 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.4 m-20 -54.81 -40.89 69.99 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.892 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 26' ' ' ALA . 98.7 t -55.97 -44.82 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 110.156 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -67.92 -30.1 69.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.16 -25.02 62.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.393 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.83 -37.33 14.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -93.63 -0.27 56.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.145 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.09 106.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.428 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.54 76.86 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.591 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mt-30 -145.85 167.96 21.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.59 42.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.55 46.0 0.59 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -63.12 -29.04 70.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -1.171 . . . . 0.0 110.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.82 -34.86 69.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.184 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -65.51 -51.16 61.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.302 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -67.6 -26.11 66.1 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.117 -0.99 . . . . 0.0 108.867 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 48' ' ' ILE . 13.5 mt -68.3 -25.26 65.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -76.69 -40.28 49.33 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.648 -0.657 . . . . 0.0 109.559 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -76.34 -21.43 56.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.859 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 5.4 mmm180 -89.05 -19.78 25.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 44' ' ' LEU . 43.9 mt -84.98 -30.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.282 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 3.1 ttpm? -81.59 -25.94 35.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.584 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 m120 -119.41 -3.54 10.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 49.16 179.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.1 166.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.852 -1.381 . . . . 0.0 111.766 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -106.07 -175.82 2.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.394 -0.816 . . . . 0.0 109.792 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 19.88 76.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.85 HG12 ' CD1' ' A' ' 56' ' ' TRP . 17.2 t -96.87 -68.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.639 -0.918 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.85 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.3 m95 -117.57 -37.72 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.501 -0.75 . . . . 0.0 109.705 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.99 -172.24 21.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.547 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.73 8.04 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.438 1.426 . . . . 0.0 111.973 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.1 mt -109.06 89.59 6.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.651 -1.281 . . . . 0.0 110.411 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.95 145.4 98.42 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.551 1.29 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.541 ' HE1' ' HA ' ' A' ' 48' ' ' ILE . 2.7 tmm? -79.04 131.89 65.26 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.413 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -65.83 134.4 37.41 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.683 1.359 . . . . 0.0 108.973 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.43 135.16 65.99 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.208 1.11 . . . . 0.0 110.211 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-80 -106.65 161.9 14.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.9 43.66 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.087 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.61 HG21 HG22 ' A' ' 48' ' ' ILE . 16.7 m -96.64 114.76 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' VAL . 24.5 p -53.36 -171.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -76.84 -42.75 38.92 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.009 -1.057 . . . . 0.0 109.773 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -64.35 -36.76 85.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 0.0 109.304 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 51.6 mt-10 -69.08 -51.51 38.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.897 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -63.5 -18.13 63.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -47.98 49.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 3' ' ' PRO . 5.1 m -68.41 -24.13 64.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 71' ' ' ALA . 88.7 mt -74.1 -34.51 63.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.613 -0.679 . . . . 0.0 109.349 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.27 -41.64 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.2 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 80' ' ' SER . 4.7 mttt -70.72 -26.8 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.459 -0.776 . . . . 0.0 109.058 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.44 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 35.8 t90 -71.84 -42.27 67.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.912 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.726 HG23 ' CD1' ' A' ' 27' ' ' TYR . 11.5 mt -65.35 -48.57 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.638 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.31 -16.05 61.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.579 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.977 . . . . 0.0 110.574 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_exo . . . . . 0 N--CA 1.481 0.756 0 N-CA-C 110.355 -0.671 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.53 -40.61 73.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.6 t -60.28 -54.69 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.429 -0.794 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -63.29 -32.48 73.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.667 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.44 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -65.39 -22.42 66.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -82.35 -50.74 8.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.421 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 18.9 m-80 -63.86 -19.88 65.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.837 ' HE3' HG12 ' A' ' 66' ' ' VAL . 15.1 mmtt -85.04 -16.48 40.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.017 -1.052 . . . . 0.0 109.9 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.97 15.26 45.96 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 10' ' ' LYS . 9.1 m -71.13 -48.67 50.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -1.213 . . . . 0.0 110.632 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.0 mmm -72.49 3.31 5.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 0.0 110.98 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.14 22.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 0.0 110.425 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.7 m -111.74 -18.43 12.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.629 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.6 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 19.2 m-70 -99.14 165.64 11.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 112.043 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.654 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -141.6 117.48 10.49 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 22.5 mm -36.2 -29.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.542 -0.724 . . . . 0.0 111.035 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' ALA . 12.9 t70 -161.04 18.04 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.158 -0.964 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.664 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -112.01 -177.73 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 110.067 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -119.92 86.16 2.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 110.67 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 1.2 mtm -95.16 -112.93 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 109.686 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.7 t -88.39 -29.41 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.793 -1.192 . . . . 0.0 109.585 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.09 170.35 15.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -65.65 134.86 39.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.513 1.27 . . . . 0.0 110.326 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.938 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.47 146.77 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 5.5 m-85 -57.52 -52.99 63.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.977 -1.077 . . . . 0.0 110.209 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.14 -50.63 58.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.421 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -56.39 -34.32 66.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.192 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 26' ' ' ALA . 60.1 t -62.64 -36.87 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.107 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -78.02 -24.42 47.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.93 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.3 -33.19 69.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.466 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -84.01 -35.51 23.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -90.72 -3.99 57.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -53.83 128.6 30.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.75 71.86 1.27 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.672 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -145.64 144.1 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.82 46.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 110.627 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.8 42.45 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -70.22 -21.0 63.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -1.126 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.5 mp0 -74.04 -36.74 64.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.552 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -46.85 82.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.343 -0.848 . . . . 0.0 109.682 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.502 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 51.5 t80 -73.76 -27.54 61.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.265 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . 11.3 mt -71.52 -24.92 62.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 72' ' ' GLN . . . -79.83 -32.37 40.63 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -80.05 -24.32 40.79 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.44 -0.787 . . . . 0.0 109.182 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 34.5 mmt-85 -90.03 -17.02 28.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 109.088 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HA ' ' CE ' ' A' ' 61' ' ' MET . 25.2 mt -88.53 -29.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.722 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.585 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -120.09 -13.39 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.238 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.3 175.06 0.02 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.21 171.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.789 -1.418 . . . . 0.0 111.369 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.589 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.63 -171.93 1.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.486 -0.759 . . . . 0.0 109.995 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.585 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.22 12.63 61.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.81 HG12 ' CD1' ' A' ' 56' ' ' TRP . 24.9 t -93.97 -59.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.544 -0.974 . . . . 0.0 109.507 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.81 ' CD1' HG12 ' A' ' 55' ' ' VAL . 97.0 m95 -120.79 -38.92 2.78 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.578 0.704 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.94 -164.54 20.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.7 7.47 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.47 1.447 . . . . 0.0 111.718 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.4 mt -108.11 78.04 0.75 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.768 -1.207 . . . . 0.0 110.545 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -56.63 140.11 89.52 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 0.8 OUTLIER -74.97 131.01 79.71 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.844 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.7 Cg_endo -67.03 128.66 19.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.642 1.338 . . . . 0.0 109.607 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.65 135.89 70.32 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.379 1.2 . . . . 0.0 110.243 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.28 170.26 8.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.878 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.41 35.18 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.386 -0.821 . . . . 0.0 109.645 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.837 HG12 ' HE3' ' A' ' 10' ' ' LYS . 34.9 m -86.31 105.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 110.151 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -42.41 153.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.251 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' OD1' ' HD3' ' A' ' 49' ' ' LYS . 3.3 m-20 -44.49 -37.57 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.705 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -41.28 90.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.021 -1.049 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 4.8 mm-40 -69.19 -36.99 77.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.524 ' HB2' HG23 ' A' ' 66' ' ' VAL . . . -73.6 -20.28 60.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 5.1 tt0 -76.34 -48.79 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -66.48 -25.78 66.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.456 HD21 HD11 ' A' ' 6' ' ' LEU . 18.6 mt -71.14 -37.4 72.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.774 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -67.16 -53.07 33.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.519 -0.738 . . . . 0.0 109.434 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -63.67 -26.29 68.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.594 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 28.0 t90 -64.89 -36.47 84.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.774 HD12 ' HA ' ' A' ' 75' ' ' ALA . 12.1 mt -71.97 -46.49 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 109.625 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 75' ' ' ALA . 1.7 mp -68.65 -11.35 60.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.27 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -179.732 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.716 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.793 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.54 -35.53 70.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.122 -0.986 . . . . 0.0 108.965 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.8 t -64.91 -53.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.394 -0.816 . . . . 0.0 109.643 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.716 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -68.61 -24.08 64.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -68.13 -29.02 67.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -39.5 19.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.773 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -62.39 -27.75 69.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 110.677 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' HG2' HG12 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -88.51 -17.86 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.105 . . . . 0.0 110.413 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.22 13.29 39.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 m -66.26 -41.06 90.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -1.205 . . . . 0.0 110.317 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.5 5.93 16.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -0.88 . . . . 0.0 110.598 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.0 -26.51 16.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 110.569 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 m -112.45 -14.65 13.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 29.3 m-70 -111.88 158.33 19.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 111.824 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.866 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -129.58 121.36 26.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 16.5 mt -39.73 -26.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.434 -0.791 . . . . 0.0 110.774 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.62 -35.34 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.956 -1.09 . . . . 0.0 111.01 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.866 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.06 -164.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.977 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -135.62 92.85 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.649 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -91.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.681 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -100.64 -45.91 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.924 . . . . 0.0 109.674 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.84 178.55 21.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.87 137.68 50.1 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.69 1.363 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.008 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.07 151.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.662 ' HD1' HG23 ' A' ' 78' ' ' ILE . 3.3 m-85 -65.32 -59.4 4.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -53.52 -45.13 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.004 -1.06 . . . . 0.0 109.756 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.6 m-20 -57.71 -39.41 77.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 110.021 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 26' ' ' ALA . 72.2 t -57.98 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 110.116 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.06 -31.26 65.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 110.512 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.21 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 110.169 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -86.53 -48.86 8.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.492 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 8.5 m-85 -73.34 -5.44 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.55 109.94 0.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.16 -27.36 2.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 1.8 mt-30 -67.52 149.08 50.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -1.124 . . . . 0.0 110.178 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 52.61 2.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.47 50.17 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -71.08 -25.48 62.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 110.042 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 75' ' ' ALA . 1.3 tt0 -67.02 -37.91 84.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 109.65 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.35 56.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.514 ' OH ' ' NE ' ' A' ' 47' ' ' ARG . 6.4 t80 -66.24 -24.15 66.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 109.086 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.548 ' O ' HD12 ' A' ' 48' ' ' ILE . 13.9 mt -69.44 -30.31 68.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.12 67.42 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -77.07 -26.56 53.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.758 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' CE ' ' A' ' 61' ' ' MET . 4.0 mmt180 -89.77 -16.41 30.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.841 . . . . 0.0 109.242 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 44' ' ' LEU . 31.2 mt -86.79 -28.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.73 -10.54 53.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -125.48 -15.18 6.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 56.69 161.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER 171.72 167.91 0.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.534 -1.568 . . . . 0.0 112.039 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.588 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -103.75 -172.38 2.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.572 -0.705 . . . . 0.0 109.983 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.16 19.9 72.54 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG12 ' CD1' ' A' ' 56' ' ' TRP . 3.0 t -98.53 -68.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.794 -0.827 . . . . 0.0 109.631 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.642 ' CZ2' HG13 ' A' ' 30' ' ' VAL . 83.0 m95 -116.45 -36.54 3.96 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.39 -0.819 . . . . 0.0 109.497 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.07 -166.48 19.01 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -71.29 15.26 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.405 1.403 . . . . 0.0 112.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 59' ' ' ILE . 5.4 mt -111.48 84.65 5.15 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 110.41 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.5 Cg_exo -60.81 134.69 55.22 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.648 1.341 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.566 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 52.5 ttp -75.37 133.72 74.24 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.335 -0.853 . . . . 0.0 110.166 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.6 Cg_endo -69.69 134.2 27.57 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.521 1.274 . . . . 0.0 109.146 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.2 Cg_exo -58.17 142.65 97.31 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.202 1.107 . . . . 0.0 110.234 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -112.83 -174.8 2.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.902 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.31 34.17 5.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.731 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 7.8 m -74.28 118.74 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.768 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.468 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -43.45 159.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 108.996 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -53.24 -50.22 65.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.878 -1.139 . . . . 0.0 110.442 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -21.87 66.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.482 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mm-40 -76.36 -40.13 52.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.917 . . . . 0.0 110.321 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB2' ' CG2' ' A' ' 66' ' ' VAL . . . -71.75 -26.1 62.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -68.85 -44.17 73.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -71.67 -24.42 61.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 71' ' ' ALA . 38.5 mt -73.46 -33.13 64.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.281 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -73.73 -50.73 19.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.139 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -26.94 68.63 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.36 -0.837 . . . . 0.0 109.044 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 40.6 t90 -68.72 -44.15 74.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 75' ' ' ALA . 20.8 mt -56.99 -51.86 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.862 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -67.43 -21.74 65.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 77' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.719 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.664 -0.552 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 5' ' ' VAL . 12.7 pt-20 -68.23 -37.11 80.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.13 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 4' ' ' GLU . 59.9 t -64.97 -55.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.506 -0.746 . . . . 0.0 109.96 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.719 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.0 pp -66.8 -21.89 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.599 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -62.54 -47.89 81.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.504 -0.747 . . . . 0.0 109.526 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -40.87 80.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.835 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.7 m120 -65.52 -19.85 66.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.812 . . . . 0.0 110.645 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' HE2' ' OE1' ' A' ' 70' ' ' GLU . 50.9 mmtt -96.93 -19.69 18.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.058 -1.026 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.63 11.74 54.83 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 16' ' ' HIS . 37.6 m -67.2 -29.71 69.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.014 -1.286 . . . . 0.0 110.141 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mtp -84.8 7.77 19.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.24 -49.49 10.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 110.391 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.6 m -102.9 -19.45 14.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 110.979 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.61 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.5 m-70 -101.61 173.71 6.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.837 -1.164 . . . . 0.0 112.069 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -153.84 -168.19 2.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 19.2 mm -90.27 -73.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.677 -1.264 . . . . 0.0 110.373 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB3' ' HG2' ' A' ' 28' ' ' LYS . 17.2 p30 -116.03 -1.2 12.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 110.572 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.451 HG23 ' OD1' ' A' ' 19' ' ' ASP . 49.8 p -87.1 161.41 18.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 110.196 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -105.96 85.85 2.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 110.651 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.415 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 1.5 mtm -88.54 -125.34 0.05 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 0.0 109.84 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 t -69.87 -39.46 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.757 -1.215 . . . . 0.0 109.649 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 173.35 14.91 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.504 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.06 136.88 50.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.719 1.379 . . . . 0.0 110.554 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.742 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . . . -42.81 154.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.661 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.4 m-85 -70.11 -62.85 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.975 . . . . 0.0 109.836 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -47.48 -33.01 5.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.077 . . . . 0.0 109.392 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.742 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 7.2 m-20 -62.68 -46.65 87.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 109.59 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.593 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 49.9 t -57.43 -32.33 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -80.79 -24.37 38.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.467 -0.771 . . . . 0.0 110.082 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.36 62.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -40.22 12.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 110.098 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.47 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 23.3 m-85 -82.7 -7.04 59.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -47.15 134.74 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.21 5.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.482 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -122.58 138.38 54.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 110.083 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 51.31 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.686 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.07 41.78 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.482 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -79.69 -23.29 42.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.226 . . . . 0.0 110.018 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.36 -36.47 68.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.09 66.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.667 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.75 -28.07 66.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 48' ' ' ILE . 11.5 mt -68.67 -25.08 64.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.38 40.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.49 -0.756 . . . . 0.0 109.559 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -77.71 -28.03 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.866 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' O ' ' HE3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -86.48 -20.24 28.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.366 -0.834 . . . . 0.0 109.25 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 44' ' ' LEU . 33.9 mt -84.79 -29.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.544 -0.722 . . . . 0.0 110.133 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HG3' HG23 ' A' ' 66' ' ' VAL . 13.3 mtpt -86.71 -17.16 34.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.062 -1.024 . . . . 0.0 110.133 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.1 t-20 -119.0 -13.59 9.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 50.33 174.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 166.47 165.03 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.869 -1.371 . . . . 0.0 111.976 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -99.56 179.59 4.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.611 -0.681 . . . . 0.0 109.544 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.82 16.15 74.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -91.95 -64.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.566 -0.961 . . . . 0.0 109.373 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.593 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.6 m95 -118.89 -36.66 3.38 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.609 0.719 . . . . 0.0 109.414 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.66 -165.11 15.22 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.14 11.79 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.506 1.471 . . . . 0.0 112.138 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 mt -110.98 88.97 8.87 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.547 -1.346 . . . . 0.0 111.038 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -62.38 132.29 37.8 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.645 1.34 . . . . 0.0 110.821 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.1 tmm? -75.19 129.43 82.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.022 -1.049 . . . . 0.0 109.843 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.419 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -68.47 133.47 28.14 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.528 1.278 . . . . 0.0 108.884 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -57.59 140.85 94.7 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.206 1.108 . . . . 0.0 110.177 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-80 -109.25 164.84 12.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.91 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.45 32.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.832 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' SER . 15.5 m -73.94 120.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.514 -0.741 . . . . 0.0 109.915 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 66' ' ' VAL . 7.4 t -47.4 175.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.46 -69.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -21.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -75.9 -48.39 21.54 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.855 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -68.2 -18.95 64.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 108.72 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -48.59 46.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -27.05 68.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.057 ' O ' HD12 ' A' ' 78' ' ' ILE . 41.3 mt -66.13 -44.41 84.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -61.23 -52.79 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 1.1 mtpt -60.93 -19.52 60.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.576 ' CZ3' ' CE2' ' A' ' 27' ' ' TYR . 38.6 t90 -80.67 -41.31 23.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.77 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.057 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.6 mp -61.24 -52.16 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 109.833 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -64.21 -23.95 67.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.395 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.242 0.544 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 1.6 m-20 -48.68 159.97 0.5 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.17 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.1 Cg_exo -60.98 -49.92 7.26 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.609 1.32 . . . . 0.0 110.313 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' HA ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 tt0 -52.0 -46.91 65.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.225 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 51.1 t -48.11 -40.39 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.384 -0.822 . . . . 0.0 108.962 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 65.4 mt -64.95 -40.01 94.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 109.734 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.652 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -58.23 -27.86 64.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.601 -0.687 . . . . 0.0 110.398 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -90.14 -36.57 14.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 110.777 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -70.57 -25.95 63.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.204 -0.935 . . . . 0.0 110.881 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.683 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 22.7 mmtm -97.9 -26.35 14.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 110.202 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.43 18.47 14.52 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 14.1 m -65.0 -32.26 73.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -1.148 . . . . 0.0 109.763 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.421 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 69.3 mmm -79.15 2.81 19.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.506 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.03 11.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 90.2 m -96.93 -15.6 21.08 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 110.961 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.4 m-70 -104.42 172.39 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.96 -1.087 . . . . 0.0 112.047 -178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.88 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -152.77 124.4 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.634 HG23 ' HB3' ' A' ' 81' ' ' GLN . 3.4 mp -37.79 -27.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 111.266 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.587 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 2.0 p-10 -155.24 -32.78 0.1 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.996 -1.065 . . . . 0.0 111.404 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.88 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 17.9 p -69.65 151.7 45.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.965 -1.085 . . . . 0.0 109.847 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -93.38 117.76 30.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.671 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 2.3 mtm -123.02 -117.79 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.478 -0.764 . . . . 0.0 109.514 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.485 HG11 ' HAC' ' A' ' 83' ' ' HEM . 51.0 t -76.45 -34.51 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.833 -1.167 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.64 171.72 15.18 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.632 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.2 137.57 48.29 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.525 1.276 . . . . 0.0 110.072 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.818 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . . . -42.28 156.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.787 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.719 ' HD1' HG23 ' A' ' 78' ' ' ILE . 5.7 m-85 -69.06 -60.55 2.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.803 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -53.06 -42.27 65.62 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.038 -1.039 . . . . 0.0 109.011 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.818 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 59.2 m-20 -58.47 -40.86 83.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.865 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 26' ' ' ALA . 16.4 t -56.27 -38.14 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.227 -0.921 . . . . 0.0 109.318 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.853 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -74.0 -24.21 59.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.496 -0.753 . . . . 0.0 109.915 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.31 -29.83 62.97 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.374 -0.829 . . . . 0.0 110.31 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -88.77 -35.44 16.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' HG2' ' A' ' 33' ' ' LYS . 3.9 m-30 -94.06 -1.75 53.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.226 -0.921 . . . . 0.0 109.84 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.853 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.05 130.23 37.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 110.177 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.15 -19.04 15.49 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 8.3 mm100 -66.58 145.78 55.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.348 -1.089 . . . . 0.0 110.027 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.33 2.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.266 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 56.49 0.21 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.609 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -75.3 -13.16 60.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -1.161 . . . . 0.0 110.287 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.796 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -75.18 -30.05 60.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.092 -1.005 . . . . 0.0 109.845 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -70.61 -52.95 17.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.278 -0.889 . . . . 0.0 109.426 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -65.55 -34.64 78.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.911 . . . . 0.0 108.806 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 48' ' ' ILE . 11.5 mt -59.18 -36.6 75.62 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -65.94 -37.75 86.84 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.521 -0.737 . . . . 0.0 109.667 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -29.54 65.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.141 -0.974 . . . . 0.0 110.08 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.498 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 29.2 mmt180 -88.42 -12.42 43.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.264 -0.898 . . . . 0.0 109.384 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.879 HD11 HMA1 ' A' ' 83' ' ' HEM . 38.7 mt -90.28 -25.16 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.452 -0.78 . . . . 0.0 109.446 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -85.53 -14.33 46.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.0 109.637 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.7 t30 -126.98 -11.71 5.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.55 174.64 0.02 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 163.87 167.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.169 -1.195 . . . . 0.0 111.414 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.0 pm0 -101.9 -161.14 0.83 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.435 -0.791 . . . . 0.0 109.925 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 56.4 19.39 25.61 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.864 HG12 ' CD1' ' A' ' 56' ' ' TRP . 60.5 t -104.54 -62.92 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.701 -0.882 . . . . 0.0 109.37 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.864 ' CD1' HG12 ' A' ' 55' ' ' VAL . 88.2 m95 -120.0 -35.53 3.46 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.595 0.712 . . . . 0.0 109.11 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.09 -175.93 31.61 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.94 6.83 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.379 1.386 . . . . 0.0 111.764 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.546 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 9.1 mt -106.05 85.37 1.59 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.84 -1.162 . . . . 0.0 109.829 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.7 Cg_endo -54.07 133.86 57.23 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.7 1.369 . . . . 0.0 110.834 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.598 ' HE3' ' HA ' ' A' ' 48' ' ' ILE . 3.2 tmm? -70.52 131.92 87.83 Favored Pre-proline 0 C--N 1.299 -1.588 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.145 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.1 Cg_exo -64.38 130.24 26.26 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.73 1.384 . . . . 0.0 109.504 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.7 Cg_endo -59.38 138.24 83.12 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.478 1.251 . . . . 0.0 110.346 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-80 -110.39 160.63 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.163 -0.961 . . . . 0.0 110.416 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.26 35.72 0.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 110.125 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 66' ' ' VAL . 19.8 m -79.86 119.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.393 -0.817 . . . . 0.0 110.028 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -46.39 172.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.569 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.93 -39.2 79.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.939 -1.1 . . . . 0.0 109.94 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.55 -34.77 74.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.871 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.4 mm-40 -71.71 -38.52 70.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.812 . . . . 0.0 110.004 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.854 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -72.51 -22.82 60.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.221 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 7.2 mt-30 -71.73 -41.68 68.21 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.53 -25.84 61.53 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' A' ' 71' ' ' ALA . 41.6 mt -72.02 -30.99 65.77 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.796 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -73.29 -53.62 10.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.517 -0.739 . . . . 0.0 109.545 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 16.8 ptmt -64.87 -20.79 66.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.227 -0.921 . . . . 0.0 109.076 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.652 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 43.7 t90 -70.7 -43.55 68.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.417 -0.802 . . . . 0.0 109.304 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.719 HG23 ' HD1' ' A' ' 27' ' ' TYR . 13.1 mt -62.81 -48.78 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.918 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -69.19 -9.75 54.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 110.475 -179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 81' ' ' GLN . 13.4 t -108.21 -5.13 17.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 0.0 110.693 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.634 ' HB3' HG23 ' A' ' 18' ' ' ILE . 13.3 mm-40 -50.51 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.026 . . . . 0.0 110.046 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.259 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.879 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.215 0.531 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.94 153.76 80.32 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.42 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_endo -60.38 -15.22 34.16 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.726 1.382 . . . . 0.0 110.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -38.15 68.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.11 -0.994 . . . . 0.0 109.227 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 4.1 t -62.99 -52.49 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.884 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -61.77 -33.85 74.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.208 -0.932 . . . . 0.0 109.661 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.446 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -68.44 -21.92 64.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -49.91 11.59 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 12.6 m-80 -65.31 -23.57 67.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.134 -0.978 . . . . 0.0 110.479 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 22.3 mmtm -84.52 -12.41 54.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 109.798 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.26 14.3 69.16 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.534 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 59.4 m -65.15 -31.7 73.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.252 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.2 mtp -88.41 7.62 31.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 110.301 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 -44.82 18.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.558 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 70.8 m -102.67 -17.61 15.58 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 110.887 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.645 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 11.1 m-70 -93.73 168.26 11.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.947 -1.096 . . . . 0.0 112.353 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.984 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -148.05 118.72 7.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.534 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.6 mp -38.66 -27.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.399 -0.813 . . . . 0.0 110.913 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 17' ' ' ALA . 7.5 p-10 -148.65 -35.9 0.19 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.041 -1.037 . . . . 0.0 110.542 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.984 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.05 -179.29 1.47 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -129.83 89.07 2.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.08 -1.012 . . . . 0.0 110.375 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -78.82 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 110.006 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 70.7 t -97.75 -25.65 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.977 -1.077 . . . . 0.0 109.396 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.94 173.76 15.07 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.651 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -68.61 133.35 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.625 1.329 . . . . 0.0 110.574 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -46.11 151.24 0.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.638 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -61.6 -64.39 0.96 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.115 -0.991 . . . . 0.0 110.098 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -48.1 -46.02 33.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.499 179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 2.8 m-20 -51.9 -47.1 64.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.486 -0.759 . . . . 0.0 110.147 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 26' ' ' ALA . 89.7 t -57.99 -34.25 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.9 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -75.78 -26.35 57.25 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.417 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.6 -28.18 60.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -85.44 -37.35 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.132 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 36' ' ' GLY . 11.5 m-85 -97.8 -3.41 38.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.189 -0.944 . . . . 0.0 110.339 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.9 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -51.27 90.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 130.93 69.14 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.458 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.4 mt-30 -144.7 149.79 36.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -1.175 . . . . 0.0 110.26 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.02 39.46 0.96 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.47 50.08 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -84.83 -42.46 15.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -1.175 . . . . 0.0 110.353 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.781 ' HA ' HD12 ' A' ' 44' ' ' LEU . 10.0 mp0 -59.73 -38.09 80.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 109.926 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.89 84.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.589 ' CZ ' ' HD2' ' A' ' 47' ' ' ARG . 28.6 t80 -70.68 -20.01 62.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.225 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.781 HD12 ' HA ' ' A' ' 41' ' ' GLU . 28.7 mt -72.86 -34.86 67.03 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.8 -31.97 59.66 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.498 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -28.13 51.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.244 -0.91 . . . . 0.0 109.863 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.589 ' HD2' ' CZ ' ' A' ' 43' ' ' TYR . 6.9 mmp_? -86.65 -16.81 35.47 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.377 -0.827 . . . . 0.0 109.547 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.928 HD11 HMA1 ' A' ' 83' ' ' HEM . 58.8 mt -88.22 -28.97 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.459 -0.775 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -80.26 -20.77 43.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.2 m120 -120.86 -17.91 7.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.109 -0.994 . . . . 0.0 110.39 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.74 169.48 0.02 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.6 OUTLIER 164.02 168.13 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 121.086 -1.243 . . . . 0.0 111.375 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -96.94 -160.97 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.313 -0.867 . . . . 0.0 110.44 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.46 19.04 59.59 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.924 -2.071 . . . . 0.0 107.924 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.849 HG12 ' CD1' ' A' ' 56' ' ' TRP . 9.4 t -98.28 -69.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.675 -0.897 . . . . 0.0 109.48 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.849 ' CD1' HG12 ' A' ' 55' ' ' VAL . 92.3 m95 -118.53 -38.25 3.17 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 108.953 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.51 -167.73 15.22 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.494 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.58 14.72 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.558 1.505 . . . . 0.0 112.07 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 8.9 mt -110.13 96.56 26.26 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 120.545 -1.347 . . . . 0.0 111.005 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.551 ' CB ' ' HB3' ' A' ' 53' ' ' GLN . 2.5 Cg_endo -65.01 128.64 21.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.615 1.324 . . . . 0.0 110.589 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.551 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.3 tmm? -69.2 128.93 92.34 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.876 -1.14 . . . . 0.0 108.796 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -64.22 129.97 25.76 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.643 1.338 . . . . 0.0 109.5 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_exo -57.27 148.95 67.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.243 1.128 . . . . 0.0 109.972 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -120.73 163.45 18.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 111.047 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.5 36.37 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 66' ' ' VAL . 16.7 m -84.4 108.62 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.352 -0.843 . . . . 0.0 110.24 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 66' ' ' VAL . 17.5 p -42.22 152.84 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 0.0 109.559 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -45.92 -48.76 16.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.027 -1.046 . . . . 0.0 110.797 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.84 -34.79 75.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.976 . . . . 0.0 110.46 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.97 -40.93 75.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.121 -0.987 . . . . 0.0 110.573 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -72.16 -21.47 61.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.02 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -70.27 -44.05 69.21 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 3' ' ' PRO . 18.9 m -70.84 -23.99 62.44 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.979 HD13 HMB1 ' A' ' 83' ' ' HEM . 31.7 mt -71.7 -37.45 70.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.47 58.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.452 -0.78 . . . . 0.0 109.159 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 80' ' ' SER . 13.2 mtmt -66.7 -22.2 66.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.85 . . . . 0.0 109.239 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 62.0 t90 -78.01 -24.04 48.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.452 -0.78 . . . . 0.0 109.92 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.67 HD12 ' O ' ' A' ' 74' ' ' LEU . 7.2 mt -84.29 -61.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.031 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.898 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -49.74 -42.17 45.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.264 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 9.2 m -86.58 -42.25 13.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.289 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.551 ' HG3' ' CB ' ' A' ' 27' ' ' TYR . 0.7 OUTLIER 37.83 -155.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.617 -0.677 . . . . 0.0 110.634 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.1 tpmt? . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.159 179.891 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.979 HMB1 HD13 ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 1' ' ' GLU . 8.2 pt-20 . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.228 0.537 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.485 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 3.3 m-20 -54.0 145.99 30.96 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.957 . . . . 0.0 110.123 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.63 ' HA ' HD21 ' A' ' 6' ' ' LEU . 2.8 Cg_endo -61.93 -33.32 84.16 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.544 1.286 . . . . 0.0 110.716 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 1.3 pt-20 -65.09 -27.56 68.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.134 -0.979 . . . . 0.0 109.134 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 2' ' ' ASP . 32.8 t -71.82 -59.25 3.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.535 -0.728 . . . . 0.0 109.404 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -62.67 -19.2 63.61 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.315 -0.866 . . . . 0.0 109.631 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.85 -53.85 23.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.446 -0.784 . . . . 0.0 109.932 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -29.78 69.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.084 -1.01 . . . . 0.0 110.463 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -67.17 -37.21 83.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.664 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.579 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 10.3 mmtp -82.31 -13.37 57.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.18 12.45 49.0 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.636 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 22.5 m -65.26 -38.62 90.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.108 -1.23 . . . . 0.0 110.26 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -80.85 7.26 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.469 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.88 -34.22 19.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 110.413 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.3 m -110.55 -14.86 14.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 0.0 110.745 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.631 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.7 m-70 -102.98 154.38 19.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.895 -1.128 . . . . 0.0 111.846 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.858 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -132.47 121.32 23.19 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.846 HG22 ' HD2' ' A' ' 28' ' ' LYS . 11.2 mt -40.34 -26.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.957 . . . . 0.0 110.724 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' ALA . 4.6 t70 -152.21 -35.68 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.165 -0.959 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.858 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.81 163.68 25.28 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.175 -0.953 . . . . 0.0 110.518 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -103.44 89.31 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 110.559 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 mtm -85.49 -95.22 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.683 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.4 t -101.13 -39.35 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.0 109.851 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.68 -179.41 18.32 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.614 ' CG ' ' CD2' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.49 129.86 22.3 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.627 1.33 . . . . 0.0 110.2 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.91 143.39 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.811 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.631 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 5.8 m-85 -53.92 -48.97 69.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.846 ' HD2' HG22 ' A' ' 18' ' ' ILE . 2.1 mtpp -57.43 -50.67 72.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.8 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -58.26 -27.13 63.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 110.242 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 26' ' ' ALA . 92.0 t -67.06 -43.09 89.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.162 -0.961 . . . . 0.0 110.047 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -74.47 -23.86 58.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.89 . . . . 0.0 110.395 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.57 -28.62 59.04 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.215 -0.928 . . . . 0.0 110.378 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -90.88 -41.7 11.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 110.852 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE2' ' CZ2' ' A' ' 56' ' ' TRP . 7.7 m-85 -78.35 -7.81 57.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.077 -1.015 . . . . 0.0 110.041 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.86 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . 155.44 -45.14 0.54 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' GLY . 5.4 mm-40 -42.24 157.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 57.58 3.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.663 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.05 57.96 0.39 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -70.7 -44.42 66.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -1.1 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 21.0 pt-20 -50.44 -37.79 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.302 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -60.8 -57.79 11.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.163 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.597 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 85.2 t80 -67.18 -13.86 62.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.252 -0.905 . . . . 0.0 109.509 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD22 HMA1 ' A' ' 83' ' ' HEM . 18.8 mt -78.42 -29.39 47.11 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.46 64.28 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.76 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.597 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 2.3 mmt180 -81.42 -16.67 51.4 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.21 -0.932 . . . . 0.0 109.521 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.608 HD11 HMA3 ' A' ' 83' ' ' HEM . 9.7 mt -81.08 -34.43 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.353 -0.842 . . . . 0.0 109.543 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.34 -12.41 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 0.0 110.685 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.32 -8.84 8.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.123 -0.986 . . . . 0.0 110.654 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 62.01 160.55 0.16 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 108.909 -1.677 . . . . 0.0 108.909 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 11.5 t -179.2 154.82 0.68 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.639 -1.507 . . . . 0.0 112.54 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -105.11 -176.31 3.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.679 -0.638 . . . . 0.0 109.703 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 66.05 10.77 52.96 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.974 HG11 HBA2 ' A' ' 83' ' ' HEM . 2.1 t -89.41 -62.25 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.482 -1.011 . . . . 0.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.614 ' CD2' ' CG ' ' A' ' 25' ' ' PRO . 73.9 m95 -115.65 -33.72 5.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.444 -0.785 . . . . 0.0 109.497 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.36 -167.31 25.76 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.7 Cg_endo -69.44 6.87 1.04 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.376 1.384 . . . . 0.0 111.695 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.549 ' O ' HMD1 ' A' ' 83' ' ' HEM . 15.6 mt -110.59 90.17 10.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 120.805 -1.185 . . . . 0.0 110.5 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -61.88 141.34 89.45 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.786 1.414 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.592 ' HE3' ' O ' ' A' ' 47' ' ' ARG . 32.4 ttp -71.92 128.48 89.31 Favored Pre-proline 0 C--N 1.302 -1.46 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.902 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -63.0 130.94 30.7 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.589 1.31 . . . . 0.0 109.379 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.1 131.2 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.322 1.169 . . . . 0.0 109.928 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.1 m-80 -105.55 163.89 12.31 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.353 -0.842 . . . . 0.0 110.537 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.66 30.32 1.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.842 . . . . 0.0 109.733 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.498 ' O ' ' CG ' ' A' ' 49' ' ' LYS . 15.8 m -74.16 116.06 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -48.85 179.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.695 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -65.5 -68.89 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 0.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -45.83 -32.19 2.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.905 . . . . 0.0 110.364 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -68.3 -51.35 45.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.351 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.963 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -63.67 -21.07 66.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -71.44 -47.32 56.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.389 -0.819 . . . . 0.0 108.815 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -68.16 -24.43 64.98 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.982 ' O ' HD12 ' A' ' 78' ' ' ILE . 70.4 mt -68.99 -41.33 77.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.581 -0.699 . . . . 0.0 109.381 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.7 -48.75 65.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.379 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -63.68 -19.2 64.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.394 -0.817 . . . . 0.0 109.458 179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.3 t90 -78.51 -46.18 20.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 110.098 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.982 HD12 ' O ' ' A' ' 74' ' ' LEU . 3.1 mt -63.06 -48.36 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 109.532 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.75 -13.71 61.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.812 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 1.0 OUTLIER -82.35 -31.79 29.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.349 -0.845 . . . . 0.0 109.652 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 65.1 mm-40 -43.09 -54.74 4.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.332 -0.855 . . . . 0.0 110.083 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.974 HBA2 HG11 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.181 0.515 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.3 156.88 83.43 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.355 -0.841 . . . . 0.0 110.078 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo -60.99 -15.12 36.92 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.678 1.357 . . . . 0.0 110.127 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -33.0 57.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.246 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.8 t -66.4 -48.74 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.572 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.4 pp -69.36 -30.57 68.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.387 -0.821 . . . . 0.0 109.268 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -58.14 -55.42 35.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -43.77 82.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.83 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.488 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -55.13 -29.45 57.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -0.889 . . . . 0.0 110.237 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.606 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 16.7 mmtm -90.69 -22.32 21.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.153 -0.967 . . . . 0.0 109.903 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.62 14.44 27.49 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.69 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 19.8 m -66.36 -36.05 81.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -1.198 . . . . 0.0 110.407 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.8 mtp -82.16 6.82 15.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 110.882 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.87 -43.87 13.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 89.9 m -101.71 -18.13 15.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.42 -0.8 . . . . 0.0 110.81 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 21.3 m-70 -101.0 167.45 10.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.975 -1.078 . . . . 0.0 111.969 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -147.26 122.8 10.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.55 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 2.1 mp -37.45 -27.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.424 -0.798 . . . . 0.0 111.075 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.576 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -155.68 -34.46 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.041 -1.037 . . . . 0.0 110.863 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.931 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 62.4 p -69.62 154.53 41.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.088 -1.007 . . . . 0.0 110.199 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.66 122.72 39.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 4.6 mtm -124.73 -98.03 0.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.875 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 68.1 t -94.2 -36.32 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 109.317 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.25 178.17 16.4 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -69.23 133.2 25.94 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.656 1.346 . . . . 0.0 110.485 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.597 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.43 150.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 110.057 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 8.2 m-85 -60.73 -56.95 15.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.186 -0.946 . . . . 0.0 110.247 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HE2' ' HD3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -50.32 -49.81 52.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.753 -1.217 . . . . 0.0 109.448 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 6.5 m-20 -53.33 -41.75 66.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 26' ' ' ALA . 49.5 t -53.98 -42.44 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 109.895 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.846 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -73.65 -23.42 59.85 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.965 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 29' ' ' ASP . . . -66.64 -34.07 77.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.281 -0.887 . . . . 0.0 110.125 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' CZ3' ' A' ' 56' ' ' TRP . 3.2 ttmt -86.92 -49.97 7.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -76.46 1.22 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.222 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.846 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -59.01 126.72 28.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.273 -0.892 . . . . 0.0 110.439 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.36 28.67 4.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.48 138.83 50.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -1.152 . . . . 0.0 110.24 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.42 41.12 1.02 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 110.415 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.95 55.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.647 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -87.15 -17.27 33.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.149 -1.207 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.697 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 2.3 mt-10 -75.63 -33.71 60.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.887 . . . . 0.0 109.611 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.16 -50.68 63.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.304 -0.873 . . . . 0.0 109.554 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -70.73 -31.65 68.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.087 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.647 HD12 ' O ' ' A' ' 40' ' ' ALA . 15.4 mt -67.46 -26.99 66.66 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HA ' ' HB1' ' A' ' 71' ' ' ALA . . . -75.61 -33.41 60.52 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.574 -0.704 . . . . 0.0 109.834 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -75.36 -36.36 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.151 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.424 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 33.5 mmt-85 -82.18 -15.76 52.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.961 HD11 HMA1 ' A' ' 83' ' ' HEM . 24.9 mt -85.99 -29.6 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.24 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -84.84 -17.75 37.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.35 -0.844 . . . . 0.0 109.696 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 10.4 t30 -126.8 -0.04 6.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.111 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 51.27 -173.76 0.13 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.2 p 167.42 158.72 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.038 -1.272 . . . . 0.0 111.871 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.681 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -106.15 -164.82 1.04 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.399 -0.813 . . . . 0.0 109.959 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 53.39 18.98 7.82 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 53' ' ' GLN . 6.7 t -94.72 -69.25 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -1.103 . . . . 0.0 109.17 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.61 ' CG ' ' HG3' ' A' ' 25' ' ' PRO . 98.4 m95 -110.41 -39.03 5.06 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.736 0.779 . . . . 0.0 108.941 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.88 -174.0 24.32 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -70.02 8.15 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.349 1.366 . . . . 0.0 111.506 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 11.3 mt -107.34 82.37 1.21 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.728 -1.233 . . . . 0.0 110.044 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -55.42 145.67 66.71 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.667 1.351 . . . . 0.0 111.563 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.549 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 1.6 ttm -74.95 132.42 77.3 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.408 -0.808 . . . . 0.0 109.406 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.715 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -67.59 129.14 19.37 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.624 1.328 . . . . 0.0 109.036 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -56.68 133.92 61.11 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.179 1.094 . . . . 0.0 110.146 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.0 m-80 -105.9 -177.99 3.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 110.961 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.19 35.41 2.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 110.036 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 66' ' ' VAL . 27.1 m -87.09 103.14 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.8 . . . . 0.0 109.962 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 40.3 t -43.61 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.2 -0.937 . . . . 0.0 109.345 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 67' ' ' SER . 1.5 m-20 -42.78 -47.51 5.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 0.0 110.507 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -59.17 -41.42 88.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.187 -0.946 . . . . 0.0 110.461 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 17.8 mt-10 -65.87 -38.94 90.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.098 -1.001 . . . . 0.0 110.817 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 45' ' ' ALA . . . -70.45 -19.92 62.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.091 -1.006 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -49.05 30.41 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -27.94 66.8 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.66 HD22 ' CMB' ' A' ' 83' ' ' HEM . 51.1 mt -69.53 -36.12 76.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.697 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -67.46 -53.4 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -0.756 . . . . 0.0 109.505 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 10.4 mttt -61.98 -24.07 66.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.914 . . . . 0.0 109.08 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.591 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 40.9 t90 -72.03 -35.44 69.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.511 -0.743 . . . . 0.0 109.57 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.735 HD13 HMA3 ' A' ' 83' ' ' HEM . 7.2 mt -74.8 -38.96 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.409 -0.807 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 4.3 mt -74.21 -11.96 60.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.367 -0.833 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.5 p -91.65 -24.24 19.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.422 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 81.9 mm-40 -55.82 125.9 23.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' HD3' ' HE2' ' A' ' 28' ' ' LYS . 2.4 tppp? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.141 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.961 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.162 0.506 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' OD2' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -80.41 162.44 61.08 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.148 -0.97 . . . . 0.0 109.901 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.73 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.0 Cg_endo -60.43 -19.32 58.29 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.645 1.34 . . . . 0.0 110.673 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.55 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 8.9 pt-20 -70.19 -39.09 75.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.957 . . . . 0.0 109.259 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.55 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 57.8 t -64.32 -54.93 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 0.0 109.976 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.73 HD21 ' HA ' ' A' ' 3' ' ' PRO . 3.8 pp -67.95 -22.66 65.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.876 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.92 -33.36 74.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 -37.86 33.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 0.0 110.169 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.8 m120 -65.11 -30.99 71.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.883 . . . . 0.0 110.877 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.596 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 6.3 mmtm -83.82 -18.09 38.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.887 -1.133 . . . . 0.0 109.772 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.8 12.34 43.92 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.731 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 15.0 m -68.03 -35.83 78.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.044 -1.268 . . . . 0.0 110.417 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.78 1.69 41.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -0.961 . . . . 0.0 111.033 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.77 -38.64 15.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.005 . . . . 0.0 110.33 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.1 m -101.24 -26.41 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 0.0 110.444 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.635 ' NE2' ' ND ' ' A' ' 83' ' ' HEM . 32.9 m-70 -106.36 166.79 10.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB2' ' HE2' ' A' ' 22' ' ' MET . . . -135.21 -176.16 4.17 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.603 HG23 ' HB3' ' A' ' 81' ' ' GLN . 45.3 mm -91.32 -26.01 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 110.402 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.6 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 2.8 p30 -162.22 19.35 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.976 -1.077 . . . . 0.0 111.06 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -114.93 -166.4 1.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.954 -1.091 . . . . 0.0 110.194 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 87.81 2.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 110.765 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.581 ' HE2' ' HB2' ' A' ' 17' ' ' ALA . 31.3 mtm -97.89 -98.43 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 109.598 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.624 HG11 ' HAC' ' A' ' 83' ' ' HEM . 94.9 t -88.87 -45.58 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.003 -1.061 . . . . 0.0 109.231 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.7 172.74 14.4 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HG3' ' HB3' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.23 143.04 82.4 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.469 1.247 . . . . 0.0 110.275 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -41.42 163.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.127 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -81.44 -53.14 6.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -52.13 -42.11 63.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.167 -0.958 . . . . 0.0 109.528 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 5.0 m-20 -58.05 -38.48 76.37 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.541 -0.724 . . . . 0.0 109.681 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 26' ' ' ALA . 91.1 t -58.55 -46.45 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.825 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.86 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.88 -19.93 61.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.552 -0.717 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.23 -32.43 62.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -43.07 13.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.932 . . . . 0.0 109.822 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -78.81 -5.76 54.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.259 -0.9 . . . . 0.0 109.854 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.86 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -62.21 89.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.13 -20.94 0.57 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.4 mt-30 -71.48 149.91 45.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.267 -1.137 . . . . 0.0 110.101 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.15 40.29 1.0 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 110.428 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.7 56.93 0.01 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.645 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -90.28 -20.16 23.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.089 -1.242 . . . . 0.0 110.45 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.93 -34.84 66.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 0.0 109.503 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.35 -50.93 63.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.375 -0.828 . . . . 0.0 109.721 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.526 ' CE1' ' CG ' ' A' ' 47' ' ' ARG . 1.2 t80 -68.11 -30.3 69.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.192 -0.942 . . . . 0.0 109.106 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 48' ' ' ILE . 9.2 mt -65.13 -29.7 70.57 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.92 66.31 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.597 -0.689 . . . . 0.0 110.008 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -76.38 -27.4 56.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 110.363 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 0.2 OUTLIER -87.72 -15.26 37.55 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.386 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.787 HD11 HMA1 ' A' ' 83' ' ' HEM . 35.2 mt -86.61 -32.31 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.382 -0.824 . . . . 0.0 109.618 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -85.06 -10.48 56.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.069 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.564 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 3.1 m-20 -124.16 -12.8 7.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 51.14 175.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 166.28 167.07 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.047 -1.267 . . . . 0.0 111.462 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.568 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -102.37 179.67 4.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.475 -0.766 . . . . 0.0 109.955 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.81 19.26 73.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.771 HG11 ' CGA' ' A' ' 83' ' ' HEM . 2.6 t -91.58 -67.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.596 -0.944 . . . . 0.0 109.459 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.592 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 88.6 m95 -119.41 -35.48 3.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.509 -0.744 . . . . 0.0 109.041 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.05 -174.29 23.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.39 11.44 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.426 1.417 . . . . 0.0 112.019 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.556 ' O ' HMD3 ' A' ' 83' ' ' HEM . 15.4 mt -109.11 87.06 4.42 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.659 -1.276 . . . . 0.0 110.316 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.15 138.41 85.77 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.593 1.312 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.555 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.6 tmm? -79.02 126.68 81.6 Favored Pre-proline 0 C--N 1.299 -1.595 0 C-N-CA 119.362 -0.935 . . . . 0.0 109.372 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.68 127.4 19.62 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.3 Cg_exo -55.18 132.99 55.56 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.241 1.127 . . . . 0.0 110.054 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.23 167.14 10.18 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.468 -0.77 . . . . 0.0 110.862 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.87 30.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.401 -0.812 . . . . 0.0 109.877 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 66' ' ' VAL . 17.9 m -76.13 113.93 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.374 -0.829 . . . . 0.0 109.667 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -50.99 -176.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.778 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.09 -60.81 2.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.019 -1.051 . . . . 0.0 110.087 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -52.86 -32.51 45.12 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 110.035 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mt-10 -68.97 -49.01 61.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 110.328 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -67.62 -17.45 64.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 109.239 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -74.41 -41.29 61.17 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.599 HG22 ' HB3' ' A' ' 3' ' ' PRO . 60.8 m -76.21 -23.39 54.62 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.702 HD13 HMB1 ' A' ' 83' ' ' HEM . 53.8 mt -75.9 -34.84 59.97 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.573 -0.704 . . . . 0.0 109.181 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.781 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -73.49 -48.3 34.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 0.0 109.081 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.576 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -66.02 -27.01 67.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.066 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.526 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 36.4 t90 -67.15 -41.46 86.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.413 -0.804 . . . . 0.0 109.355 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 75' ' ' ALA . 16.2 mt -61.72 -50.55 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.381 -0.824 . . . . 0.0 109.521 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.559 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.6 mt -62.08 -25.35 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.834 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.13 -33.68 73.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.191 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.603 ' HB3' HG23 ' A' ' 18' ' ' ILE . 50.2 mm-40 -53.27 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.471 ' HB3' ' HG3' ' A' ' 28' ' ' LYS . 6.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.329 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.787 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.333 0.587 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.2 m-20 -83.27 153.86 66.17 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.923 . . . . 0.0 110.156 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.759 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.2 Cg_exo -61.48 -14.95 38.06 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.664 1.349 . . . . 0.0 110.608 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.71 -39.41 66.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.194 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 96.0 t -65.41 -54.99 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.857 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 3' ' ' PRO . 2.2 pp -68.57 -24.16 64.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -0.874 . . . . 0.0 110.349 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -70.13 -33.54 71.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -84.59 -37.64 20.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.07 -1.019 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.16 -35.59 77.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.501 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.845 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 1.0 OUTLIER -85.27 -10.49 56.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.045 -1.034 . . . . 0.0 110.589 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.44 58.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.599 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 20.4 m -62.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -1.234 . . . . 0.0 110.412 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 mtp -85.51 10.68 12.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.893 . . . . 0.0 110.465 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.21 13.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 92.7 m -105.82 -21.57 13.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 110.711 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 14.8 m-70 -94.95 167.34 11.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.004 -1.06 . . . . 0.0 112.71 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.948 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -145.15 120.11 10.0 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG23 ' HG3' ' A' ' 81' ' ' GLN . 7.8 mt -39.98 -25.21 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.221 -0.925 . . . . 0.0 111.15 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' ALA . 1.9 p30 -147.52 -39.59 0.19 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.792 -1.192 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.948 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -70.51 153.93 42.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.013 . . . . 0.0 110.428 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -98.37 97.64 8.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.359 -0.838 . . . . 0.0 109.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.573 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 16.6 mtm -97.13 -121.58 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.299 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 64.3 t -70.4 -32.59 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.768 -1.208 . . . . 0.0 109.819 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.99 173.24 15.43 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.632 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -66.48 131.61 26.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.627 1.33 . . . . 0.0 110.502 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -47.01 153.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.873 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 16' ' ' HIS . 10.3 m-85 -66.81 -51.15 59.11 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.203 -0.936 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HE3' HG22 ' A' ' 18' ' ' ILE . 10.8 mttt -53.93 -49.88 67.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.534 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -53.68 -43.36 68.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.99 179.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 26' ' ' ALA . 75.5 t -53.94 -39.54 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.92 -28.52 62.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 110.489 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.1 -27.61 63.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.143 -0.973 . . . . 0.0 110.502 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.14 -42.9 10.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -88.28 0.85 55.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.033 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.24 122.37 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.932 . . . . 0.0 110.176 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.57 13.6 20.11 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.642 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.34 141.16 29.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -1.199 . . . . 0.0 110.214 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.37 52.89 2.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.116 -0.99 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.76 48.03 0.24 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -73.83 -22.52 59.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.144 -1.21 . . . . 0.0 110.092 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 3.3 pt-20 -71.3 -29.16 64.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.7 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -65.31 -53.06 49.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -0.818 . . . . 0.0 109.674 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.608 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -70.09 -28.47 65.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.578 ' O ' HD12 ' A' ' 48' ' ' ILE . 19.7 mt -68.67 -26.24 65.21 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -73.14 -39.18 65.9 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.408 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -77.26 -23.13 51.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.542 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.608 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 19.5 mmt180 -90.13 -17.64 27.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.344 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.776 HD11 HMA1 ' A' ' 83' ' ' HEM . 26.8 mt -85.32 -31.02 6.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.475 -0.766 . . . . 0.0 109.294 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -86.98 -11.97 48.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 110.1 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 86.3 m-20 -121.04 -13.32 8.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 109.951 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 54.74 169.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER 168.88 166.27 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.804 -1.41 . . . . 0.0 111.857 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -105.6 -173.9 2.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.0 109.777 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.567 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.0 9.92 54.93 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.712 HG12 ' CD1' ' A' ' 56' ' ' TRP . 39.8 t -89.82 -50.96 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.398 -1.06 . . . . 0.0 109.459 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.712 ' CD1' HG12 ' A' ' 55' ' ' VAL . 92.5 m95 -129.22 -36.11 1.75 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.41 -166.53 24.55 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.2 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.411 1.408 . . . . 0.0 111.53 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG22 HMD3 ' A' ' 83' ' ' HEM . 10.3 mt -109.67 83.14 2.55 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.844 -1.16 . . . . 0.0 110.567 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -58.64 160.5 17.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.716 1.377 . . . . 0.0 111.1 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.569 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 54.0 ttp -96.91 131.21 28.28 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.519 -0.738 . . . . 0.0 109.501 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.431 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -67.59 132.33 26.78 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.653 1.344 . . . . 0.0 109.033 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.9 139.9 92.85 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.267 1.14 . . . . 0.0 110.344 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 10.9 m-80 -114.8 165.68 12.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 0.0 110.793 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.46 38.31 0.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.034 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 66' ' ' VAL . 27.3 m -71.31 116.41 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.312 -0.867 . . . . 0.0 110.375 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.451 ' N ' ' HB2' ' A' ' 70' ' ' GLU . 29.1 m -51.62 178.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -59.15 5.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.004 -1.06 . . . . 0.0 109.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -59.6 -13.5 9.71 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.933 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mm-40 -82.29 -46.0 14.22 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.219 -0.926 . . . . 0.0 110.201 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.02 -23.28 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.026 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -44.32 39.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.492 -0.755 . . . . 0.0 109.059 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 3' ' ' PRO . 35.5 m -74.44 -22.1 59.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.116 HD22 ' CMB' ' A' ' 83' ' ' HEM . 30.2 mt -75.5 -39.46 58.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.662 -0.649 . . . . 0.0 109.393 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -72.06 -43.54 64.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.017 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HE3' ' OE2' ' A' ' 41' ' ' GLU . 46.5 mttt -65.82 -30.83 71.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.362 -0.836 . . . . 0.0 109.216 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.568 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 33.4 t90 -66.55 -44.38 82.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.634 -0.666 . . . . 0.0 109.918 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.623 HD11 ' HHB' ' A' ' 83' ' ' HEM . 73.4 mt -61.43 -47.02 95.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.185 -0.947 . . . . 0.0 109.643 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.1 -12.73 60.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.381 -0.824 . . . . 0.0 109.76 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -89.72 -19.94 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.091 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.983 ' HG3' HG23 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -40.65 -28.95 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.416 -0.803 . . . . 0.0 110.249 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 81' ' ' GLN . 2.2 tttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.416 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 1.116 ' CMB' HD22 ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.208 0.527 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.31 155.03 66.67 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 110.192 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.562 ' HA ' HD12 ' A' ' 6' ' ' LEU . 3.0 Cg_endo -60.61 -38.14 74.56 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.674 1.355 . . . . 0.0 110.296 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.84 -43.33 65.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.483 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 99.0 t -54.53 -37.82 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.298 -0.876 . . . . 0.0 109.432 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 3' ' ' PRO . 71.3 mt -65.0 -36.82 85.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.796 . . . . 0.0 109.759 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -69.01 -23.25 64.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.546 -0.721 . . . . 0.0 110.491 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.2 -34.5 17.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.342 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.3 m120 -71.23 -36.08 71.71 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.156 -0.965 . . . . 0.0 110.576 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.875 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 0.0 OUTLIER -89.87 -13.33 36.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 110.599 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.86 17.93 52.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 7' ' ' ALA . 35.4 m -63.38 -22.37 66.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -1.083 . . . . 0.0 110.715 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.6 mtp -90.82 8.79 33.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 110.822 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.37 -51.41 6.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 110.566 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.477 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 72.5 m -93.7 -16.29 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.38 -0.825 . . . . 0.0 110.94 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.606 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 15.1 m-70 -104.68 160.41 14.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.126 . . . . 0.0 112.289 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.012 ' HB2' ' SD ' ' A' ' 22' ' ' MET . . . -142.47 126.8 17.65 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.914 HG23 ' HG3' ' A' ' 81' ' ' GLN . 2.3 mp -38.72 -26.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.421 -0.799 . . . . 0.0 111.243 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.541 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 60.8 m-20 -152.19 -37.43 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.987 -1.071 . . . . 0.0 110.75 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.79 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -69.22 165.74 19.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -113.9 95.6 5.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.07 -1.019 . . . . 0.0 110.863 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 1.012 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -85.05 -88.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.688 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.477 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 71.8 t -104.46 -27.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 109.566 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.27 177.23 16.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -67.69 137.04 40.95 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.677 1.357 . . . . 0.0 110.455 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.932 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -44.9 163.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.909 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.795 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.0 m-85 -78.39 -46.69 19.32 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -56.86 -54.32 47.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 0.5 OUTLIER -50.67 -36.61 36.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.443 -0.786 . . . . 0.0 110.257 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 26' ' ' ALA . 94.7 t -61.5 -44.34 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.131 -0.981 . . . . 0.0 110.446 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HB2' ' HG ' ' A' ' 79' ' ' LEU . . . -72.71 -23.81 60.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.403 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.79 -23.38 52.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.241 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -90.06 -42.27 11.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.48 3.82 38.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.039 -1.038 . . . . 0.0 110.09 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.34 95.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.49 -39.01 0.86 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.5 mm-40 -49.21 138.74 12.06 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.106 -1.232 . . . . 0.0 110.354 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.19 50.49 1.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.392 -0.818 . . . . 0.0 110.121 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.69 42.46 0.05 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -75.99 -18.78 59.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -1.134 . . . . 0.0 110.269 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.654 ' HG2' ' HB1' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -75.06 -37.0 61.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.489 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -66.45 -52.03 50.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 43' ' ' TYR . 0.9 OUTLIER -65.91 -32.26 73.66 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 108.78 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.641 ' O ' HD12 ' A' ' 48' ' ' ILE . 12.6 mt -64.57 -30.69 71.71 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -69.65 -34.47 74.05 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.655 -0.653 . . . . 0.0 109.581 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.8 -44.32 64.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.342 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.76 -20.33 60.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 110.132 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.734 HD11 HMA1 ' A' ' 83' ' ' HEM . 47.5 mt -80.61 -31.53 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 110.26 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -88.41 -20.28 25.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.965 -1.084 . . . . 0.0 109.939 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' GLY . 20.2 t30 -113.73 -5.8 13.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 57.64 162.93 0.05 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.2 t 177.51 161.4 0.5 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.455 -1.614 . . . . 0.0 112.47 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -109.26 -175.07 2.66 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.836 -0.54 . . . . 0.0 109.951 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 69.09 16.58 70.95 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.818 HG12 ' CD1' ' A' ' 56' ' ' TRP . 89.4 t -97.96 -60.64 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.569 -0.96 . . . . 0.0 109.731 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.818 ' CD1' HG12 ' A' ' 55' ' ' VAL . 98.3 m95 -118.43 -39.8 2.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.48 -0.763 . . . . 0.0 109.46 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.73 -166.32 21.32 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.91 12.54 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.31 1.34 . . . . 0.0 111.902 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG22 HMD3 ' A' ' 83' ' ' HEM . 8.7 mt -109.61 78.54 1.19 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 120.612 -1.305 . . . . 0.0 110.431 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.1 140.33 94.62 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.518 1.272 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.652 ' HE2' HBA1 ' A' ' 83' ' ' HEM . 7.6 ttp -72.89 135.45 80.55 Favored Pre-proline 0 C--N 1.301 -1.529 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.489 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -69.36 135.11 30.54 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.798 1.42 . . . . 0.0 108.725 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.05 148.36 85.77 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.289 1.152 . . . . 0.0 110.392 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.467 ' HB2' HG13 ' A' ' 66' ' ' VAL . 1.7 m-80 -127.76 173.79 9.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.487 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.11 35.5 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.798 HG12 ' HG2' ' A' ' 10' ' ' LYS . 25.9 m -73.5 103.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.801 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -43.16 163.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.63 -68.08 0.2 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 0.0 110.13 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -21.0 1.31 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.216 -0.927 . . . . 0.0 110.305 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' CG ' ' NZ ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -73.86 -47.2 39.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.986 . . . . 0.0 110.191 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 74' ' ' LEU . . . -71.14 -16.51 62.55 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 109.167 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -41.92 50.81 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -76.11 -27.6 57.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.009 HD13 HMB1 ' A' ' 83' ' ' HEM . 24.1 mt -71.87 -34.17 69.0 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -70.37 -49.81 45.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.429 -0.795 . . . . 0.0 109.397 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.2 OUTLIER -67.19 -24.71 65.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 108.896 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.54 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 54.3 t90 -71.27 -33.33 69.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.528 -0.733 . . . . 0.0 109.328 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.801 HD12 ' HA ' ' A' ' 75' ' ' ALA . 15.4 mt -69.88 -48.42 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.796 . . . . 0.0 109.612 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.733 HD12 ' O ' ' A' ' 75' ' ' ALA . 2.6 mp -72.39 -17.05 61.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 109.87 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 3.1 m -89.09 -13.86 37.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.213 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.914 ' HG3' HG23 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -41.8 -46.84 4.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.327 -0.858 . . . . 0.0 110.449 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.486 ' HB3' ' HG3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.285 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 1.009 HMB1 HD13 ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 1' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.299 0.571 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 6' ' ' LEU . 93.1 m-20 -77.1 163.29 65.96 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.867 . . . . 0.0 110.003 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HA ' HD11 ' A' ' 6' ' ' LEU . 2.9 Cg_endo -59.61 -29.11 89.04 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.581 1.306 . . . . 0.0 110.141 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' C ' ' OE1' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -69.33 -31.37 69.78 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.316 -0.865 . . . . 0.0 108.743 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.8 t -70.76 -59.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.417 -0.802 . . . . 0.0 109.177 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.673 HD11 ' HA ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -62.08 -21.49 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.804 . . . . 0.0 109.536 179.261 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -76.0 -29.33 58.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.364 -0.835 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.77 -27.82 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.807 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.2 m120 -72.34 -38.7 68.56 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.392 -0.817 . . . . 0.0 110.33 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.911 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 0.8 OUTLIER -83.09 -4.69 58.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.053 -1.029 . . . . 0.0 110.193 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.52 18.01 65.02 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.516 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 23.8 m -63.82 -38.21 90.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.304 . . . . 0.0 110.44 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.76 7.09 13.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.576 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.43 -36.62 17.62 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.922 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.9 m -106.01 -17.68 14.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 110.604 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 22.2 m-70 -99.61 171.08 8.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.033 -1.042 . . . . 0.0 111.769 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.863 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -146.6 119.03 8.42 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.1 mp -37.78 -33.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.492 -0.755 . . . . 0.0 111.149 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.515 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 1.2 p30 -156.58 8.36 0.2 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.889 -1.132 . . . . 0.0 111.744 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.863 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -103.75 -176.1 2.99 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.708 -1.245 . . . . 0.0 109.921 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HE2' ' OD2' ' A' ' 29' ' ' ASP . 9.8 mmtp -121.22 104.71 9.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.14 -0.975 . . . . 0.0 110.65 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 21.7 mtp -118.26 -106.55 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.013 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.418 HG11 ' HAC' ' A' ' 83' ' ' HEM . 78.6 t -89.07 -39.61 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.85 -1.157 . . . . 0.0 109.666 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.83 168.82 12.65 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -66.27 135.29 39.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.605 1.318 . . . . 0.0 110.502 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.865 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.8 150.02 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.937 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 10.4 m-85 -63.29 -59.91 4.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.199 -0.938 . . . . 0.0 109.925 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -47.59 -47.64 28.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.412 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.492 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 18.2 m-20 -57.33 -39.27 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 0.0 110.009 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 26' ' ' ALA . 73.3 t -57.08 -36.25 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -79.68 -29.62 40.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.461 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.37 -24.18 62.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 110.438 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -90.2 -42.89 10.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.017 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -90.43 9.18 30.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.292 -0.88 . . . . 0.0 109.849 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.83 140.89 40.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -12.0 67.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 3.8 mm-40 -54.06 147.25 13.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -1.161 . . . . 0.0 110.353 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.79 49.15 1.68 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.354 -0.841 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.82 53.24 0.37 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -73.47 -20.15 60.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -1.167 . . . . 0.0 110.371 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.576 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 1.1 pt-20 -66.95 -23.25 65.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 0.0 109.966 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -72.92 -59.54 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.206 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.622 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.5 t80 -65.27 -25.7 67.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.927 . . . . 0.0 109.046 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 48' ' ' ILE . 16.5 mt -66.75 -34.86 78.78 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.55 -31.86 67.47 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -74.26 -37.12 63.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.11 -0.994 . . . . 0.0 110.558 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.1 mmt180 -84.55 -14.91 47.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.973 -1.08 . . . . 0.0 109.644 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.952 HD11 HMA1 ' A' ' 83' ' ' HEM . 30.2 mt -85.98 -25.5 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.029 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.678 ' HG2' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -84.36 -19.36 33.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.42 -0.8 . . . . 0.0 110.447 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.602 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 4.8 m120 -127.99 -4.02 5.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 110.454 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.14 173.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.7 167.85 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.825 -1.397 . . . . 0.0 111.594 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -100.21 177.86 4.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 109.921 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.44 21.96 79.06 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 56' ' ' TRP . 10.5 t -95.17 -71.23 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.518 -0.989 . . . . 0.0 109.91 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.755 ' CD1' HG12 ' A' ' 55' ' ' VAL . 88.1 m95 -117.75 -34.88 4.08 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.053 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -151.45 -172.25 20.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.22 13.55 0.4 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.56 1.506 . . . . 0.0 112.231 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' O ' HAD2 ' A' ' 83' ' ' HEM . 8.2 mt -110.63 93.35 16.35 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.615 -1.303 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.545 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -61.8 131.01 33.34 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.644 1.339 . . . . 0.0 110.811 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.545 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 5.4 tmm? -73.73 132.2 81.01 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.8 Cg_endo -64.37 139.0 63.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.706 1.371 . . . . 0.0 108.702 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.5 Cg_endo -60.27 142.97 99.43 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.274 1.144 . . . . 0.0 110.274 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 2.8 m-80 -113.22 161.06 17.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.168 -0.957 . . . . 0.0 110.529 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.49 34.1 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' HG2' ' A' ' 49' ' ' LYS . 28.6 m -80.87 114.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 109.768 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.0 m -50.52 -177.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.048 -1.033 . . . . 0.0 109.597 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.1 -59.07 3.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.993 -1.067 . . . . 0.0 109.967 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -33.4 50.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 19.2 mm-40 -67.47 -50.14 60.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.219 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.839 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -64.23 -21.68 66.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -45.31 61.04 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.395 -0.816 . . . . 0.0 108.82 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 3' ' ' PRO . 57.6 m -72.59 -22.13 61.03 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.839 HD12 ' HA ' ' A' ' 71' ' ' ALA . 62.0 mt -73.0 -36.86 67.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.543 -0.723 . . . . 0.0 109.253 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -70.64 -50.72 33.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.201 -0.937 . . . . 0.0 108.956 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.7 OUTLIER -61.51 -24.16 66.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.36 -0.838 . . . . 0.0 109.021 178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.509 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 38.6 t90 -74.55 -41.19 61.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.496 -0.753 . . . . 0.0 109.863 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.736 HD13 HMA3 ' A' ' 83' ' ' HEM . 37.3 mt -60.51 -42.36 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.591 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.767 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -75.05 -13.53 60.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.339 -0.851 . . . . 0.0 110.511 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -100.06 -15.7 18.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.927 . . . . 0.0 110.473 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.507 ' HB3' HG23 ' A' ' 18' ' ' ILE . 18.1 mm-40 -50.6 92.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 80' ' ' SER . 11.8 mmtp . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.104 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.952 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.235 0.54 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -50.55 154.94 2.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.959 . . . . 0.0 109.961 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HB3' HG22 ' A' ' 73' ' ' THR . 2.8 Cg_endo -60.55 -26.76 83.54 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.663 1.349 . . . . 0.0 110.302 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -68.95 -38.33 79.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.206 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 50.8 t -62.65 -50.19 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.711 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.75 HD11 HD21 ' A' ' 74' ' ' LEU . 1.3 pp -72.08 -20.92 61.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 0.0 109.457 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -65.05 -37.51 87.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.782 . . . . 0.0 109.605 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -83.71 -38.06 21.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.823 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.482 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.5 m120 -60.21 -35.34 75.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.442 -0.786 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.689 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 46.3 mmtm -87.01 -14.05 42.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.152 -0.968 . . . . 0.0 110.313 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.59 10.29 56.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.657 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 19.5 m -62.62 -39.03 92.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.261 . . . . 0.0 110.031 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 3.32 22.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 111.019 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.88 -43.51 14.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.048 -1.032 . . . . 0.0 110.423 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 39.9 m -98.04 -23.09 15.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.276 -0.89 . . . . 0.0 110.459 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.555 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 30.1 m-70 -103.84 -175.18 2.73 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.362 1.077 . . . . 0.0 112.419 -177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.607 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -162.11 -171.6 2.91 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.408 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 23.7 mm -86.41 -69.0 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 120.669 -1.27 . . . . 0.0 110.118 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -110.08 -19.56 13.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.802 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.1 p -72.11 -169.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.333 -0.854 . . . . 0.0 110.038 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 5.3 pttt -150.51 87.46 1.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 110.582 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.6 mtm -79.88 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.92 . . . . 0.0 109.885 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 11.4 t -83.52 -29.61 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.994 -1.066 . . . . 0.0 110.089 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.0 171.48 14.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_exo -65.33 144.05 78.99 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.488 1.257 . . . . 0.0 110.077 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.83 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.58 162.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.6 m-85 -77.29 -60.62 2.29 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.525 ' HG3' ' HA ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -50.97 -37.77 46.73 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.599 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.7 m-20 -61.91 -46.29 90.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.828 . . . . 0.0 109.802 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 26' ' ' ALA . 68.7 t -52.17 -37.28 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.81 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.669 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . -85.08 -21.07 29.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.0 110.299 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.8 -26.25 60.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -87.21 -48.02 8.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.913 . . . . 0.0 110.092 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ALA . 13.9 m-85 -77.1 -13.11 60.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.164 -0.96 . . . . 0.0 110.02 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -43.15 109.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.944 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.74 34.3 0.7 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 2.5 mt-30 -125.93 144.37 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.125 -1.22 . . . . 0.0 110.304 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.39 47.6 1.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 0.0 110.859 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.78 40.56 0.07 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.013 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -80.72 -31.39 36.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -1.133 . . . . 0.0 109.874 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.6 OUTLIER -67.98 -22.93 64.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.457 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.47 -53.15 20.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.536 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 8.9 t80 -68.7 -24.87 64.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 48' ' ' ILE . 8.9 mt -69.69 -32.52 71.18 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.56 68.71 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.94 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.24 -37.31 63.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.036 -1.04 . . . . 0.0 110.287 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 5.3 mmt-85 -78.18 -18.41 55.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.912 . . . . 0.0 109.569 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.938 HD11 HMA1 ' A' ' 83' ' ' HEM . 30.7 mt -80.34 -36.04 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.576 -0.702 . . . . 0.0 109.857 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -78.13 -31.08 49.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 110.431 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.412 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.8 m-80 -109.28 -4.46 16.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.202 -0.936 . . . . 0.0 110.154 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.545 ' HA2' ' HE3' ' A' ' 61' ' ' MET . . . 57.76 166.38 0.1 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.3 OUTLIER 174.52 164.33 0.23 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.599 -1.53 . . . . 0.0 112.386 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -108.37 -171.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.626 -0.671 . . . . 0.0 109.848 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 20.58 76.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.005 HG12 ' CD1' ' A' ' 56' ' ' TRP . 78.7 t -102.81 -70.75 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.583 -0.951 . . . . 0.0 109.58 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 1.005 ' CD1' HG12 ' A' ' 55' ' ' VAL . 99.0 m95 -110.67 -41.07 4.39 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 109.5 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.23 -167.37 19.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -70.63 11.41 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.437 1.425 . . . . 0.0 111.895 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.407 ' O ' HMD3 ' A' ' 83' ' ' HEM . 10.4 mt -107.71 77.45 0.63 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.631 -1.293 . . . . 0.0 110.601 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.8 Cg_exo -56.38 139.05 86.03 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.535 1.281 . . . . 0.0 110.841 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.655 ' HE2' HBA1 ' A' ' 83' ' ' HEM . 12.3 ttp -71.29 133.03 85.6 Favored Pre-proline 0 C--N 1.299 -1.62 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.511 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.556 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -67.64 134.62 33.33 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.681 1.358 . . . . 0.0 108.992 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.0 Cg_endo -59.32 136.04 69.47 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.269 1.141 . . . . 0.0 110.53 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 9.5 m-80 -113.75 170.47 8.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.822 . . . . 0.0 110.474 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.83 34.95 1.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 66' ' ' VAL . 16.0 m -78.15 114.42 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -0.854 . . . . 0.0 110.12 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 66' ' ' VAL . 2.7 t -50.84 -176.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.343 -0.848 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -71.1 -42.11 69.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.174 -0.953 . . . . 0.0 110.324 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.05 -35.36 80.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.938 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.7 mt-10 -72.97 -40.79 65.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.203 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.74 -21.63 60.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.316 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -77.81 -43.35 30.81 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.261 -0.899 . . . . 0.0 108.577 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 3' ' ' PRO . 19.8 m -72.87 -24.5 60.87 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.859 HD22 ' CMB' ' A' ' 83' ' ' HEM . 23.6 mt -72.58 -46.17 55.62 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -64.19 -42.93 96.47 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.371 -0.83 . . . . 0.0 109.183 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 80' ' ' SER . 0.0 OUTLIER -69.56 -26.48 64.51 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.323 -0.861 . . . . 0.0 109.044 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.563 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 30.6 t90 -68.99 -43.08 75.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.495 -0.753 . . . . 0.0 109.298 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.789 HD13 HMA3 ' A' ' 83' ' ' HEM . 6.0 mt -62.07 -43.57 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.263 -0.898 . . . . 0.0 109.021 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.669 HD23 ' HB1' ' A' ' 31' ' ' ALA . 2.0 mt -75.48 -14.12 60.41 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.542 -0.724 . . . . 0.0 109.351 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 47.9 t -83.5 -31.73 26.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.467 -0.771 . . . . 0.0 110.11 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 3.1 mm100 -52.54 157.9 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.012 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.525 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 2.2 tptt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.938 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.151 0.501 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' OD1' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -74.76 167.26 38.09 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.0 Cg_endo -61.43 -17.82 55.77 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.618 1.325 . . . . 0.0 110.393 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.96 -32.95 65.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.372 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 t -66.69 -51.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.727 ' C ' HD12 ' A' ' 6' ' ' LEU . 2.5 pp -66.37 -31.28 71.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.398 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -56.45 -46.72 80.19 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.301 -0.874 . . . . 0.0 109.481 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -68.32 -37.53 80.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 0.0 109.736 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -61.88 -22.94 65.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.424 -0.797 . . . . 0.0 110.229 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 6' ' ' LEU . 45.5 mmtm -95.5 -25.17 16.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 109.812 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.57 13.12 28.9 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.507 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 24.6 m -64.69 -39.74 94.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.244 . . . . 0.0 110.255 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.36 2.55 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 110.855 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.09 -48.27 16.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.065 -1.022 . . . . 0.0 110.051 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 97.0 m -100.31 -27.02 13.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.43 -0.794 . . . . 0.0 110.453 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.636 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 14.7 m-70 -97.62 168.32 10.42 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.211 1.005 . . . . 0.0 112.35 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.602 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -151.61 -166.79 2.61 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.416 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 27.6 mm -90.44 -75.73 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.781 -1.199 . . . . 0.0 110.145 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -115.14 -1.44 13.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.124 -0.985 . . . . 0.0 110.501 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.667 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 4.9 p -81.28 -168.79 1.98 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.166 -0.958 . . . . 0.0 110.03 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.44 108.84 7.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.186 -0.946 . . . . 0.0 110.407 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 11.6 mtm -117.65 -119.52 0.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.046 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.603 HG11 ' HAC' ' A' ' 83' ' ' HEM . 42.7 t -77.75 -35.41 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.845 -1.159 . . . . 0.0 109.807 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.8 168.89 12.76 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.582 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 3.1 Cg_exo -64.76 139.65 63.89 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.726 1.382 . . . . 0.0 110.574 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -43.21 154.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.396 -0.815 . . . . 0.0 109.752 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.624 ' CE1' HG12 ' A' ' 78' ' ' ILE . 1.4 m-85 -70.51 -58.01 4.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 110.007 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' CG ' ' HA ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -48.04 -47.25 33.72 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.924 . . . . 0.0 109.443 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 22.4 m-20 -52.0 -45.56 64.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.413 -0.804 . . . . 0.0 109.929 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 26' ' ' ALA . 81.3 t -55.45 -37.96 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 110.123 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.818 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -76.33 -25.48 54.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.361 -0.837 . . . . 0.0 110.425 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.38 -29.86 65.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.234 -0.916 . . . . 0.0 110.622 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -85.41 -42.12 14.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -90.63 7.09 41.06 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.896 . . . . 0.0 109.696 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -61.03 118.28 6.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 110.384 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.38 -8.17 26.58 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.536 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -66.17 147.03 53.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.203 -1.174 . . . . 0.0 110.098 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.22 56.17 3.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 110.51 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.02 46.63 0.3 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -72.38 -16.03 61.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -1.226 . . . . 0.0 110.234 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HA ' HD12 ' A' ' 44' ' ' LEU . 2.7 mt-10 -70.17 -37.76 75.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.808 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -51.46 69.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 t80 -67.42 -31.82 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 108.953 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 41' ' ' GLU . 24.0 mt -64.75 -25.17 67.81 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.4 -35.06 41.27 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.706 -0.621 . . . . 0.0 109.929 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -77.57 -24.52 49.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.108 -0.995 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.587 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 11.8 mmp_? -89.46 -21.8 22.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.541 HG22 HG21 ' A' ' 66' ' ' VAL . 48.1 mt -84.6 -26.67 6.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.62 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -90.1 -8.06 52.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.397 -0.814 . . . . 0.0 110.484 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -133.14 -7.49 3.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.062 -1.023 . . . . 0.0 111.202 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 69.06 162.17 2.75 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -174.36 150.11 1.43 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.585 -1.538 . . . . 0.0 112.855 -179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.68 -173.71 2.3 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.694 -0.629 . . . . 0.0 109.558 178.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 62.25 16.29 53.44 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.961 HG12 ' CD1' ' A' ' 56' ' ' TRP . 98.0 t -93.13 -71.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.637 -0.919 . . . . 0.0 109.225 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.961 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.8 m95 -109.86 -39.57 5.04 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.718 0.771 . . . . 0.0 109.012 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.58 -178.03 28.52 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -68.91 8.09 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 121.498 1.466 . . . . 0.0 112.091 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.575 ' O ' HMD3 ' A' ' 83' ' ' HEM . 4.5 mt -107.12 80.04 0.78 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.674 -1.266 . . . . 0.0 109.651 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.0 Cg_endo -55.37 148.9 49.13 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.854 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.659 ' HE2' HBA1 ' A' ' 83' ' ' HEM . 7.9 ttp -76.79 131.97 72.57 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.057 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.511 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.9 Cg_endo -65.9 134.57 37.83 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.617 1.325 . . . . 0.0 109.122 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.3 132.42 48.8 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.289 1.152 . . . . 0.0 110.075 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 4.2 m-80 -107.88 160.35 15.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 110.522 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.13 32.8 0.9 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 109.791 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 66' ' ' VAL . 22.9 m -72.35 114.62 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.504 -0.748 . . . . 0.0 110.212 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 66' ' ' VAL . 33.6 m -47.74 174.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.215 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.53 -64.62 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.808 -1.183 . . . . 0.0 110.186 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.47 -22.22 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.87 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 11.4 mm-40 -72.42 -52.54 15.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.32 -0.863 . . . . 0.0 110.22 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -67.21 -18.76 65.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.184 -0.948 . . . . 0.0 108.785 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.93 -47.63 43.97 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 3' ' ' PRO . 3.9 m -68.0 -24.49 65.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.063 ' O ' HD12 ' A' ' 78' ' ' ILE . 75.6 mt -73.19 -33.6 65.49 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.76 -51.46 40.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.42 -0.8 . . . . 0.0 109.61 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.3 OUTLIER -60.98 -32.07 71.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.151 -0.968 . . . . 0.0 109.108 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.466 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 27.9 t90 -64.71 -48.08 75.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 109.716 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.063 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.6 mt -60.34 -56.35 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.448 -0.782 . . . . 0.0 110.028 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 31' ' ' ALA . 1.5 mt -66.82 -11.74 56.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.855 . . . . 0.0 110.604 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 39.9 t -95.95 -20.31 18.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 110.413 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 77' ' ' TRP . 2.9 mm100 -46.34 -66.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.09 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HA ' ' CG ' ' A' ' 28' ' ' LYS . 2.6 mttm . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.855 ' CGA' HG11 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.182 0.515 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 3.1 m-20 -66.66 164.1 36.08 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.999 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo -61.57 -45.48 17.62 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.697 1.367 . . . . 0.0 110.462 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 2' ' ' ASP . 7.2 pt-20 -48.65 -45.97 39.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.285 -0.884 . . . . 0.0 109.542 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.521 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 37.9 t -51.06 -47.12 31.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.259 -0.9 . . . . 0.0 109.078 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 71.0 mt -56.06 -50.52 70.75 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.586 0.707 . . . . 0.0 109.801 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . . . -51.94 -26.27 10.06 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.582 -0.698 . . . . 0.0 110.251 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -56.69 3.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 110.994 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 15.1 m-80 -64.44 -11.3 32.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.911 -1.118 . . . . 0.0 110.467 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.732 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 71.2 mmtt -101.42 -15.01 17.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 110.03 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.05 12.11 71.7 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.569 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 29.4 m -63.23 -40.46 97.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.084 -1.245 . . . . 0.0 110.347 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.434 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -74.44 2.47 9.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.148 -0.97 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.14 -50.55 12.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.002 -1.061 . . . . 0.0 110.454 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 80.6 m -99.64 -14.26 19.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.919 . . . . 0.0 110.785 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.629 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 19.6 m-70 -105.34 174.13 6.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.076 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -149.87 -179.47 7.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 3.3 mp -90.66 -24.83 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.869 -1.144 . . . . 0.0 110.414 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 12.5 p-10 -157.77 -27.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.101 -1.0 . . . . 0.0 111.463 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 81.0 p -68.86 -173.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.772 -1.205 . . . . 0.0 110.115 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 104.64 8.85 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.1 -1.0 . . . . 0.0 111.011 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.431 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -107.88 -132.19 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.373 -0.83 . . . . 0.0 109.112 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.6 t -69.4 -48.17 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.864 -1.147 . . . . 0.0 109.061 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.03 167.79 21.89 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.579 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -67.0 143.32 65.4 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.572 1.301 . . . . 0.0 110.31 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.723 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -44.97 170.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.731 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.5 m-85 -86.93 -54.6 4.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.953 -1.092 . . . . 0.0 110.04 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 82' ' ' LYS . 1.1 tmmm? -50.54 -49.74 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.928 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -54.64 -42.81 71.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.431 -0.793 . . . . 0.0 110.073 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 26' ' ' ALA . 53.5 t -56.07 -38.06 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.85 . . . . 0.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.63 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -76.5 -26.58 55.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 110.142 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.39 -29.11 65.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.2 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -84.64 -47.77 10.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -0.968 . . . . 0.0 109.984 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -77.28 -3.71 41.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -0.987 . . . . 0.0 109.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -52.27 121.91 7.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.934 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.24 -37.45 2.65 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 2.9 mm100 -63.17 126.28 26.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.36 -1.082 . . . . 0.0 110.06 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.2 46.05 1.29 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 110.375 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.57 40.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 44' ' ' LEU . . . -79.92 -12.74 59.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 109.908 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.538 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -75.11 -22.45 58.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 0.0 109.907 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -71.62 -51.52 22.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.664 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.556 ' CE1' ' NE ' ' A' ' 47' ' ' ARG . 45.5 t80 -69.64 -33.4 72.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.605 ' O ' HD12 ' A' ' 48' ' ' ILE . 22.6 mt -61.38 -30.12 70.34 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.22 -38.85 60.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.391 -0.818 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.94 -19.44 60.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.051 -1.031 . . . . 0.0 109.845 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' NE ' ' CE1' ' A' ' 43' ' ' TYR . 6.5 mmt180 -90.17 -24.15 21.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.613 HD11 HMA1 ' A' ' 83' ' ' HEM . 62.6 mt -86.71 -19.75 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.331 -0.856 . . . . 0.0 109.318 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -22.99 24.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 110.516 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 57.6 m-80 -126.21 -6.71 6.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.073 -1.017 . . . . 0.0 110.407 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.555 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 52.16 173.98 0.03 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 2.8 t 162.11 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.413 -1.051 . . . . 0.0 111.172 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 1.2 pm0 -100.16 -165.26 1.2 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.239 -0.913 . . . . 0.0 110.165 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 64.14 18.72 62.99 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.014 -2.035 . . . . 0.0 108.014 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.808 HG11 ' CBA' ' A' ' 83' ' ' HEM . 2.4 t -95.5 -67.73 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.739 -0.859 . . . . 0.0 109.099 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.579 ' CB ' ' HG3' ' A' ' 25' ' ' PRO . 95.5 m95 -124.1 -36.38 2.7 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.65 -177.44 20.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.514 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -69.46 8.25 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.457 1.438 . . . . 0.0 112.038 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.479 ' O ' HAD2 ' A' ' 83' ' ' HEM . 6.3 mt -105.86 100.78 29.58 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.715 -1.241 . . . . 0.0 110.851 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.553 ' CG ' ' HB3' ' A' ' 53' ' ' GLN . 2.4 Cg_endo -64.63 133.41 36.68 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.457 1.24 . . . . 0.0 110.602 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.647 ' HE2' ' NA ' ' A' ' 83' ' ' HEM . 0.9 OUTLIER -71.87 135.6 83.0 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD2' ' HG2' ' A' ' 61' ' ' MET . 3.0 Cg_endo -64.21 130.46 27.17 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.735 1.387 . . . . 0.0 109.456 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.23 135.79 64.29 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.401 1.211 . . . . 0.0 110.61 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -109.05 163.83 12.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.67 36.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.969 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' VAL . 15.5 m -84.38 105.09 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.056 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.443 ' C ' ' O ' ' A' ' 66' ' ' VAL . 75.1 p -42.58 147.2 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 0.0 109.224 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 72' ' ' GLN . 8.0 p-10 -42.57 -31.44 0.45 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.993 -1.067 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.45 -47.96 68.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.109 -0.994 . . . . 0.0 109.564 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.496 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 52.7 mt-10 -63.62 -48.05 78.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.371 -0.831 . . . . 0.0 110.161 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -67.27 -16.64 64.4 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.02 . . . . 0.0 109.142 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -74.33 -45.62 46.07 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.55 -27.74 63.39 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.829 HD12 ' HA ' ' A' ' 71' ' ' ALA . 49.6 mt -69.77 -34.96 74.48 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -67.46 -54.65 18.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' SER . 6.2 mttp -58.43 -25.12 61.83 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.406 -0.809 . . . . 0.0 108.871 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' LEU . 35.9 t90 -70.51 -43.11 70.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.61 -0.681 . . . . 0.0 109.515 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' A' ' 27' ' ' TYR . 4.9 mt -59.38 -50.91 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.739 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.63 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -73.72 -9.97 59.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.32 -0.863 . . . . 0.0 110.074 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 36.7 t -97.5 -16.46 20.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 110.326 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' HG3' ' HB3' ' A' ' 27' ' ' TYR . 22.5 mm-40 -43.7 -44.0 6.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.059 -1.026 . . . . 0.0 110.212 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 81' ' ' GLN . 10.8 tttt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.922 -1.037 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.808 ' CBA' HG11 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.227 0.537 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.62 164.79 0.39 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.101 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.551 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 3.1 Cg_exo -61.28 -27.22 83.04 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.678 1.357 . . . . 0.0 110.268 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.28 -33.92 73.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.221 -0.924 . . . . 0.0 108.626 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 98.0 t -64.45 -58.02 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.643 -0.661 . . . . 0.0 109.718 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.747 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.7 pp -64.16 -24.42 67.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.536 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -67.72 -29.49 68.75 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.407 -0.808 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -52.16 8.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 0.0 110.322 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.529 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 15.1 m-80 -63.27 -16.48 60.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.091 -1.006 . . . . 0.0 110.383 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.562 ' HE3' HG12 ' A' ' 66' ' ' VAL . 34.2 mmtt -87.97 -18.8 28.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.0 109.835 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.63 13.53 53.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.618 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 57.4 m -69.72 -38.68 76.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -1.235 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mtp -82.36 6.0 18.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.166 -0.959 . . . . 0.0 110.782 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.52 -35.71 19.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 110.353 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 36.4 m -106.0 -22.95 12.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -0.819 . . . . 0.0 110.391 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.64 ' CB ' ' CZ ' ' A' ' 27' ' ' TYR . 28.7 m-70 -103.35 153.84 20.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 111.415 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.891 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -129.89 123.93 31.96 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.655 HD13 ' OE1' ' A' ' 81' ' ' GLN . 35.7 mm -36.78 -29.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.572 -0.705 . . . . 0.0 111.014 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.606 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -153.45 -32.33 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.177 -0.952 . . . . 0.0 111.088 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.891 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -69.43 179.33 2.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.023 -1.048 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -117.69 120.42 37.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -0.872 . . . . 0.0 110.741 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 19.5 mtp -125.22 -108.08 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 25.3 t -86.32 -31.78 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 109.495 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 171.71 17.26 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -66.0 140.42 60.15 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.682 1.359 . . . . 0.0 110.383 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.032 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -42.44 149.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.875 . . . . 0.0 110.233 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.64 ' CZ ' ' CB ' ' A' ' 16' ' ' HIS . 3.0 m-85 -63.43 -60.19 3.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.207 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -49.68 -49.19 48.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.966 . . . . 0.0 109.635 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.585 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 12.8 m-20 -55.48 -40.07 71.21 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.418 -0.801 . . . . 0.0 110.027 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.032 HG23 ' O ' ' A' ' 26' ' ' ALA . 95.5 t -57.84 -38.39 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.344 -0.848 . . . . 0.0 110.003 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -75.92 -25.83 56.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 110.001 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.51 -27.49 63.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.208 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 19.1 tttt -86.56 -43.75 12.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.329 -0.857 . . . . 0.0 110.153 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -82.82 -2.25 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.124 -0.985 . . . . 0.0 109.978 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -55.7 101.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.274 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.73 33.81 0.42 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -116.78 145.86 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -1.2 . . . . 0.0 110.229 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.07 41.57 1.05 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.36 48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.94 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -76.92 -33.66 57.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.214 -1.168 . . . . 0.0 110.1 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.642 ' HG2' ' HB3' ' A' ' 75' ' ' ALA . 3.0 tm-20 -64.29 -24.79 67.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -0.825 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.34 -51.6 23.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.174 -0.954 . . . . 0.0 109.985 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.617 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 1.3 t80 -71.32 -21.79 62.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.14 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.94 HD12 ' O ' ' A' ' 40' ' ' ALA . 3.5 mt -74.5 -26.67 60.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.24 46.14 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.636 -0.665 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.544 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -77.15 -34.66 56.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.961 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.617 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 75.5 mmt-85 -81.37 -22.11 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.778 HD11 ' CMA' ' A' ' 83' ' ' HEM . 19.3 mt -80.98 -30.05 11.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.39 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.05 -23.35 26.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 110.204 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLY . 0.7 OUTLIER -118.63 0.25 11.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 110.364 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 58.01 158.76 0.02 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.511 ' CB ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -177.32 158.63 1.47 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.546 -1.561 . . . . 0.0 112.595 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.587 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -111.34 -172.57 2.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.62 -0.675 . . . . 0.0 109.688 179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.4 19.07 75.81 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.749 HG12 ' CD1' ' A' ' 56' ' ' TRP . 27.7 t -99.16 -74.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.632 -0.922 . . . . 0.0 109.814 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.756 ' HZ2' HG13 ' A' ' 30' ' ' VAL . 97.5 m95 -106.91 -38.8 5.95 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.37 -0.831 . . . . 0.0 109.605 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.42 -165.74 18.82 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.05 13.44 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.383 1.389 . . . . 0.0 111.963 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.647 ' O ' HMD3 ' A' ' 83' ' ' HEM . 6.3 mt -110.76 80.16 2.06 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.569 -1.332 . . . . 0.0 110.301 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -60.18 144.71 99.48 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.674 1.355 . . . . 0.0 110.997 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.622 ' HE2' HBA1 ' A' ' 83' ' ' HEM . 5.9 ttp -73.93 134.55 77.96 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.661 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.701 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -69.77 139.26 39.75 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.668 1.352 . . . . 0.0 109.065 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 132.34 41.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.254 1.134 . . . . 0.0 110.133 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.4 m-80 -108.03 173.38 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.744 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.08 33.4 2.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.969 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG12 ' HE3' ' A' ' 10' ' ' LYS . 16.7 m -78.41 120.84 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 0.0 109.885 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 66' ' ' VAL . 6.2 m -49.68 -178.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.889 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.04 -58.2 4.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 109.694 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.86 -17.45 36.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.24 -0.913 . . . . 0.0 109.44 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.498 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 1.6 mm-40 -77.6 -50.23 12.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -66.42 -22.68 66.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.262 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -72.52 -44.61 61.97 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 3' ' ' PRO . 1.6 m -71.24 -24.05 62.11 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.809 HD13 HMB1 ' A' ' 83' ' ' HEM . 27.1 mt -68.39 -38.21 81.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.642 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . . . -69.79 -51.2 35.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 109.135 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' O ' ' CB ' ' A' ' 80' ' ' SER . 1.2 mttp -62.42 -23.34 66.8 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.358 -0.839 . . . . 0.0 109.309 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.536 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 33.9 t90 -73.64 -42.15 61.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.485 -0.759 . . . . 0.0 109.9 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.898 ' CD1' HMA2 ' A' ' 83' ' ' HEM . 96.7 mt -63.29 -56.44 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 31' ' ' ALA . 1.3 mp -65.78 -18.43 65.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.852 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 3.6 t -78.48 -29.81 46.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.373 -0.829 . . . . 0.0 110.148 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.655 ' OE1' HD13 ' A' ' 18' ' ' ILE . 12.0 mt-30 -57.61 -167.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.094 -1.004 . . . . 0.0 109.981 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.371 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.898 HMA2 ' CD1' ' A' ' 78' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.686 ' HG3' HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -69.35 175.12 2.33 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.167 -0.958 . . . . 0.0 110.09 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.61 ' HA ' HD21 ' A' ' 6' ' ' LEU . 2.8 Cg_endo -62.1 -20.82 71.08 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.626 1.33 . . . . 0.0 110.577 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 5.7 tm-20 -68.35 -44.64 74.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.686 HG11 ' HG3' ' A' ' 1' ' ' GLU . 25.9 t -58.77 -50.13 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.354 -0.841 . . . . 0.0 110.087 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.792 HD12 ' N ' ' A' ' 7' ' ' ALA . 4.2 pp -70.85 -22.6 62.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.351 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.792 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -62.45 -38.95 91.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.571 -0.705 . . . . 0.0 109.392 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.32 -41.14 34.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.843 . . . . 0.0 109.966 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.9 m120 -62.95 -23.46 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 17.7 mmtt -91.14 -14.53 30.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.93 11.59 58.73 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.615 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 17.6 m -69.49 -38.58 77.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -1.202 . . . . 0.0 110.48 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.35 6.78 9.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.954 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.25 -46.56 10.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.077 -1.014 . . . . 0.0 110.319 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 94.8 m -99.0 -16.56 18.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.402 -0.811 . . . . 0.0 110.578 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.623 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 14.7 m-70 -110.07 178.63 4.34 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.387 1.089 . . . . 0.0 112.435 -177.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -155.29 -169.17 3.07 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.536 HD13 ' OE1' ' A' ' 81' ' ' GLN . 29.9 mm -90.8 -73.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.683 -1.261 . . . . 0.0 110.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -112.55 -10.14 13.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 110.004 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.73 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.3 p -77.4 -161.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.398 -0.814 . . . . 0.0 109.879 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 119.74 9.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.0 110.323 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.508 ' CE ' ' O ' ' A' ' 16' ' ' HIS . 15.4 mtm -121.58 -113.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.749 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 54.1 t -78.19 -32.78 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.801 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -120.78 175.33 16.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.539 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.63 142.12 69.41 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.617 1.325 . . . . 0.0 110.235 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -42.6 157.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.936 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.623 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.4 m-85 -73.41 -61.33 1.87 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.076 -1.015 . . . . 0.0 109.936 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 27' ' ' TYR . 5.8 tttt -46.29 -45.77 17.53 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 0.0 109.462 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -51.58 -45.56 63.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.489 -0.757 . . . . 0.0 109.811 179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' ALA . 88.6 t -55.03 -45.21 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.324 -0.86 . . . . 0.0 109.931 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -69.94 -21.25 63.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.768 . . . . 0.0 110.155 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.09 -27.68 42.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 110.531 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -35.14 15.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.119 -0.988 . . . . 0.0 110.084 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' ALA . 16.6 m-85 -85.9 -9.24 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.552 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -42.73 111.2 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -0.836 . . . . 0.0 110.018 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.94 40.28 2.16 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.785 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -102.81 152.22 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 110.335 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.02 42.12 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.878 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.98 46.45 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -66.19 -29.68 70.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -1.107 . . . . 0.0 110.532 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 0.6 OUTLIER -68.66 -32.22 71.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 109.736 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.19 -52.86 16.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 13.3 t80 -70.38 -19.39 63.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.154 -0.966 . . . . 0.0 109.276 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.683 HD22 HMA2 ' A' ' 83' ' ' HEM . 10.8 mt -73.97 -33.82 64.01 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.75 69.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.735 -0.603 . . . . 0.0 109.5 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -43.75 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.0 OUTLIER -77.51 -17.21 58.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.437 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.986 HD11 HMA1 ' A' ' 83' ' ' HEM . 13.3 mt -83.19 -24.75 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.492 -0.755 . . . . 0.0 109.349 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.442 ' HG3' HG23 ' A' ' 66' ' ' VAL . 3.0 mtpp -85.34 -29.15 24.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.293 -0.879 . . . . 0.0 110.396 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 36.6 p30 -114.46 -5.15 12.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 110.634 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 59.05 172.1 0.42 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.62 163.5 0.12 Allowed 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.705 -1.468 . . . . 0.0 112.422 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.581 ' CB ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -110.33 -178.91 3.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.433 -0.792 . . . . 0.0 109.876 179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.565 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 74.51 20.22 79.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.947 HG12 ' CD1' ' A' ' 56' ' ' TRP . 71.3 t -103.91 -67.09 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.679 -0.895 . . . . 0.0 109.765 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.947 ' CD1' HG12 ' A' ' 55' ' ' VAL . 99.5 m95 -111.07 -40.13 4.56 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.338 -0.851 . . . . 0.0 110.114 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.54 -165.84 18.16 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.72 5.06 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.479 1.453 . . . . 0.0 111.619 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.772 HG22 ' CMD' ' A' ' 83' ' ' HEM . 7.1 mt -108.29 85.62 2.87 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.79 -1.194 . . . . 0.0 111.174 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.581 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.16 155.49 39.64 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.627 1.33 . . . . 0.0 110.275 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.585 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 49.9 ttp -87.92 134.85 34.44 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.791 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -67.29 132.95 28.96 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.768 1.404 . . . . 0.0 109.172 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -59.04 136.09 70.82 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.269 1.142 . . . . 0.0 110.461 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.0 m-80 -112.03 163.25 14.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.401 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.8 36.94 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.963 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 66' ' ' VAL . 16.0 m -77.71 108.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.374 -0.828 . . . . 0.0 110.421 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -43.72 146.22 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 67' ' ' SER . 7.7 p-10 -41.15 -40.91 1.66 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.104 -0.997 . . . . 0.0 110.872 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.35 -45.22 94.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.126 -0.984 . . . . 0.0 110.085 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 72.9 mm-40 -64.09 -42.38 96.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.482 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -66.97 -22.17 65.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.008 . . . . 0.0 109.699 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -72.15 -41.21 67.36 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 77' ' ' TRP . 1.2 m -73.96 -24.49 59.64 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.915 ' O ' HD12 ' A' ' 78' ' ' ILE . 41.8 mt -72.42 -37.86 68.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.557 -0.714 . . . . 0.0 109.18 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -71.83 -49.51 37.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.127 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 80' ' ' SER . 2.8 mttt -63.78 -25.15 68.05 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.353 -0.842 . . . . 0.0 108.816 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.595 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 24.7 t90 -70.39 -51.9 26.31 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.478 -0.764 . . . . 0.0 109.541 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.915 HD12 ' O ' ' A' ' 74' ' ' LEU . 4.3 mt -54.68 -49.66 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -0.806 . . . . 0.0 109.789 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -71.15 -17.36 62.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.142 -0.973 . . . . 0.0 109.847 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' LYS . 11.9 t -93.34 -8.7 41.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.862 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.536 ' OE1' HD13 ' A' ' 18' ' ' ILE . 15.1 mm-40 -40.62 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.283 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' SER . 28.2 mmmt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.245 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.986 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.27 170.3 3.76 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.289 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.84 -40.05 56.97 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.644 1.339 . . . . 0.0 110.541 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.89 -48.36 78.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.722 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.4 t -49.77 -34.26 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.511 HD12 ' CG2' ' A' ' 73' ' ' THR . 39.8 mt -71.45 -38.38 71.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HB1' ' CH2' ' A' ' 77' ' ' TRP . . . -58.47 -27.14 64.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.676 . . . . 0.0 110.141 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -90.0 -46.9 8.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.932 . . . . 0.0 110.528 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.0 m120 -63.99 -16.75 62.3 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.243 -0.911 . . . . 0.0 111.052 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.643 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 54.4 mmtt -104.46 -25.38 12.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.056 . . . . 0.0 110.487 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.21 15.0 22.89 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.554 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 17.0 m -66.79 -35.05 79.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.276 -1.132 . . . . 0.0 110.2 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mmm -79.71 5.96 12.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.263 -0.898 . . . . 0.0 110.914 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.48 -37.21 15.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.109 -0.994 . . . . 0.0 110.482 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -105.33 -16.59 14.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.669 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.624 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 22.0 m-70 -105.16 166.78 10.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.903 -1.123 . . . . 0.0 112.082 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -146.91 120.13 8.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 17.9 mt -37.36 -29.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' OD1' HG23 ' A' ' 20' ' ' THR . 2.3 p30 -151.75 -36.13 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.077 -1.015 . . . . 0.0 110.614 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.923 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 19.8 p -70.0 163.11 26.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.999 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -104.25 129.08 52.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 0.0 110.635 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.455 ' HE3' ' O ' ' A' ' 16' ' ' HIS . 10.3 mtm -127.27 -88.75 0.56 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.609 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -108.44 -33.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.47 174.5 16.26 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.529 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -64.71 129.65 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.56 1.294 . . . . 0.0 110.305 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.874 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -38.91 149.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.448 -0.782 . . . . 0.0 110.073 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.787 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.4 m-85 -65.4 -58.98 4.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 110.52 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -48.27 -47.12 36.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.954 -1.091 . . . . 0.0 109.623 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.13 -40.47 67.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.363 -0.836 . . . . 0.0 109.8 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 26' ' ' ALA . 59.0 t -58.45 -39.9 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -77.34 -19.9 55.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.35 -0.844 . . . . 0.0 109.994 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.41 -28.71 46.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.296 -0.878 . . . . 0.0 110.057 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -40.34 12.66 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.285 -0.884 . . . . 0.0 109.719 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.85 -11.46 59.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.79 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.0 103.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 109.985 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 130.7 33.82 0.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -129.75 128.49 42.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -1.198 . . . . 0.0 110.157 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.22 56.17 3.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.275 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.52 44.81 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' HD12 ' A' ' 44' ' ' LEU . . . -74.41 -50.61 17.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 10.3 pt-20 -48.47 -35.62 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.365 -0.834 . . . . 0.0 110.527 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -56.85 -54.58 44.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 109.881 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.47 -38.11 88.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.208 -0.932 . . . . 0.0 109.204 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.81 HD23 HMA3 ' A' ' 83' ' ' HEM . 0.9 OUTLIER -59.79 -27.45 66.58 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -73.51 -36.48 65.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.564 -0.71 . . . . 0.0 109.644 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.99 -37.34 69.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.263 -0.898 . . . . 0.0 110.465 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 23.2 mmt180 -80.65 -16.49 53.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.933 HD11 HMA1 ' A' ' 83' ' ' HEM . 49.9 mt -87.72 -23.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.709 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -19.95 30.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.506 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 76.8 m-20 -136.28 2.25 2.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.009 -1.057 . . . . 0.0 110.544 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 50.64 175.33 0.02 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER 169.14 167.89 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.761 -1.435 . . . . 0.0 111.802 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.571 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -109.25 -177.72 3.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.324 -0.86 . . . . 0.0 109.545 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 73.8 21.44 79.29 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.823 HG12 ' CD1' ' A' ' 56' ' ' TRP . 8.0 t -99.38 -68.34 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.68 -0.894 . . . . 0.0 109.646 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.823 ' CD1' HG12 ' A' ' 55' ' ' VAL . 86.3 m95 -118.55 -36.71 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.369 -0.832 . . . . 0.0 109.749 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.36 -171.82 23.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.555 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.32 9.73 0.49 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.582 1.521 . . . . 0.0 112.115 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.717 ' O ' HMD3 ' A' ' 83' ' ' HEM . 6.3 mt -109.53 84.17 2.98 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 120.714 -1.241 . . . . 0.0 110.453 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.04 144.24 99.45 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.663 1.349 . . . . 0.0 111.192 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.583 ' HE2' ' NA ' ' A' ' 83' ' ' HEM . 1.0 OUTLIER -77.18 134.88 66.86 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 110.012 179.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.743 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.6 Cg_endo -69.18 137.43 37.14 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 N-CA-C 108.395 -1.425 . . . . 0.0 108.395 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -56.89 156.51 23.36 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.224 1.118 . . . . 0.0 110.081 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 8.0 m-80 -128.62 164.38 22.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 111.059 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.66 34.9 0.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.427 -0.796 . . . . 0.0 109.512 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.664 HG21 HG22 ' A' ' 48' ' ' ILE . 10.6 m -86.89 109.62 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.513 -0.742 . . . . 0.0 110.441 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.474 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 2.1 m -47.06 173.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -57.3 13.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.997 -1.064 . . . . 0.0 110.42 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.98 -19.29 41.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 0.0 110.093 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 66' ' ' VAL . 10.6 mt-10 -78.58 -45.74 21.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -0.903 . . . . 0.0 110.427 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -70.7 -22.17 62.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.11 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -44.28 58.22 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.511 ' CG2' HD12 ' A' ' 6' ' ' LEU . 4.0 m -71.78 -25.2 61.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 71' ' ' ALA . 46.0 mt -77.33 -27.0 52.66 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -75.26 -52.58 10.53 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.549 -0.719 . . . . 0.0 109.215 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -59.75 -29.22 68.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 108.623 178.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.728 ' CH2' ' HB1' ' A' ' 7' ' ' ALA . 31.7 t90 -61.48 -53.34 57.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.61 -0.682 . . . . 0.0 109.507 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.787 HG23 ' CD1' ' A' ' 27' ' ' TYR . 7.2 mt -60.29 -40.98 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 110.159 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -76.88 -9.81 58.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.271 -0.893 . . . . 0.0 110.598 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 76' ' ' LYS . 41.7 m -121.08 7.64 10.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.071 -1.018 . . . . 0.0 110.644 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.6 ' OE1' ' CD2' ' A' ' 77' ' ' TRP . 17.3 mm100 -42.64 -54.87 3.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.126 -0.983 . . . . 0.0 110.416 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.358 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.933 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.242 0.544 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -87.28 153.0 53.5 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.226 -0.921 . . . . 0.0 110.222 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 2.9 Cg_endo -61.34 -24.13 78.12 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.704 1.37 . . . . 0.0 110.28 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.09 -32.14 64.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.296 -0.877 . . . . 0.0 109.861 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 48.8 t -71.51 -45.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.84 . . . . 0.0 110.044 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.705 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -69.02 -31.4 70.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -59.68 -55.89 28.7 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -55.45 -42.59 74.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.1 m120 -59.9 -27.89 67.11 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 110.521 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 1.024 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 75.2 mmtt -93.32 -16.29 24.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 0.0 110.12 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.95 18.45 34.33 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.668 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 9.1 m -68.86 -42.34 77.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.05 -1.265 . . . . 0.0 109.992 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.54 5.11 16.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.887 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.45 -44.26 11.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 110.651 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 57.4 m -96.73 -19.84 18.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.593 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.612 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 26.5 m-70 -98.72 165.88 11.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.015 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.802 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -136.82 114.27 10.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 81' ' ' GLN . 2.5 mp -37.16 -35.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.49 -0.756 . . . . 0.0 110.89 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -151.78 9.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.956 . . . . 0.0 111.191 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.802 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -112.69 -160.54 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.981 -1.074 . . . . 0.0 109.889 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.71 131.38 35.54 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.015 -1.053 . . . . 0.0 110.591 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.5 mtp -140.83 -99.57 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 15' ' ' CYS . 5.9 t -93.86 -31.28 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.025 -1.047 . . . . 0.0 109.22 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.76 171.77 18.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 3.0 Cg_endo -65.92 136.57 45.57 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.6 1.316 . . . . 0.0 110.381 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 20' ' ' THR . . . -42.6 152.63 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.047 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.633 ' CD1' HG23 ' A' ' 78' ' ' ILE . 3.6 m-85 -67.37 -57.45 6.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.971 . . . . 0.0 110.213 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.64 -50.13 60.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.855 -1.153 . . . . 0.0 109.638 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 3.8 m-20 -54.33 -44.14 71.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.357 -0.84 . . . . 0.0 109.992 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' ALA . 23.1 t -54.16 -33.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 110.019 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -80.46 -26.35 38.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.373 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.25 -29.37 63.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.1 -38.02 19.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.88 . . . . 0.0 109.749 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -88.15 -4.08 58.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.746 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.69 109.04 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.213 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.31 -23.76 2.84 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 1.5 mm-40 -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -1.146 . . . . 0.0 110.018 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.85 39.45 0.93 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 110.401 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.49 43.28 0.04 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -69.54 -15.0 63.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -1.176 . . . . 0.0 110.093 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.526 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.4 pt-20 -80.49 -34.24 35.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.249 -0.907 . . . . 0.0 109.081 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.794 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -65.04 -48.98 71.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.495 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 0.7 OUTLIER -64.64 -46.0 84.38 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.769 HD22 HMA2 ' A' ' 83' ' ' HEM . 20.2 mt -55.97 -21.3 20.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.794 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -74.91 -43.11 56.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.554 -0.716 . . . . 0.0 109.945 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 43' ' ' TYR . 1.9 pt20 -75.6 -20.53 58.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.099 -1.001 . . . . 0.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' O ' ' CE ' ' A' ' 61' ' ' MET . 8.7 mmt85 -90.54 -16.92 27.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.311 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.037 HD11 HMA1 ' A' ' 83' ' ' HEM . 25.6 mt -85.91 -32.14 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.564 -0.71 . . . . 0.0 109.454 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.77 -21.17 37.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 2.5 m120 -116.68 -11.45 10.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 60.84 161.19 0.11 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 1.3 t -179.24 163.33 1.27 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.636 -1.508 . . . . 0.0 112.621 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.579 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -104.68 -178.0 3.53 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.642 -0.661 . . . . 0.0 109.618 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.49 20.41 78.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.918 HG12 ' CD1' ' A' ' 56' ' ' TRP . 44.2 t -96.88 -70.23 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.63 -0.923 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.918 ' CD1' HG12 ' A' ' 55' ' ' VAL . 98.9 m95 -114.68 -37.53 4.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.525 -0.734 . . . . 0.0 109.679 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.72 -169.45 20.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -70.21 11.41 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.566 1.511 . . . . 0.0 112.063 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.516 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 14.1 mt -109.59 86.04 4.23 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.651 -1.281 . . . . 0.0 110.586 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.3 Cg_exo -59.9 135.32 62.42 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.541 1.285 . . . . 0.0 111.013 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.565 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 52.5 ttp -71.75 130.8 86.58 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.458 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.08 138.52 47.81 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.648 1.341 . . . . 0.0 109.346 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.548 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -60.02 136.75 71.4 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.342 1.18 . . . . 0.0 110.054 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 3.2 m-80 -107.8 -174.65 2.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.02 . . . . 0.0 110.865 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.88 36.98 3.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.751 . . . . 0.0 110.018 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 66' ' ' VAL . 25.8 m -81.37 114.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.044 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB2' ' OE1' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -46.8 174.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 109.631 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.77 -41.11 97.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.994 -1.066 . . . . 0.0 110.392 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -71.17 -23.25 62.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.299 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.56 ' HG2' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -81.1 -36.75 29.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 110.148 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB2' HG23 ' A' ' 66' ' ' VAL . . . -76.31 -27.9 56.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.037 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 4.1 mt-30 -74.1 -41.97 60.82 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.558 ' HA ' ' CG ' ' A' ' 76' ' ' LYS . 85.8 m -73.8 -24.02 59.76 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.946 HD22 ' CMB' ' A' ' 83' ' ' HEM . 18.5 mt -74.51 -33.72 62.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.7 . . . . 0.0 109.124 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.53 -50.04 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.393 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.558 ' CG ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -67.46 -23.26 65.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.138 178.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.512 ' HA ' ' OG ' ' A' ' 80' ' ' SER . 49.3 t90 -75.84 -36.74 59.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.606 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.673 HD13 HMA3 ' A' ' 83' ' ' HEM . 17.3 mt -65.77 -46.47 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.805 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.686 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -74.12 -13.37 60.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 77' ' ' TRP . 89.2 p -102.29 -5.97 23.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.528 ' HB3' HG23 ' A' ' 18' ' ' ILE . 11.0 mm-40 -39.2 -46.39 1.48 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.0 110.736 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 4.8 tttt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.096 -1.002 . . . . 0.0 110.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 1.037 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.253 0.549 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.503 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -77.07 142.0 68.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.945 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 2.7 Cg_endo -63.42 -29.1 71.55 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.507 1.267 . . . . 0.0 110.629 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 18.9 pt-20 -73.0 -33.64 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.527 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 4' ' ' GLU . 43.5 t -72.72 -46.69 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.346 -0.846 . . . . 0.0 109.944 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.761 ' C ' HD12 ' A' ' 6' ' ' LEU . 4.0 pp -73.58 -22.74 59.96 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.156 -0.965 . . . . 0.0 109.209 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -67.8 -40.96 83.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.571 -0.706 . . . . 0.0 109.28 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -42.76 71.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.818 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.9 m120 -63.08 -26.08 68.67 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.286 -0.884 . . . . 0.0 110.664 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 74.8 mmtt -92.96 -13.2 29.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.025 -1.047 . . . . 0.0 110.345 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.78 66.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.513 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 34.1 m -65.95 -15.09 62.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.961 -1.317 . . . . 0.0 110.515 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.1 mtp -99.26 10.88 40.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.119 -0.988 . . . . 0.0 110.332 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.55 -49.73 6.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.494 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 79.4 m -97.35 -17.84 19.5 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.402 -0.811 . . . . 0.0 110.702 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.627 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 13.2 m-70 -102.87 174.08 6.03 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.138 -0.976 . . . . 0.0 112.169 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -156.29 -170.24 3.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.432 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 28.1 mm -90.36 -62.49 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.72 -1.238 . . . . 0.0 110.272 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 26' ' ' ALA . 3.0 p30 -124.76 -3.18 7.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.925 -1.109 . . . . 0.0 110.613 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 17' ' ' ALA . 69.4 p -83.6 162.44 20.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.964 . . . . 0.0 110.157 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -107.91 91.76 3.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.1 -1.0 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 1.7 mtm -97.22 -132.18 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 109.696 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' O ' HMD3 ' A' ' 83' ' ' HEM . 72.8 t -69.64 -33.03 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.922 -1.111 . . . . 0.0 109.26 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.92 163.84 12.15 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.537 ' HG3' ' CB ' ' A' ' 56' ' ' TRP . 2.7 Cg_endo -63.8 142.74 83.96 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 O-C-N 123.706 1.372 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.901 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -46.02 153.72 0.29 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 1.7 m-85 -71.33 -60.74 2.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.705 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -48.0 -45.08 31.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.602 179.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.691 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 13.8 m-20 -55.44 -45.05 76.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.419 -0.8 . . . . 0.0 109.731 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 26' ' ' ALA . 87.6 t -55.43 -33.81 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 110.144 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -75.93 -37.66 58.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.392 -0.817 . . . . 0.0 110.511 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.63 -27.67 66.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.3 -0.875 . . . . 0.0 110.424 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -84.24 -41.06 17.31 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -0.882 . . . . 0.0 109.968 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 15.5 m-85 -88.59 -0.96 57.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.809 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -53.23 136.27 36.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.991 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.4 -35.24 5.19 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 3.2 mt-30 -54.02 129.04 32.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -1.16 . . . . 0.0 110.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 50.63 2.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.265 -0.897 . . . . 0.0 110.465 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.72 55.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.03 -23.29 21.51 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.254 -1.145 . . . . 0.0 110.141 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 42' ' ' ALA . 8.0 pt-20 -71.23 -25.78 62.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . -68.98 -51.39 39.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.927 . . . . 0.0 109.933 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 47' ' ' ARG . 4.9 t80 -72.29 -27.9 62.76 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.13 -0.981 . . . . 0.0 108.962 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.699 HD22 HMA2 ' A' ' 83' ' ' HEM . 21.4 mt -68.18 -26.94 66.0 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.08 -36.36 55.83 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.553 -0.717 . . . . 0.0 109.702 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.21 -26.66 59.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 110.082 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ ' ' A' ' 43' ' ' TYR . 1.2 mmt-85 -89.26 -17.55 28.78 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.703 HD11 HMA1 ' A' ' 83' ' ' HEM . 37.1 mt -85.33 -26.61 6.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -85.84 -16.22 39.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 110.272 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.6 t30 -130.93 -1.62 4.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.095 -1.003 . . . . 0.0 110.584 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 53.83 168.75 0.03 OUTLIER Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER 172.6 170.42 0.12 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.605 -1.526 . . . . 0.0 112.084 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -110.25 -175.63 2.78 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.406 -0.809 . . . . 0.0 109.804 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 71.01 23.92 77.63 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.851 HG12 ' CD1' ' A' ' 56' ' ' TRP . 34.1 t -105.89 -65.6 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.732 -0.864 . . . . 0.0 109.901 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.851 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.7 m95 -120.83 -37.59 2.97 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.27 -0.894 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.29 -174.56 25.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.537 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.74 6.72 1.2 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.504 1.469 . . . . 0.0 111.793 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.486 ' O ' HBD1 ' A' ' 83' ' ' HEM . 7.3 mt -107.85 81.92 1.3 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.758 -1.214 . . . . 0.0 110.301 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.6 Cg_exo -55.28 145.46 66.31 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.586 1.309 . . . . 0.0 111.295 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.541 ' O ' ' HA3' ' A' ' 51' ' ' GLY . 40.9 ttp -79.17 133.9 60.11 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.479 -0.763 . . . . 0.0 109.603 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.6 Cg_endo -67.56 138.23 45.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.517 1.272 . . . . 0.0 108.99 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.26 140.11 93.08 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.372 1.196 . . . . 0.0 110.16 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 5.3 m-80 -113.01 170.93 7.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.797 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.53 48.86 0.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.416 -0.803 . . . . 0.0 109.84 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 71' ' ' ALA . 11.2 m -101.56 107.45 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 110.107 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 66' ' ' VAL . 1.8 m -42.07 148.41 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.346 -0.847 . . . . 0.0 109.526 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 67' ' ' SER . 14.0 t0 -42.85 -37.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.993 -1.067 . . . . 0.0 110.734 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -64.93 -44.08 90.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.987 -1.071 . . . . 0.0 109.918 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 62.3 mt-10 -66.03 -46.64 77.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.355 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.829 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -69.61 -19.56 63.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.179 -0.951 . . . . 0.0 109.19 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -73.62 -44.32 57.34 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.8 m -70.53 -27.84 64.47 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.06 ' O ' HD12 ' A' ' 78' ' ' ILE . 47.3 mt -65.92 -43.28 88.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.584 -0.697 . . . . 0.0 109.249 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 41' ' ' GLU . . . -62.79 -45.94 90.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 80' ' ' SER . 5.7 mttm -65.53 -23.88 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 3' ' ' PRO . 30.9 t90 -72.32 -46.11 57.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.494 -0.753 . . . . 0.0 109.831 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.06 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.8 mp -59.59 -48.25 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.05 -22.68 61.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 109.846 179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 82' ' ' LYS . 12.4 m -84.83 -16.38 41.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.7 OUTLIER -45.07 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 80' ' ' SER . 9.8 tppt? . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.166 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.845 HBA2 HG11 ' A' ' 55' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.293 0.568 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.402 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 44.7 m-20 -77.6 164.54 57.29 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 110.285 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HB3' HG22 ' A' ' 73' ' ' THR . 3.2 Cg_exo -61.14 -43.59 28.61 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.805 1.424 . . . . 0.0 110.829 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -53.5 -45.9 69.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 109.433 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 66.0 t -55.52 -34.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.253 -0.904 . . . . 0.0 109.374 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 3' ' ' PRO . 62.5 mt -72.19 -30.27 64.8 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.605 0.717 . . . . 0.0 109.548 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 12' ' ' CYS . . . -66.87 -30.77 71.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.408 -0.807 . . . . 0.0 110.261 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -87.01 -43.73 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 110.385 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.4 m120 -66.4 -29.06 69.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.138 -0.976 . . . . 0.0 110.44 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 1.022 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 73.2 mmtt -96.15 -12.33 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.132 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.27 15.78 63.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.394 -1.083 . . . . 0.0 110.394 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.708 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 18.6 m -64.15 -21.75 66.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 0.0 110.073 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.429 ' CG ' ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -93.69 15.24 16.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 110.482 -179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.55 -31.68 10.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.937 . . . . 0.0 110.373 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 m -112.0 -16.94 12.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 110.798 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 34.8 m-70 -110.81 160.98 16.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.787 -1.195 . . . . 0.0 112.432 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.989 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -135.51 121.6 20.11 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.497 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 1.6 mp -38.65 -28.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 110.766 -178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -149.95 -32.1 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.205 -0.935 . . . . 0.0 111.11 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.989 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -68.9 -161.79 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.974 -1.079 . . . . 0.0 109.751 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.83 127.21 18.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.652 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.887 ' SD ' ' HB2' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -131.9 -100.54 0.29 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.71 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.9 t -90.93 -30.84 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.985 -1.072 . . . . 0.0 109.454 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.1 163.59 17.75 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 26' ' ' ALA . 3.0 Cg_exo -61.7 142.68 94.97 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.587 1.309 . . . . 0.0 110.584 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.955 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.24 147.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 109.894 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.726 ' CD1' HG23 ' A' ' 78' ' ' ILE . 2.7 m-85 -65.07 -61.48 2.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.056 -1.027 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -47.3 -48.07 25.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.048 . . . . 0.0 109.336 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.4 m-20 -54.81 -40.89 69.99 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.892 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 ' O ' ' A' ' 26' ' ' ALA . 98.7 t -55.97 -44.82 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 110.156 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -67.92 -30.1 69.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.16 -25.02 62.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.317 -0.864 . . . . 0.0 110.393 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -89.83 -37.33 14.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 110.221 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -93.63 -0.27 56.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.905 . . . . 0.0 110.145 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -54.09 106.98 0.22 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.428 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.54 76.86 0.88 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.591 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 1.9 mt-30 -145.85 167.96 21.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.59 42.85 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.55 46.0 0.59 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -63.12 -29.04 70.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -1.171 . . . . 0.0 110.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.82 -34.86 69.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.184 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -65.51 -51.16 61.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.302 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -67.6 -26.11 66.1 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.117 -0.99 . . . . 0.0 108.867 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 48' ' ' ILE . 13.5 mt -68.3 -25.26 65.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 42' ' ' ALA . . . -76.69 -40.28 49.33 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.648 -0.657 . . . . 0.0 109.559 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -76.34 -21.43 56.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.859 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 5.4 mmm180 -89.05 -19.78 25.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.541 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.849 HD11 HMA1 ' A' ' 83' ' ' HEM . 43.9 mt -84.98 -30.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.534 -0.729 . . . . 0.0 109.282 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' A' ' 66' ' ' VAL . 3.1 ttpm? -81.59 -25.94 35.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.489 -0.757 . . . . 0.0 110.172 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.584 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 1.1 m120 -119.41 -3.54 10.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 110.436 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 49.16 179.61 0.01 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.1 166.79 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 O-C-N 120.852 -1.381 . . . . 0.0 111.766 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -106.07 -175.82 2.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.394 -0.816 . . . . 0.0 109.792 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.23 19.88 76.17 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.85 HG12 ' CD1' ' A' ' 56' ' ' TRP . 17.2 t -96.87 -68.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.639 -0.918 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.85 ' CD1' HG12 ' A' ' 55' ' ' VAL . 96.3 m95 -117.57 -37.72 3.43 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.501 -0.75 . . . . 0.0 109.705 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.99 -172.24 21.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.547 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -69.73 8.04 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.438 1.426 . . . . 0.0 111.973 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.521 ' O ' ' CGD' ' A' ' 83' ' ' HEM . 10.1 mt -109.06 89.59 6.88 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.651 -1.281 . . . . 0.0 110.411 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.1 Cg_exo -59.95 145.4 98.42 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.551 1.29 . . . . 0.0 110.804 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.535 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 2.7 tmm? -79.04 131.89 65.26 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.509 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -65.83 134.4 37.41 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.683 1.359 . . . . 0.0 108.973 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.9 Cg_endo -58.43 135.16 65.99 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.208 1.11 . . . . 0.0 110.211 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.8 m-80 -106.65 161.9 14.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 0.0 110.472 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.9 43.66 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.334 -0.854 . . . . 0.0 110.087 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.61 HG21 HG22 ' A' ' 48' ' ' ILE . 16.7 m -96.64 114.76 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.462 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' VAL . 24.5 p -53.36 -171.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -76.84 -42.75 38.92 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.009 -1.057 . . . . 0.0 109.773 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 2.1 p30 -64.35 -36.76 85.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.262 -0.899 . . . . 0.0 109.304 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 51.6 mt-10 -69.08 -51.51 38.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.897 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -63.5 -18.13 63.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 109.214 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -47.98 49.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 3' ' ' PRO . 5.1 m -68.41 -24.13 64.71 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.897 HD12 ' HA ' ' A' ' 71' ' ' ALA . 88.7 mt -74.1 -34.51 63.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.613 -0.679 . . . . 0.0 109.349 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -72.27 -41.64 66.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.367 -0.833 . . . . 0.0 109.2 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 80' ' ' SER . 4.7 mttt -70.72 -26.8 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.459 -0.776 . . . . 0.0 109.058 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.602 ' CD2' ' OE1' ' A' ' 81' ' ' GLN . 35.8 t90 -71.84 -42.27 67.13 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.912 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.726 HG23 ' CD1' ' A' ' 27' ' ' TYR . 11.5 mt -65.35 -48.57 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.315 -0.865 . . . . 0.0 110.242 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.638 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -72.31 -16.05 61.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.579 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' ' C ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -117.94 10.42 13.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.136 -0.977 . . . . 0.0 110.574 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.602 ' OE1' ' CD2' ' A' ' 77' ' ' TRP . 4.0 mm100 -33.66 129.93 0.29 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.662 -0.649 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.5 tttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.146 179.849 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 1.022 HBB1 ' HB3' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.3 pt-20 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.236 0.541 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -81.05 153.63 72.28 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.194 -0.941 . . . . 0.0 110.141 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HB2' ' CD1' ' A' ' 77' ' ' TRP . 3.0 Cg_exo -60.38 -17.75 49.19 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.709 1.373 . . . . 0.0 110.355 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -70.53 -40.61 73.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.087 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 76.6 t -60.28 -54.69 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.429 -0.794 . . . . 0.0 110.003 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.4 pp -63.29 -32.48 73.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.881 . . . . 0.0 109.667 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.44 ' N ' ' HG ' ' A' ' 6' ' ' LEU . . . -65.39 -22.42 66.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.526 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -82.35 -50.74 8.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.421 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 5' ' ' VAL . 18.9 m-80 -63.86 -19.88 65.4 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.837 ' HE3' HG12 ' A' ' 66' ' ' VAL . 15.1 mmtt -85.04 -16.48 40.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.017 -1.052 . . . . 0.0 109.9 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.97 15.26 45.96 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 9.1 m -71.13 -48.67 50.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -1.213 . . . . 0.0 110.632 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 81.0 mmm -72.49 3.31 5.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 0.0 110.98 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.14 22.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 0.0 110.425 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 50.7 m -111.74 -18.43 12.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.629 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.6 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 19.2 m-70 -99.14 165.64 11.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 112.043 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.654 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -141.6 117.48 10.49 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.531 ' HA ' ' HB2' ' A' ' 27' ' ' TYR . 22.5 mm -36.2 -29.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.542 -0.724 . . . . 0.0 111.035 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 17' ' ' ALA . 12.9 t70 -161.04 18.04 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.158 -0.964 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.664 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -112.01 -177.73 3.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.042 . . . . 0.0 110.067 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -119.92 86.16 2.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 110.67 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.445 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 1.2 mtm -95.16 -112.93 0.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 0.0 109.686 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.503 HG12 HMD1 ' A' ' 83' ' ' HEM . 55.7 t -88.39 -29.41 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.793 -1.192 . . . . 0.0 109.585 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.09 170.35 15.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.604 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.9 Cg_endo -65.65 134.86 39.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.513 1.27 . . . . 0.0 110.326 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.938 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.47 146.77 0.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 16' ' ' HIS . 5.5 m-85 -57.52 -52.99 63.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.977 -1.077 . . . . 0.0 110.209 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.14 -50.63 58.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.978 -1.076 . . . . 0.0 109.421 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -56.39 -34.32 66.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.192 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 26' ' ' ALA . 60.1 t -62.64 -36.87 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 110.107 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.664 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -78.02 -24.42 47.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.93 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.3 -33.19 69.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.466 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -84.01 -35.51 23.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -90.72 -3.99 57.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.437 -0.789 . . . . 0.0 109.76 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -53.83 128.6 30.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.75 71.86 1.27 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.672 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -145.64 144.1 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.178 -1.19 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.82 46.73 1.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.88 . . . . 0.0 110.627 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.8 42.45 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -70.22 -21.0 63.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -1.126 . . . . 0.0 109.981 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.5 mp0 -74.04 -36.74 64.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.552 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -46.85 82.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.343 -0.848 . . . . 0.0 109.682 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.502 ' CE2' ' HG3' ' A' ' 47' ' ' ARG . 51.5 t80 -73.76 -27.54 61.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.224 -0.922 . . . . 0.0 109.265 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . 11.3 mt -71.52 -24.92 62.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 72' ' ' GLN . . . -79.83 -32.37 40.63 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -80.05 -24.32 40.79 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.44 -0.787 . . . . 0.0 109.182 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 43' ' ' TYR . 34.5 mmt-85 -90.03 -17.02 28.57 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.791 . . . . 0.0 109.088 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.94 HD11 HMA1 ' A' ' 83' ' ' HEM . 25.2 mt -88.53 -29.89 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -87.59 -16.93 33.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.116 -0.99 . . . . 0.0 109.722 179.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.585 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -120.09 -13.39 8.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 110.238 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 51.3 175.06 0.02 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 167.21 171.72 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.789 -1.418 . . . . 0.0 111.369 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.589 ' N ' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -107.63 -171.93 1.97 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.486 -0.759 . . . . 0.0 109.995 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.585 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 67.22 12.63 61.0 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.81 HG12 ' CD1' ' A' ' 56' ' ' TRP . 24.9 t -93.97 -59.14 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.544 -0.974 . . . . 0.0 109.507 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.81 ' CD1' HG12 ' A' ' 55' ' ' VAL . 97.0 m95 -120.79 -38.92 2.78 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.578 0.704 . . . . 0.0 109.521 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.94 -164.54 20.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 Cg_endo -69.7 7.47 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.47 1.447 . . . . 0.0 111.718 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.478 HG22 HMD3 ' A' ' 83' ' ' HEM . 15.4 mt -108.11 78.04 0.75 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.768 -1.207 . . . . 0.0 110.545 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HB3' ' N ' ' A' ' 53' ' ' GLN . 3.4 Cg_exo -56.63 140.11 89.52 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.605 ' HE2' ' NA ' ' A' ' 83' ' ' HEM . 0.8 OUTLIER -74.97 131.01 79.71 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.844 179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HG2' HBC2 ' A' ' 83' ' ' HEM . 2.7 Cg_endo -67.03 128.66 19.06 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.642 1.338 . . . . 0.0 109.607 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -58.65 135.89 70.32 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.379 1.2 . . . . 0.0 110.243 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -107.28 170.26 8.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.911 . . . . 0.0 110.878 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.41 35.18 0.81 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.386 -0.821 . . . . 0.0 109.645 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.837 HG12 ' HE3' ' A' ' 10' ' ' LYS . 34.9 m -86.31 105.0 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.51 -0.744 . . . . 0.0 110.151 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -42.41 153.76 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.383 -0.823 . . . . 0.0 109.251 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' OD1' ' HD3' ' A' ' 49' ' ' LYS . 3.3 m-20 -44.49 -37.57 3.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.705 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -41.28 90.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.021 -1.049 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 4.8 mm-40 -69.19 -36.99 77.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 0.0 110.666 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.524 ' HB2' HG23 ' A' ' 66' ' ' VAL . . . -73.6 -20.28 60.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -0.984 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 5.1 tt0 -76.34 -48.79 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -66.48 -25.78 66.87 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.958 HD13 HMB1 ' A' ' 83' ' ' HEM . 18.6 mt -71.14 -37.4 72.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.774 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -67.16 -53.07 33.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.519 -0.738 . . . . 0.0 109.434 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' CG ' ' HG2' ' A' ' 41' ' ' GLU . 0.0 OUTLIER -63.67 -26.29 68.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.113 -0.992 . . . . 0.0 108.928 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.594 ' CH2' ' CE2' ' A' ' 27' ' ' TYR . 28.0 t90 -64.89 -36.47 84.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.487 -0.758 . . . . 0.0 109.334 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.856 HD13 HMA3 ' A' ' 83' ' ' HEM . 12.1 mt -71.97 -46.49 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 109.625 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 75' ' ' ALA . 1.7 mp -68.65 -11.35 60.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.336 -0.852 . . . . 0.0 110.27 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 m -95.34 -12.29 26.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.493 ' NE2' ' NE1' ' A' ' 77' ' ' TRP . 64.7 mm-40 -61.83 -27.44 68.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.95 . . . . 0.0 110.179 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.133 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.958 HMB1 HD13 ' A' ' 74' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.71 ' HG2' HG11 ' A' ' 5' ' ' VAL . 1.1 mp0 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.208 0.527 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.69 169.48 0.18 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.201 -0.937 . . . . 0.0 110.194 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.716 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.1 Cg_exo -61.99 -22.33 74.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.778 1.41 . . . . 0.0 110.494 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -71.54 -35.53 70.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.122 -0.986 . . . . 0.0 108.965 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG11 ' HG2' ' A' ' 1' ' ' GLU . 3.8 t -64.91 -53.9 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.394 -0.816 . . . . 0.0 109.643 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.716 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.2 pp -68.61 -24.08 64.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.47 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -68.13 -29.02 67.83 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -39.5 19.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.773 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 2.2 m120 -62.39 -27.75 69.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.382 -0.824 . . . . 0.0 110.677 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.934 ' HB3' HBB1 ' A' ' 83' ' ' HEM . 0.1 OUTLIER -88.51 -17.86 29.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.105 . . . . 0.0 110.413 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.22 13.29 39.56 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.691 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 14.1 m -66.26 -41.06 90.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -1.205 . . . . 0.0 110.317 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.5 5.93 16.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.292 -0.88 . . . . 0.0 110.598 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.0 -26.51 16.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 110.569 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 m -112.45 -14.65 13.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.607 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 29.3 m-70 -111.88 158.33 19.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 111.824 -178.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.866 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -129.58 121.36 26.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.58 HG23 ' HB3' ' A' ' 81' ' ' GLN . 16.5 mt -39.73 -26.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.434 -0.791 . . . . 0.0 110.774 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -150.62 -35.34 0.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.956 -1.09 . . . . 0.0 111.01 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.866 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -69.06 -164.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.199 -0.938 . . . . 0.0 109.977 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -135.62 92.85 2.88 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 0.0 110.649 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -91.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.681 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.8 t -100.64 -45.91 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.924 . . . . 0.0 109.674 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.84 178.55 21.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HG3' ' CG ' ' A' ' 56' ' ' TRP . 2.8 Cg_endo -65.87 137.68 50.1 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.69 1.363 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.008 ' O ' HG23 ' A' ' 30' ' ' VAL . . . -43.07 151.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.662 ' HD1' HG23 ' A' ' 78' ' ' ILE . 3.3 m-85 -65.32 -59.4 4.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.5 ' CD ' ' HA ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -53.52 -45.13 69.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.004 -1.06 . . . . 0.0 109.756 179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 1.6 m-20 -57.71 -39.41 77.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 110.021 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 26' ' ' ALA . 72.2 t -57.98 -40.4 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 110.116 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 35' ' ' ALA . . . -72.06 -31.26 65.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 110.512 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.26 -29.21 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 110.169 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HD3' ' CZ3' ' A' ' 56' ' ' TRP . 0.2 OUTLIER -86.53 -48.86 8.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.492 ' CE1' ' CZ2' ' A' ' 56' ' ' TRP . 8.5 m-85 -73.34 -5.44 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -57.55 109.94 0.79 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -0.871 . . . . 0.0 110.233 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.16 -27.36 2.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 1.8 mt-30 -67.52 149.08 50.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -1.124 . . . . 0.0 110.178 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.27 52.61 2.55 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.47 50.17 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 37' ' ' GLN . . . -71.08 -25.48 62.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 110.042 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 75' ' ' ALA . 1.3 tt0 -67.02 -37.91 84.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.93 . . . . 0.0 109.65 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 -53.35 56.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.756 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.514 ' OH ' ' NE ' ' A' ' 47' ' ' ARG . 6.4 t80 -66.24 -24.15 66.54 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 109.086 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.726 HD22 HMA2 ' A' ' 83' ' ' HEM . 13.9 mt -69.44 -30.31 68.21 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.12 67.42 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -77.07 -26.56 53.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.758 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' CE ' ' A' ' 61' ' ' MET . 4.0 mmt180 -89.77 -16.41 30.32 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.355 -0.841 . . . . 0.0 109.242 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.975 HD11 HMA1 ' A' ' 83' ' ' HEM . 31.2 mt -86.79 -28.15 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.73 -10.54 53.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 110.125 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -125.48 -15.18 6.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 110.486 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 61' ' ' MET . . . 56.69 161.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER 171.72 167.91 0.1 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.534 -1.568 . . . . 0.0 112.039 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.588 ' HB3' ' HB3' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -103.75 -172.38 2.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.572 -0.705 . . . . 0.0 109.983 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 68.16 19.9 72.54 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.768 HG11 ' CGA' ' A' ' 83' ' ' HEM . 3.0 t -98.53 -68.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.794 -0.827 . . . . 0.0 109.631 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.642 ' CZ2' HG13 ' A' ' 30' ' ' VAL . 83.0 m95 -116.45 -36.54 3.96 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.39 -0.819 . . . . 0.0 109.497 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -160.07 -166.48 19.01 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.529 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -71.29 15.26 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.405 1.403 . . . . 0.0 112.106 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 59' ' ' ILE . 5.4 mt -111.48 84.65 5.15 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.542 -1.349 . . . . 0.0 110.41 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 3.5 Cg_exo -60.81 134.69 55.22 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.648 1.341 . . . . 0.0 110.959 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.577 ' SD ' ' NA ' ' A' ' 83' ' ' HEM . 52.5 ttp -75.37 133.72 74.24 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.335 -0.853 . . . . 0.0 110.166 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 61' ' ' MET . 2.6 Cg_endo -69.69 134.2 27.57 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.521 1.274 . . . . 0.0 109.146 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.2 Cg_exo -58.17 142.65 97.31 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.202 1.107 . . . . 0.0 110.234 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -112.83 -174.8 2.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.902 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.31 34.17 5.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.967 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.731 ' CG2' ' HB2' ' A' ' 71' ' ' ALA . 7.8 m -74.28 118.74 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.344 -0.848 . . . . 0.0 109.768 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.468 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -43.45 159.81 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 0.0 108.996 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -53.24 -50.22 65.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.878 -1.139 . . . . 0.0 110.442 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -21.87 66.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.482 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 26.6 mm-40 -76.36 -40.13 52.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.917 . . . . 0.0 110.321 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB2' ' CG2' ' A' ' 66' ' ' VAL . . . -71.75 -26.1 62.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.148 -0.97 . . . . 0.0 109.053 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -68.85 -44.17 73.9 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -71.67 -24.42 61.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.707 HD22 ' CMB' ' A' ' 83' ' ' HEM . 38.5 mt -73.46 -33.13 64.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.281 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 78' ' ' ILE . . . -73.73 -50.73 19.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.407 -0.808 . . . . 0.0 109.139 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -26.94 68.63 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.36 -0.837 . . . . 0.0 109.044 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.461 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 40.6 t90 -68.72 -44.15 74.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.806 HD13 HMA3 ' A' ' 83' ' ' HEM . 20.8 mt -56.99 -51.86 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.862 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -67.43 -21.74 65.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -77.75 -23.56 49.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.58 ' HB3' HG23 ' A' ' 18' ' ' ILE . 36.1 mm-40 -49.94 -177.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.161 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.5 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.089 -1.007 . . . . 0.0 110.336 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 0.975 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.297 0.57 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.42 159.96 78.61 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 110.222 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.719 ' HA ' HD21 ' A' ' 6' ' ' LEU . 3.0 Cg_exo -60.75 -23.58 76.71 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.676 1.356 . . . . 0.0 110.664 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' CG ' ' N ' ' A' ' 5' ' ' VAL . 12.7 pt-20 -68.23 -37.11 80.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.13 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 4' ' ' GLU . 59.9 t -64.97 -55.77 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.506 -0.746 . . . . 0.0 109.96 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.719 HD21 ' HA ' ' A' ' 3' ' ' PRO . 4.0 pp -66.8 -21.89 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.599 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . -62.54 -47.89 81.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.504 -0.747 . . . . 0.0 109.526 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -40.87 80.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.447 -0.783 . . . . 0.0 109.835 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.513 ' ND2' ' N ' ' A' ' 9' ' ' ASN . 1.7 m120 -65.52 -19.85 66.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.812 . . . . 0.0 110.645 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' HE2' ' OE1' ' A' ' 70' ' ' GLU . 50.9 mmtt -96.93 -19.69 18.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.058 -1.026 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.63 11.74 54.83 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.63 ' N ' ' HAB' ' A' ' 83' ' ' HEM . 37.6 m -67.2 -29.71 69.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.014 -1.286 . . . . 0.0 110.141 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mtp -84.8 7.77 19.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.24 -49.49 10.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 110.391 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.6 m -102.9 -19.45 14.64 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.318 -0.864 . . . . 0.0 110.979 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.636 ' NE2' ' NA ' ' A' ' 83' ' ' HEM . 14.5 m-70 -101.61 173.71 6.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.837 -1.164 . . . . 0.0 112.069 -178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 27' ' ' TYR . . . -153.84 -168.19 2.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 81' ' ' GLN . 19.2 mm -90.27 -73.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.677 -1.264 . . . . 0.0 110.373 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' HB3' ' HG2' ' A' ' 28' ' ' LYS . 17.2 p30 -116.03 -1.2 12.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.859 -1.151 . . . . 0.0 110.572 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.451 HG23 ' OD1' ' A' ' 19' ' ' ASP . 49.8 p -87.1 161.41 18.14 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 110.196 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.2 ttpp -105.96 85.85 2.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.115 -0.991 . . . . 0.0 110.651 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.415 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 1.5 mtm -88.54 -125.34 0.05 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 0.0 109.84 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 t -69.87 -39.46 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.757 -1.215 . . . . 0.0 109.649 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 173.35 14.91 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HD3' HBD1 ' A' ' 83' ' ' HEM . 2.8 Cg_endo -65.06 136.88 50.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.719 1.379 . . . . 0.0 110.554 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.742 ' HB3' ' OD2' ' A' ' 29' ' ' ASP . . . -42.81 154.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.661 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD2' ' O ' ' A' ' 17' ' ' ALA . 1.4 m-85 -70.11 -62.85 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.139 -0.975 . . . . 0.0 109.836 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -47.48 -33.01 5.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.976 -1.077 . . . . 0.0 109.392 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.742 ' OD2' ' HB3' ' A' ' 26' ' ' ALA . 7.2 m-20 -62.68 -46.65 87.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 109.59 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.593 ' HA ' ' CH2' ' A' ' 56' ' ' TRP . 49.9 t -57.43 -32.33 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.37 -0.831 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 79' ' ' LEU . . . -80.79 -24.37 38.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.467 -0.771 . . . . 0.0 110.082 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.53 -29.36 62.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.44 -40.22 12.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.303 -0.873 . . . . 0.0 110.098 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.47 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 23.3 m-85 -82.7 -7.04 59.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.307 -0.871 . . . . 0.0 109.88 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 31' ' ' ALA . . . -47.15 134.74 10.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.385 -0.822 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.08 44.21 5.73 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.482 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -122.58 138.38 54.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -1.138 . . . . 0.0 110.083 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 51.31 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 110.686 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.07 41.78 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.482 ' HB2' ' CB ' ' A' ' 37' ' ' GLN . . . -79.69 -23.29 42.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -1.226 . . . . 0.0 110.018 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.47 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -72.36 -36.47 68.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.509 179.381 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.65 -50.09 66.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 0.0 109.667 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -68.75 -28.07 66.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 48' ' ' ILE . 11.5 mt -68.67 -25.08 64.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.38 40.86 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.49 -0.756 . . . . 0.0 109.559 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -77.71 -28.03 50.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.866 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' HB3' ' CGA' ' A' ' 83' ' ' HEM . 0.2 OUTLIER -86.48 -20.24 28.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.366 -0.834 . . . . 0.0 109.25 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.02 HD11 HMA1 ' A' ' 83' ' ' HEM . 33.9 mt -84.79 -29.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.544 -0.722 . . . . 0.0 110.133 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HG3' HG23 ' A' ' 66' ' ' VAL . 13.3 mtpt -86.71 -17.16 34.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.062 -1.024 . . . . 0.0 110.133 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 63' ' ' PRO . 11.1 t-20 -119.0 -13.59 9.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.132 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . 50.33 174.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 0.5 OUTLIER 166.47 165.03 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.869 -1.371 . . . . 0.0 111.976 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.572 ' HG2' ' N ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -99.56 179.59 4.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.611 -0.681 . . . . 0.0 109.544 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . 70.82 16.15 74.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.872 HG11 ' CGA' ' A' ' 83' ' ' HEM . 3.1 t -91.95 -64.44 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.566 -0.961 . . . . 0.0 109.373 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.593 ' CH2' ' HA ' ' A' ' 30' ' ' VAL . 96.6 m95 -118.89 -36.66 3.38 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.609 0.719 . . . . 0.0 109.414 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.66 -165.11 15.22 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 Cg_endo -71.14 11.79 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.506 1.471 . . . . 0.0 112.138 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.512 HG22 HMD3 ' A' ' 83' ' ' HEM . 6.1 mt -110.98 88.97 8.87 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.547 -1.346 . . . . 0.0 111.038 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HB3' ' CB ' ' A' ' 53' ' ' GLN . 3.2 Cg_exo -62.38 132.29 37.8 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.645 1.34 . . . . 0.0 110.821 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.554 ' CE ' ' HA ' ' A' ' 48' ' ' ILE . 3.1 tmm? -75.19 129.43 82.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.022 -1.049 . . . . 0.0 109.843 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.419 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 2.7 Cg_endo -68.47 133.47 28.14 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.528 1.278 . . . . 0.0 108.884 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 50' ' ' ASN . 3.1 Cg_exo -57.59 140.85 94.7 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.206 1.108 . . . . 0.0 110.177 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 62' ' ' PRO . 3.1 m-80 -109.25 164.84 12.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.91 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.45 32.64 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -0.835 . . . . 0.0 109.832 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.475 ' O ' ' O ' ' A' ' 67' ' ' SER . 15.5 m -73.94 120.54 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.514 -0.741 . . . . 0.0 109.915 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 66' ' ' VAL . 7.4 t -47.4 175.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.813 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.46 -69.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -21.89 1.67 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 110.177 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -75.9 -48.39 21.54 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.855 ' HA ' HD12 ' A' ' 74' ' ' LEU . . . -68.2 -18.95 64.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 108.72 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -48.59 46.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -27.05 68.48 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.057 ' O ' HD12 ' A' ' 78' ' ' ILE . 41.3 mt -66.13 -44.41 84.31 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -61.23 -52.79 63.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.546 -0.721 . . . . 0.0 109.856 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HG2' ' HG3' ' A' ' 41' ' ' GLU . 1.1 mtpt -60.93 -19.52 60.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.576 ' CZ3' ' CE2' ' A' ' 27' ' ' TYR . 38.6 t90 -80.67 -41.31 23.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.469 -0.77 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.057 HD12 ' O ' ' A' ' 74' ' ' LEU . 1.6 mp -61.24 -52.16 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.936 . . . . 0.0 109.833 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -64.21 -23.95 67.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.003 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 81' ' ' GLN . 0.6 OUTLIER -74.09 -28.46 61.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.395 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.784 ' HG3' HD12 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -43.88 -53.65 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.105 -0.997 . . . . 0.0 110.277 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 81' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HEM . . . . . 1.02 HMA1 HD11 ' A' ' 48' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_